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"I found the task so truly arduous... that I was almost tempted to think... that the movement of 
the heart was only to be comprehended by God." 
 
Sir William Harvey, 
De motu Cordis, 1628 
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 Chapter 1 
Introduction 
The	  words	   of	   Jean-­‐Martin	  Charcot,	   the	  Father	   of	   Clinical	  Neurology,	   still	   resonate	  150	   years	   later,	  
when	  he	  spoke	  of	  a	  patient	  suffering	   from	  bulbar	  amyotrophic	   lateral	  sclerosis13:	   "Yes,	   the	  disease	  
that	  this	  man	  has	  is	  implacable...	  It's	  sad	  to	  say,	  but	  it's	  true.	  However,	  for	  the	  doctor,	  whether	  it's	  sad	  
or	  not,	  it's	  not	  the	  issue;	  the	  truth	  is	  the	  issue.	  Let	  the	  patient	  live	  in	  illusion	  to	  the	  end.	  That	  is	  fine.	  It's	  
humane	  and	  the	  best.	  But	  the	  doctor,	  is	  it	  his	  role	  to	  do	  the	  same?	  No,	  gentlemen,	  our	  responsibility	  is	  
otherwise.	  Let	  us	  keep	  looking,	  in	  spite	  of	  everything.	  Let	  us	  keep	  searching.	  It	  is	  indeed	  the	  best	  method	  
for	  finding,	  and	  perhaps	  thanks	  to	  our	  efforts,	  the	  verdict	  we	  will	  give	  this	  patient	  tomorrow	  will	  not	  be	  
the	  same	  as	  we	  must	  give	  him	  today15."	  
	  
These	   words	   haven’t	   lost	   their	   strong	   resonance,	   possibly	   because	   on	   one	   hand,	   Charcot	   was	   a	  
physician	  who	  understood	  the	  vulnerable	  nature	  of	  the	  human	  patient,	  the	  importance	  of	  protecting	  
the	   quality	   of	   life	   even	   in	   the	   progress	   of	   fatal	   pathologies	   and	   the	   preservation	   of	   hope	   in	   the	  
treatment	  of	  diseases.	  On	  the	  other	  hand,	  he	  was	  also	  a	  scientist,	  who	  accentuated	  the	  need	  for	  the	  
endless	  search	  of	  the	  truth,	  emphasized	  the	  power	  of	  the	  moral	  scientific	  method,	  as	  the	  only	  way	  for	  
the	  prevention,	  treatment	  and	  alleviation	  of	  suffering	  from	  diseases,	  which	  is	  perhaps	  humankind’s	  
greatest	  achievement.	  	  
	  
Since	   Charcot,	   the	   benefits	   of	   applying	   scientific	   thought	   to	   the	   practice	   of	   medicine	   have	   been	  
remarkable.	  For	  instance,	  the	  progress	  in	  the	  field	  of	  Infectious	  Diseases	  is	  enormously	  tangible	  at	  
the	   level	   of	   public	   health,	   such	   as	   the	   eradication	   of	   small	   pox	   worldwide	  with	   the	   last	   reported	  
spontaneous	   case	   in	   197917,	   and	   Polio	   from	   the	   Western	   Hemispheres	   around	   1990,	   after	   the	  
famous	   work	   of	   Salk	   in	   developing	   the	   oral	   vaccine18.	   The	   successful	   completion	   of	   the	   Human	  
Genome	  Project	   in	  200319	  is	  certainly	  another	  global	  scientific	  achievement	  in	  the	  field	  of	  Genetics.	  
Despite	  the	  innumerable	  advances	  that	  were	  made	  to	  improve	  life	  expectancy,	  predicting	  the	  pace	  
of	   scientific	   research	   in	   other	   multitudinous	   pathologies	   is	   highly	   uncertain.	   The	   diseases	   of	   the	  
heart	  are	  no	  exception.	  	  
	  
Scientific	  information,	  especially	  genetic	  and	  molecular,	  is	  in	  conspicuous	  expansion	  and	  the	  need	  to	  
translate	   this	   information	   into	   improved	   therapies	   is	   pivotal20.	   Over	   the	   last	   century,	   tools	   and	  
techniques	   in	   the	   exploration	   of	   the	   heart	   have	   undergone	   tremendous	   development;	   from	  
investigating	   its	   primary	   physiological	   output,	   i.e.	   its	   ability	   to	   pump	   blood	   rhythmically	   through	  
contraction	  and	  relaxation,	  to	  the	  comprehension	  of	  the	  cellular	  events	  and	  molecular	  mechanisms	  
and	  to	  the	  appreciation	  of	  the	  structure	  and	  function	  of	  the	  various	  proteins	  involved	  in	  leading	  up	  
to	  its	  almost	  perfect	  performance…	  or	  deterioration.	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The	   complexity	   in	   approaching	   cardiovascular	   physiology	   was	   nicely	   summarized	   by	   Berne	   and	  
Levy21,	  who	  wrote:	  “The	  precise	  mathematical	  expression	  of	  the	  pulsatile	  flow	  of	  blood	  through	  the	  
cardiovascular	  system	  is	   insuperable.	  The	  heart	   is	  a	  complicated	  pump	  and	  its	  behavior	   is	  affected	  
by	   a	   variety	   of	   physical	   and	   chemical	   factors.	   […]	   The	   blood	   itself	   is	   not	   a	   simple,	   homogeneous	  
solution	  but	   is	   instead	  a	  complex	  suspension	  of	   red,	  white	  corpuscles,	  platelets	  and	   lipid	  globules	  
dispersed	  in	  a	  colloidal	  solution	  of	  proteins.”	  Despite	  this	  inherent	  complexity	  of	  the	  cardiovascular	  
system,	   considerable	   knowledge	   was	   gathered	   starting	   from	   simple	   and	   elementary	   mechanical	  
principles,	   followed	   by	   an	   understanding	   of	   the	   electrophysiology	   underlying	   the	   mechanical	  
contraction22,	  which	  contributed	  significantly	  to	  the	  prolongation	  of	  life	  expectancy	  of	  patients	  with	  
cardiovascular	  diseases.	  	  
	  
In	  1913,	  Sir	  James	  Mackenzie	  described	  angina	  pectorisi	  in	  his	  Diseases	  of	  the	  Heart23	  as	  caused	  by	  a	  
nervous	  irritation,	  where	  patients	  are	  prone	  to	  die	  “during	  a	  faint”24.	  The	  work	  of	  Einthoven	  in	  1895	  
offered	   the	   possibility	   to	   record	   and	   interpret	   the	   electrocardiogram25,	   which	   gave	   cardiac	  
symptoms	  an	  electrocardiographic	  component.	  Several	  reports	  in	  the	  recent	  decades	  confirmed	  the	  
higher	  probability	  of	  cardiac	  electrical	  disturbances,	  or	  arrhythmias,	  occurring	  in	  the	  15-­‐30min	  post	  
an	  acute	  ischemic	  event,	  which	  are	  mainly	  due	  to	  abnormal	  automaticity26	  (See	  section	  1.3.5).	  	  Mines	  
hypothesized	  about	  the	  origin	  of	  arrhythmias	  as	  early	  as	  1914,	  and	  attributed	  them	  to	  a	  reentry	  (See	  
section	  1.3.7)	  mechanism27,	  an	  excitation	  with	  a	  predilection	  to	  travel	  in	  rings	  of	  tissue.	  He	  based	  his	  
hypothesis	   on	  Mayer’s	   observation	   of	   the	  Cassiopea	   xamachana	   almost	   a	   decade	   earlier,	  where	   a	  
contraction	  wave	  traveled	  endlessly	  in	  circles	  secondary	  to	  a	  point	  stimulus	  on	  the	  jellyfish	  tissue28.	  
Mayer	  recognized	  important	  parameters	  that	  facilitate	  the	  sustenance	  of	  reentry29:	  the	  path	  length	  
or	  the	  wavelength,	  the	  conduction	  velocity	  (CV)	  and	  the	  refractory	  period	  (RP),	  which	  he	  referred	  to	  
as	  “the	  time	  needed	  for	  the	  tissue	  to	  rest”.	  The	  work	  of	  Mines	  on	  the	  amphibian	  heart	  contributed	  
significantly	   to	   the	   development	   of	   the	   concept	   of	   reentry,	   by	   emphasizing	   on	   the	   importance	   of	  
conduction	   slowing	   in	   such	   a	   mechanism.	   He	   recognized	   that	   if	   the	   impulse	   was	   conducted	   too	  
rapidly	  around	  the	  ring	  in	  one	  direction,	  it	  would	  return	  to	  its	  original	  point	  of	  initiation	  before	  the	  
tissue	   has	   recovered	   from	   the	   previous	   excitation.	  Whereas,	   if	   the	   conduction	   is	   slowed	   and	   the	  
refractory	  period	   shorter,	   by	   the	   time	   the	   impulse	   returns	   to	   its	   initial	   position,	   the	   tissue	  would	  
have	  regained	  excitability	  and	  the	  impulse	  will	  circulate	  endlessly27.	  It	  was	  the	  work	  of	  Janse	  et	  al.	  in	  
1980,	  which	  provided	  evidence	  that	  the	  sequence	  of	  activation	  of	  the	  ectopic	  beats	  and	  the	  flow	  of	  
injury	  currents	  at	  the	  borders	  between	  the	  ischemic	  and	  healthy	  myocardium	  reinforced	  a	  reentrant	  
mechanism30	  at	   the	  early	   stages	  after	   coronary	  occlusion,	  which	  could	   facilitate	   the	  occurrence	  of	  
fatal	  cardiac	  rhythm	  abnormalities,	  such	  as	  ventricular	  fibrillation	  (V-­‐Fib).	  	  
	  
V-­‐Fib	   is	  a	   fatal	  arrhythmia	  that	   involves	  the	  bulk	  cardiac	  tissue.	  On	  an	  ECGii,	  V-­‐Fib	   is	  diagnosed	  as	  
“aperiodic	  electrical	  complexes	  with	  irregular	  beat-­‐to-­‐beat	  changes	  in	  amplitude	  and	  morphology”31.	  
During	  V-­‐Fib,	  the	  ventricular	  rate	  is	  extremely	  fast	  (>500bpm),	  in	  consequence	  the	  cardiac	  pumping	  
function	   is	   compromised	   and	   death	   ensues	   in	   several	  minutes32.	   Terminating	   such	   lethal	   cardiac	  
activity	  with	  a	  high-­‐energy	  shock	  was	  made	  possible	  in	  1961,	  after	  the	  introduction	  of	  the	  external	  
defibrillator33	  in	  specialized	  cardiac	  care	  units.	  Better	  understanding	  of	  the	  sequential	  activation	  of	  
proteins,	  cardiac	  ion	  channels,	  involved	  in	  the	  initiation,	  sustenance	  and	  propagation	  of	  the	  electrical	  
impulse,	  action	  potential	  (AP),	  played	  a	  major	  role	  in	  the	  development	  antiarrhythmic	  drugs	  (AADs).	  
In	   early	   1970s,	   antiarrhythmic	   cardiac	   surgery	   and	   electrophysiological	   interventions	   using	  
catheter	   ablation	  became	   the	   second	   line	   treatment	   in	  patients	  with	  drug-­‐refractory	   arrhythmias.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
i	  Angina	  pectoris	  -­‐commonly	  referred	  to	  as	  angina-­‐	  is	  chest	  discomfort	  due	  to	  poor	  blood	  flow	  through	  the	  blood	  vessels	  in	  
the	   heart,	   or	  myocardial	   ischemia.	   Infarction	   –or	   scarring-­‐	  would	   eventually	   follow,	   if	   no	   interventional	   procedure	  was	  
performed	  to	  reopen	  the	  closed	  artery	  and	  reperfuse	  the	  ischemic	  tissue.	  	  
ii	   The	   ECG	   (acronym	   for	   electrocardiogram)	   is	   a	   tracing	   that	   represents	   the	   heart's	   electrical	   activity	   derived	   by	  
amplification	  of	  the	  minutely	  small	  electrical	  impulses	  normally	  generated	  by	  the	  heart.	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The	   implantable	  cardioverter	  defibrillator	   (ICD)	  offered	  a	  major	  contribution	   in	  prolonging	  the	   life	  
expectancy	  of	  patients	  susceptible	   to	  spontaneous	  V-­‐Fib	  and	  sudden	  cardiac	  death	   (SCD)	  since	   its	  
application34	   to	   humans	   starting	   1980.	   Despite	   these	   leading	   advances	   in	   cardiology	   and	  
electrophysiology	   in	   terms	  of	  diagnosis,	   treatment	  and	  prevention,	  SCD	  remains	   the	  most	  difficult	  
problem	   to	   overcome	   for	   clinicians	   and	   basic	   medical	   scientists	   alike,	   with	   more	   than	   300,000	  
deaths	   annually	   in	   the	  US	  alone35.	   Prevention	   remains	   inadequate	   and	   treatment	   suboptimal.	  The	  
efficacy	  of	  antiarrhythmic	  therapy	  has	  failed	  to	  show	  commensurate	  control32,	  except	  in	  particular	  
non-­‐fatal	  settings,	  and	  proarrhythmiaiii	  prevails	  as	  the	  major	  side	  effect	  of	  antiarrhythmic	  therapy36,	  
37.	  This	  in	  itself	  is	  a	  sufficient	  rationale	  for	  research	  in	  cardiac	  electrophysiology38.	  	  
	  
With	   improvement	   of	   management	   in	   the	   setting	   of	   acute	   coronary	   syndromes,	   patients	   are	  
increasingly	   surviving	   the	  acute	  event.	  These	  patients	  are	  presenting	  a	   few	  years	   later	  with	  more	  
chronic	  pathologies	   and	   complications	   that	   issue	   from	  cardiac	   remodeling	   secondary	   to	   ischemia,	  
such	   as	   heart	   failure,	   which	   poses	   an	   increasing	   problem	   for	   global	   healthcare	   systems39	   in	   the	  
Western	  Hemisphere	  due	  to	  repetitive,	  costly	  and	  prolonged	  hospitalizations.	  	  Currently,	  more	  than	  
14	  million	  people	  in	  Europe	  suffer	  from	  heart	  failure	  and	  this	  number	  is	  forecast	  to	  reach	  30	  million	  
by	  the	  year	  202038,	  50%	  of	  whom	  will	  die	  from	  an	  arrhythmic	  event40.	  	  
	  
Unfortunately,	   the	   electrophysiological	   ward	   is	   no	   longer	   restricted	   to	   the	   older	   population	  
presented	   above,	   it	   also	   includes	   a	  much	   younger	   population	   of	  apparently	   healthy	   individuals	   at	  
risk	  of	  SCD41,	  where	  up	  to	  50%	  of	  cases,	  sudden	  death	  is	  the	  first	  and	  only	  clinical	  manifestation	  of	  
an	  inherited	  cardiac	  disease	  that	  had	  remained	  undetected	  by	  conventional	  clinical	  investigations42.	  
During	  the	  last	  two	  decades,	  considerable	  progress	  has	  been	  made	  in	  the	  identification	  of	  new	  genes	  
associated	   with	   monogenic	   hereditary	   arrhythmogenic	   syndromes,	   so	   called	   “channelopathies”43,	  
giving	   the	  opportunity	   to	  delineate	   their	  molecular	  pathogenesis	  and	   identify	  potential	   targets	   for	  
therapeutic	  interventions44.	  Multidisciplinary	  integrated	  type	  of	  research	  is	  necessary	  for	  achieving	  
such	   a	   target.	   Channelopathies	   remain	   an	   active	   area	   of	   research,	   because	   the	   relations	   between	  
electrophysiological	   changes	   in	   patients	  with	   hereditary	   or	   chronic	   cardiac	   diseases	   are	   often	   far	  
from	   clear.	   Identification	   of	   genetic	   mutations	   and	   their	   associated	   molecular	   abnormalities,	  
coupled	   to	   cellular	   electrophysiological	   studies	   are	   often	   hard	   to	   extrapolate	   to	   the	   level	   of	   the	  
organ42.	  Hence,	  functional	  electrophysiological	  studies	  at	  the	  organ	  level	  (such	  as	  optical	  mapping	  of	  
intact	   hearts)	   and	   biophysical	   modeling	   of	   the	   electrical	   activation	   are	   crucial	   for	   a	   complete	  
characterization	   of	   diseases45.	   Even	   with	   such	   a	   combined	   approach,	   a	   discrepancy	   could	   be	  
expected,	  when	  those	  findings	  are	  extrapolated	  to	  the	  level	  of	  the	  organism.	  
	  
The	  work	  of	  this	  thesis	  falls	  under	  integrative	  cardiac	  physiology	  (1.6).	  By	  using	  a	  multidisciplinary	  
approach,	  we	   investigate	  how	  targeting	   the	  cardiac	  Na-­‐channel	   (NaV1.5),	  whether	   through	  genetic	  
mutations	  or	  pharmacological	  interventions,	  can	  destabilize	  the	  normal	  electrical	  propagation	  in	  the	  
cardiac	   tissue.	   Detailed	   understanding	   of	   propagation	   instabilities	   in	   the	   whole	   heart	   has	   been	  
impeded	  by	  technical	  difficulties	  in	  mapping	  a	  beating	  organ;	  a	  particular	  challenging	  task	  in	  murine	  
electrophysiology,	  due	  to	  the	  small	  sized	  heart	  and	  very	  rapid	  heart	  rate.	  The	  strength	  of	  the	  work	  
done	   in	   this	   thesis	   is	   founded	   on	   the	   methodology	   used	   to	   directly	   investigate	   instabilities	   in	  
conduction	   and	   precisely	  measure	   the	   functional	   parameters	   at	   play.	   Using	   high	   spatial-­‐temporal	  
optical	  mapping,	  we	  characterize	  conduction	  abnormalities	  in	  the	  mouse	  heart,	  which	  is	  often	  used	  
as	   an	   in-­‐vitro	  model	   of	   different	   human	   cardiac	   pathologies.	   This	   technique	   is	   crucial	   for	   a	  more	  
precise	  and	  accurate	  description	  of	  macroscopic	  events	  occurring	  in	  the	  normal	  and	  abnormal	  heart,	  
leading	  to	  a	  better	  understanding	  of	  fundamental	  mechanisms	  involved	  in	  arrhythmogenesis.	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
iii	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  to	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  1.5	  for	  a	  detailed	  description	  of	  proarrhyhtmic	  effects.	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1.1. The Heart: An Electromechanical Pump 
Almost	  two	  century	  ago,	  Luigi	  Galvani,	  later	  known	  as	  the	  “father	  of	  animal	  electricity”	  laid	  down	  the	  
foundation	   of	   electrophysiology46	   by	   providing	   evidence	   for	   the	   electrical	   nature	   of	   the	   “fluid”,	  
previously	  referred	  to	  as	  the	  “animal	  spirit”,	   involved	  in	  nerve	  conduction	  and	  muscle	  contraction.	  
He	   conducted	   his	   crucial	   experiment	   on	   September	   1786,	   that	   was	   later	   published	   in	   the	  
Commentarius	   in	   1792,	   where	   he	   showed	   that	   a	   dead	   and	   “prepared”	   frog’s	   muscle	   elicited	  
spontaneous	   contractions	   upon	   joining	   the	   nerve	   and	   the	  muscular	   tissue	   with	   a	   metallic	   arc.	   It	  
wasn’t	   before	   1856,	   that	   Kölliker	   and	   Müller47	   demonstrated	   the	   presence	   of	   myocardial	  
depolarization	   and	   repolarization.	   Although	   the	   conducted	   experiment	   was	   not	   complicated,	   the	  
results	  were	  puzzling	  and	  hard	  to	  explain	  at	  the	  time.	  	  
1.1.1. The Functional Syncytium 
The	  circulatory	  system	  is	  designed	  to	  supply	  the	  body	  tissues	  with	  oxygen	  and	  nutrients	  in	  amounts	  
adequate	   with	   their	   metabolic	   requirements,	   and	   to	   remove	   carbon	   dioxide	   and	   other	   waste	  
products	  for	  excretion	  by	  the	  lungs	  and	  kidneys.	  This	  goal	  is	  achieved	  by	  electrical	  stimulation	  that	  
produces	   sequential	   ventricular	   emptying	   and	   filling.	   The	   heart	   is	   delicately	   designed	   in	   order	   to	  
function	   with	   optimal	   mechanical	   efficiency,	   determined	   by	   force	   vectors	   generated	   by	   each	  
sarcomere	   through	   active	   shortening	   and	   contraction.	   The	   cardiac	  myocytes	   are	   embedded	   in	   an	  
extracellular	   collagen	   matrix,	   chiefly	   made	   of	   fibroblasts,	   a	   scaffold	   responsible	   of	   maintaining	  
muscle	  fiber	  orientation,	  alignment,	  ventricular	  shape	  and	  size48.	  	  
	  
The	   heart	   is	   a	   four-­‐chambered	   organ	  made	   of	   two	   atria	   and	   two	   ventricles.	   These	   ventricles	   are	  
connected	  to	  the	  atria	  and	  to	  the	  major	  vessels	  through	  valves.	  The	  right	  atrium	  (RA)	  receives	  the	  
deoxygenated	  blood	  from	  the	  body	  via	  the	  superior	  and	  inferior	  vena	  cava,	  empties	  its	  content	  into	  
the	  right	  ventricle	  (RV),	  which	  ejects	  the	  blood	  directly	  into	  the	  pulmonary	  arteries.	  The	  blood	  once	  
oxygenated	   in	   the	   lungs	   returns	   to	   the	   left	   side	  of	   the	  heart	   via	   the	  pulmonary	  veins	   into	   the	   left	  
atrium.	  The	  opening	  of	  the	  mitral	  valve	  allows	  the	  conduit	  of	  blood	  into	  the	  left	  ventricle	  (LV),	  which	  
is	  then	  distributed	  back	  to	  the	  body	  tissues	  via	  the	  aorta.	  The	  coronary	  arteries,	  which	  branch	  from	  
the	   root	   of	   the	   aorta,	   supply	   the	  heart	  with	   blood	   via	   the	   coronary	   circulation.	   The	   atria	   are	   thin	  
walled,	  low-­‐pressure	  chambers	  that	  function	  mainly	  as	  reservoirs	  facilitating	  blood	  entry	  into	  their	  
respective	   ventricles.	   A	   continuum	  of	  muscle	   fibers,	   originating	   from	   the	   fibrous	   skeleton	   around	  
the	  aortic	  orifice,	  run	  toward	  the	  apex	  at	  the	  epicardial	  surface,	  then	  pass	  toward	  the	  endocardium	  
as	   they	  gradually	  undergo	  a	  180°	   shift	   rotation	   to	   lie	  parallel	   to	   the	  epicardial	   fibers,	   forming	   the	  
endocardium	  and	  papillary	  muscles49.	  
	  
At	   the	   apex	   the	   fibers	   twist	   and	   turn	   inward	   to	   form	  papillary	  muscles,	  whereas	   at	   the	   base	   and	  
around	  the	  valve	  orifices	  they	  form	  a	  thick	  and	  powerful	  muscle	  that	  not	  only	  decreases	  ventricular	  
circumference	   for	  ejection	  of	  blood	  but	  also	  narrows	   the	  atrioventricular	   valve	   orifices	   facilitating	  
valve	  closure21.	  Ventricular	  ejection	  is	  accomplished	  by	  a	  reduction	  in	  circumference	  in	  addition	  to	  
the	  decent	  of	  the	  base	  along	  the	  longitudinal	  axis	  (mainly	  the	  RV).	  The	  blood	  is	  propelled	  toward	  the	  
outflow	   tracts	   by	   an	   earlier	   contraction	   of	   the	   apex,	   coupled	   with	   an	   approximation	   of	   the	  
ventricular	  walls21.	  The	  RV	  of	  the	  adult	  human	  heart	  develops	  a	  mean	  pressure	  about	  one	  seventh	  
that	  developed	  by	  the	  LV,	  hence	  considerably	  thinner50.	  The	  heart	   lies	   in	  the	  middle	  mediastinum,	  
and	  is	  enclosed	  in	  the	  pericardial	  sac,	  a	  1mm-­‐thick	  layer	  of	  dense	  collagen	  that	  provides	  lubrication	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The	   sequential	   contraction	   and	   activation	   of	   atria	   and	   ventricle	   occur	   in	   each	   cardiac	   cycle:	   the	  
isovolumic	   contraction	   coincides	   with	   the	   abrupt	   rise	   in	   ventricular	   pressure	   on	   the	   pressure-­‐
volume	  curve52,	   known	  as	   the	  pre-­‐ejection	   tension.	   This	  phase	   is	   followed	  by	  a	   rapid	  and	   reduced	  
ejection,	   an	   isovolumic	   post-­‐ejection	   relaxation,	   characterized	   by	   a	   precipitous	   fall	   in	   ventricular	  
pressure	  that	  signals	  the	  beginning	  of	  ventricular	  diastole,	  which	  is	  followed	  by	  a	  rapid	  filling	  phase	  
and	   diastesis	   before	   the	   next	   cycle	   starts	   again.	   Major	   intrinsic	   mechanisms	   that	   influence	   the	  
cardiac	   pumping	   function	   are	   the	   Frank-­‐Starling	   effect53	   and	   the	   length-­‐dependent	   regulation	   of	  
stroke	   volumeiv54,	   as	   well	   as	   the	   treppe-­‐	   or	   Bowditch	   effect55	   (these	   mechanisms	   will	   not	   be	  
developed	   here,	   check	   references	   for	   more	   details).	   This	   description,	   although	   still	   considered	  
correct,	   adopts	   simple	   assumptions56	   regarding	   ventricular	   function:	   it	   implicitly	   suggests	   for	  
instance,	  that	  the	  cardiac	  muscle	  is	  homogeneous	  in	  such	  a	  way	  that	  all	  cardiac	  fibers	  contract	  and	  
relax	  simultaneously.	  It	  fails	  to	  recognize	  the	  complex	  multilayer	  muscle	  architecture	  underlying	  the	  
fairly	   heterogeneous	   contractile	   behavior,	   such	   as	   narrowing,	   twisting	   and	   regional	   myocardial	  
straining56.	  
1.1.2. The Electrical Conduction System 
The	  cardiac	  muscle	  generates	  propagating	  electrical	   impulses,	  action	  potentials	   or	  AP	   (Figure	  2a).	  
Hence	  it’s	  classified	  in	  the	  category	  of	  excitable	   tissues,	  together	  with	  skeletal	  muscles	  and	  nerves.	  
Additional	  intrinsic	  properties	  to	  the	  cardiac	  tissue	  are	  rhythmicity	  and	  automaticity,	  i.e.	  the	  ability	  
to	   regularly	   and	   spontaneously	   initiate	   APs.	   Under	   normal	   sinus	   rhythm,	   the	   propagating	  wave	   of	  
electrical	   excitation	   is	   initiated	   in	   the	  pacemaker	   cells	  of	   the	   sinoatrial	  node	   (SAN)	   situated	   in	   the	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
iv	  The	  stroke	  volume	   is	  defined	  as	  the	  volume	  of	  blood	  ejected	  from	  the	  LV	  per	  beat.	  The	  cardiac	  output	   is	  defined	  as	  the	  
volume	  of	  blood	  ejected	  from	  the	  LV	  in	  a	  minute.	  Hence	  the	  cardiac	  output	  is	  the	  product	  of	  stroke	  volume	  and	  heart	  rate	  
(beats/min)	  
Figure	  1.	  Heart	  Anatomy	  and	  Electrical	  
Conduction	  System.	  a.	  Dorsal	  aspect	  of	  
a	  human	  heart	   showing	  mainly	  LV1:	  1.	  
L.	   brachiocephalic	   vein.	   2.	   Pulmonary	  
trunk.	   3.	   Aorta.	   4.	   Pulmonary	   veins.	   5.	   L.	  
atrial	   appendage.	   6.	   L.	   anterior	  
descending	   artery.	   7.	   L.	   ventricular	   bulk	  
muscle.	   8.	   Apex.	   b.	   Heterogeneous	  
interior	   of	   LV	   muscle	   (endocardium)	  
showing	   several	   trabeculae	   and	   the	  
papillary	   muscles4.	   c.	   Main	  
components	   of	   electrical	   conduction	  
system5:	  9.	   Interatrial	  pathway.	  10.	  SAN.	  
11.	   Internodal	   pathway.	   12.	   His	   Bundle.	  
13.	   AVN.	   14.	   Right	   bundle	   branch.	   15.	  	  
Left	   bundle	  branch.	  Human	  heart	  weight	  
varies	  between	  300-­‐350g	  with	  apex-­‐base	  
distance	   ~110mm	   and	   the	   largest	  
transverse	  dimension	  ~75mm8.	  Pictures	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groove	  where	  the	  superior	  vena	  cava	  joins	  the	  RA57	  (Figure	  1c).	  From	  the	  SAN,	  the	  cardiac	  impulse	  
travels	  radially	  throughout	  the	  RA58	  along	  ordinary	  atrial	  cells	  at	  CV~1m.s-­‐1.	  A	  special	  pathway,	  the	  
anterior	  interatrial	  myocardial	  band	  (or	  Bachmann’s	  bundle)	  conducts	  the	  impulse	  from	  the	  SAN	  to	  
the	  left	  atrium.	  The	  impulse	  reaches	  the	  atrioventricular	  node	  (AVN),	  before	  gaining	  access	  to	  the	  His	  
Bundle,	   the	  specialized	  conducting	  system	  of	   the	  ventricles.	  Several	   features	  of	   the	  AV	  conduction	  
are	   of	   physiological	   and	   clinical	   significance59.	   The	   principal	   delay	   in	   the	   passage	   of	   the	   impulse	  
from	   the	   atria	   to	   the	   ventricles	   occurs	   in	   the	   AVN,	   allowing	   for	   optimal	   ventricular	   filling	   during	  
atrial	  contraction.	  The	  His	  Bundle	  passes	  subendocardially	  for	  about	  1cm	  and	  then	  divides	  into	  right	  
and	   left	   bundle	   branches.	   The	   left	   bundle	   further	   divides	   into	   thin	   anterior	   and	   thick	   posterior	  
divisions.	   The	   bundle	   branches	   ultimately	   subdivide	   into	   a	   complex	   network	   of	   fast	   conducting	  
Purkinje	   fibers60.	   The	   excitation	   travels	   through	   the	   bulk	   muscles	   almost	   coherently	   in	   a	   quasi-­‐
planar	  fashion,	  triggering	  cardiac	  contraction	  and	  synchronizing	  its	  blood	  pumping	  ability.	  
	  
The	  unique	  property	  of	  the	  cardiac	  muscle	  to	  initiate	  rhythmically	  its	  own	  contractions,	  a	  function	  
that	   is	   primarily	   associated	   with	   SAN	   cells,	   is	   known	   as	   the	   central	   dogma	   of	   automaticity.	   The	  
failure	   of	   the	   SAN	   to	   entrain	   the	   heart	   at	   the	   frequency	   of	   its	   pacemaker	   cells	   facilitates	   the	  
triggering	  of	  ectopic	  beats	  (secondary	  or	  accessory	  pacemakers),	  at	  slower	  rates	  than	  the	  SAN.	  The	  
rate	  of	  impulse	  initiation	  due	  to	  automaticity	  of	  cells	  in	  the	  SAN	  is	  sufficiently	  rapid	  that	  potentially	  
automatic	   cells	   elsewhere	   in	   the	   heart	   are	   excited	   by	   propagated	   impulses	   before	   they	   can	  
depolarize	  spontaneously	   to	   threshold	  potential61.	  This	   inhibition	   is	  called	  overdrive	  suppression62,	  
which	  means	  driving	  a	  pacemaker	  cell	  faster	  than	  its	  intrinsic	  spontaneous	  rate.	  A	  shift	  in	  the	  site	  of	  
impulse	  generation	  to	  a	  region	  other	  than	  the	  SAN	  would	  be	  expected	  to	  occur	  when	  the	  sinus	  rate	  
falls	  considerably	  below	  the	  intrinsic	  rate	  of	  the	  subsidiary	  pacemakers	  having	  the	  capabilities	  for	  
normal	   automaticity63.	   The	   sequence	   of	   accessory	   pacemakers	   starts	  with	   the	  AV	  nodal	   cells	   that	  
will	  fire	  at	  a	  rate	  <60bpm,	  followed	  by	  Purkinje	  fibers	  (at	  a	  rate	  <40bpm)64.	  The	  latter	  is	  considered	  
usually	   not	   sufficient	   to	   allow	   the	   heart	   to	   pump	   an	   adequate	   cardiac	   output.	   The	   Ionic	   Basis	   of	  
Electrical	  Activation	  is	  detailed	  in	  section	  1.1.4.	  
1.1.3.  Biophysics of Excitable Membranes  
The	  whole	  organ	  cardiac	  dynamics	  can	  be	  traced	  back	  to	  cellular	  events	  regulating	  intracellular	  ion	  
homeostasis65.	   Cells,	   by	   virtue	   of	   their	   compartmentalization,	   have	   intracellular	   and	   extracellular	  
environments	  with	  many	  vital	  biochemical	  processes	  taking	  place	  in	  or	  on	  membrane	  surfaces.	  For	  
cellular	   processes	   to	   run	   efficiently	   inside	   the	   cell,	   cells	   have	   developed	   the	   appropriate	   energy	  
producing	   tools	   (such	   as	   ATP	   hydrolysis)	   to	   use	   the	   chemistry	   of	   their	   environment	   to	   their	  
benefit66.	  Since	  ions	  cannot	  readily	  cross	  the	  lipid	  bilayer,	  cells	  make	  use	  of	  the	  gradient	  of	  electrical	  
energy	  as	  a	  key	  driving	  force	  in	  the	  movement	  of	  salt	  (therefore	  water),	  an	  essential	  element	  in	  the	  
signaling	   processes,	   and	   ultimately	   the	   basis	   of	   all	   cognitive	   processes67.	   Na-­‐K-­‐ATPase,	   a	  
ubiquitously	  expressed	  transmembrane	  protein,	  creates	  this	  gradient	  by	  hydrolyzing	  ATP,	  therefore	  
maintains	   the	   large	   outwardly	   directed	   K+	   gradient	   and	   large	   inwardly	   directed	   Na	   gradient,	   a	  
hallmark	   of	   all	   animal	   cells.	   Another	   physiological	   parameter	   that	   helps	   maintain	   this	   electrical	  
gradient	  is	  an	  intrinsic	  property	  of	  the	  bilayer:	  permselectivity68,	  which	  means	  that	  cell	  membranes	  
display	   different	   degrees	   of	   permeability	   to	   different	   ions	   establishing	   an	   uneven	   distribution	   of	  
ions	  across	  the	  membrane.	  Negatively	  charged,	  nonpermeant	  proteins	  present	  predominantly	  in	  the	  
intracellular	   compartment,	   are	   large	  molecular	  weight	   substances	   and	   therefore	   do	   not	   cross	   the	  
plasma	  membrane.	   In	   consequence,	   they	  will	   attract	   positively	   charged	   ions	   and	   repel	   negatively	  
charged	  ones.	  If	  diffusion	  of	  positive	  ions	  into	  the	  cell	  were	  indefinite,	  it	  would	  eventually	  alter	  ion,	  
volume	  and	  pH	  homeostasis,	  leading	  to	  cell	  destruction69.	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With	  all	   the	  above	  forces	  at	  play,	   the	  cell	  establishes	  a	  Gibbs-­‐Donnan	  equilibrium	  when	  the	  altered	  
distribution	  of	  cations	  and	  anions	  results	   in	  an	  electrochemical	  equilibrium	   for	   the	  major	  principal	  
ions	  moving	  in	  and	  out	  of	  the	  cell70.	  Under	  resting	  conditions,	  since	  the	  cardiac	  cell	  is	  categorized	  as	  
excitable,	  the	  plasma	  membrane	  is	  highly	  permeable	  to	  K+.	  The	  injection	  of	  a	  strong	  enough	  current	  
will	  cause	  the	  cardiac	  cell	  to	  respond	  by	  eliciting	  an	  AP,	  the	  result	  of	  sequential	  transient	  changes	  of	  
membrane	  permeability	  to	  the	  principal	  ions	  Na+,	  K+,	  Ca2+	  and	  Cl-­‐.	  The	  equilibrium	  potential	  for	  each	  
of	  the	  major	  3	  ions	  with	  a	  significant	  influence	  in	  bioelectrical	  phenomena	  (Ca2+	  to	  a	  certain	  extent	  
in	  heart	   tissues)	  and	   it	   approximates	  as	   the	   following:	  +62mV	   for	  Na+,	   -­‐94mV	   for	  K+,	  +120mV	   for	  
Ca2+	  and	  -­‐80mV	  for	  Cl-­‐.	  VEq	  of	  K+	  and	  Na+	  set	  boundary	  conditions	  for	  the	  electrical	  potentials	  across	  
the	  membrane.	   A	   cardiac	   tissue	   cannot	   normally	   be	  more	   negative	   than	   -­‐94mV	   or	  more	   positive	  
than	   +62mV,	   simply	   because	   there	   are	   no	   relevant	   chemical	   gradients	   that	   could	   produce	   larger	  
potential	   differences67.	   Any	   manipulation	   of	   the	   concentration	   gradients	   (experimentally	   or	  
pathologically)	  will	  ultimately	  affect	  the	  equilibrium	  potential	  of	  that	  particular	  ion.	  When	  multiple	  
permeating	   ions	  are	  at	  play,	   then	   the	  resulting	  resting	  membrane	  potential	  Vrmp	  can	  be	  calculated	  




	   	  is	  relative	  membrane	  permeability	  for	  that	  particular	  ion	   	  
	   	  is	  the	  concentration	  of	  the	  ion	  species	  inside	  and	  outside	  the	  cell	  	   	  
The	   permeability	   of	   the	   membrane	   to	   any	   of	   the	   ions	   can	   change	   dramatically	   upon	   changes	   in	  
membrane	   potential,	   by	   alterations	   in	   the	   conducting	   properties	   of	   voltage	   dependent	  
transmembrane	  pore-­‐forming	  proteins,	  known	  as	  channels.	  Any	  process	  that	  abruptly	  changes	  the	  
membrane	   potential	   beyond	   a	   critical	   value	   threshold	   (Vthres)	   will	   induce	   an	   AP	   capable	   of	  
propagation.	  Fundamental	  properties	  of	  excitable	  tissues	  can	  be	  summarized	  as	  follows:	  
a. The	  resting	  excitable	  state,	  where	  minor	  perturbations	  of	  the	  membrane	  potential	  will	  decay	  
without	  pushing	  the	  system	  toward	  the	  excited	  state.	  	  
b. Perturbations	  strong	  enough	  to	  cross	  Vthres	  will	  push	  the	  system	  to	  display	  a	  characteristic	  
transient	  behavior	  producing	  an	  AP,	  through	  a	  process	  called	  depolarization.	  	  
c. The	  system	  will	   return	   to	   its	   initial	   resting	  state	   through	  repolarization,	  during	  which	   two	  
particular	  divisions	  of	  time	  take	  place	  consecutively:	  the	  first	  where	  the	  system	  is	  absolutely	  
non-­‐excitable	   (effective	   refractory	   period-­‐RP);	   the	   second	   where	   it	   displays	   depressed	  
responses	  due	  to	  reduced	  excitability	  (relative	  RP)	  
1.1.4. Ionic Basis of Electrical Activation  
At	   the	   level	   of	   cardiac	   ventricular	   myocyte,	   the	   fast	   response	   is	   triggered	   by	   the	   activation	   of	  
voltage-­‐gated	  Na-­‐channels,	  Nav1.5.	  The	   rapid	   depolarization	   phase	   (phase	  0)	   is	   almost	   exclusively	  
mediated	  by	   the	  rush	  of	   the	  Na+	   ions	   into	   the	  cell,	  by	  virtue	  a	  sudden	  brief	   increase	   in	  membrane	  
permeability	   to	   Na+73.	   The	   detailed	   concerted	  mechanism	   of	   Nav1.5	   activation	   and	   inactivation	   is	  
thoroughly	   explained	   in	   section	   1.4.1.	   An	   important	   difference	   in	   the	   general	   morphology	   of	   the	  
cardiac	  AP,	  as	  compared	  to	  the	  skeletal	  and	  nervous	  AP,	  is	  a	  plateau	  (phase	  2)	  that	  separates	  the	  fast	  
depolarization	  from	  repolarization	  (phase	  3).	  The	  plateau	  is	  physiologically	  significant	  to	  allow	  for	  a	  
substantial	   enough	   increase	   of	   intracellular	   Ca2+	   to	   mediate	   contraction74.	   The	   durations	   of	   both	  
Phase	   2	   and	   3	   provide	   control	   of	   mechanical	   contraction,	   prevent	   premature	   arrhythmogenic	  
excitation	   and	   modulate	   AP	   time	   course	   and	   duration.	   This	   section	   will	   explore	   the	   ionic	  
mechanisms	   and	   cellular	   complexity	   involved	   in	   generating	   the	   ventricular	   AP,	   and	   the	  
electrophysiological	   heterogeneity	   that	   exists	   between	   different	   layers	   of	   the	   ventricular	   wall.	  







+[ ]in + pNa Na
+[ ]in + pCl Cl
"[ ]in
pK K
+[ ]out + pNa Na














12	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Chapter	  1	  Introduction	  
Figure	  2.	  Ventricular	  AP	  and	  ventricular	  myocyte.	  a.	  Membrane	  current	  generating	  a	  normal	  AP75.	  The	  5	  different	  
phases	  of	   the	  AP:	   resting	   (4),	   upstroke	   (0),	   early	   repolarization	   (1),	   plateau	   (2)	   and	   final	   repolarization	   (3).	   The	  major	  
inward	  INa,	   ICa	  and	  If	  currents	  are	  shown	  in	  yellow	  boxes.	  The	  outward	  currents	  are	  illustrated	  in	  grey	  boxes.	  The	  Na-­‐Ca	  
exchanger	   (NCX)	   pump	   is	   electrogenic:	   it	  mediates	   in-­‐/out-­‐ward	   currents.	   	   b.	   Cellular	  machinery	   at	  work:	   proteins,	  
intracellular	  organelles,	  ionic	  movement	  involved	  in	  excitation-­‐contraction	  coupling76.	  The	  ventricular	  cell	   is	  kept	  
at	  hyperpolarized	  state	  with	  the	  efflux	  of	   inward	  rectifier	  IK1	  current,	  and	  the	  Na-­‐K-­‐ATPase	  maintains	  the	  ionic	  gradient	  
across	  the	  membrane.	  The	  propagated	  action	  potential	  reaches	  the	  ventricular	  myocyte	  initially	  through	  ions	  that	  slowly	  
depolarize	   the	   membrane	   potential	   to	   threshold	   value,	   opening	   the	   Nav1.5,	   creating	   the	   upstroke	   and	   triggering	   the	  
opening	   of	   L-­‐Type	   voltage	   gated	   Ca-­‐channels	   (ICa,L)	   and	   K-­‐channels	   (IKur).	   During	   the	   plateau,	   CICR	   increases	   the	  
intracellular	   calcium	   almost	   100	   folds,	   via	   RyR2.	   Ca2+	   binds	   to	   troponin	   C,	   and	   initiates	   contraction.	   K+	   conductivity	  
increase	  ends	  the	  plateau	  phase	  (IKr,	  IKs)	  and	  initiates	  cellular	  relaxation,	  with	  synchronized	  reuptake	  of	  Ca2+	  into	  the	  SR	  
mainly	   via	   Ca-­‐pump	   and	   NCX.	   Phosphorylation	   of	   troponin	   I	   inhibits	   Ca2+-­‐binding	   to	   troponin	   C,	   which	   permits	  
tropomyosin	  blocking	  of	  acting-­‐myosin	  interacting	  site	  and	  sarcomere	  relaxation.	  Red	  stars	  corresponds	  to	  proteins	  when	  
mutates	   cause	   primary	   arrhythmia	   syndromes.	   Green	   stars	   correspond	   to	   multiple	   genes	   when	   involved	   cause	  
cardiomyopathies	  that	  often	  involved	  arrhythmia.	  Pictures	  taken	  from	  references	  as	  noted.	  
Ions	  channels	  that	  sequentially	  mediate	  the	  AP	  provide	  pathways	  of	  low	  resistance	  to	  the	  passage	  of	  
ionic	  species	  across	  the	  membrane.	  Unlike	  the	  Na-­‐K-­‐ATPase	  that	  hydrolyses	  ATP	  for	  ion	  transport	  
energy,	   the	   activated	   channels	   permit	   passive	   movement	   of	   ions,	   resulting	   in	   ion	   flux	   that	   is	  
characteristically	   rapid	   (107ions/s)77,	   78.	   By	   convention,	   inward	   currents	   are	   the	   equivalent	   to	   the	  
movement	  of	  positive	  charges	  into	  the	  intracellular	  milieu.	  Therefore,	  inward	  currents	  are	  generally	  
depolarizing	   currents79	   (fast	   inward	   INa	   in	   ventricular	   myocytes	   and	   ICa	   in	   nodal	   cells).	   The	  
movement	   of	   positive	   charges	   (carried	  mainly	   by	   K+)	   to	   the	   extracellular	  milieu	   defines	   outward	  
currents.	  IKs	  is	  the	  major	  outward	  current	  opposing	  the	  influx	  of	  Ca2+	  during	  the	  plateau80.	  Cl-­‐	  influx	  
into	  the	  cell	  is	  also	  considered,	  based	  on	  the	  previous	  definition,	  an	  outward	  repolarizing	  current.	  	  
	  
Ohmic	  currents	  obey	  Ohm’s	  law	  (∆Vmbr	  =	  IionR),	  which	  states	  that	  a	  current	  is	  linearly	  coupled	  to	  the	  
membrane	  voltage	  and	  the	  resistance	   is	  voltage-­‐	  and	  time-­‐independent81.	   IKs,	   the	  slowly	  activating	  
component	  of	  the	  IK	  current	  during	  repolarization	  displays	  ohmic	  properties.	  The	  rapid	  component	  
of	   the	   IK	   (IKr)	   displays	   rectification	   properties82,	   83.	   Rectification	   describes	   the	   dependence	   of	  
!"#"
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resistance	  on	  membrane	  voltage,	  with	  outward	  and	  inward	  characteristics84.	  Outward	  rectification	  
occurs	  when	  the	  membrane	  conducts	  an	  outward	  flow	  of	  current	  at	  voltages	  more	  positive	  than	  the	  
equilibrium	  potential	  of	  the	  ion	  VEq(ion),	  more	  easily	  than	  it	  does	  an	  inward	  one	  at	  potentials	  negative	  
to	   VEq(ion)71.	   Inward	   rectification	   involves	   easier	   conductance	   of	   an	   inward	   current	   at	   membrane	  
voltages	   negative	   to	   VEq(ion)	   ,	   than	   of	   an	   outward	   one	   at	   potentials	   positive	   to	   VEq(ion)84.	   The	  
rectification	   behavior	   was	   first	   described	   in	   skeletal	   muscles85	   and	   K+	   currents	   displaying	   this	  
property	  were	  originally	  known	  as	  anomalous	  currents,	  they	  were	  characteristically	  different	  from	  
the	   repolarizing	   K+	   current	   described	   in	   the	   giant	   squid	   axon	   by	   Hodgkin	   and	   Huxley86.	   Unlike	  
voltage-­‐gated	  K-­‐channels	  (Kv),	  channels	  with	  inward	  rectification	  properties	  (Kir2.x)	  do	  not	  depend	  
on	  Vmbr	  only,	  but	  also	  on	  the	  difference	  between	  Vmbr	  and	  VEq,K,	  as	  [K+]o	  is	  changed31,	  87.	  They	  play	  a	  
major	  role	   in	  maintenance	  of	   the	  Vrmp	  and	  control	  AP	  duration	  (APD),	   through	  their	  characteristic	  
gating	  kinetics80.	   In	   channels	  mediating	   IK1,	   the	  main	   gating	  particles	   are	   intracellular	  polyamines	  
and	  Mg2+,	   which	   are	   now	  widely	   accepted	   as	   the	   primary	  mechanism	   in	   the	   inward	   rectification	  
property	  of	  those	  channels88,	  89.	  	  	  
	  
o AP	  Upstroke	   (Phase	  0).	   During	   electrical	   diastole,	   Vrmp	   is	  maintained	   by	   IK1	   via	   inwardly	  
rectifying	  channels90.	  Voltage-­‐gated	  channels	  have	  charges	  or	  dipoles	  that	  sense	  changes	  in	  
membrane	   potential	   and	   respond	   with	   changes	   in	   conformation.	   These	   conformational	  
changes	   generate	   small	   currents,	   gating	   currents91	   that	   precede	   the	   voltage	   dependence	  
conductance.	  When	  Na+	   influx	   is	   strong	   enough	   to	   counteract	   the	   effects	   of	   K+	   efflux,	   Vmbr	  
slightly	   depolarizes	   to	  Vthres,	   increasing	   the	   opening	  probability	   of	  Nav1.592.	  Once	  Vthres	   (~-­‐
65mv)	  is	  reached,	  Na+	  membrane	  conductance	  abruptly	  rises,	  depolarizing	  the	  membrane	  to	  
~+30mV.	   The	   fast-­‐inward	   current	   (INa,i),	   mediated	   by	   Nav1.5,	   generates	   the	   AP	   upstroke,	  
then	  quickly	   inactivates.	  The	  rapidity	  of	  depolarization	  is	  responsible	   for	  the	  fast	  response	  
that	  will	  ensure	  whole	  myocardium	  depolarization	  in	  less	  than	  20ms,	  a	  nearly	  synchronous	  
excitation	   followed	  by	   contraction93.	  The	  maximum	  rate	  of	   rise	  of	   the	  upstroke	   (dV/dt)max	  
reflects	  non-­‐linearly	  the	  magnitude	  of	  the	  total	  fast-­‐inward	  current94.	  	  Purkinje	  fibers,	  which	  
have	   the	   highest	   (dV/dt)max	   ~750-­‐1000V/s95,	   also	   have	   the	   highest	   density	   of	   Nav1.5	  
channels	  than	  do	  ventricular	  myocytes	  with	  (dV/dt)max	  ~200-­‐300V/s.	  Factors	  that	  decrease	  
Nav1.5	   availability,	   decrease	   INa,i	   magnitude,	   hence	   expected	   to	   decrease	   (dV/dt)max96.	   In	  
pathological	   conditions,	   where	   Vrmp	   is	   set	   to	  more	   depolarized	   potentials,	   suprathreshold	  
stimuli	  will	  elicit	  depressed	  fast	  responses,	  due	  to	  lower	  availability	  of	  Nav1.5	  in	  their	  resting	  
excitable	   states.	   	   For	   instance,	   crushing	   injuries	   rapidly	   releases	   K+	   into	   the	   blood	   from	  
damaged	  tissues,	  increasing	  [K+]o	  from	  its	  lower	  value	  of	  ~4mMol	  (normally)	  to	  a	  few	  mmol	  
higher,	  which	  can	  have	  drastic	  effects	  on	  the	  Vrmp,	  as	  predicted	  by	  the	  Goldman	  (equation	  in	  
section	  1.1.3).	  In	  acute	  ischemia,	  Na-­‐K-­‐ATPase	  failure	  contributes	  to	  the	  increase	  in	  the	  [K+]o,	  
exacerbated	  by	  both	  the	  low	  [K+]o	  starting	  value	  and	  low	  interstitial	  fluid	  volume	  in	  confined	  
organs	  such	  as	   the	  heart97.	   If	  Vrmp	   is	  depolarized	   to	   -­‐55mV,	  almost	  all	  Nav1.5	  will	  not	  open	  
and	  the	  tissue	  is	  no	  longer	  excitable98.	  As	  discussed	  later	  in	  section	  1.3.6,	  (dV/dt)max	  and	  AP	  
amplitude	  are	  important	  determinants	  of	  CV	  throughout	  the	  myocardium99.	  
	  
o Early	  repolarization	  (Phase	  1).	  The	  AP	  upstroke	  is	  followed	  by	  a	  phase,	  which	  repolarizes	  
the	   membrane	   to	   ~+15mV.	   This	   rapid	   repolarization	   is	   mainly	   due	   to	   activation	   of	   the	  
transient	  outward	  K+	   current	   IK,to	   or	   Ito,1,	   the	   calcium	  dependent	   inward	  Cl-­‐	   current	   ICa.Cl	   or	  
Ito,2,	   and	   the	   time-­‐dependant	   inactivation	  of	  Nav1.5.	   	   Prominent	   Ito	   currents	  were	   recorded	  
from	   ventricular	   cells	   of	   many	   species,	   including	   mice,	   rabbits,	   dogs	   and	   humans100.	   A	  
notable	  exception	  is	  the	  guinea	  pig,	  where	  Ito	  is	  absent	  or	  practically	  non-­‐measurable	  101,	  102.	  	  
Ito,1	  is	  rapidly	  activating	  (time	  constant~10ms),	  calcium-­‐independent	  and	  displays	  outward	  
rectification	   properties7.	   It	   is	   further	   composed	   of	   at	   least	   two	   functionally	   different	  
components:	   fast	   Ito,f	   and	   slow	   Ito,s,	  which	  mainly	  differ	   in	   their	   inactivation	  kinetics.	  Their	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recovery	  time	  constants	  are	  on	  the	  order	  of	  tens	  of	  ms	  and	  thousands	  of	  ms,	  respectively.	  Ito,f	  
is	  the	  principal	  subtype	  expressed	  in	  the	  human	  atria,	  whereas	  the	  ventricles	  express	  both	  
types.	  Ito	  is	  more	  prominent	  in	  myocardial	  regions	  with	  shorter	  APD,	  such	  as	  the	  epicardium,	  
RV,	   and	   septum	   with	   a	   spike	   and	   dome	   configuration.	   In	   the	   endocardium,	   Ito	   is	   weakly	  
expressed	  and	  phase	  1	  is	  practically	  negligible103.	  Ito,f	  channels	  contribute	  significantly	  to	  the	  
rapid	  repolarization	  in	  murine	  ventricular	  myocytes104,	  a	  property	  deemed	  to	  be	  necessary	  
in	  order	  to	  maintain	  the	  very	  high	  resting	  heart	   frequency	  (>11Hz)	   in	   these	  animals105,	   106.	  
This	   electrical	   diversity	   arises	   from	   combined	   effects	   of	   spatial	   tissue	   gradients	   of	   gene	  
expression,	   biophysical	   channel	   gating	  mechanisms	   and	   second	  messenger	   systems107.	   α–
adrenergic	   stimulation	   reduces	   Ito	   in	   human	   myocytes	   through	   PKA-­‐dependent	  
phosphorylation.	   In	   heart	   failure,	   this	   current	   is	   also	   reduced	   and	   seems	   to	   be	   associated	  
with	  APD	  prolongation108.	  Ito,2,	  unlike	  Ito,1,	  is	  a	  calcium-­‐dependant	  Cl-­‐	  current	  and	  insensitive	  
to	  4-­‐aminopyridine109.	  The	  effects	  of	  Ito,2	  are	  variable:	  at	  positive	  membrane	  potentials,	  Cl-­‐	  is	  
driven	  into	  the	  cell	  by	  virtue	  of	  its	  electrostatic	  and	  diffusional	  forces,	  driving	  the	  membrane	  
potential	   to	   more	   negative	   values.	   Intracellular	   Ca2+	   homeostasis	   plays	   a	   key	   role	   in	  
determining	  the	  contribution	  of	   Ito,2	   to	  the	  total	   Ito	  repolarizing	  current,	  since	   its	  activation	  
correlates	  with	  Ca2+	  release	  from	  the	  sarcoplasmic	  reticulum	  (SR),	  which	  in	  turn	  is	  triggered	  
by	  the	  influx	  of	  Ca2+	  through	  L-­‐type	  channels110.	  
	  
o The	  plateau	  (Phase	  2).	  This	  phase	  reflects	  a	  delicate	  balance	  between	  inward	  and	  outward	  
currents.	  Inactivation	  of	  INa	  and	  significant	  decrease	  in	  IK1	  conductance	  increases	  membrane	  
resistance.	  If	  IK1	  conductance	  during	  phase	  2	  were	  equal	  to	  the	  one	  in	  phase	  4,	  the	  efflux	  of	  
K+	  would	   greatly	   exceed	   the	   influx	   of	   Ca2+	   and	   a	   plateau	   phase	  would	   be	   unsustainable21.	  
Opening	  of	  the	  voltage-­‐dependent	  calcium	  channels	  is	  reflected	  by	  a	  gradual	  increase	  in	  Ca2+	  
conductance,	   which	   immediately	   begins	   after	   the	   depolarizing	   upstroke.	   Two	   types	   of	  
transmembrane	   Ca2+	   channels	   co-­‐exist	   in	   the	   heart111.	   The	   less	   abundant	   T-­‐type	   (T	   for	  
transient)	  channels	  activate	  at	  Vmbr	  ~-­‐70mV,	  then	  inactivate	  very	  quickly.	  ICa,T	  is	  restricted	  to	  
pacemaker,	  atrial	  and	  Purkinje	  cells7.	  ICa,L	  (L	  for	  long	  lasting;	  L-­‐type	  channels	  are	  also	  known	  
as	  Dihydropyridine	  receptors	  or	  DHPR)	  is	  present	  in	  all	  cardiac	  cells	  and	  activates	  at	  more	  
positive	  potentials	   (~-­‐25mV).	   It	   provides	   a	   depolarizing	   inward	   current	   that	   supports	   the	  
AP	   plateau	   against	   the	   repolarizing	   outward	   K+	   currents.	   Even	  when	   it	   activates	  with	   the	  
upstroke,	  ICa,L	  reaches	  its	  peak	  value	  at	  a	  rate	  of	  two	  orders	  of	  magnitude	   less	   than	  the	  fast	  
inward	  INa.	  Hence	  its	  peak	  contribution	  to	  the	  rising	  upstroke	  is	  considered	  negligible112.	  At	  
depolarized	  potentials,	   the	   ICa,L	   recovers	   from	  inactivation	  very	  slowly	  (>100ms	  at	  0mV)77:	  
it’s	  the	  dome	  shape	  of	  the	  calcium	  curve	  that	  contributes	  to	  the	  maintenance	  of	  the	  plateau.	  
ICa,L	  inactivation	  is	  time-­‐,	  voltage-­‐	  and	  [Ca2+]i	  dependentv,	  the	  latter	  is	  by	  far	  predominant113.	  
The	  principal	   function	  of	   the	   ICa,L	   is	   triggering	  Ca2+	   release	   from	  the	  SR,	   to	  provide	  enough	  
intracellular	  free	  Ca2+	  for	  contraction	  to	  occur	  (See	  section	  1.1.5).	  ICa,L	  can	  be	  modulated	  by	  
various	   factors,	   hence	   influencing	   cardiac	   contractility.	   Cathecholamines	   interact	   with	   β-­‐
receptors,	  which	  increases	  intracellular	  cAMP,	  lead	  to	  an	  increase	  in	  ICa,L	  magnitude,	  without	  
affecting	  ICa,T.	  	  
	  
In	  addition	  to	  ICa,L,	  repolarization	  is	  delayed	  by	  two	  other	  inward	  Na-­‐mediated	  currents:	  INCX	  and	  the	  
late	  or	  persistent	  Na-­‐current	   INa.p.	  The	  Na-­‐Ca-­‐exchanger	  pump	  (NCX)	  contributes	  to	  the	  plateau	  by	  
generating	   a	   net	   inward	   Na-­‐current.	   By	   virtue	   of	   its	   stoichiometry	   (Na+:Ca2+	   =	   3:1)	   and	   its	  
electrogenicity,	  the	  direction	  of	  exchange	  adopted	  by	  the	  pump	  is	  coupled	  to	  combined	  VEq,NCX	  of	  the	  
involved	  ions	  and	  Vmbr114.	  At	  resting	  states,	  the	  VEq,NCX	  approximates	  to	  -­‐40mV,	  a	  more	  positive	  than	  
the	   Vmbr.	   Hence	   the	   pump	   operates	   in	   its	   direct	   mode,	   producing	   a	   net	   inward	   Na+	   current	   and	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extruding	   Ca2+.	   During	   the	   brief	   phase	   0	   and	   1,	   Vmbr	   is	   depolarized	   to	   positive	   values,	   exceeding	  
VEq,NCX	   ,	  which	   results	   in	   a	   brief	   outward	   current	  with	  NCX	  operating	   in	   the	   indirect	  mode114.	   The	  
increase	  in	  [Ca2+]i	  during	  phase	  2	  pushes	  the	  VEq,NCX	  to	  more	  positive	  values,	  reverting	  the	  pump	  to	  
the	  direct	  mode,	  thereby	  generating	  a	  net	  inward	  current115,	  116.	  	  
	  
In	   ventricular	   and	  Purkinje	   fibers,	   inactivation	  of	  Nav1.5	   is	   fast,	   however	  possibly	   incomplete93.	  A	  
relatively	  minuscule	  current	  (<0.5%	  of	  peak	  INa,i	  current117	  under	  normal	  conditions),	  known	  as	  the	  
window	  current,	  is	  present	  due	  to	  reactivation	  of	  a	  very	  small	  fraction	  of	  Nav1.5	  at	  fairly	  depolarized	  
potentials118.	  Under	  physiological	  conditions,	  this	  late	  current	  is	  restricted	  and	  confined	  to	  a	  narrow	  
range	   of	   voltages,	   with	   a	   hampered	   effect	   on	   the	   AP	   repolarization	   dynamics119.	   This	   positive	  
current	   flows	   at	   positive	   Vmbr,	   where	   the	   Hodgkin-­‐Huxley	   model	   predicted	   zero	   current.	   At	   the	  
molecular	  level,	  the	  fact	  that	  a	  population	  of	  Nav1.5	  is	  open	  in	  this	  voltage	  window,	  in	  the	  absence	  of	  
pathological	   conditions,	   implies	   the	   finite	   possibility	   that	   inactivation	   could	   be	   a	   reversible	  
process120,	   allowing	   channels	   to	   open	   after	   they	   have	   inactivated.	   However	   under	   pathological	  
conditions,	   the	   sodium	   current	   could	   become	   non-­‐inactivating	   or	   persistent	   (INa,p)	   and	   flows	  
throughout	  the	  AP121,	  122,	  lasting	  50-­‐100	  times	  longer	  than	  the	  upstroke	  time,	  which	  could	  contribute	  
substantially	   to	  Na	   loading	  during	  each	  cardiac	  cycle93.	  Under	  pathologically	  acquired	   (hypoxia123,	  
heart	  failure124)	  or	  congenital	  conditions125	  (such	  as	  Long	  QT	  Syndrome	  3	  or	  LQTS3vi),	  amplification	  
and	  sustenance	  of	  this	  current	  has	  been	  strongly	  implicated	  in	  arrhythmogenesis,	  particularly	  since	  
[Na+]i	   homeostasis	   is	   tightly	   coupled	   to	   Ca2+	   regulation126,	   127.	   Linkage	   between	   this	   sustained	  
current,	  AP	  prolongation	  and	  proarrhythmic	  activity	  has	  been	  validated	  in	  quantitative	  modeling128.	  
Increased	   [Na+]i	   has	   also	   been	   shown	   to	   augment	   a	  Na-­‐activated	  K-­‐current	   or	   IK(Na)	   and	   has	   been	  
suggested	   to	   affect	  APD	  under	   conditions	  of	   [Na+]i	   overload126,	   129.	   INa,K	   (the	  Na-­‐K-­‐ATPase	   current)	  
contributes	   slightly	   to	   the	   AP	   plateau	   by	   extruding	   Na+	   ions	   that	   entered	   the	   cell	   during	   the	  
upstroke,	  partly	  due	  to	  its	  voltage-­‐dependence	  property130.	  
	  
The	   delayed	   rectifier	   K+	   (IK)	   is	   generally	   considered	   the	   dominant	   outward	   current.	   The	   IK	  
conductance	  increases	  gradually	  throughout	  phase	  2131.	  As	  long	  as	  the	  efflux	  of	  K+	  is	  balanced	  by	  the	  
influx	  of	  Ca2+,	  the	  plateau	  persists.	  The	  three	  components	  of	  the	  IK	  (ultra	  rapid:	  IKur,	  rapid:	  IKr,	  slow:	  
IKs)	   activate	   slowly	   (compared	   to	   INa,i)	   over	   a	   range	   of	   several	   hundreds	   of	   ms,	   at	   voltages	   that	  
prevail	  toward	  the	  end	  of	  phase	  0132.	  Their	  deactivation	  is	  sufficiently	  slow	  that	  their	  contribution	  to	  
the	  AP	  is	  mainly	  in	  restoring	  repolarization	  and	  ending	  the	  plateau82.	  IKur	  ,	  highly	  expressed	  in	  atrial	  
cells	  (but	  not	  in	  ventricular	  or	  Purkinje	  fiber),	  is	  rapidly	  activating,	  non-­‐inactivating	  current	  and	  is	  
believed	   to	   shape	   the	   shorter	  APD	  duration	   in	   atrial	   cells133.	   IKr	   is	   the	   rapid	   delayed	   rectifier	   and	  
increases	  faster	  than	  IKs	  at	  the	  initial	  phase	  of	  the	  AP,	  however	  reaches	  a	  smaller	  magnitude	  (lower	  
peak	   current	   amplitude)	   than	   IKs,	   due	   to	   its	   inward	   rectification	   properties	   that	   prevail	   at	  
depolarized	  potentials.	   It’s	   heterogeneously	   expressed	   in	   the	  heart,	  with	  higher	  density	   in	   the	  LA	  
and	  endocardium134,	   135.	  As	   the	  membrane	  slowly	  repolarizes,	   IKr	   curve	  reaches	   its	   local	  maximum	  
due	   to	   decreased	   inward	   rectification.	   	   Compared	   with	   IKr,	   IKs	   increases	   slowly	   due	   to	   slower	  
activation	  kinetics.	  However,	  it	  reaches	  a	  higher	  peak	  than	  IKr	  during	  much	  of	  the	  plateau,	  due	  to	  its	  
linear	   (non-­‐rectifying)	   conductance,	   greater	   density	   of	   IKs	   channel	   in	   the	   membrane112,	   and	   its	  
dependence	   on	   [Ca2+]i	   increase	   via	   a	   calmodulinvii	   (CaM)	  modulating	   process132.	   It’s	   ubiquitously	  
expressed,	  however	  reduced	  in	  the	  midmyocardial	  cells,	  partly	  explaining	  their	  longest	  APD	  across	  
the	   myocardium134.	   IKs	   is	   the	   major	   repolarizing	   current	   that	   ends	   the	   plateau	   phase,	   before	   IK1	  
conductance	   takes	   over	   and	   initiates	   the	   final	   repolarization	   (mid	   phase	   3),	   restoring	   the	   resting	  
membrane	  potential	  (phase	  4).	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
vi	  Refer	  to	  section	  1.4.3	  
vii	  Refer	  to	  section	  1.1.5	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o Final	   repolarization	   (phase	   3)	   and	   restoration	   of	   Vrmp	   (phase	   4).	   As	   repolarization	  
proceeds,	   IK1	   channels,	   which	   were	   closed	   during	   phase	   2,	   are	   progressively	   reactivated,	  
peaking	   at	   the	   late	   rapid	   repolarization	   phase	   (mid	   phase	   3)	   and	   regenerating	   Vrmp136.	  
Modulation	   of	   IK1	   is	   likely	   to	   play	   a	   profound	   effect	   on	   cardiac	   excitability	   and	  
arrhythmogenesis,	   especially	   after	   its	   role	   has	   been	   highlighted	   in	   Andersen-­‐Tawil	  
syndrome137,	  a	  disease	  characterized	  by	  episodes	  of	  muscle	  weakness,	  dysmorphic	  features	  
and	  a	  prolonged	  QT	  interval	  on	  resting	  ECG.	  The	  strong	  inward	  rectification	  of	  IK1	  limits	  the	  
outward	  currents	  during	  phases	  0,1	  and	  2,	  therefore	  preventing	  a	  short-­‐circuit	  of	  the	  AP	  and	  
excessive	  loss	  of	  K+	  into	  the	  confined	  extracellular	  milieu84.	  	  The	  outward	  I/V	  relationship	  of	  
ventricular	   IK1	   is	   defined	   by	   an	   n-­‐shape	   curve	   with	   a	   negative	   conductance	   slope	   at	  
depolarized	   potentials90.	   The	   different	   IK1	   channel	   isoforms	   (Kir2.x)	   in	   the	   heart	   have	  
different	   rectification	   properties138,	   non-­‐homologous	   responses	   to	   changes	   in	   [K+]o139	   and	  
with	   an	   interesting	   heterogeneous	   distribution	   throughout	   the	   heart140:	   IK1	   channels	   are	  
almost	   non-­‐existent	   in	   nodal	   cells,	   whereas	   the	   IK1	   current	   density	   is	   6-­‐10	   higher	   in	   the	  
ventricles	  compared	  to	  the	  atria31,	  with	  a	  predominance	  of	  a	  stronger	  rectification	  behavior	  
in	   the	   RV	   vs.	   LV141.	   Such	   a	   high	   density	   of	   Kir2.x	   in	   the	   ventricles	   results	   in	   a	   faster	  
repolarization	  phase	  and	  a	  more	  hyperpolarized	  Vrmp.	  The	  latter	  has	  important	  physiological	  
consequences.	  First,	   it	  protects	  ventricular	  cells	   from	  pacemaker	  activity:	  SAN	  cells,	  which	  
lack	   Kir2.x	   channels,	   have	   a	   relatively	   depolarized	   Vrmp	   (~-­‐50mV	   in	   SAN	   vs.	   ~-­‐85mV	   in	  
ventricular	  cells),	  where	  small	   inward	  nonselective	  currents,	  known	  as	  the	  If	  current142,	   143,	  
are	   capable	   of	   slowly	   depolarizing	   the	   membrane	   to	   Vthres	   during	   diastole,	   maintaining	  
automaticity140.	   Second,	   it	   confers	  energetic	  efficiency	   in	  AP	  generation,	  by	  stabilizing	  Vrmp	  
and	   cellular	   input	   resistanceviii,	   preventing	   therefore	   depressed	   fast	   depolarization	   under	  
normal	  conditions144.	  	  
	  
Mechanism	  of	  automaticity.	   Pacemaker	  activity	   initiates	   and	   sustains	   electrical	   excitation	   in	   the	  
heart,	  independently	  of	  any	  central	  nervous	  system	  interference145.	  The	  intrinsic	  rhythmicity	  of	  SAN	  
cells	   is	  determined	  by	  an	  unstable	  diastolic	  membrane	  potential,	  which	  merges	  smoothly	  with	   the	  
depolarization	  upstroke.	   Phase	  4	   depolarization	   is	   thought	   to	   be	   generated	  by	   time-­‐	   and	   voltage-­‐
dependent	  currents	  (except	  for	  INa,b),	  where	  the	  net	  current	  must	  be	  inward:	  IK,	  delayed	  rectifier	  K-­‐
current	   activated	   during	   the	   preceding	   AP;	   INa,b,	   a	   background	   current	   carried	   predominantly	   by	  
Na+;	   If,	   a	   non-­‐selective	   hyperpolarization-­‐activated	   current;	   INCX,	   mediated	   by	   the	   NCX	   pump;	   ICa,	  
mediated	   by	   T-­‐	   and	   L-­‐type	   Ca-­‐channels146.	   	   The	   current	   dogma	   of	   automaticity	   suggests	   that	   the	  
basis	  of	  automaticity	   is	  primarily	  due	  to	  If,	  which	  is	  mainly	  activated	  at	  Vmbr	  negative	  to	  -­‐40mV.	  In	  
the	  preceding	  AP,	   IK	   is	  outward	  and	  contributes	  to	  repolarization,	   followed	  by	  Kv	  channels	  closure	  
and	  decrease	   in	  K-­‐conductance.	   If	   carries	  an	   inward	  current	   (Na+	  and	  K+;	  VEq~-­‐10mV)	   throughout	  
the	   range	   of	   pacemaker	   potential,	   and	   in	   the	   face	   of	   decreased	   K-­‐conductance,	   it	   accounts	   for	  
bringing	   Vmbr	   to	   threshold.	   ICa	   accelerates	   the	   rate	   of	   diastolic	   depolarization,	   generating	   the	  
upstroke.	   Most	   importantly,	   SAN	   cells	   are	   under	   parasympathetic	   control	   in	   terms	   of	   basal	   rate,	  
slowing	  the	  heart	  rate	  to	  60-­‐70bpm	  in	  humans.	  Ca2+	  seemed	  to	  be	  involved	  with	  pacemaker	  activity	  
in	  other	  ways.	  In	  2010,	  Lakatta	  et	  al.	  delineated	  in	  their	  landmark	  report	  the	  possibility	  of	  a	  coupled-­‐
clocks	   pacemaker	   system,	   involving	   Ca2+	   homeostasis	   and	   local	   Ca2+	   signaling	   in	   the	   SAN	   cells	  
rhythmicity	   regulation147.	   In	   their	  presented	   scheme,	   the	  membrane	   clock	   (M-­‐clock)	   that	   involves	  
the	  above-­‐described	  currents	  remains	  an	  integral	  part	  of	  the	  automaticity	  paradigm.	  However,	  they	  
integrated	   the	   rhythmic	   ryanodine	   receptor	   (RyR)	   -­‐generated	   subsarcolemmal	   local	   calcium	  
releases	   (LCR)	   as	   a	   Ca-­‐clock,	   which	   appears	   to	   be	   directly	   coupled	   to	   the	  M-­‐clock	   by	   regulating	  
[Ca2+]i.	  The	  details	  of	  this	  regulation	  are	  still	  to	  be	  elucidated,	  but	  the	  notion	  that	  Ca2+	  sequestration	  
and	  release	  of	  Ca2+	  from	  internal	  stores	  in	  SAN	  cells	  (similar	  to	  the	  effect	  seen	  in	  ventricular	  cells)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
viii	  Cellular	  input	  resistance	  is	  defined	  as	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  voltage	  range.	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regulates	   rhythmic	   cardiac	   excitation	   is	   believed	   to	   be	   an	   important	   advancement	   and	   a	   possible	  
shift	  of	  paradigms	  in	  this	  area148.	  	  
1.1.5.  Excitation-Contraction Coupling (ECC) 
The	  complex	  process	  of	  converting	  electrical	  signal	  to	  a	  mechanical	  contraction	  is	  termed	  ECC.	  It’s	  
closely	  coupled	  to	  a	  high-­‐energy	  turnover,	  offered	  by	  commensurate	  oxygen	  and	  nutrients	  supply	  to	  
the	   myocardium	   for	   an	   efficient	   functioning	   of	   its	   metabolic	   machinery	   (oxygen	   consumption	  
~0.1mL/g.min	  at	  basal	  rates149).	  The	  myocardium	  is	  an	  oxidative	  muscle	  (with	  the	  highest	  volume	  
density	   of	   mitochondria150	   in	   the	   body	   and	   estimated	   to	   be	   ~25.3%	   in	   humans151),	   expected	   to	  
perform	   for	   a	  whole	   lifetime	  without	   fatigue.	   For	   that,	   it’s	   endowed	  with	   a	   rich	   capillary	   supply,	  
about	   one	   capillary	   per	   fiber.	   Bidirectionally	   along	   the	   length	   of	   the	   fiber,	   electron	   micrographs	  
show	  deep	  invaginations	  of	  the	  sarcolemma	  into	  the	  fiber,	  known	  as	  transverse	  or	  T-­‐tubules	  (~200-­‐
300nm	  in	  diameter152,	   153).	   	  The	   lumina	  of	  T-­‐tubules	  are	  continuous	  with	  the	  bulk	   interstitial	   fluid,	  
and	  they	  play	  a	  role	  key	  in	  ECC	  (Figure	  2b	  and	  Figure	  3b).	  
	  
Striated	  muscles	   (skeletal	   and	   cardiac)	   have	   important	  morphological	   and	   functional	   differences.	  
However	   their	   basic	   functional	   unit-­‐	   the	   sarcomere,	   their	   contractile	   elements	   and	   the	   sliding-­‐
contraction	   mechanism	   are	   quite	   similar.	   A	   striking	   observation,	   when	   comparing	   cardiac	   and	  
skeletal	   tissues	   with	   a	   light-­‐microscope,	   is	   the	   semblance	   of	   a	   syncytium	   of	   cardiac	  muscle	   with	  
branching	  interconnecting	  fibers21,	  with	  the	  unique	  organization	  of	  myocyte-­‐myocyte	  contacts.	  Even	  
though	  the	  myocardium	  is	  far	  from	  being	  a	  true	  syncytium	  anatomically,	  the	  cardiac	  muscle	  behaves	  
as	  one,	  when	  an	  all-­‐or-­‐none	  depolarizing	  wave	  that	  is	  fast	  enough	  to	  cover	  the	  whole	  myocardium	  in	  
20ms93,	  is	  followed	  by	  a	  contraction	  of	  almost	  the	  entire	  myocardium.	  Skeletal	  and	  cardiac	  muscles	  
show	  similar	  length-­‐force	  relationship.	  The	  developed	  force	  is	  maximal	  when	  the	  muscle	  begins	  its	  
contractions	  at	  resting	  sarcomere	  length	  (2-­‐2.4µm),	  where	  there’s	  optimal	  overlap	  of	  thick	  and	  thin	  
filaments	  with	  maximal	  number	  of	  cross-­‐bridges154,	  155.	  In	  general,	  the	  length-­‐force	  relationship	  can	  
be	   extrapolated	   from	   the	   fiber	   to	   the	   level	   of	   the	   entire	  organ	  by	   substituting	  ventricular	   systolic	  
pressure	  for	  force	  and	  end-­‐diastolic	  ventricular	  volume	  for	  sarcomere	  length.	  In	  the	  normal	  heart,	  
the	  peak	  force	  might	  be	  attained	  at	  a	  filling	  pressure	  of	  12mmHg,	  which	  corresponds	  to	  a	  sarcomere	  
length	  of	  2.2μm21.	  
	  
Functional	   unit	   of	   contraction2.	   Sarcomeres	   span	   the	   area	   between	   Z-­‐lines	   (~0.1µm).	   They	   are	  
constituted	   of	   interdigitating	   thick	   (~15nm	   in	   diameter)	   and	   thin	   (~10nm)	   filaments,	   which	   are	  
polymers	  of	  noncovenlently	  associated	  myosin	   and	  actin	  molecules,	   respectively	   (Figure	  3a).	  They	  
are	   responsible	   for	   cardiac	   muscles’	   striated	   appearance	   (Figure	   3d)	   due	   to	   alternating	   A-­‐	   (for	  
anisotropic)	  and	  I-­‐	  (for	  isotropic)	  bands.	  Specific	  proteins	  stabilize	  the	  position	  of	  the	  thick	  and	  thin	  
filaments	   in	   the	  sarcomere	   (such	  as	   titin)	  and	  others	   regulate	   their	   interactions	   (such	  as	   troponin	  
and	   tropomyosin).	   	   The	  A-­‐band	   (~1.6µm)	   is	   located	   nearly	   in	   the	  middle	   of	   the	   sarcomere	   and	   is	  
further	   dissected	   into	   3	   regions:	   the	  H-­‐band,	   a	   less	   dense	   zone	  within	   the	   A-­‐band;	   the	  pseudo	  H-­‐
band,	  a	  lighter	  zone	  within	  the	  H-­‐band	  and	  the	  M-­‐line,	  which	  contains	  myomesin	  and	  it’s	  where	  thick	  
filaments	  interconnect	   in	  a	  narrow	  band	  of	  high-­‐density	  in	  the	  pseudo	  H-­‐band.	  Thin	  myofilaments	  
run	  from	  their	  initial	  attachments	  on	  the	  Z-­‐line,	  through	  half	  the	  I	  band	  (~1.0µm),	  into	  the	  A-­‐band	  
where	  they	  overlap	  partially	  with	  the	  thick	  filaments.	  The	  H-­‐band	  appears	  lighter	  within	  the	  A-­‐band,	  
because	  it	  doesn’t	  contain	  overlapping	  myofilaments	  (Figure	  3b).	  Titin,	  known	  also	  as	  connectin,	   is	  
found	  in	  both	  M-­‐	  and	  Z-­‐lines.	  The	  integrity	  of	  the	  sarcomere,	  when	  the	  actin	  and	  myosin	  filaments	  
are	   stretched	   beyond	   their	   overlapping	   zone,	   is	   held	   together	   by	   this	   giant	   protein	   (~3MDa)156,	  
which	   not	   only	   provides	   a	   template	   of	   the	   organization	   of	   the	   myofibrillar	   proteins	   during	  
development,	   but	   also	   acts	   as	   a	   molecular	   spring	   that	   is	   responsible	   for	   the	   key	   aspect	   of	   the	  
contractile	  behavior	  of	  the	  muscle157.	  Titin	  in	  the	  heart	  muscle	  has	  some	  unique	  features.	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It	  was	  suggested	  that	  the	  smaller	  titin	  isoform,	  such	  as	  the	  one	  seen	  in	  the	  cardiac	  muscular	  tissue,	  
sets	  “the	  slack	   length	  on	  the	  ascending	  part	  of	   the	   length-­‐tension	  curve”158,	  which	  should	  help	  the	  
heart	  adapt	   to	   increased	   filling	  by	  stronger	  contractions	   (i.e.	   a	  better	  adaptation	   to	  higher	   resting	  
tensions	   using	   the	   Frank-­‐Startling	   mechanism)53.	   The	   non-­‐linearity	   elasticity	   of	   titin	   would	   not	  
impair	   filling	   over	   a	   limited	   range	   but	   could	   provide	   enough	   diastolic	   tone	   to	   resist	   cardiac	  
overfilling158.	  Changes	  in	  titin	  isoform	  expression	  were	  found	  to	  significantly	  impact	  diastolic	  filling	  
by	   lowering	   myocardial	   stiffness,	   in	   end-­‐stage	   heart	   failure	   patients	   with	   non-­‐ischemic	   dilated	  
cardiomyopathy159.	  
	  
Figure	   3.	   Molecular	   basis	   of	  
cardiac	   muscle	   striation	   and	  
functional	   domains	   within	   the	  
cardiac	   myocyte.	   a.	   An	   electron	  
micrograph2	   of	   longitudinally	  
sectioned	   myofibrils,	   showing	   a	  
sarcomere	   spanning	   the	   area	  
between	   the	  Z-­‐lines.	  A-­‐	   and	   I-­‐bands	  
and	  M-­‐lines	  are	  shown	  (see	   text).	  b.	  
Scheme	   of	   the	   cardiac	   sarcomere	  
in	   relation	   to	   the	   membranous	  
structures	   responsible	   for	  
intracellular	  Ca2+	  handling6.	  TT:	  t-­‐
tubule;	   TC:	   terminal	   cisternae;	  
DHPR:	   dihydropyridine	   receptor	   at	  
the	   TT	   membrane;	   RyR:	   ryanodine	  
receptor	  (Ca2+	  release	  channel	  of	  the	  
SR)	   with	   foot	   structures	   at	   the	   TC	  
membrane9.	   M-­‐line;	   Z-­‐line10.	   MyPB-­‐
C,	   a	   hypothetical	   localization	   of	   the	  
myosin	   binding	   protein	   C,	   localizes	  
to	   the	   eleven	   transverse	   stripes	   on	  
either	  side	  of	  the	  M-­‐line	  and	  binds	  to	  
myosin	   and	   titin.	   Two	   nebulette	  
molecules	   are	   associated	   with	   each	  
actin	   filament,	  which	  originate	   from	  
the	   Z-­‐line,	   and	   tropomodulin	   caps	  
the	   actin	   filaments	   at	   their	   pointed	  
end12.	  c.	  Schematic	  representation	  
of	   the	   three	   well-­‐identified	  
specialized	   domains	   for	   channel	  
expression	   in	   cardiac	   myocyte14:	  
(1)	   the	   ECC	   domain	   composed	  of	   t-­‐
tubule	  and	  terminal	  cisternae	  of	  the	  
SR,	   (2)	   the	   costamere	   at	   the	   lateral	  
membrane	   (see	   text),	   and	   (3)	   the	  
intercalated	   disk	   (ID).	   d.	   Laser	  
scanning	   confocal	   micrograph	   of	  
healthy	  cardiac	  ventricular	  tissue	  
stained	   for	   F-­‐actin16.	   Staining	  
shows	   clear	   striations.	   Large,	  
intensely	   staining	   bands	   are	   most	  
likely	  to	  be	  the	  ID	  (~30µm,	  at	  white	  
arrow	   upward)	   that	   joins	  
longitudinally	   adjacent	   cells	   (white	  
arrow).	   Yellow	   arrows	   point	   at	   the	  
lateral	   membrane.	   Pictures	   taken	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The	   ECC	   process	   is	   generated	   at	   the	   level	   of	   the	   Z-­‐line,	   where	   the	   t-­‐tubular	   system	   allows	   the	  
functional	  coupling	  of	  electrical	  activity	  with	  the	  release	  of	  Ca2+	  from	  the	  SR,	  triggering	  contraction2.	  
In	  the	  cardiac	  myocyte,	  three	  crucial	  structural	  and	  functional	  entities	  can	  be	  delineated:	  (1)	  the	  ECC	  
domain	   composed	   of	   t-­‐tubular	   system	   and	   terminal	   cisternae	   of	   the	   SR	   and	   sarcomere,	   (2)	   the	  
intercalated	  disk	  (ID)	  at	  the	  cell-­‐cell	  junction,	  and	  (3)	  the	  lateral	  membrane	  domain14	  (Figure	  3c).	  
	  
ECC	  is	  mediated	  mainly	  by	  Ca2+.	  A	  couplon160,	  161	  or	  a	  local	  Ca2+	  signaling	  complex	  is	  a	  nanospace	  
within	  the	  ECC	  domain,	  defined	  by	  the	  cleft	  between	  the	  sacolemma	  and	  the	  SR,	  where	  10-­‐25	  L-­‐type	  
channels	   and	   100-­‐200	   ryanodine	   receptors	   (RyR,	   see	   below)	   are	   clustered162.	   The	   t-­‐tubules	  
functionally	  couple	  the	  rise	  of	  [Ca2+]i	   from	  the	  extracellular	  to	  the	  intracellular	  domains	  directly	  at	  
the	  Z-­‐line153.	  Upon	  activation	  of	   ICa,L	   in	   the	  designated	  couplon,	   [Ca2+]i	   rises	   in	  <1ms	  two	  orders	  of	  
magnitude	  	  from	  its	  basal	  concentration	  of	  ~10-­‐2µM.	  This	  local	  increase	  in	  Ca2+	  triggers	  the	  opening	  
of	  6-­‐20	  RyR113	  and	  more	  calcium	  is	  released	  into	  the	  cytoplasm	  from	  the	  SR	  storage.	  This	  process,	  
termed	  calcium-­‐induced-­‐calcium	  release	  or	  CICR,	  rises	  junctional	  [Ca2+]i	  to	  200-­‐400µM162.	  Ca2+	  then	  
diffuses	   from	   the	   cleft	   to	   the	   cytosol	   to	   activate	   the	   contractile	   myofilaments.	   Under	   normal	  
conditions,	  Ca2+	  doesn’t	  activate	  the	  RyRs	  of	  the	  neighboring	  cleft,	  which	  is	  ~1.5µm	  away	  (nearest	  
neighbor:	  0.78±0.07µm)163.	  This	  independent	  function	  of	  couplons	  dictates	  that	  all	  20,000	  couplons	  
in	  the	  cardiomyocyte	  must	  be	  simultaneously	  activated,	  for	  a	  synchronous	  activation	  to	  take	  place,	  
the	  dynamics	  of	  which	  normally	  occurs	  with	  each	  AP164.	  	  
	  
Mechanism	   of	  myofibrillar	   activation21.	   The	   sudden	   increase	   in	   [Ca2+]i	   due	   to	   ICa,L	   and	   CICR	   is	  
buffered	   almost	   instantaneously	   by	   troponin	   C	   (TnC)165.	   The	   latter	   along	  with	   troponin	   T	   (TnT),	  
troponin	  I	  (TnI)	  and	  tropomyosin	  (TM)	  forms	  a	  regulatory	  unit	  that	  controls	  actin	  molecules165.	  In	  
the	  absence	  of	  the	  Ca-­‐TnC	  complex,	  TM	  and	  TnI	  hinder	  the	  actin-­‐binding	  site	  for	  myosin	  in	  a	  blocked	  
state.	  The	  reversible	  binding	  of	  Ca2+	  to	  TnC	  results	  in	  increased	  affinity	  of	  TnC	  to	  TnI,	  which	  releases	  
its	   inhibitory	   control	  on	  actin.	  TM,	  partially	   released	   from	  TnT,	  performs	   initially	  a	  ~10°	   rotation	  
and	  partially	  exposing	  the	  actin	  binding	  site;	  therefore	  promoting	  myosin	  hydrophobic	  interactions,	  
which	  will	  further	  rotate	  TM	  an	  additional	  25°166.	  At	  this	  point,	  all	  actin	  binding	  sites	  are	  available	  
for	   interaction	  with	   the	  myosin	  heads167.	  This	   contributes	   to	   the	   strong	  cooperativity	  observed	   in	  
myofilament	   sensitivity	   curves168.	  When	   the	   binding	   takes	   place,	   actin	   activates	   the	   ATPase,	   and	  
splits	   an	   ATP	  molecule	   on	   the	  myosin	   head.	   The	   energy	   released	   decreases	   the	   angle	   of	   contact	  
between	  actin	  and	  myosin	   from	  90°	   to	  45°,	   thus	  pulling	   the	  actin	   filament.	  Detachment	  of	  myosin	  
from	   actin	   requires	   another	   ATP	   binding	   to	   myosin166.	   As	   long	   as	   [Ca2+]i	   is	   high	   enough	   for	  
sustaining	   the	   formation	   of	   the	   Ca-­‐TnC	   complex,	   a	   new	   cycle	   of	   crossbridges	   begins.	   Many	   such	  
cycles	   occur	   in	   single	   muscle	   activation,	   mainly	   due	   to	   the	   reciprocal	   Ca-­‐force	   interaction.	  
Crossbridges’	   binding	   and	   force	   generation	   enhance	   the	   affinity	   of	   Ca2+	   binding	   to	   TnC,	   thereby	  
prolonging	  the	  active	  state	  of	  contraction162.	  As	  Ca2+	  is	  being	  sequestered	  back	  into	  the	  SR	  via	  active	  
transport,	  the	  decrease	  in	  [Ca2+]i	  breaks	  the	  Ca-­‐TnC	  complex,	  reestablishing	  resting	  conditions74.	  	  
	  
Ca2+	  reuptake	  via	  SERCA.	  The	  active	  cytosolic	  Ca2+	  transport	  into	  the	  SR	  is	  accomplished	  by	  SERCA	  
pumps,	  which	  exist	  in	  3	  different	  isoforms169.	  SERCA2	  is	  the	  cardiac	  isoform.	  Both	  protein	  kinase	  A	  
(PKA)	  and	  Ca-­‐Calmodulin	  protein	  kinase	  (CaMKII)	  can	  regulate	  SR	  Ca2+	  reuptake	  via	  phospholamban	  
(PLB)	  phosphorylation,	  removing	  the	  continuous	  SERCA2	  inhibition	  by	  PLB170.	  Ca2+	  is	  also	  extruded	  
out	  of	   the	   cell	   through	   the	  electrogenic	  pump	  NCXix.	   In	   the	   steady	   state,	   a	  delicate	  Ca2+	  balance	   is	  
maintained,	  where	  the	  amount	  of	  Ca2+	  taken	  up	  by	  the	  SR	  during	  relaxation	  must	  equal	  the	  amount	  
released	  and	  the	  amount	  that	  enters	  through	  ICa,L	  must	  equal	   the	  amount	  extruded	  by	  NCX162.	  The	  
fraction	  of	  activating	  Ca2+	  that	  returns	  back	  into	  the	  SR	  and	  out	  to	  the	  cell	  varies	  among	  species113.	  In	  
human	  ventricles,	  almost	  70%	  of	  activating	  Ca2+	  are	  cycled	  through	  the	  SR,	  the	  remaining	  20-­‐28%	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through	   the	   NCX113.	   In	   contrast,	   more	   than	   95%	   is	   cycled	   through	   the	   SR	   in	   mouse	   and	   rat	  
ventricle113.	  In	  heart	  failure	  (HF),	  in	  which	  typically	  SERCA	  function	  is	  decreased	  and	  NCX	  function	  
is	  enhanced,	  this	  balance	  shifts	  to	  almost	  50-­‐50%171.	  
	  
The	  SR	  Ca2+	  release	  channel	  or	  ryanodine	  receptor	  (RyR).	  The	  diversity	  of	  SR	  release	  properties	  
is	   not	   yet	   completely	   understood.	   	   RyR	   is	   among	   the	   largest	   known	   proteins,	   consisting	   of	  
homotetramers	  each	  over	  5,000	  amino	  acids	  with	  a	  molecular	  mass	  of	  ~550kDa172.	  RyR	  is	  present	  
in	  mammalian	  muscles	  in	  distinct	  isoforms:	  RyR1	  is	  the	  dominant	  one	  in	  skeletal	  muscles	  and	  RyR3	  
is	  restricted	  to	  a	  few	  skeletal	  muscles	  in	  the	  post-­‐natal	  period173.	  RyR2	  is	  the	  cardiac	  isoform	  and	  is	  
never	   expressed	   in	   skeletal	   muscles172,	   174.	   Since	   the	   expression	   of	   specific	   RyR2	   isoform	   isn’t	  
diverse	  in	  the	  cardiac	  muscle,	  modulation	  of	  RyR2	  activity	  is	  related	  to	  many	  factors	  including	  many	  
interacting	  proteins.	  	  
o Calsequestrin	   (CASQ)	   is	   the	   most	   important	   binding	   protein	   inside	   the	   SR	   and	   is	   mainly	  
located	   in	   the	   terminal	   cysternae	   in	   close	  proximity	   to	  RyR.	  Due	   to	   its	   acidic	   residues,	   the	  
multimeric	  CASQ2	  (cardiac	  isoform)	  can	  bind	  up	  to	  50-­‐75%	  of	  the	  Ca2+	  taken	  up	  by	  the	  SR113,	  
175.	  Extensive	  research	  is	  ongoing	  to	  determine	  CASQ	  modulation	  of	  RyR,	  where	  mutations	  in	  
CASQ	   were	   shown	   to	   trigger	   exercise-­‐induced	   ventricular	   arrhythmia	   (Catecholaminergic	  
Polymorphic	  Ventricular	  Tachycardia	  or	  CPVT)176.	  Although	  direct	  effects	  of	  CASQ2	  on	  RyR2	  
have	   been	   described,	   it’s	   now	   believed	   that	   CASQ2	   modulates	   RyR2	   function	   through	  
integral	  membrane	  proteins	  triadin	  (TRD)	  and	  junctin	  (JN)177.	  When	  [Ca2+]SR	  is	  low,	  CASQ2	  is	  
bound	  to	  TRD	  and/or	  JN,	  stabilizing	  RyR2	  closure.	  When	  [Ca2+]SR	  is	  restored,	  CASQ2	  unbinds	  
from	   TRD/JN	   and	   the	   inhibitory	   effect	   of	   CASQ2	   on	   RyR2	   terminates,	   increasing	   opening	  
probabilities	  of	  RyR2175,	  178.	  	  	  	  
o DHPR.	  The	  coupling	  between	  those	  two	  proteins	  differs	  tremendously	  between	  cardiac	  and	  
skeletal	   muscles179.	  While	   Ca2+	   is	   indispensable	   for	   the	   CICR	   in	   cardiac	  muscles,	   which	   is	  
accelerated	  by	  the	  vicinity	  of	  DHPR	  to	  RyR2;	  the	  direct	  mechanical	  coupling	  between	  DHPR	  
and	  RyR	  that	  prevails	  in	  the	  skeletal	  muscle	  is	  Ca2+	  independent	  and	  DHPR’s	  role	  is	  reduced	  
to	  the	  one	  of	  a	  voltage	  sensor	  for	  RyR	  opening180.	  An	  index	  of	  the	  proportion	  of	  RyR	  directly	  
controlled	  by	  the	  DHPR	  is	  given	  by	  the	  ratio	  DHPR:RyR.	  This	  index	  was	  shown	  to	  decrease	  
with	  aging	  in	  skeletal	  muscles181.	  However	  it’s	  not	  known	  yet,	  whether	  this	  process	  occurs	  in	  
the	  heart	  as	  well.	  	  
o Calmodulin	  or	  CaM.	  This	  molecule	  ubiquiously	  binds	  cytosolic	  Ca2+	  and	  affects	  RyR2	  function	  
by	   direct	   binding182.	   	   At	   [Ca2+]i	   <1µM,	   CaM	   inhibits	   opening	   of	   the	   RyR2183.	   Ca-­‐dependent	  
inactivation	  of	  ICa,L	  is	  also	  mediated	  by	  CaM:	  upon	  [Ca2+]i	  increase,	  the	  Ca-­‐CaM	  complex	  binds	  
to	  the	  IQ	  motif	  of	  DHPR,	  accelerating	  ICa,L	  inactivation184.	  	  	  
o FKBP-­‐12	   and	   FKPB-­‐12.6	   are	   both	   classified	   as	   immunophilins	   and	   modulate	   Ca2+	   release	  
properties	   of	   RyR2185;	   in	   particular,	   they	   stabilize	   the	   full	   conductance	   or	   the	   closed	  
conformation	   state	   of	   the	   channel186.	   PKA	  phosphorylation	   of	  RyR2	  dissociates	   FKBP-­‐12.6	  
and	  regulates	  the	  channel	  open	  probability187.	  	  
	  
1.2.  Anisotropy 
Lewis	   et	   al.	   recorded	   the	   first	   observation	   pointing	   to	   the	   link	   between	   CV	   and	   the	   direction	   of	  
propagation	   in	   the	  cardiac	  muscle,	   in	  1914188.	  The	  propagation	  of	  excitation	   in	   the	  cardiac	  muscle	  
has	   generally	   been	   approached	   as	   though	   it	   occurred	   in	   a	   continuous	   excitable	   medium	   -­‐	   the	  
Hodgkin-­‐Huxley	   equations	  of	   excitation	  and	  propagation	  were	  modeled	  on	   the	  giant	   squid	   axon86	  
for	  instance.	  In	  fact,	  the	  cellular	  and	  tissue	  structures	  in	  the	  heart	  are	  a	  confluence	  of	  discontinuities	  
brought	   together	   through	   highly	   organized	   specialized	   electrical	   and	   mechanical	   coupling	  
systems189.	   The	   result	   is	   this	   distinctive	   spatial	   distribution	   of	   propagation,	   termed	   anisotropy,	  
where	   the	   impulse	   propagation	   is	   faster	   in	   the	   direction	   parallel	   to	   the	   cardiac	   fiber,	   than	   in	   the	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direction	  perpendicular	  to	  it21,	   190.	  Anisotropy	  is	  the	  consequence	  of	  characteristics	  detected	  at	  the	  
level	   of	   the	   cell,	   as	   well	   as	   the	   multicellular	   tissue.	   The	   former	   is	   attributed	   to	   spatial	   non-­‐
uniformities	  in	  the	  membrane	  properties,	  whereas	  the	  latter	  to	  the	  specialized	  sarcolemmal	  regions	  
containing	   arrays	   of	   densely	   packed	   transmembrane	   channels	   connecting	   the	   cytoplasmic	  
compartments	  of	  adjacent	  cells100.	  As	  introduced	  in	  the	  beginning	  of	  section	  1.1.5,	  the	  cardiac	  cell	  is	  
a	   highly	   differentiated	   structurally	   polarized	   cell	   with	   well-­‐developed	   domains,	   where	   the	   ECC	  
domain	  was	   described.	   In	   this	   section	   both	   the	   ID	   domain,	   and	   the	   remaining	   lateral	  membrane	  
(LM)	  domain	  are	  described.	  	  
1.2.1.  Passive Molecular Determinants of Anisotropy  
By	   examining	   a	   healthy	   cardiac	   tissue	   sectioned	   in	   a	   plane	   parallel	   to	   the	   direction	   of	   its	   fibers,	  
(Figure	   3d),	   highly	   dense	   structures	   appear	   to	   connect	   two	   adjacent	   cardiomyocytes.	   These	  
intercalated	  disks	  (ID)	  contain	  multiple	  adhesive	  components	  that	  ensure	  mechanical	  coupling	  and	  
rapid	  coordinated	  electrical	  propagation,	  therefore	  are	  vital	  for	  the	  integrity	  of	  the	  myocardium	  and	  
its	  ability	  to	  function	  as	  a	  whole191.	  Three	  types	  of	  adhesive	  junctions	  exist	  in	  the	  ID	  domain:	  fascia	  
adherens	   and	  desmosomes,	  which	  are	  primarily	  mechanical;	  whereas	  gap	   junctions	   are	   the	  sites	  of	  
intercellular	  electrical	  coupling.	  
	  
Fascia	   adherens	   and	   desmosomes	   anchor	   actin	   filaments	   (described	   previously,	   involved	   in	   the	  
contractile	  machinery)	  and	  intermediate	  filaments	  (a	  component	  of	  the	  cytoskeleton)	  at	  the	  plasma	  
membrane	   of	   adjoining	   cells	   respectively,	   thereby	   provide	   physical	   and	   mechanical	   attachment	  
between	  the	  cells191,	  192.	  In	  fascia	  adherens,	  transmembrane	  protein	  N-­‐cadherin	  connects	  sarcomeric	  
actin	   filaments	   and	   maintains	   strong	   cell-­‐cell	   adhesion.	   Desmosomes	   are	   small	   and	   discrete	  
structures	   composed	   of	   three	   separate	   families	   of	   proteins:	   desmosomal	   cadherin,	   armadillo	  
proteins	   and	   plakins193.	   In	   the	   normally	   working	   myocardium,	   both	   fascia	   adherens	   and	  
desmosomes	   are	   involved	   in	   the	   sensing	   and	   regulation	   of	   mechanical	   stresses	   acting	   along	   the	  
longitudinal	  axis.	  The	  area	  composita,	  a	  mixed	  type	  of	  junctional	  structure,	  is	  exclusive	  to	  the	  ID	  of	  
mammalian	   species	   suggesting	   an	   evolutionary	  mechanism	   to	   strengthen	  mechanical	   coupling	   in	  
the	   heart	   of	   higher	   vertebrates194.	   	   Their	   role	   is	   essential	   in	   organs	   subjected	   to	   high	  mechanical	  
stresses,	  such	  as	  the	  skin	  and	  the	  heart.	  Mutations	  in	  genes	  coding	  for	  these	  junctional	  proteins	  are	  
involved	  in	  cardio-­‐cutaneous	  inherited	  pathologies195,	  such	  as	  Naxo’s	  disease196,	  197.	  	  
	  
Connexin43	   (Cx43)	   is	   the	   major	   protein	   constituting	   gap	   junctions,	   which	   are	   made	   of	   two	  
connexons	  (or	  hemichannels)198	  and	  allow	  non-­‐selective	  diffusion	  of	  ~1kDa	  molecules199,	  ions,	  and	  
second	  messengers,	   thereby	  offering	   electro-­‐metabolic	   coupling.	   3	   types	  of	   connexins	   exist	   in	   the	  
heart:	  Cx40,	  43	  and	  45	  (the	  number	  refers	  to	  their	  molecular	  weights;	  43	  being	  the	  most	  abundant).	  
Saffitz	  et	  al.	  describe	  the	  spatial	  distribution	  of	  gap	  junctions	  as	  well	  suited	  for	  the	  heart’s	  functional	  
requirements200,	  where	   large	   gap	   junctions	   at	   the	   ends	   of	   cells	   presumably	   facilitate	   the	   efficient	  
intercellular	   current	   transfer	   and	   provide	   favorable	   current-­‐to-­‐load	   conditionsx	   201.	   Gap	   junction	  
specific	  proteins	  and	  density	  have	  a	  direct	  influence	  on	  the	  velocity	  of	  propagation.	  	  The	  measured	  
CV	  in	  Purkinje	  fibers	  (~3m.s-­‐1)	  is	  considerably	  higher	  than	  the	  one	  recorded	  in	  the	  ventricular	  bulk	  
muscle	   (~0.5-­‐0.7	  m.s-­‐1	   longitudinally;	   0.3-­‐0.4	  m.s-­‐1	   transversely)202.	   The	   fast	   propagation	   is	   partly	  
due	  to	  the	  presence	  of	  different	  connexins	  in	  the	  gap	  junctions	  of	  these	  cells,	  where	  the	  amount	  of	  
Cx40	  is	  at	  least	  3	  folds	  higher	  in	  Purkinje	  fibers	  than	  regular	  cardiomyocytes203.	  On	  the	  other	  hand,	  
high	   anisotropic	   ratio	   	   (AR)	   was	   also	   attributed	   to	   the	   shape	   of	   cells,	   the	   number	   and	   spatial	  
orientation	  of	  cellular	  connections	  rather	  than	  the	  anisotropic	  distribution	  of	  gap	  junctions190.	  The	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
x	  Saffitz	  et	  al.	  defined	  current-­‐to-­‐load	  as	  the	  difference	  between	  the	  minimum	  amounts	  of	  current	  required	  in	  maintaining	  
conduction	  and	  the	  actual	  amount	  delivered.	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crista	  terminalis,	  a	  discrete	  bundle	  of	  atrial	  fibers	  that	  conducts	  impulses	  from	  the	  SAN	  to	  the	  AVN,	  
is	   characterized	   by	   a	   relatively	   high	   AR	   compared	   to	   the	   bulk	   ventricular	   muscle	   (~10	   vs.	   ~3	  
respectively),	  despite	  the	  relatively	  fewer	  gap	  junctions	  present201.	  It	  was	  suggested	  that	  because	  of	  
the	   elongated	   shape	   of	   the	   cells	   found	   in	   the	   crista	   terminalis,	   wave	   fronts	   traveling	   in	   the	  
transverse	  direction	  must	  traverse	  more	  intercellular	  junctions	  per	  unit	  distance	  traveled,	  and	  thus	  
would	  encounter	  more	  resistance	  to	  their	  propagation	  than	  wave	  fronts	  traveling	  in	  the	  longitudinal	  
direction190,	  204.	  	  
	  
In	   reality,	  mechanical	   stresses	   can	   induce	  changes	   in	  gap	   junction	  density	  at	   the	   ID,	   subsequently	  
affecting	  the	  intercellular	  communication	  and	  propagation	  velocity	  on	  the	  macroscopic	  level.	  Saffitz	  
et	  al.	  argue	  that	  the	  close	  proximity	  of	  gap	  junctions	  to	  mechanical	  adhesive	  junctions	  within	  the	  ID,	  
and	  their	  ribbon	  like	  structures	  oriented	  perpendicular	  to	  the	  long	  axis	  of	  the	  cell	  is	  a	  revolutionary	  
adaptation	  that	  would	  protect	  them	  from	  shear	  stress200.	  	  In	  favor	  of	  this	  point,	  pulsatile	  mechanical	  
stretch	   was	   shown	   to	   markedly	   upregulate	   Cx43	   in	   cultured	   neonatal	   cardiomyocytes,	   inducing	  
remodeling	  and	  redistribution	  of	  gap	  junctions	  and	  possibly	  alterations	  in	  electrical	  conduction205.	  
In	  addition,	  observations	  suggest	  that	  mechanical	  integrity	  is	  a	  requirement	  for	  a	  normal	  excitation,	  
and	   formation	   of	   adhesion	   junctions	   is	   a	   prerequisite	   for	   gap	   junction	   formation206.	   On	   the	   other	  
hand,	  Cx43	  was	  not	   found	  to	  be	  a	  prerequisite	   for	  the	  organization	  of	  mechanical	   junctions192	  and	  
that	   electrical	   conduction	   was	   maintained	   in	   Cx43-­‐deficient	   mice,	   suggesting	   an	   alternative	  
mechanism	  of	  electrical	  propagation	  in	  the	  context	  of	  severely	  reduced	  gap	  junctions207.	  A	  growing	  
line	  of	  evidence	  suggests	  that	  altered	  mechanical	  coupling	  or	  loss	  of	  cell-­‐cell	  contact	  for	  any	  reason	  
(chemical	   mediator,	   hypertrophy,	   dilatation,	   scarring…	   etc.)	   would	   directly	   modulate	   electrical	  
pacing	  of	  the	  heart.	  Whereas,	  the	  opposite	  is	  not	  yet	  as	  tangible:	  impaired	  electrical	  coupling	  doesn’t	  
affect	  mechanical	  coupling206.	  	  
	  
Under	  normal	  physiological	  conditions,	  cardiac	  cells	  don’t	  show	  similar	  electrical	  coupling	  along	  the	  
transverse	  axis,	  as	  they	  do	  along	  the	  longitudinal	  one14.	  The	  costamere	  and	  the	  t-­‐tubules	  are	  the	  two	  
major	  structures	  in	  the	  LM	  domain	  (Figure	  3c).	  The	  term	  costamere	  refers	  to	  the	  rib-­‐like	  bands	  that	  
encircle	   the	   cardiomycoyte	   perpendicular	   to	   its	   long	   axis208.	   It	   consists	   of	   a	   complex	   protein	  
network	   that	   not	   only	   forms	   a	   physical	   attachment	   of	   the	   underlying	   Z-­‐line	   to	   its	   outer	   stress	  
tolerant	   extracellular	   matrix	   (ECM),	   but	   also	   is	   the	   site	   where	   contractile	   forces	   within	   the	  
cardiomyocyte	  are	  directly	  transmitted	  to	  the	  ECM209.	  In	  fact,	  externally	  applied	  strain	  on	  the	  ECM	  
was	   sufficient	   through	   this	   protein	   complex	   to	   induce	  myofibril	   contraction,	   indicating	   that	   both	  
externally	   applied	   and	   intrinsically	   stimulated	  mechanical	   forces	  were	  bidirectionally	   transmitted	  
through	   the	   costameres209.	   The	   major	   consequence	   of	   muscular	   contraction	   is	   shortening	   and	  
deformation.	   A	   process	   during	   which	   the	   contractile	   machinery	   of	   the	   sarcomere	   must	   remain	  
connected	   to	   both	   the	   sarcolemma	   and	   the	   ECM,	   for	   the	   adequate	   transmission	   of	   force	   and	   the	  
proper	   coordination	   of	   contraction	   within	   the	   three-­‐dimensional	   muscular	   structure210.	  
Cardiomyocytes,	  as	  load-­‐bearing	  cells,	  not	  only	  generate	  and	  transmit	  mechanical	  contractions,	  but	  
they	   are	   also	   equipped	   through	   the	   costameres	   to	   sense	   physical	   forces,	   to	   transduce	   them	   into	  
biochemical	  signals,	  and	  generate	  appropriate	  responses	  leading	  to	  alterations	  in	  cellular	  structure	  
and	   function211.	   This	  mechanotransduction	   is	   particularly	   complex	   in	   the	   heart,	   since	   individual	  
cardiac	   cells	   should	   adapt	   to	   many	   simultaneously	   ongoing	   processes212:	   externally	   applied	  
mechanical	  forces,	  internal	  loads	  (blood	  volume,	  arterial	  pressure),	  neurohormonal	  modulations,	  by	  
either	   reacting	   instantaneously	   on	   the	   short-­‐term	   or	   modifying	   gene	   expression	   for	   long-­‐term	  
responses212,	  then	  transmitting	  the	  same	  message	  to	  adjacent	  cells	  and	  their	  surrounding	  ECM	  for	  a	  
synchronized	  contraction.	  	  
	  
Two	   important	  macromolecular	  protein	   complexes	  play	   the	   regulatory	   role	   at	   the	   costamere:	   the	  
dystrophin-­‐syntrophin	  mutliprotein	  complex	  (DSMC)	  and	  the	  integrin	  complex14	  (Figure	  3c).	  Integrins	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are	  heterodimers	   composed	  of	   chains	  with	   a	   long	   extracellular	  domain,	  which	  binds	   extracellular	  
laminin	   to	   the	   cytoskeletal	   actin213.	   The	   principal	   role	   of	   the	   integrin	   complex	   is	  
mechanotransduction,	   anchoring	   at	   its	   cytoplasmic	   side	   many	   signaling	   molecules	   and	   kinases.	  
Inactivation	  of	   the	  cardiac	   integrin	  gene	   in	  mice	  resulted	   in	  an	  enhanced	  predisposition	   to	  stress-­‐
induced	  cardiomyopathy214	  and	  dilated	  ventricular	  chambers215.	  	  
1.2.2. The Dystrophin Molecule and the DSMC 
The	   DSMC,	   similarly	   to	   the	   integrin	   complex,	   is	   composed	   of	   transmembrane,	   cytoplasmic	   and	  
extracellular	  proteins216.	   In	   the	  cardiac	  cell,	   the	   transmembrane	  proteins	  are	   the	  sarcoglycans,	   the	  
sarcospan	  and	  the	  dystroglycans	  that	  in	  turn	  bind	  to	  extracellular	  laminin.	  On	  the	  cytoplasmic	  side,	  
dystrophin	   binds	   to	   syntrophin,	   dystrobrevin217,	   and	   neuronal	   nitric	   oxide	   synthase	   and	   attaches	  
this	   multimolecular	   complex	   to	   cytoskeletal	   actin218.	   The	   DSMC	   is	   essential	   in	   stabilizing	   the	  
sarcolemma	  upon	  physical	  stresses.	  Dystrophin	  (~430kDa)	  is	  mainly	  expressed	  in	  striated	  muscles,	  
including	  cardiac	  muscle	  cells219	  and	  its	  main	  function	  lies	  in	  linking	  membrane	  proteins	  to	  the	  actin	  
cytoskeleton220	   and	   maintaining	   the	   stability	   of	   the	   dystrophin-­‐syntrophin	   multiprotein	   complex	  
(DSMC)	  in	  the	  LM	  domain221.	  An	  interesting	  fact	  is	  that	  dystrophin	  isn’t	  restricted	  to	  muscles,	  but	  is	  
also	   expressed	   in	   the	   central	   nervous	   system	   (such	   as	   the	   cerebellum,	   cortical	   neurons,	  
hippocampus)222.	   Mutations	   of	   dystrophin	   lead	   to	   a	   severe	   progressive	   muscle	   wasting	   disease,	  
Duchenne	  muscular	  dystrophy	  (DMD),	  or	  to	  a	  less	  severe	  form	  Becker’s	  dystrophy223.	  	  
	  
DMD	  is	  a	  devastating	  X-­‐linked	  degenerative	  muscle	  disease,	  with	  an	   incidence	  of	  1:3300	  live	  male	  
births	  annually223.	  In	  patients	  with	  DMD,	  muscular	  biopsies	  characteristically	  demonstrate	  encoring	  
or	   degenerating	   muscle	   fibers,	   often	   observed	   in	   clusters224.	   Small	   immature	   centrally	   nucleated	  
cells	   are	   also	   observed	   and	   they	   correspond	   to	   the	   regenerative	   processes	   that	   take	   place	   in	   the	  
early	  phases	  of	  the	  disease,	  creating	  a	  balance	  between	  necrotic	  and	  regenerating	  muscle	  tissue225.	  
Later,	   the	   regenerative	   capacity	   of	   the	   muscle	   is	   exhausted	   and	   muscle	   fibers	   are	   continuously	  
replaced	   with	   connective	   and	   adipose	   tissues225.	   The	   pathology	   becomes	   more	   prominently	  
manifested	  with	  age	  and	  patients	  are	  usually	  wheelchair	  ridden	  in	  early	  adolescence224.	  
	  
The	  responsible	  gene	  and	  its	  product,	  dystrophin,	  have	  been	  identified	  more	  than	  30	  years	  ago226,	  
and	  the	  mouse	  model	  (mdx)	  harboring	  a	  spontaneous	  mutation	  similar	  to	  the	  one	  observed	  in	  man	  
has	  been	  extensively	  studied,	  as	  a	  mouse	  model	  of	  the	  pathology227,	  228.	  These	  experimental	  murine	  
models	  are	  one	  of	  the	  best	  tools	  not	  only	  to	  investigate	  the	  primary	  defect,	  but	  also	  to	  delineate	  the	  
causal	  chain	  of	  events	  leading	  to	  the	  observed	  pathological	  finding229,	  230.	  In	  the	  case	  of	  DMD,	  despite	  
major	   advancements	  done	   in	   the	   field,	   a	   comprehensive	  understanding	  of	   the	  mechanism	   leading	  
from	  the	  absence	  of	  dystrophin	  to	  the	  muscular	  degeneration	  is	  still	  lacking231.	  Several	  hypotheses	  
have	   been	   proposed	   to	   clarify	   the	   pathophysiology	   of	   the	   underlying	   deficits	   resulting	   from	   the	  
absence	   of	   dystrophin232.	   Among	   the	   current	   hypotheses	   is	   the	   mechanical	   hypothesis,	   which	  
suggests	  that	  membrane	  fragility	  in	  DMD	  patients	  allows	  the	  accumulation	  of	  proteins	  that	  are	  not	  
normally	  present	  in	  the	  muscle	  fibers,	  indicating	  increased	  membrane	  permeability233.	  On	  the	  other	  
hand,	   the	  calcium	  hypothesis	  proposes	  that	  disruptions	  to	  the	  DSMC	  can	  result	   in	   instability	  of	   the	  
sarcolemma	  that	  permits	  calcium	  entry	  through	  membrane	  tears,	  when	  the	  sarcolemma	  is	  stretched	  
during	   lengthening	  muscle	   contractions234.	   For	   a	   comprehensive	   review	  on	   the	  different	   available	  
hypotheses	  involved	  in	  the	  pathology	  of	  DMD,	  refer	  to	  the	  review	  by	  Deconinck	  and	  Dan	  (2007)231.	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The	   importance	  of	  dystrophin	   from	  a	  cardiac	  perspective	  becomes	  obvious	  when	  almost	  all	  DMD-­‐
patientsxi	   develop	   severe	   cardiac	   manifestations	   of	   their	   disease,	   that	   culminate	   into	   dilated	  
cardiomyopathy235,	  heart	   failure	  and	   increased	  propensity	  of	   sudden	  cardiac	  death224.	  Henceforth,	  
understanding	  the	  mechanisms	  behind	  the	  induced	  arrhythmia	  in	  the	  dystrophic	  substrate	  requires	  
the	  knowledge	  not	  only	  of	  the	  membrane	  effects	  due	  to	  the	  primary	  channel	  defect,	  but	  also	  of	  the	  
intracellular	  signals,	  developmental	  effects	  on	   intercellular	  communication,	   integration	  of	  possible	  
compensatory	   responses	   and	   other	   environmental	   factors	   that	   modulate	   the	   translation	   of	   the	  
primary	  defect	  from	  the	  gene	  to	  the	  organ229.	  Despite	  known	  discrepancies	  in	  the	  electrophysiology	  
of	  mouse	  and	  man,	  the	  mdx	  mouse	  has	  been	  continuously	  developed	  in	  the	  last	  30	  years	  to	  elucidate	  
the	  role	  of	  dystrophic	  loss	  in	  the	  pathology	  of	  DMD.	  
	  
Dystrophin	   has	   multiple	   protein-­‐protein	   interaction	   domains,	   including	   a	   specific	   domain	   in	   its	  
carboxylic	  terminus	  facilitating	  its	  interaction	  with	  syntrophin217.	  The	  latter	  has	  a	  PDZ	  domain	  xiithat	  
mediates	   interactions	  with	   the	  carboxylic	  end	  of	  various	   ionic	  channels,	   including	  NaV1.5xiii,	  which	  
has	   a	   PDZ-­‐domain	   binding	   motif	   in	   its	   carboxylic-­‐terminal	   tail.	   Interestingly,	   among	   the	   nine	  
different	  NaV	   channels,	   only	   the	   ones	   expressed	   in	   striated	  muscles	   (i.e.	   NaV1.4	   and	  NaV1.5)	   have	  
such	  PDZ-­‐binding	  motifs	   in	  their	  carboxylic	  ends236.	  This	  domain	  was	  found	  necessary	  for	   indirect	  
interactions	   with	   dystrophin	   via	   syntrophin236.	   Gavillet	   et	   al.	   have	   initially	   shown	   that	   NaV1.5	  
expression	  was	  decreased	  in	  the	  mdx	  mouse,	  the	  functional	  consequence	  of	  which	  was	  a	  reduction	  
in	  the	  whole	  cell	  INa,f	  current237.	  The	  authors	  ruled	  out	  other	  factors	  that	  could	  potentially	  lower	  the	  
availability	  of	  NaV1.5,	  hence	  decrease	  the	  upstroke	  current	  (such	  as	  increased	  Vrmp,	  or	  alterations	  in	  
activation-­‐inactivation	   kinetics	   of	   NaV1.5	   in	   the	   mdx	   heart).	   As	   dystrophin	   and	   syntrophin	   are	  
virtually	  absent	   from	  IDs	   in	  normal	  condition,	  Petitprez	  et	  al.	  subsequently	  demonstrated	  that	  the	  
interaction	   between	   NaV1.5	   and	   dystrophin	   is	   exclusive	   to	   the	   LM	   of	   the	   myocytes238.	   All	   these	  
findings	   combined,	   suggest	   that	   NaV1.5	   is	   exclusively	   regulated	   by	   dystrophin	   on	   the	   LM	   of	  
cardiomyocytes,	   the	  absence	  of	  which	   in	  the	  dystrophin-­‐deficient	  mouse	  ensues	  the	   loss	  of	  NaV1.5	  
from	  the	  LM	  and	  reduction	   in	   the	  total	   INa,f	  at	   the	  upstroke.	  On	  the	  other	  hand,	  other	  studies	  have	  
emphasized	   the	   interaction	  of	   SAP97	   (another	   regulatory	  protein	  described	   in	   section	  1.4.6)	  with	  
cardiac	  ionic	  channels239,	  240	   including	  NaV1.5	  at	  the	  IDs238,	  which	  also	  involves	  the	  PDZ-­‐domain.	  In	  
these	  studies,	  SAP97	  enhanced	  INa,f	  without	  affecting	  the	  biophysical	  properties	  of	  the	  current	  or	  the	  
intrinsic	  properties	  of	  the	  channels238.	  SAP97	  has	  been	  also	  found	  not	  to	  have	  any	  major	  influence	  
on	  conductance	  or	  opening	  probability	  nor	  time	  of	  the	  channels;	  rather	  it	  is	  thought	  to	  enhance	  the	  
density	  of	   functional	   channels241.	   Silencing	  SAP97	   lead	  however	   to	   a	  drastic	  deterioration	  of	  both	  
INa,f	   and	   Ito,1	   (the	   transient	   outward	   K+	   current	   or	   early	   repolarization	   current)238.	   How	   SAP97	  
modulates	  functional	  NaV1.5	  is	  not	  yet	  well	  understood.	  
1.2.3. Active Determinants of Anisotropy 
NaV1.5xiv	   is	   a	   transmembrane	   protein,	   the	   localization	   of	   which	   has	   been	   subject	   to	   controversy.	  
Studies	  that	  have	  investigated	  the	  localization	  of	  NaV1.5	  have	  described	  channel	  staining	  within	  the	  
surface	   of	   t-­‐tubular	   membranes,	   concentrated	   principally	   in	   the	   perinexus	   region	   near	   gap	  
junctions242	   and	   more	   exclusively	   at	   the	   intercalated	   disks	   (IDs)243,	   244.	   Initial	   evidence	   of	   the	  
subcellular	  distribution	  of	  NaV1.5	  in	  adult	  mammalian	  cardiomyocytes	  was	  provided	  by	  Haimovich	  
et	  al.	  (1984)	  with	  their	  immunohistochemical	  staining	  of	  muscle	  cells245.	  Cohen	  et	  al.	  subsequently	  
demonstrated	  that	  NaV1.5	  inhomogeneity	  had	  a	  distinct	  subcellular	  pattern	  in	  adult	  rat	  ventricular	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xi	  DMD	  stands	  for	  Duchenne	  Muscular	  Dystrophy,	  a	  severe	  progressive	  muscle	  wasting	  disease	  secondary	  to	  mutations	  in	  
the	  dystrophin	  gene,	  followed	  by	  the	  complete	  absence	  of	  the	  protein	  in	  the	  striated	  muscles	  of	  affected	  individuals.	  	  
xii	  The	  PDZ	  is	  a	  protein-­‐protein	  interaction	  domain.	  Refer	  to	  section	  1.4.6	  under	  “Anchoring	  and	  modulating	  proteins”.	  
xiii	  The	  cardiac	  Na-­‐channel	  (NaV1.5)	  is	  addressed	  in	  detail	  in	  section	  1.4.	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muscle,	  in	  which	  there	  was	  intense	  immunolabeling	  of	  NaV1.5	  at	  the	  IDs	  with	  little	  immunolabeling	  
of	   the	   remaining	   surfaces242.	   In	   the	   paper	   by	   Petitprez	   et	   al.	   authors	   demonstrate	   that	   NaV1.5	   is	  
present	   all	   along	   the	   plasma	   membrane	   of	   both	   rat	   and	   mouse	   cardiomyocytes238.	   Reduction	   of	  
lateral	  NaV1.5	  expression	  in	  the	  dystrophin	  deficient	  (mdx)	  myocytes	  without	  measurable	  alteration	  
in	  the	  expression	  of	  the	  channel	  at	  IDs	  proposes	  the	  existence	  of	  at	  least	  two	  pools	  of	  NaV1.5	  in	  the	  
cardiac	   tissue	   regulated	   by	   a	   distinct	   set	   of	   proteins.	   This	   finding	   is	   consistent	   with	   previous	  
measurements	  done	  on	  isolated	  cardiac	  myocytes	  showing	  a	  50%	  decrease	  in	  the	  total	  expression	  
of	  NaV1.5	   in	   the	  absence	  of	  dystrophin,	  with	  an	  ancillary	   INa,f	   reduction237.	  These	  results	  combined	  
suggest	  that	  possibly	  a	  considerable	  fraction	  of	  NaV1.5	  is	  located	  outside	  the	  IDs,	  the	  loss	  of	  which	  
from	   the	   LM	   in	   the	   mdx	   cardiac	   cell	   is	   likely	   to	   be	   associated	   with	   conduction	   abnormalities	  
supported	  by	  the	  previously	  found	  significant	  decrease	  in	  INa,f238.	  
	  
1.3. Complexity of Activation in the Cardiac Tissue 
The	   heart,	   as	   described	   before	   in	   section1.1.1,	   has	   a	   complicated	   3D	   architecture	   (Figure	   1),	   in	  
which	  the	  3D	  arrangement	  of	  the	  different	  types	  of	  cells	  impinge	  on	  our	  ability	  to	  understand	  how	  
propagation	   “really”	   occurs	   in	   the	   heart.	   Particular	   emphasis	   has	   been	   given	   recently	   to	   the	   3D	  
myocyte	  composition	  at	  the	  organ	  scale246.	  Knowledge	  of	  3D	  propagation	  depends	  on	  our	  ability	  to	  
image	   and	   resolve	   3D	   structure	   and	   to	   make	   functional	   measurements	   that	   are	   relevant	   to	   the	  
underlying	   physiology.	   It’s	   currently	   accepted	   to	   consider	   2D	  measurements	   of	   cardiac	   tissue	   as	  
appropriate	   models	   to	   investigate	   propagation,	   since	   images	   of	   myocardial	   tissue	   with	   sufficient	  
resolution	   have	   visualized	   cells	   in	   2	   dimensional	   rather	   than	   3	   dimensional	   dimensional	  
structures246.	  At	  the	  level	  of	  the	  whole	  organ,	  the	  geometry	  of	  the	  heart	  can	  be	  reconstructed	  in	  3D,	  
using	   measurements	   done	   at	   tissue	   scale	   resolution	   using	   various	   imaging	   modalities247-­‐249.	  
Measuring	   3D	   electrical	   activity	   in	   the	   heart	   wall	   with	   equivalent	   precision	   is	   still	   considered	   a	  
challenging	   task	   from	   a	   technical	   perspective.	   Validation	   of	   3D	   reconstruction	   using	   2D	  
measurements	   performed	   on	   the	   tissue	   scale	   will	   have	   to	   wait	   until	   sufficiently	   high	   spatial-­‐
temporal	  resolution	  becomes	  available	  for	  3D	  whole-­‐heart	  measurements250.	  
1.3.1. Continuous vs. Discontinuous Propagation in Cardiac Muscle 
Propagation	  of	  electrical	  activity	  in	  the	  heart	  has	  generally	  been	  treated	  as	  though	  it	  occurred	  in	  a	  
homogeneous	  and	  continuous	  medium,	  such	  as	  the	  squid	  axon	  that	  motivated	  the	  pioneering	  work	  
of	   Hodgkin	   and	  Huxley	   in	   195286.	   Spach	   argues	   that	   this	   perspective	   to	   the	   cardiac	  muscle	   came	  
about	  not	  because	  it	  was	  assumed	  to	  be	  anatomically	  or	  histologically	  “continuous”,	  rather	  because	  
the	  continuous	  cable	  theory	  showed	  an	  obvious	  success	  when	  implicated	  in	  excitable	  neurons	  and	  
many	  early	  cardiac	  experiments	  showed	  a	  consistency	  with	   the	  results	   found	   in	  nerves251.	   Indeed	  
there	  are	  palpable	  analogies	  between	  a	  cardiac	   fiber	  and	  a	  continuous	  nerve	  axon,	   that	  have	  been	  
exploited	  in	  the	  modeling	  of	  cardiac	  AP	  propagation252,	  253.	  For	  a	  propagating	  AP,	  the	  distribution	  of	  
transmembrane	  voltage	  ahead	  of	  the	  depolarization	  wave	  front	  is	  the	  outcome	  of	  two	  simultaneous	  
events:	   the	   discharge	   of	   the	   depolarized	   membrane	   and	   redistribution	   of	   inward	   currents246.	  
Increasing	   the	   inward	   flux	   of	   depolarizing	   charges	   will	   raise	   the	   rate	   at	   which	   the	   neighboring	  
quiescent	  tissue	  reaches	  threshold,	  which	  will	  consequently	  fasten	  CV	  in	  the	  medium.	  A	  decrease	  in	  
membrane	   time	   constant	   will	   translate	   into	   a	   decrease	   in	   the	   corresponding	   CV254.	   Computer	  
modeling	  provides	  an	  effective	  framework	  for	  integrating	  experimental	  data	  acquired	  at	  the	  cell	  and	  
molecular	  levels.	  Multiscale	  models	  that	  integrate	  cell	  activation	  models	  within	  a	  3D	  anatomy	  offer	  a	  
means	   of	   simulating	   macroscopic	   scale	   cardiac	   activation.	   Typically,	   these	   finite	   element	   models	  
assume	   electrical	   properties	   to	   be	   continuous	   within	   the	   cell	   and	   across	   gap	   junctions255.	   These	  
assumptions	   will	   tend	   to	   homogenize	   electrical	   activity	   across	   large	   tissue	   volumes,	   which	   can	  
reduce	  the	  efficiency	  of	  these	  models	  to	  detect	  heterogeneity	  in	  activation	  on	  a	  large	  scale246.	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Evidence	  has	  shown	  that	  propagation	  in	  the	  cardiac	  muscle	  rather	  displays	  a	  discontinuous	  nature:	  
Microscopic	   components	   derived	   from	   active	   ionic	   and	   passive	   membrane	   properties,	   and	  
macroscopic	   discontinuities	   reflecting	   branching	   anatomical	   features	   or	   other	   structural	  
heterogeneities,	   can	   produce	   changes	   in	   the	   shape	   of	   the	   AP	   and	   CV,	   characteristics	   of	   cardiac	  
conduction	   that	   cannot	   be	   predicted	   by	   continuous	   propagation	   models256.	   Discontinuous	  
propagation	   implies	   that	   the	   delicate	   local	   source-­‐sink	   balance	   governs	   successful	   conduction,	  
where	  the	  amount	  of	  charges	  supplied	  by	  the	  source	  must	  be	  at	  least	  equal	  to	  the	  charges	  required	  
to	  excite	  the	  cardiac	  membrane	  at	  the	  sink257.	  At	  the	  cellular	  level,	  this	  is	  controlled	  by	  membrane	  
excitability	   followed	  by	   the	  state	  of	  electrical	  coupling	  between	  cells.	  Predictions	  of	  discontinuous	  
propagation	   differ	   extensively	   from	   the	   ones	   predicted	   by	   continuous	   models.	   For	   instance,	   gap	  
junctional	  conduction	  has	  been	  represented	  by	  reciprocal	  values	  of	  simple	  resistors	   in	  continuous	  
models	  of	  propagation.	  Double	  voltage	  clamp	  measurements,	  used	  to	  describe	  the	  kinetics	  of	  single	  
connexins,	   showed	   that	   gap	   junctional	   conductance	   was	   a	   dynamical	   process,	   during	   which	   it	  
increases	  moderately	   immediately	   after	   the	   passage	   of	   the	  wave	   front258.	   Conduction	   is	   therefore	  
relatively	   rapid	   within	   cells	   with	   long	   delays	   across	   junctions	   that	   increase	   progressively	   as	  
coupling	  between	   cells	   is	   reduced.	  These	  key	   features	   are	  necessary	   to	   be	   fully	   captured	   in	  more	  
realistic	   models	   of	   cardiac	   propagation,	   to	   improve	   our	   understanding	   of	   mechanisms	   based	   on	  
propagation	  instabilities	  in	  arrhythmogenesis.	  
	  
In	   the	   ventricular	   myocardium,	   the	   principal	   active	   determinant	   of	   excitability	   is	   probably	   the	  
cardiac	  NaV1.5xv,	  where	  the	  magnitude	  of	  the	  fast-­‐inward	  Na+	  current	  (INa,f)	  plays	  the	  decisive	  role	  in	  
the	  subsequent	  propagation	  of	  the	  electrical	  wave	  from	  the	  source	  location	  further	  across	  the	  tissue.	  
In	   a	   simplistic	   fashion,	   this	   axial	   current	   flows	   along	   the	   cellular	   network	   from	   one	   depolarized	  
myocyte	  to	  its	  quiescent	  neighbor	  via	  gap	  junctions.	  If	  this	  current	  is	  of	  sufficient	  magnitude,	  it	  will	  
depolarize	   the	   resting	   cell	   beyond	   its	   activation	   threshold,	   forcing	  NaV1.5	   channels	   to	   acquire	   an	  
open-­‐state	   conformation	   at	   takeoff	   of	   the	   AP	   upstroke	   for	   ~1ms	   and	   inactivate	   almost	  
instantaneously259.	   Meticulous	   opening	   and	   closing	   of	   the	   cardiac	   ion	   channels	   results	   in	   the	  
generation	   of	   the	   AP,	   ensures	   its	   successful	   propagation,	   maintains	   the	   intricate	   coupling	   of	  
electrical	  and	  mechanical	  activities	  and	  orchestrates	  the	  sequence	  of	  ionic	  channels	  to	  bring	  about	  
the	  lucrative	  termination	  of	  the	  AP260.	  Henceforth,	  abnormalities	  of	  NaV1.5	  expression,	  regulation	  or	  
kinetics	  will	   translate	   into	   cardiac	   instabilities	   that	   induce	   electrical	   vulnerability	   and	   precipitate	  
rhythm	  disturbances.	  
1.3.2. Natural Heterogeneity in the Heart 
The	   early	   investigations	   done	   on	   the	   cardiac	   tissue	  were	   limited	   to	   the	   functional	   data	   gathered	  
from	   either	   Purkinje	   fibers	   or	   from	   the	   ventricular	   myocardium.	   Antzelevitch	   and	   colleagues	  
pioneered	   the	   notion	   that	   heterogeneities	   of	   cellular	   repolarization	   in	   different	   cell	   types	   can	   by	  
itself	   represent	   a	  mechanism	   for	   the	   propensity	   of	   arrhythmia	   in	   pathologies	   that	   are	   associated	  
with	   sudden	   cardiac	   death261,	   262.	   There	   exists	   currently	   ample	   evidence	   that	   the	   ventricular	  
myocardium	   is	   comprised	  of	  3	   functionally	  different	   types	  of	   cells:	   epicardial,	  midmyocardial	   and	  
endocardial,	  which	  exhibit	  distinct	  electrophysiological	  properties	  and	  pharmacological	  profiles263,	  
264.	   The	   relative	   expression	   of	   channels	  mediating	   repolarizing	   currents	   (mainly	   the	  KV	   channels)	  
appears	   to	   contribute	   substantially	   to	   the	   electrophysiological	   heterogeneity	   of	   the	   ventricle,	   and	  
the	   observed	  morphological	   differences	   in	   ventricular	   AP	   at	   different	   sites	   of	   the	  myocardium103.	  
Although	   differences	   between	   action	   potential	   characteristics	   of	   ventricular	   subepicardial	   and	  
subendocardial	   tissues	   have	   long	   been	   recognized,	   systemic	   studies	   tackling	   the	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electrophysiological	   differences	   from	   a	   molecular	   and	   pharmacological	   perspective	   have	   been	  
slightly	   delayed265,	   until	   studies	   by	   Antzelevitch	   and	   colleagues	   highlighted	   the	   differences	   in	   AP	  
morphology,	   ionic	   channels	   and	   pharmacological	   responses	   between	   the	   different	   ventricular	  
layers266.	  They	  emphasized	  on	  the	  role	  played	  by	  the	  transient	  outward	  current	  (Ito,1)	  prominently	  
present	   in	   the	  epicardium,	  but	  not	  endocardium	  in	  generating	   the	  repolarization	  gradient	  and	  the	  
observed	  difference	  in	  rate	  dependency	  of	  the	  APD	  (i.e.	  different	  restitution	  properties)	  across	  the	  
ventricular	   wall267.	   The	   hallmark	   of	   midmyocardial	   cells	   (or	   M-­‐cells),	   which	   lie	   between	   the	  
epicardial	  and	  endocardial	  surfaces	  along	  with	  transitional	  cells,	  is	  the	  ability	  of	  their	  corresponding	  
APD	  to	  exceed	  epicardial	  or	  endocardial	  APD	  in	  response	  to	  different	  factors	  such	  as	  heart	  rate,	  or	  
agents	  that	  normally	  prolong	  the	  APD268,	  269.	  As	  these	  cells	  are	  strongly	  coupled	  to	  one	  another	  in	  the	  
normal	   myocardium,	   the	   repolarization	   gradients	   typically	   found	   in	   isolated	   cells	   from	   different	  
layers	  of	   the	  ventricular	  wall	   are	   smoothed	  out,	   and	   together,	   the	  degree	  of	   electrotonic	   coupling	  
and	   intrinsic	   differences	   in	   APD	   determine	   the	   extent	   of	   the	   spatial	   dispersion	   of	   repolarization	  
(SDR)264,	   270.	   Antzelevitch	   also	   postulated	   that	   although	   spatial	   and	   temporal	   heterogeneity	   is	   a	  
constitutional	  property	  of	  the	  ventricular	  wall,	  amplification	  of	   transmural	  heterogeneities	   leading	  
to	   an	   SDR	   accentuation	   is	   the	   principal	   arrhythmogenic	   substrate	   in	   acquired	   or	   congenital	   SCD	  
syndromes,	  such	  as	  Long	  QT	  (LQTS)xvi264.	  	  
1.3.3. Role of Heterogeneity in Cardiac Pathologies 
The	   role	   of	   functional	   heterogeneity	   has	   only	   started	   to	   unwrap	   in	   the	   context	   of	   cardiac	  
pathologies,	   whether	   acquired	   ones	   (such	   as	   in	   heart	   failure	   (HF)271,	   ischemia272,	   hypoxia273,	  
hyperkalemia274,	   275…	   etc.)	   or	   congenital	   ones	   (such	   as	   in	   LQTS261,	   Brugada	   Syndrome276,	  
Arrhythmogenic	   Right	   Ventricular	   Dysplasia277,	   Catecholaminergic	   Polymorphic	   Ventricular	  
Tachycardia278…	  etc.).	  Experimental	  studies	  done	  on	  arterially	  perfused	  LV	  canine	  wedges	  showed	  
that	   under	   conditions	   where	   intrinsic	   heterogeneity	   was	   amplified,	   triggered	   activity	   further	  
reduced	   the	   net	   repolarizing	   currents,	   making	   the	   ventricular	   wall	   more	   prone	   to	   develop	  
arrhythmias279,	  280.	  Models	  of	  LQTS	  suggest	  that	  preferential	  prolongation	  of	  the	  M	  cell	  APD,	  under	  
conditions	  such	  as	  adrenergic	  stimulation,	  leads	  to	  an	  increase	  in	  the	  QT-­‐interval,	  as	  well	  as	  increase	  
in	  SDR,	  which	  contributes	   to	   the	  development	  of	   spontaneous	  and	  stimulated	  arrhythmias281.	  The	  
investigators	   found	   these	   results	   to	   be	   in	   concordance	   with	   what	   is	   reported	   clinically,	   since	  
sympathetic	  influences	  in	  some	  subtypes	  of	  LQTS	  patients	  is	  known	  to	  increase	  the	  QT-­‐interval	  and	  
precipitate	  ventricular	  arrhythmias282.	  	  
	  
	  	   Prominence	   of	   High	   Resolution	   Optical	   Mapping	   in	   Characterizing	   Heterogeneity.	  
Highly	   complex,	   interactive	   and	   dynamic	   changes	   in	   the	   structural,	   metabolic	   and	  
electrophysiological	   properties	   of	   the	   cardiac	   tissue	   collectively	   predispose	   the	   heart	   to	   lethal	  
electrical	   disturbances.	   Despite	   major	   advances	   done	   on	   the	   molecular	   and	   cellular	   levels	   to	  
characterize	   cardiac	   vulnerability	   to	   arrhythmias,	   the	   effects	   observed	   level	   on	   the	   cellular	   level	  
cannot	  predict	  the	  mechanism	  involved	  in	  facilitating	  arrhythmias	  in	  the	  multicellular	  tissue	  and	  on	  
the	   organ	   level.	   High-­‐resolution	   optical	   mapping	   is	   therefore	   a	   critical	   tool	   to	   measure	   and	  
characterize	  the	  macroscopic	  translation	  of	  these	  molecular	  and	  ionic	  channel	  defects,	  particularly	  
when	  the	  mechanisms	  of	  arrhythmogenesis	  are	  based	  on	  multicellular	  effects	  such	  as	  SDR.	  	  
	  
The	   importance	   of	   using	   optical	   mapping	   measurements	   is	   not	   restricted	   to	   the	   evaluation	   of	  
temporal	   gradients	   in	   the	   heart,	   but	   is	   also	   of	   crucial	   importance	   in	   describing	   global	   effects	   in	  
conduction.	  Conduction	  velocity	  (CV)	  has	  been	  evaluated	  with	  more	  traditional	  tools	  before	  optical	  
mapping,	   the	  results	  of	  which	  have	  been	  considered	  relevant,	  since	   it	  has	  been	  assumed	  that	  only	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xvi	  See	  section	  1.4.3	  for	  more	  details	  on	  Long	  QT	  Syndrome	  (LQTS).	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two	   requisites	   are	   necessary	   to	  measure	   CV	   in	   a	  medium:	   a	   spatial	   component	   (distance)	   over	   a	  
temporal	   one	   (time).	   These	   simplistic	   assumptions,	   although	   contributed	   significantly	   to	   our	  
understanding	   of	   electrical	   conduction	   in	   the	   cardiac	   tissue,	   will	   obviously	   fail	   when	   conduction	  
becomes	  a	  global	  outcome	  of	  heterogeneously	  distributed	  zones.	  For	  instance,	  Cx43xvii	  depletion	  has	  
been	  widely	   investigated	   in	   the	   context	   of	   heart	   failure	   (HF),	  where	   a	   reduction	   of	  ~50%	  of	   this	  
protein	   have	   been	   reported	   in	   end-­‐stage	   HF	   in	   humans283.	   In	   animal	   (murine)	   models,	   high	  
resolution	  mapping	  studies	  revealed	  no	  change	  in	  CV	  with	  Cx43	  depletion	  up	  to	  60%284,	  285.	  However	  
>80%	  Cx43	   depletion	  was	   necessary	   to	   cause	   a	   reduction	   in	   CV,	   an	   altered	   anisotropy286	   and	   an	  
increased	  susceptibility	  for	  ventricular	  tachycardia287.	  Be	  that	  as	  it	  may,	  it	  has	  been	  argued	  that	  such	  
a	  severe	  global	  reduction	  in	  Cx43	  may	  not	  be	  clinically	  attainable	  on	  one	  hand,	  for	  such	  a	  molecular	  
mechanism	   to	   occur	   in	   the	   failing	   human	   heart283.	   On	   the	   other	   hand,	   it	   has	   been	   shown	   that	  
cardiomyopathy	   is	   rather	   associated	   with	   a	   spatially	   heterogeneous	   distribution	   of	   Cx43,	   which	  
ensures	  that	  some	  regions	  of	  the	  failing	  heart	  might	  probably	  reach	  the	  threshold	  depletion	  of	  Cx43	  
at	   which	   impulse	   propagation	   could	   be	   sufficiently	   slowed,	   providing	   therefore	   a	   substrate	   for	  
reentry288.	  In	  this	  regard,	  optical	  mapping	  has	  proven	  to	  be	  a	  fundamental	  experimental	  tool	  in	  the	  
study	   of	   spatially	   extended	   electrophysiological	   heterogeneity	   of	   the	   cardiac	   substrate,	   without	  
which	  appreciation	  of	  the	  complexity	  of	  this	  model	  wouldn’t	  have	  been	  possible.	  
1.3.4. APD Prolongation and Repolarization Reserves 
In	  their	  review,	  Tomaselli	  and	  Zipes	  approach	  APD	  prolongation	  as	  “the”	  cause	  of	  SCD	  in	  HF289.	  The	  
underlying	   molecular	   basis	   of	   APD	   prolongation	   is	   expected	   to	   be	   multifactorial,	   however	  
alterations	   in	   repolarization	   reservesxviii	   or	   Ca2+	   homeostasis	   are	   sufficient	   to	   cause	   APD	  
prolongation	   and	   subject	   the	   patient	   to	   increased	   risk	   of	   SCD32,	   289.	   Prolongation	   of	   the	   APD	   is	   a	  
hallmark	  of	  cells	  and	  tissues	  isolated	  from	  failing	  hearts	  (isolated	  myocytes290	  or	  whole	  ventricular	  
preparations291),	   independent	   of	   the	   underlying	   cause	   that	   originally	   lead	   to	   this	   clinical	   state292.	  
More	  importantly,	  APD	  prolongation	  is	  heterogeneously	  distributed	  across	  the	  ventricles;	  therefore	  
it	   is	   often	  associated	  with	   an	  exaggeration	  of	  physiological	   inhomogeneity	   in	   electrical	  properties	  
forming	   a	   substrate	   for	   functional	   reentryxix	   and	   lethal	   ventricular	   arrhythmias291.	   The	   main	  
repolarizing	  currents	  in	  a	  cardiac	  cells	  are	  the	  ones	  mediated	  by	  distinct	  KV	  channelsxx.	  The	  relative	  
density	  of	  these	  currents	  and	  their	  response	  to	  stress	  varies	  considerably	  in	  different	  regions	  of	  the	  
heart.	  Hence	  prolongation	  of	  APD,	  when	  associated	  with	  down-­‐regulation	  of	   repolarizing	   and	  up-­‐
regulation	  of	  depolarizing	  currents	   lead	   to	   spatially	  and	   temporally	   labile	   repolarization	   that	  may	  
predispose	  to	  afterdepolarization-­‐mediated	  triggered	  activity	  and	  functional	  reentryxxi.	  	  
1.3.5. Triggered Activity and Ectopic Conduction the Heart Muscle 
There	   is	   a	  wide	   agreement	   among	   investigators	   that	   abnormal	   impulse	   generation	   in	   susceptible	  
cells	   could	   initiate	   arrhythmia.	   Triggered	   activity	   is	   one	   example,	   where	   membrane	   voltage	  
oscillations	  are	  generated	  as	  a	  consequence	  of	  a	  prior	  normal	  AP293.	  Triggered	  activity	  travels	  more	  
slowly	   across	   the	   myocardium	   than	   a	   normal	   impulse,	   secondary	   to	   the	   infringement	   of	   the	  
electrical	   excitation	   on	   repolarization294.	   These	   afterdepolarizations	   were	   generally	   described	   by	  
Cranefield	  almost	  forty	  years	  ago	  and	  classified	  into	  two	  categories:	  early	  and	  delayed,	  relatively	  to	  
the	  phase	  of	  the	  AP	  where	  the	  intrusion	  occurs295.	  The	  strong	  association	  between	  triggered	  activity	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xvii	  Refer	  to	  section	  1.2.1	  for	  a	  detailed	  description	  of	  this	  gap	  junctional	  protein.	  	  
xviii	  Loss	  of	  a	  K+	  current	  can	  impair	  repolarization,	  but	  there	  is	  a	  redundancy	  of	  K+	  currents	  in	  a	  normal	  cardiac	  cell	  so	  that	  
when	   one	   K+	   current	   is	   dysfunctional,	   other	   K+	   currents	   increase	   to	   compensate,	   a	   phenomenon	   called	   repolarization	  
reserve	  (Reference:	  Circ.	  Res.	  (1995)	  77:140-­‐152).	  
xix	  Refer	  to	  section	  1.3.7	  for	  a	  description	  of	  the	  difference	  between	  the	  main	  types	  of	  reentry:	  anatomical	  and	  functional.	  	  
xx	  Refer	  to	  section	  1.1.4	  for	  a	  detailed	  description	  of	  repolarizing	  currents	  in	  a	  cardiac	  myocyte.	  
xxi	  See	  section	  1.3.5	  below	  for	  a	  detailed	  description	  of	  EAD	  and	  DAD,	  and	  their	  role	  in	  triggered	  activity.	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and	   arrhythmogenic	   substrates	   leaves	   little	   uncertainty	   that	   such	   events,	   when	   occurring	   in	   the	  
susceptible	  cell,	   could	   lead	  to	  complex	  activation	  patterns	  on	  the	  myocardial	   tissue	   level296	  and	  to	  
arrhythmias	   at	   the	   organ	   level297,	   298.	   Nevertheless,	   despite	   this	   temptation	   the	   translation	   of	  
abnormal	  cellular	  activity	  to	  the	  3D	  multicellular	  heart	  isn’t	  that	  straightforward.	  When	  an	  activity	  
propagates	  the	  excitation	  wave	  front	  is	  a	  source	  of	  depolarizing	  current	  for	  the	  quiescent	  tissue	  to	  
reach	  threshold	  and	  depolarize	  ensuring	  wave	  propagation,	  otherwise	  conduction	  block	  occurs	  due	  
to	   large	  source-­‐sink	  mismatch299.	  Hence	  the	   imperative	  aim	  prevails	  to	  understand	  the	  underlying	  
ionic	   subcellular	   mechanisms,	   the	   role	   of	   cellular	   coupling	   in	   the	   amplification	   of	   single	   cellular	  
events	  and	  the	  effect	  of	   functional	  heterogeneity	   in	  facilitating	  overt	  ventricular	  arrhythmia	  in	  the	  
heart.	  	  
	  
Different	   ionic	  mechanisms	  have	  been	  attributed	   to	  describe	   the	  proclivity	  of	  a	   cell	   to	  develop	  an	  
early	   (EAD)	   or	   delayed	   afterdepolarization	   (DAD),	   which	   may	   lead	   to	   cardiac	   arrhythmias	   in	   a	  
variety	  of	  clinical	  settings300.	  EADs	  are	  secondary	  depolarizations	  that	  occur	  during	  the	  repolarizing	  
phase	   of	   the	   cardiac	   AP	   (end	   of	   phase	   2,	   early	   phase	   3),	   particularly	   prominent	   with	   APD	  
prolongation,	  slow	  heart	  rate	  and	  QT-­‐interval	  prolongation	  on	  the	  ECG301.	  EADs	  have	  been	  induced	  
experimentally	  in	  isolated	  cardiac	  tissues	  under	  a	  variety	  of	  conditions	  that	  either	  enhance	  inward	  
currents	   or	   reduce	   repolarizing	   currents	   (including	   bradycardia297,	   hypokalemia302,	   303,	   reduced	  
(acidic)	   pH304,	   hypocalcemia305,	   hypoxia306	   and	   the	   use	   of	   some	   AADS,	   such	   as	   procainamide307),	  
which	   could	   intuitively	   explain	   repolarization	   delay	   but	   does	   not	   necessarily	   explain	   the	   time-­‐
dependent	   voltage	   oscillations	   that	   are	   characteristic	   of	   EADs.	   In	   generic	   terms,	   it’s	   currently	  
believed	  that	  any	  mechanism	  with	  the	  capacity	  to	  regeneratively	   increase	  net	   inward	  currents	  and	  
by	  doing	   so	   compromises	   the	  myocyte’s	   ability	   to	   repolarize	   could	   trigger	  EADs308.	   In	   the	  voltage	  
range	  of	  EADs,	  two	  currents	  could	  potentially	   fulfill	   these	  properties:	  ICa,L	  and	  INCX.	  Although	  at	  the	  
beginning	  of	  repolarization	  Ca2+	   is	  still	  driven	   inward	  electrochemically,	   ICa,L	  eventually	   inactivates	  
through	  a	  Ca2+-­‐CaM	  dependent	  mechanismxxii,	  once	  [Ca2+]i	  has	  significantly	  declined.	  Normally,	   ICa,L	  
inactivation	   is	   slow	   (~100ms	   at	   0mV)77,	   but	   it’s	   accelerated	   at	   hyperpolarized	   potentials.	   Under	  
circumstances	  where	  repolarization	  reserves	  are	  compromised	  and	  the	  plateau	  phase	  has	  lingered	  
long	  enough	  at	  voltage	   ranges	   that	   facilitate	   recovery	   from	   inactivation308,	   ICa,L	  will	   regeneratively	  
increase	  to	  reverse	  repolarization	  and	  trigger	  the	  EAD	  upstroke309.	  INCX	  could	  play	  either	  a	  primary	  
or	  complementary	  role	  in	  triggering	  EADs255.	  During	  phase	  2	  and	  3,	  INCX	  performs	  in	  the	  direct	  mode	  
with	   a	   net	   inward	   current	   opposing	   repolarization,	   however	   not	   sufficient	   enough	   to	   reverse	   it	  
unless	  [Ca2+]i	  increases.	  Whenever	  the	  initial	  [Ca2+]i	  increase	  is	  mainly	  due	  to	  reactivation	  of	  the	  L-­‐
type	  Ca2+	  channels	  (as	  explained	  above),	  the	  role	  of	  NCX	  is	  considered	  complementary	  in	  facilitating	  
EAD-­‐triggered	   activity.	   Under	   other	   pathological	   conditions,	   [Ca2+]i	   could	   remain	   sufficiently	   high	  
(due	   to	   SR	   leakage	   for	   instance),	   promoting	   primarily	   NCX	   activity	   in	   the	   direct	   mode,	   hence	  
prolonging	  the	  plateau	  long	  enough	  to	  allow	  L-­‐type	  Ca2+	  channels	  to	  recover	  from	  inactivation	  and	  
trigger	   an	   EAD	   upstroke.	   The	   synergistic	   action	   of	   both	   currents	   is	   of	   clinical	   importance,	   since	  
targeting	  either	  current	  alone	  may	  be	  sufficient	  to	  suppress	  EAD	  triggered	  oscillations308.	  	  
	  
DADs	  are	  initiated	  at	  Vrmp	  after	  the	  preceding	  AP	  has	  fully	  repolarized,	  and	  are	  widely	  accepted	  to	  be	  
caused	   by	   Ca2+	   overload,	   such	   as	   during	   spontaneous	   diastolic	   SR	   Ca2+	   release	   events162.	   Unlike	  
EADs,	  DADs	  are	  enhanced	  by	   tachycardia	  and	  slow	  heart	   rates	  suppress	  DAD	   formation310,	  where	  
experiments	   using	   catecholamines298,	   high	   digitalis	   concentrations298,	   311	   and	   hypercalcemia312	  
showed	  an	  increased	  frequency	  of	  DAD-­‐triggered	  activity.	  These	  voltage	  oscillations	  may	  be	  in	  the	  
subthreshold	   range313,	   but	   with	   sufficient	   increase	   [Ca2+]i	   could	   largely	   amplify	   Ca2+-­‐dependent	  
inward	  currents,	  mainly	  INCX,	  and	  Vmbr	  can	  depolarize	  to	  threshold	  values	  leading	  to	  DAD-­‐triggered	  
APs.	  In	  this	  regard,	  EAD	  induction	  with	  INCX	  being	  primarily	  involved	  appears	  to	  be	  mechanistically	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similar	   to	   DAD	   initiation314.	   Because	   DAD	   amplitude	   increases	   as	   the	   preceding	   cycle	   length	  
decreases,	   if	   one	   afterdepolarization	   reaches	   threshold	   and	   causes	   premature	   firing,	   it	   is	   highly	  
probable	  that	  the	  next	  depolarization	  reaches	  threshold	  and	  initiates	  a	  response,	  reinforcing	  a	  self-­‐
sustaining	  rhythm300.	   	  As	  described	  earlierxxiii,	  a	  substantial	  amount	  of	   independent	  couplons	  must	  
be	   activated	   simultaneously	   in	  order	   for	   contraction	   to	  occur,	   since	  Ca2+	  doesn’t	   diffuse	   from	  one	  
cleft	   to	   another	   triggering	   CICR163.	   Hence,	   the	   spontaneous	   SR	   Ca2+	   release	   probably	   needs	   to	  
propagate	  in	  the	  cell	  as	  a	  Ca2+	  wave	  for	  an	  after-­‐contraction	  to	  be	  generated.	  	  
1.3.6. Excitability: A Main Determinant of Conduction in the Heart 
A	  major	  factor	  affecting	  the	  propagation	  of	  the	  cardiac	  impulse	  is	  the	  magnitude	  of	  the	  rapid	  inward	  
Na-­‐current	  (INa,f)315.	  A	  decrease	  in	  this	  current	  is	  expected	  to	  decrease	  both	  the	  maximum	  rise	  of	  the	  
AP	   upstroke	   (dV/dt)max	   and	   CV315.	   For	   a	   single	   cardiac	   cell	   under	   space-­‐clamp	   conditionsxxiv,	   a	  
proportionality	   relation	   between	   (dV/dt)max	   and	   INa,f	   exists:	   all	   Na+	   ions	   entering	   the	   cell	   upon	  
depolarization	  are	  used	  to	  discharge	  the	  local	  capacitance254.	  This	  proportionality	  is	  expected	  to	  be	  
lost	  in	  the	  propagating	  AP	  in	  a	  multicellular	  network,	  because	  the	  depolarizing	  charges	  are	  divided	  
between	  discharging	  the	  local	  capacitance	  and	  depolarizing	  the	  membrane	  of	  downstream	  cells254.	  
One	  factor	  that	  directly	  governs	  CV	  in	  the	  cardiac	  tissue	  is	  the	  rate	  and	  amplitude	  of	  depolarization.	  	  
Arsndorf	  defines	  cardiac	  excitability	  as	  an	  intuitive	  term	  that	  describes	  the	  ease	  with	  which	  cardiac	  
cells	  undergo	  individual	  and	  sequential	  depolarization	  and	  repolarization	  repetitively,	  communicate	  
with	  each	  other	  and	  propagate	  the	  electrical	  signal316.	  These	  events	  can	  be	  summarized	  in	  a	  matrix	  
of	   electrophysiological	   properties,	   which	   includes	   the	   major	   determinants	   of	   normal	   cardiac	  
excitability	  such	  as	  Vrmp,	  active	  and	  passive	  cellular	  properties316.	  	  	  
	  
Ventricular	   cardiac	   cells	   lose	   excitability	   with	   more	   positive	   Vrmp	   and	   generate	   depressed	   fast	  
responses	  (i.e.	  an	  AP	  with	  reduced	  amplitude	  and	  maximum	  upstroke	  velocity	  (dV/dt)max),	  a	  direct	  
consequence	   of	   decreased	   Nav1.5	   availability.	   A	   less	   negative	   Vrmp	   delays	   Nav1.5	   recovery	   from	  
inactivation	   causing	   refractoriness	   to	   lag	   far	   behind	   the	   end	   of	   repolarization,	   in	   contrast	   to	   the	  
normal	   case	   where	   recovery	   of	   excitability	   should	   be	   completed	   by	   the	   end	   of	   repolarization317.	  
Thus	  cells	  with	  decreased	  excitability	  may	  not	  respond	  as	  fast	  to	  the	  next	  stimulus	  after	  the	  end	  of	  
repolarization,	   facilitating	   conduction	   block	   as	   the	   need	   for	   a	   shorter	   time	   to	   complete	  
repolarization	  increases,	  such	  as	  with	  increased	  heart	  rate318.	  	  
	  
Classically,	   rhythm	   disturbances	   have	   been	   classified	   into	   one	   of	   the	   primary	   abnormalities	   in	  
electrical	  activity:	  Either	  an	  abnormality	  of	  impulse	  generation,	  impulse	  propagation	  or	  both313.	  It’s	  
now	  widely	  acceptable	  to	  assume	  that	  under	  appropriate	  conditions,	  most	  if	  not	  all	  cells	  in	  the	  heart	  
can	   become	   foci	   of	   ectopic	   beats	   and	   entrain	   the	   heart	   away	   from	   the	   normal	   sinus	   rhythm293.	  
Unidirectional	   block	   and	   reentry	   have	   been	   described	   as	   the	   underlying	   mechanisms	   behind	  
abnormalities	  in	  impulse	  propagation.	  Since	  the	  refractory	  period	  of	  a	  cardiac	  AP	  is	  relatively	  long	  
(~200ms)	   and	   CV	   in	   cardiac	  muscle	   reasonably	   fast	   (~0.5m.s-­‐1),	   it	  was	   assumed	   that	   the	   loop	   of	  
tissue	   around	   which	   reentry	   occurs	   needs	   to	   be	   quite	   long293.	   Thereafter,	   studies	   on	   depressed	  
responses	  in	  Purkinje	  fibers	  revealed	  that	  under	  specific	  conditions	  cardiac	  impulses	  might	  become	  
sufficiently	   slow	   to	   support	   reentry318.	   It	  was	  generally	   concluded	   that	  all	   that	   is	   essential	   for	   the	  
occurrence	  of	  reentry	  was	  unidirectional	  block,	  i.e.	  some	  asymmetry	  in	  the	  rate	  at	  which	  membrane	  
properties	  change	  as	  a	   function	  of	  distance,	  and	  conduction	  slowing318.	  With	  the	  emergence	  of	  the	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  Refer	  to	  section	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xxiv	  The	  equation	  relates	  the	  transmembrane	  potential	  Vmbr	  to	  the	  total	  transmembrane	  ionic	  current	  (INa,f)	  at	  the	  upstroke	  
and	  states	  that	  the	  changes	  in	  Vmbr	  occur	  due	  to	  displacement	  of	  charges	  on	  the	  membrane	  capacitance	  by	  the	  movement	  
of	  Na-­‐ions	  across	  the	  cell	  membrane,	  where	  (dVmbr/dt)max	  =	  -­‐1/Cmbr	  .	  INa	  (Cmbr	  =	  membrane	  capacitance)	  (Reference:	  Kleber	  
and	  Rudy.	  Physiological	  Reviews	  (2004)	  84:431-­‐488).	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work	   by	   Spach	   and	   colleagues	   in	   1980xxv,	   addressing	   the	   discrepancies	   found	   between	   the	  
continuous	  propagation	  theory	  and	  experimental	  data	  on	  conduction	  in	  the	  cardiac	  tissue,	  coupling	  
excitability,	  the	  rate	  of	  rise	  of	  the	  upstroke	  and	  CV	  has	  become	  more	  complicated	  than	  expected319.	  
1.3.7. The Concept of Reentry  
Under	  normal	  physiological	  conditions,	  the	  conducting	  impulse	  dies	  out	  after	  sequential	  activation	  
of	   the	  atria	  and	  ventricles	  because	  depolarization	   is	   followed	  by	  a	  period	  of	   refraction,	  where	   the	  
tissue	   enters	   temporarily	   inexcitability	   awaiting	   the	   subsequent	   activation	   arising	   from	   the	   SA	  
node21.	  Reentry	  in	  simple	  terms	  means	  that	  “the	  propagating	  impulse	  doesn’t	  die	  out	  after	  complete	  
activation	  of	   the	  myocardium,	  but	  persists	   to	  reexcite	   the	  cardiac	   tissue	  once	   it	   recovers	   from	  the	  
effective	  RP”,	  entraining	  the	  myocardium	  far	  from	  the	  control	  of	  the	  SA	  node320.	  The	  atrial	  effective	  
RP	  is	  approximated	  around	  150ms	  in	  human	  hearts,	  whereas	  the	  ventricular	  one	  is	  much	  prolonged	  
reaching	  500ms321.	  An	  impulse	  destined	  to	  cause	  reentry	  must	  therefore	  survive	  the	  effective	  RP	  by	  
resuming	   conductance	   in	   an	   isolated	  pathway,	  which	   could	  provide	   a	   return	   route	   to	   the	   regions	  
that	  have	  been	  previously	  excited	  and	  must	  be	  sufficiently	  long	  to	  permit	  propagation	  of	  the	  impulse	  
throughout	  the	  RP28.	  Such	  pathway	  with	  a	  normally	  propagating	  impulse	  would	  not	  likely	  to	  exist	  in	  
the	  heart.	  However	  reentry	  would	  still	  be	   likely	   to	  occur,	   if	   such	  an	   impulse	   is	   sufficiently	  slowed	  
down,	   that	   the	   wavelength	   would	   be	   significantly	   shorter28,	   322.	   Such	   a	   pathway	   could	   physically	  
exist	  as	  an	  anatomical	  substrate	  for	  reentry,	  in	  conditions	  where	  fibrosis	  could	  potentially	  isolate	  a	  
part	   of	   the	   cardiac	   tissue	   from	   the	   rest	   of	   the	   heart254.	   However,	   structurally	   normal	   heart	   could	  
conceivably	  harbor	  functional	  substrates	  for	  reentry,	  where	  the	  CV	  of	  the	  traveling	  impulse	  and	  the	  
RP	   of	   the	   designated	   cells	   characterize	   the	   wavelength	   of	   the	   circuit,	   rather	   than	   a	   well-­‐defined	  
anatomical	  barrier254.	  
	  
1.4. The Cardiac Sodium Channel NaV1.5 
The	   central	   selective	   pressure	   for	   voltage-­‐gated	   sodium	   channels	   (NaV)	   has	   consistently	   been	  
preserved	   throughout	   evolution,	   an	   element	   particularly	   preferred	   by	   nature	   when	   high-­‐speed	  
coordination	  and	  communication	  within	  higher	  organisms	  is	  of	  essence78,	  hence	  their	  expression	  in	  
excitable	   tissues	   (brain,	   heart,	   skeletal	   muscle,	   neuroendocrine	   cells…	   etc.).	   A	   canine	   Purkinje	  
myocyte	  expresses	  more	  than	  100,000	  NaV323,	  but	  only	  20,000	  L-­‐type	  Ca2+	  channels324	  and	  relatively	  
fewer	   relevant	   replicates	   of	   each	  KV	   family78.	  NaV	   also	   have	   a	   shy	   presence	   in	   non-­‐excitable	   cells,	  
however	   their	   physiological	   role	   remains	   unclear325.	   	   They	   are	   the	   founding	   members	   of	   the	   S4	  
superfamily	   of	   voltage-­‐gated	   channels326,	   327,	   in	   terms	   of	   their	   discovery	   as	   a	   protein	   and	  
characterization	  of	  their	  genetic	  and	  amino	  acids	  sequences.	  The	  standardized	  nomenclature	  for	  the	  
different	   NaV	   was	   developed	   by	   Goldin	   et	   al.328,	   based	   on	   a	   numerical	   system	   that	   defines	  
subfamilies	  and	  subtypes	  relying	  on	  similarities	  between	  the	  amino	  acid	  sequences	  of	  the	  channels.	  
For	   instance,	   the	   name	   of	   an	   individual	   channel	   consists	   of	   the	   chemical	   symbol	   of	   the	   principal	  
permeating	   ion	  (Na).	  The	  subscript	   in	  NaV	  refers	   to	   the	  main	  physiological	  sensor	  or	  regulator	  (in	  
this	  case:	  voltage).	  The	  number	  following	  the	  subscript	  indicates	  the	  gene	  subfamily	  (currently	  only	  
NaV1	   for	   all	  NaV	   isoforms),	   and	   the	  number	   following	   the	   full	   point	   identifies	   the	   specific	   channel	  
isoform	   (e.g.,	  NaV1.1).	   This	   last	   number	  has	  been	   assigned	   according	   to	   the	   approximate	  order	   in	  
which	   each	   gene	  was	   identified.	  Nine	  mammalian	  NaV	   have	   been	   identified,	   and	   their	   amino	   acid	  
sequences	  aligned	   for	  a	  direct	   comparison,	   to	  possibly	  gain	   insights	  on	   their	  evolutionary	  origins.	  
NaV1.1,	   NaV1.2,	   NaV1.3,	   and	   NaV1.7	   are	   highly	   tetrodotoxinxxvi	   (or	   TTX)-­‐sensitive	   and	   are	   broadly	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xxv	  Discontinuous	  propagation	  in	  the	  cardiac	  tissue	  was	  addressed	  in	  detail	  in	  section	  1.3.1.	  	  
xxvi	  Tetrodotoxin	  (TTX)	  is	  a	  potent	  neurotoxin,	  named	  after	  the	  order	  of	  fish	  from	  which	  it	  is	  most	  commonly	  associated,	  
the	  Tetraodontiformes	  (tetras-­‐four	  and	  odontos-­‐tooth),	  or	  the	  tetraodon	  pufferfish.	  TTX	  inhibits	  NaV	  channels	  in	  a	  highly	  
potent	   and	   selective	   manner.	   It	   blocks	   NaV	   only	   from	   outside	   of	   the	   nerve	   membrane,	   and	   is	   due	   to	   binding	   to	   the	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expressed	  in	  neurons.	  Their	  genes	  are	  all	  located	  on	  human	  chromosome	  2q23-­‐24,	  consistent	  with	  a	  
common	  evolutionary	  origin.	  On	  the	  other	  hand,	  NaV1.5,	  NaV1.8,	  and	  NaV1.9	  are	  also	  closely	  related	  
and	  their	  amino	  acid	  sequences	  are	  greater	  than	  64%	  identical	  to	  those	  of	  the	  four	  sodium	  channels	  
encoded	  on	  chromosome	  2325.	  Their	  genes	  are	  located	  on	  human	  chromosome	  3p21-­‐24,	  consistent	  
with	  a	  common	  evolutionary	  origin326.	  These	  channels	  unlike	  the	  ones	  on	  chromosome	  2	  are	  TTX-­‐
resistant	  to	  varying	  degree.	  The	  reason	  behind	  NaV1.5	  insensitivity	   is	  elaborated	  in	  section	  1.4.	  The	  
isoforms	   NaV1.4	   (chromosome	   17q23-­‐25),	   expressed	   primarily	   in	   skeletal	   muscle,	   and	   NaV1.6	  
(chromosome	   12q13),	   in	   the	   central	   nervous	   system,	   are	   set	   apart	   from	   these	   other	   two	   closely	  
related	   groups	   of	   sodium	   channel	   genes.	   They	   are	   considered	   to	   have	   a	   distant	   evolutionary	  
relationship	   than	   the	   previous	   two	   groups,	   despite	   84%	   similarity	   in	   genetic	   material	   when	  
compared	  to	  the	  ones	  on	  chromosome	  2329.	  	  
1.4.1. Structure, Function and Conformational States 
The	   need	   to	   fully	   characterize	   the	   pathogenesis	   of	   hereditary	   channelopathies	   with	  
electrophysiological	   methods	   has	   further	   strengthened	   the	   need	   to	   understand	   the	   structure-­‐
function	  relationship	  of	  ionic	  channels.	  Almost	  all	  voltage-­‐gated	  ionic	  channels	  are	  highly	  selective:	  
i.e.	   their	   conducting	  pore	   is	  mostly	   permeable	   to	   a	   single	   ionic	   species	   (for	   instance,	  we	  describe	  
NaV1.5	  permeability	   to	   cations	   as	   such:	  Na+>K+>Ca2+)325.	   It’s	  not	   yet	   clear	  how	  particular	   residues	  
could	  confer	  a	  selectivity	  of	  more	  than	  100:1	  in	  favor	  of	  Na+	  over	  other	  cations,	  a	  remarkable	  feature	  
considering	   an	   ionic	   transport	   rate	   that	   exceeds	   107	   ions	   per	   second78.	   Among	   cation	   selective	  
voltage-­‐gated	   channels,	   the	   structure	   of	   the	   pore,	   the	   selectivity	   filter,	   the	   activation	   and	  
inactivation	   gates	   are	   highly	   conserved,	   that	   structure-­‐function	   can	   almost	   be	   deduced	   from	   one	  
channel	  to	  the	  next330.	  In	  simple	  terms	  the	  process	  that	  accounts	  for	  the	  opening	  and	  closing	  of	  ionic	  
channels	   is	   called	   gating73.	   In	   general,	   voltage-­‐dependent	   channels	   can	   assume	   two	   conductance	  
states:	   open	   or	   closed.	   During	   repolarization,	   the	   opening	   probability	   of	   NaV1.5	   is	   normally	  
extremely	   low,	   i.e.	   only	   a	   few	   channels	   open	   randomly.	   Depolarization	   enhances	   activation	   by	  
increasing	  the	  opening	  probability	  of	  the	  channel,	  when	  the	  channel	   is	   initially	   in	  the	  resting	  state	  
and	  fully	  deactivated91.	  Upon	  depolarization,	  several	  voltage-­‐dependent	  sequential	  steps,	  involving	  
the	  movement	  of	  gating	  charges	  through	  the	  membrane,	  are	  needed	  to	  open	  the	  activation	  gate	  and	  
move	  the	  channel	  from	  its	  resting	  state	  to	  the	  conducting	  one331.	  The	  channel’s	  intrinsic	  inactivation	  
occurs	   within	   a	   few	   ms,	   and	   under	   unclamped	   conditions,	   it	   basically	   leads	   to	   membrane	  
repolarization	  even	   in	   the	  absence	  of	   any	  KV330.	  Unlike	  activation,	  which	   requires	   several	   voltage-­‐
dependant	   steps	   preceding	   the	   channel	   conducting	   state,	   the	   inactivation	   gate	   closes	   relatively	  
slowly	  after	  depolarization	  in	  a	  single	  step98.	  For	  some	  ionic	  channels,	  conductance	  is	  sustained	  as	  
long	  as	  membrane	  depolarization	  continues.	  For	  the	  NaV1.5	  channel,	  maintenance	  of	  depolarization	  
beyond	  the	  activation	  time	  of	  the	  channel	  reduces	  open	  probability	  by	  channel	   inactivation	  that	   is	  
no	  longer	  voltage-­‐dependent	  but	  time-­‐dependent,	  leading	  to	  a	  closed	  state	  from	  which	  the	  channel	  
cannot	  be	  activated332.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
selectivity	   filter	   resulting	   in	   prevention	   of	   sodium	   ion	   flow.	   It	   does	   not	   impair	   the	   channel	   gating	   mechanism.	   More	  
recently,	  TTX-­‐resistant	  NaV	  have	  been	  discovered	  in	  the	  nervous	  system	  and	  received	  much	  attention	  because	  of	  their	  role	  
in	  pain	  sensation	  (Reference:	  Proc	  Jpn	  Acad	  Ser	  B	  Phys	  Biol	  Sci.	  2008;84(5):147-­‐154).	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The	   apparent	   voltage-­‐sensitivity	   of	   inactivation	   comes	   from	   the	   fact	   that	   the	   receptor	   of	   the	  
inactivation	  particle	  becomes	  available	  only	  when	  the	  activation	  gate	  is	  fully	  or	  partially	  activated,	  
rendering	  inactivation	  directly	  coupled	  to	  activation333.	  This	  inactive	  state	  is	  a	  non-­‐conducting	  state,	  
different	   from	   the	  one	   taking	  place	   at	   the	   resting	  membrane	  potential,	   since	   inactivated	   channels	  
don’t	  respond	  to	  membrane	  depolarization.	  Among	  the	  NaV1.5	  channel	  population,	  some	  channels	  
move	  from	  the	  resting	  closed	  state	  to	  the	   inactive	  state	  without	  ever	  opening,	  a	   transition	  termed	  
closed-­‐state	   inactivation332,	   a	   fundamental	   gating	   process	   that	   critically	   distinguishes	  NaV1.5	   from	  
other	  NaV	  isoforms.	  Both	  neuronal	  and	  skeletal	  NaV	  exhibit	  far	  less	  closed-­‐state	  inactivation,	  hence	  
remain	  excitable	  at	  more	  depolarized	  resting	  Vmbr	  in	  their	  respective	  tissues100.	  The	  rate	  of	  channel	  
opening	  may	  be	  maximal	  at	   the	  onset	  of	  Vmbr	   change	  or	  delayed,	  with	  direct	   consequences	  on	   the	  
shape	  of	  the	  mediated	  current.	  The	  number	  of	  closed	  states	  that	  precede	  channel	  opening	  determine	  
the	  activation	  kinetics,	  i.e.	  the	  occurrence	  of	  multiple	  closed	  states	  leads	  to	  delays	  in	  activation77.	  To	  
reverse	   inactivation,	   the	   membrane	   potential	   must	   repolarize,	   for	   the	   NaV1.5	   to	   recover	   from	  
inactivation,	   a	   highly	   voltage-­‐dependent	   mechanism	   accelerated	   by	   hyperpolarization.	   This	   is	  
!"
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Figure	  4.	  Nav1.5	  sodium	  channel	  and	  different	  transient	  states.	  a.	  A	  schematic	  topology	  of	  the	  Nav1.5,	  the	  pore	  
forming	  alpha-­‐subunit	  and	  its	  associated	  beta-­‐subunits3.	  Nav1.5	  consists	  of	  4	  domains	  (DI-­‐DIV),	  each	  containing	  6	  
transmembrane	   segments	   (S1-­‐S6).	   All	   S4	   segments	   are	   positively	   charged	   and	   act	   as	   voltage	   sensors,	   the	   concerted	  
movement	  of	  which	  represents	  “voltage	  dependant	  gating”	  that	  precedes	  activation.	  The	  4	  domains	  fold	  around	  an	  ion-­‐
conducting	  pore	  (not	  shown),	  which	  is	   lined	  by	  the	  loops	  of	  the	  S5	  and	  S6	  segments.	  The	  beta	  subunit	   is	  composed	  of	  
one	  transmembrane	  segment.	  The	  DIII-­‐DIV	  interlinker	  contains	  the	  IFM	  motif	  that	  plays	  a	  major	  role	  in	  fast	  inactivation.	  
b.	  The	  state	  diagram	  as	  proposed	  by	  Leblanc	  et	  al.	  for	  the	  sodium	  channel7.	  The	  initial	  closed	  state	  the	  resting	  state,	  
while	  CN	   is	  the	  state	   that	  precedes	   the	  complete	  conductance	  activated	  state	  O.	  Channel	  enters	  the	   inactive	   state	  after	  
depolarization	   and	   doesn’t	   open	   before	   recovery	   from	   repolarization	   occurred.	   The	   C-­‐I	   transition	   may	   occur	   from	  
multiple	   closed	   states,	   however	   resolving	   the	   kinetics	   between	   them	   is	   difficult	   to	   do	  with	   certainty,	   because	   they’re	  
non-­‐conducting7.	  This	  transition	  is	  bidirectional	  and	  leads	  to	  cyclic	  connections	  of	  states,	  by	  the	  restraint	  of	  microscopic	  
reversibility11.	   If	   Vmbr	   is	   abruptly	   returned	   to	   its	   hyperpolarized	   resting	   value	  while	   the	   channel	   is	   open,	   it	   closes	   by	  
deactivation,	  a	  reversal	  of	  the	  activation	  process.	  Pictures	  taken	  from	  references	  as	  noted.	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functionally	   crucial	   for	   the	   stability	   of	   repolarization;	   otherwise	   any	   influx	   of	   Na+	   through	   a	  
conducting	  channel	  would	  be	  capable	  of	   inducing	  depolarization,	  since	  the	  recovery	  process	  takes	  
place	  at	  negative	  voltages333.	  The	  steepness	  of	  voltage	  dependence	  of	  opening	  varies	  among	  voltage-­‐
gated	   channels:	   the	   sodium	   channel	   increases	   its	   activation	   kinetics	   by	   ~e-­‐fold	   (2.73)	   for	   4mV	  
change	   in	   Vmbr	   depolarization,	   whereas	   the	   potassium	   channel	   increases	   by	   an	   e-­‐fold	   for	   5mV	  
depolarization146.	  
	  
Some	  40	  years	  ago,	  Hodgkin	  and	  Huxley	  (HH)	  designed	  a	  mathematical	  model	  that	  accounted	  for	  the	  
different	   transients	   of	   the	   Na+	   channel86.	   More	   complicated	   models	   have	   surged	   in	   parallel	   with	  
more	  extensive	  and	  complex	  electrophysiological	  techniques45,	  334.	  Despite	  these	  advances,	  the	  core	  
of	  HH-­‐model	   is	   still	   considered	  valid335.	  The	  described	   sodium	  conductance	  being	  proportional	   to	  
m3.h,	   where	  m	   (activation)	   and	   h	   (inactivation)	   are	   voltage-­‐	   and	   time-­‐	   dependent	   variables,	   with	  
values	  ranging	  between	  0	  and	  1;	  as	  m	  increases,	  h	  decreases	  otherwise	  no	  current	  flows.	  When	  h~0,	  
inactivation	  is	  complete11.	  At	  resting	  state,	  the	  m	  is	  small,	  h	  is	  relatively	  large,	  such	  that	  the	  product	  
m3.h	  is	  small	  and	  counteracts	  the	  fourth	  power	  of	  the	  activation	  variable	  n	  of	  the	  KV	  channel.	  Resting	  
channels	  have	  the	  m-­‐gate	  in	  the	  closed	  position,	  whereas	  the	  h-­‐gate	  in	  the	  open	  position.	  With	  both	  
gates	  in	  the	  open	  position,	  Na+	  moves	  into	  the	  cell.	  Even	  with	  maintained	  depolarization,	  the	  h-­‐gate	  
moves	   into	   the	   closed	   position,	   terminating	   the	   INa,i.	  With	   repolarization,	   the	  m-­‐gate	   assumes	   the	  
closed	   position	   (a	   process	   of	   only	   a	   few	  ms).	   Relatively,	   a	   substantial	   amount	   of	   time	   is	   needed	  
before	  the	  h-­‐gate	  can	  assume	  the	  open	  position	  (a	  process	  of	  ~100ms)335.	  	  
	  
Over	  the	  last	  20	  years,	  the	  molecular	  analysis	  of	  the	  sodium	  channel	  has	  made	  enormous	  progress,	  
that	   was	   most	   recently	   described	   by	   Caterall326.	   It	   might	   suffice	   here	   to	   summarize	   the	   basic	  
findings.	  The	  human	  cardiac	  NaV	  (hH1)	  is	  composed	  of	  an	  α-­‐pore	  forming	  subunit	  (encoded	  by	  the	  
gene	  SCN5A)	   and	   associated	  β-­‐subunits	   (only	   the	  heart	   and	  brain	  has	  4	   subunits	   bound	   to	   the	  α-­‐
subunit	  by	  disulfide	  bonds336,	  337).	  The	  pore-­‐forming	  α-­‐subunit	  is	  sufficient	  for	  functional	  expression,	  
but	  the	  kinetics	  and	  voltage	  dependence	  of	  channel	  gating	  are	  modified	  by	  the	  subunits,	  which	  also	  
play	   a	   role	   in	   channel	   localization	   and	   interaction	   with	   cell	   adhesion	   molecules,	   ECM,	   and	  
intracellular	  cytoskeleton.	  Although	  NaV1.5	   is	   the	  predominant	  sodium	  channel	   in	   the	  mammalian	  
myocardium,	   studies	   revealed	   that	   notable	   mRNA	   encoding	   NaV1.1,	   NaV1.3	   (both	   predominantly	  
expressed	  in	  the	  brain)338,	  339	  and	  NaV1.4	  (skeletal	  muscle)340	  are	  also	  expressed	  in	  the	  heart.	  Their	  
physiological	  effect	  on	  the	  myocardium	  is	  still	  elusive,	  except	  for	  one	  report	  where	  TTX	  application	  
leads	   to	   APD	   shortening	   in	   canine	   Purkinje	   fibers,	   which	   could	   indicate	   a	   possible	   role	   of	   these	  
isoforms	  in	  the	  generation	  of	  INa,p,	  the	  persistent	  component	  of	  the	  sodium	  current341.	  
	  
Structure	  and	  function	  of	  the	  α-­‐subunit.	  This	  pore	  forming	  subunit	  is	  a	  tetramer	  (domains	  I	  to	  IV,	  
~260kDa),	  where	   each	   domain	   is	   composed	   of	   6	   transmembrane	   α-­‐helices	   (S1-­‐S6)	   connected	   by	  
intra-­‐	  and	  extra-­‐	  cellular	  loops,	  the	  interlinkers342,	  343	  (Figure	  4a).	  The	  α-­‐subunit	  determines	  the	  main	  
characteristics	  of	  ion	  selectivity,	  ion-­‐conducting	  pore,	  the	  voltage	  sensors,	  gates	  and	  binding	  sites	  of	  
endogenous	   and	   exogenous	   substances330.	   All	   NaV	   channels	   α-­‐subunits	   are	   subjected	   to	   post-­‐
translational	   modifications	   such	   as	   glycosylation,	   an	   essential	   step	   for	   the	   maintenance	   of	   cell-­‐
surface	  expression	  of	  NaV	  channels	  in	  excitable	  cells344.	  Unlike	  other	  NaV	  channels,	  which	  are	  heavily	  
glycosylated	  with	  more	   than	   40%	   of	   their	   weight	   attributed	   to	   carbohydrates345,	   only	   5%	   of	   the	  
NaV1.5	  α-­‐subunit’s	  weight	   is	  sugar346.	  The	  reason	  behind	  such	  a	  discrepancy	   is	  still	  unknown.	  The	  
linkers	  between	  segments	  S5	  and	  S6	  in	  each	  domain	  (P-­‐loops),	  denoted	  as	  SS1-­‐SS2	  (the	  N-­‐terminal	  
part	  and	  C-­‐terminal	  part	  respectively),	  form	  the	  pore	  of	  the	  channel.	  A	  combination	  of	  site	  directed	  
mutagenesis	  and	  toxin	  binding	  essays	  showed	  that	  neutralization	  of	  the	  negative	  residues	  found	  in	  
the	  P-­‐region	  abolished	  the	  ability	  of	  positively	  charged	  toxins	  to	  block	  the	  channel,	  which	  suggests	  
that	   the	   P-­‐region	   contributes	   to	   the	   lining	   of	   the	   pore347.	   Initially,	   the	   activation	   gate	   was	  
hypothesized	  to	  physically	  exist	  on	  the	  internal	  side	  of	  the	  permeation	  pathway,	  because	  pore	  lining	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residues	   remain	   accessible	   to	   externally	   applied	   reagents	   regardless	   of	   the	   conformational	   state	  
adopted	  by	  the	  channel348.	  Targeted	  mutations	  of	  the	  S6-­‐segments	  altered	  NaV	  gating	  and	  responses	  
to	   different	   drugs349.	   In	   later	   studies	   done	   on	   the	   KV	   channel,	   the	   S6	   segments	   were	   found	   to	  
physically	  occlude	  the	   inner	  channel	  mouth	  upon	  changes	   in	  voltage350;	  and	  when	  associated	  with	  
the	   previous	   results,	   this	   finding	   suggests	   the	   highly	   probable	   role	   of	   S6	   segments	   acting	   as	   the	  
physical	  activation	  gate78.	  	  Selectivity	  filters	  are	  common	  structures	  in	  voltage-­‐gated	  channels.	  A	  few	  
well-­‐targeted	  alterations	  in	  the	  P-­‐region	  could	  shift	  the	  channel’s	  selectivity351:	  substitution	  of	  lysine	  
and	  alanine	  residues	  with	  glutamate	  made	  the	  NaV1.5	  channel	  selective	  for	  calcium352.	  	  
	  
The	  S4	  α-­‐helices	   in	  all	   four	  domains	  have	  a	   remarkable	   repetitive	   structure	  and	  carry	  arginine	   or	  
lysine	   at	   every	   third	  position,	   the	   intervening	   residues	  being	  hydrophobic343.	  Nevertheless,	   unlike	  
the	   KV	   channels,	   the	   number	   of	   positive	   charges	   carried	   by	   each	   segment	   isn’t	   similar	   and	   the	  
contribution	  of	  each	  of	  the	  four	  S4	  segments	  to	  activation	  is	  markedly	  asymmetrical353,	  354.	  When	  the	  
channel	   is	   assuming	   the	   resting	   state,	   all	   the	   S4	   segments	   are	   pushed	   inward	   by	   the	   negative	  
voltage,	  which	  physically	  prevents	  the	  opening	  of	  the	  activation	  gate355.	  The	  S4	  segments	  being	  the	  
voltage	  sensors	  of	  the	  NaV1.5,	  a	  conserved	  structure	  among	  most	  voltage-­‐gated	  channels356,	  move	  in	  
a	  concerted	  stepwise	  outward	  manner	  during	  activation;	  therefore	  induce	  pore	  opening353,	  355.	  Even	  
when	   the	   channel	   is	   blocked	   pharmacologically,	   the	  movement	   of	   these	   charged	   segments	   in	   the	  
electrical	   membrane	   is	   still	   measurable	   and	   is	   the	   basis	   of	   gating	   currents357.	   The	   asymmetrical	  
dynamics	  of	  the	  S4	  segments	  mediate	  the	  stepwise	  recovery	  from	  inactivation	  during	  repolarization	  
as	  well,	  forcing	  closure	  of	  the	  activation	  gate	  and	  the	  dislocation	  of	  the	  inactivation	  particle	  from	  its	  
receptor	  site	  and	  returning	  the	  channel	  into	  its	  resting	  deactivated	  state259.	  	  
	  
Most	  of	  the	  α-­‐subunits	  expressed	  in	  the	  brain	  and	  the	  skeletal	  muscles	  are	  sensitive	  to	  tetrodotoxin,	  
which	   in	   µM	   concentrations	   blocks	   ion	   flux	   by	   binding	   to	   the	   aromatic	   residues	   of	   DI	   S5-­‐S6	  
interlinker	  and	  occluding	  the	  external	  mouth	  of	  the	  pore.	  NaV1.5	  is	  ~200	  times	  less	  sensitive	  to	  this	  
toxin,	  due	  to	  the	  presence	  of	  a	  cysteine	  residue	  at	  the	  equivalent	  position	  of	  the	  aromatic	  ones	  in	  the	  
other	   NaV	   isoforms358,	   359.	   Finally,	   local	   anesthetics	   (lidocaine),	   antiarrhythmic	   drugs	   (AADs)	   and	  
anticonvulsants360	   bind	   to	   the	   overlapping	   receptor	   sites	   located	   in	   the	   inner	   cavity	   of	   the	   pore.	  
Amino	  acid	  residues	   in	   the	  S6	  segments	   from	  at	   least	   three	  of	   the	   four	  domains	  contribute	   to	   this	  
complex	  drug	   receptor	   site,	  with	   the	  DIV-­‐S6	  segment	  playing	   the	  dominant	   role326.	  The	  affinity	  of	  
the	   receptor	   site	   to	   the	   blocking	   molecule	   has	   been	   the	   subject	   of	   a	   strenuous	   debate.	   Several	  
assumptions	   regarding	   the	   mechanisms	   of	   drug-­‐receptor	   interaction	   were	   made	   from	   early	  
electrophysiological	  observations	  that	  anticipated	  state-­‐dependency,	  from	  which	  two	  models	  were	  
proposed361,	   362	   to	   explain	   the	   mechanism	   of	   action	   of	   AADxxvii.	   While	   these	   major	  
electrophysiological	   hypotheses	   remain	   both	   elegant	   explanations	   for	   the	   data	   gathered	   from	  
cellular	  studies,	  there	  has	  been	  renewed	  interest	  in	  the	  study	  of	  Class	  I	  AADs	  particularly	  after	  the	  
discovery	   that	   NaV1.5	   is	   by	   itself	   an	   elite	   target	   underlying	   many	   sudden	   cardiac	   death	   (SCD)	  
syndromes.	  
	  
Fast	   inactivation	   is	   defined	   by	   the	   rapid,	   almost	   simultaneous	   and	   complete	   decay	   of	   currents	   in	  
response	  to	  the	  couple	  of	  ms	  depolarization.	  It	  derives	  most	  of	  its	  voltage	  dependence	  from	  coupling	  
to	   activation11.	   During	   phase	   2	   of	   the	   AP	   in	   human	   ventricular	   myocytes,	   ~99%	   of	   the	   NaV	  
population	   is	   in	   an	   inactivated,	   non-­‐conducting	   state363.	   It’s	   a	   distinctive	   form	   channel	   closure	  
involving	   the	   outward	  motion	   of	   DIII-­‐S4	   and	  DIV-­‐S4	   in	   particular356.	   Intracellular	   introduction	   of	  
pronasexxviii	  abolished	  inactivation,	  which	  suggested	  the	  presence	  of	  a	  physical	  fast-­‐inactivating	  gate	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xxvii	  Refer	  to	  section	  1.4.7,	  for	  further	  information	  regarding	  the	  two	  models:	  the	  modulated	  receptor	  hypothesis	  and	  the	  
guarded	  receptor	  hypothesis	  that	  were	  proposed	  to	  explain	  AAD	  blocking	  mechanism.	  	  
xxviii	  Pronase:	  proteinsases	  isolated	  from	  the	  extracellular	  fluid.	  It’s	  a	  protein-­‐digesting	  enzyme.	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accessible	  from	  the	  cytoplasm364.	  Based	  on	  these	  results,	  Armstrong	  and	  Bezanilla	  (1973)	  proposed	  
a	   hinged-­‐lid	   model	   for	   the	   fast	   inactivation	   gate364.	   Mutagenesis	   experiments	   confirmed	   the	   Na-­‐
channel	   DIII-­‐DIV	   interlinker	   to	   be	   the	   fast	   inactivation	   gate.	   In	   fact,	   substituting	   glutamine	   for	  
glycine	   in	   that	   particular	   loop	   slows	   channel	   inactivation365,	   and	   leads	   to	   the	   life	   threatening	  
potassium	   aggravated	   myotonia366.	   	   The	   inactivation	   particle	   itself	   consists	   of	   three	   consecutive	  
amino	  acids,	   isoleucine,	  phenylalanine,	   and	  methionine	   forming	   the	  hydrophobic	   IFM	  motif	  or	   lid.	  
Substituting	   IFM	   with	   a	   designed	   triplet	   of	   glutamine,	   abolished	   inactivation	   completely365.	   The	  
hinges	  appear	  to	  be	  a	  pair	  of	  glycine	  and	  proline	  residues	  situated	  in	  the	  vicinity	  of	  phenylalanine.	  
	  
Upon	  prolonged	  depolarization	  NaV1.5progressively	  enter	  the	  slow	  inactivation	  process	  or	  the	  core-­‐
inactivation	  (also	  called	  C-­‐inactivation),	  a	  more	  stable	  non-­‐conducting	  state	   that	  could	  range	   from	  
hundreds	   of	   ms	   to	   many	   seconds367,	   368	   and	   is	   detectable	   even	   when	   fast	   inactivation	   has	   been	  
abolished11.	  The	  molecular	  determinants	  of	  slow	  inactivation	  are	  not	  as	  well-­‐understood	  as	  the	  ones	  
of	   fast	   inactivation,	   however	   the	   S5-­‐S6	   loops	   (P-­‐segments)	   seem	   to	   play	   a	   major	   role369.	   An	  
intermediate	   state	  of	   slow	   inactivation	   (IM)	  develops	   in	  NaV1.5	  with	  a	   time	   course	   relevant	   to	   the	  
duration	  of	  depolarization370.	  
	  
Structure	   and	   function	   of	   the	   β-­‐subunits.	   So	   far,	   NaV1.5	   (with	   other	   brain	   isoforms)	   has	   been	  
identified	  to	  have	  4-­‐associated	  β-­‐subunits337	  (encoded	  by	  four	  genes	  SCN1B	  to	  SCN4B)	  that	  modify	  
channel	   function	  and	  mediate	  protein-­‐protein	   interactions.	  All	  β-­‐subunits	  contain	  a	  cleaved	  signal	  
sequence,	   an	   extracellular	   immunoglobin-­‐like	   fold,	   a	   transmembrane	   segment,	   and	   a	   short	  
intracellular	  C-­‐terminal	  tail.	  A	  notable	  difference	  is	  that	  β1	  and	  β3	  are	  noncovalently	  associated	  with	  
the	  α-­‐subunit	  and	  have	  four	  cysteine	  residues	  in	  their	  immunoglobin-­‐like	  fold371,	  whereas	  β2	  and	  β4	  
have	  five	  extracellular	  cysteines,	   i.e.	   their	   fold	  contain	  an	  unpaired	  cysteine,	  which	  allows	  them	  to	  
form	   disulfide	   bonds	   with	   the	   α-­‐subunit372.	   The	   β-­‐subunits	   display	   several	   important	   functional	  
properties.	  For	  instance,	  it	  was	  shown	  that	  NaV	  loses	  its	  fast-­‐gating	  kinetics,	  when	  the	  α-­‐subunit	  was	  
expressed	   alone373	   in	   Xenopusxxix	   oocytes374.	   Coexpression	   of	   the	   β-­‐subunits	   (mainly	   β1	   and	   β2)	  
resulted	   in	   a	   substantial	   acceleration	   of	   the	   rate	   of	   inactivation372.	   Nevertheless,	   a	   β4-­‐subunit	  
mutation	  was	  reported	  in	  a	  patient	  who	  presented	  with	  a	  LQTS3	  electrocardiographic	  phenotypexxx,	  
where	   the	   mechanism	   seems	   to	   be	   a	   non-­‐inactivating	   NaV1.5	   or	   an	   increased	   persistent	   INa,p375.	  
Three	  other	  mutations	  were	  identified	  in	  the	  β1-­‐subunit	  of	  NaV1.5	  in	  a	  population	  of	  patients,	  who	  
presented	   with	   Brugada	   syndrome	   (BrS)	   and	   idiopathic	   cardiac	   conduction	   disease	   (ICCD)	  
phenotypesxxxi	   without	   any	   mutation	   detected	   in	   the	   SCN5A	   gene376.	   β-­‐subunit	   mutations	   of	   the	  
brain	   channel	   isoform	   have	   been	   documented	   in	   human	   diseases	   such	   as	   generalized	   epilepsyxxxii	  
with	  febrile	  seizures377,	  378.	  	  
1.4.2. Modulation of the Cardiac Na-Channel (NaV1.5) 
Meticulous	  opening	  and	  closing	  of	   cardiac	   ion	  channels	   result	   in	  generation	  of	  AP,	  propagation	  of	  
the	   electrical	   excitation,	   then	   repolarizaton;	   an	   electrical	   activity	   is	   coupled	   to	   contraction	   and	  
relaxation.	   Besides	   genetic	  mutations,	   developmental	   and	   acquired	   ones	   can	   ultimately	   affect	   the	  
genetic	  expression	  of	  the	  tissue	  restricted	  Na-­‐channels.	  For	  instance,	  abnormal	  electrical	  patterns	  or	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xxix	  Expression	  cloning	  using	  Xenopus	  oocytes,	  since	  being	  pioneered	  in	  1971,	  has	  been	  proven	  to	  be	  highly	  satisfactory	  tool	  
for	  the	  structural	  and	  functional	  identification	  of	  proteins	  of	  all	  origins.	  The	  Xenopus	  oocyte	  is	  able	  to	  efficiently	  transcribe	  
and	   translate	   injected	   genetic	   information,	   perform	   assembly	   of	   the	   foreign	   protein	   products,	   correctly	   process	   the	  
resulting	  polypeptides,	  and	  target	  them	  to	  their	  proper	  subcellular	  compartments	  (Markovich,	  2007).	  	  
xxx	  See	  section	  1.4.3	  for	  the	  description	  of	  long	  QT	  Syndrome,	  LQTS3.	  
xxxi	  	  See	  section	  1.4.5	  for	  the	  description	  of	  Brugada	  Syndrome	  (BrS)	  and	  idiopathic	  cardiac	  conduction	  disease	  (ICCD).	  
xxxii	  Generalized	  epilepsy	  with	  febrile	  seizures	  is	  a	  recently	  described	  epilepsy	  syndrome,	  comprising	  febrile	  seizures	  with	  
childhood	  onset	   (~1year),	  but	  unlike	   typical	   febrile	  convulsions,	  attacks	  with	   fever	  continue	  beyond	  6	  years	  of	  age	  and	  
afebrile	  seizures	  start	  to	  cease	  by	  puberty.	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epilepsy	  can	  alter	  NaV	  gene	  expression	  in	  the	  brain78,	  379.	  Chronic	  exposure	  to	  Na-­‐blocking	  AADs	  was	  
found	  to	  increase	  steady	  state	  NaV1.5	  mRNA,	  which	  could	  tend	  to	  counteract	  the	  effects	  of	  channel	  
blockade,	  a	  probable	  factor	  mediating	  resistance	  to	  treatment	  and	  facilitating	  proarrhythmic	  effects	  
of	   AADs	   upon	   withdrawal380.	   Alterations	   in	   cell-­‐cell	   coupling,	   heart	   disease	   congenital	   channel	  
abnormalities,	   drug	   interventions	   or	   electrolyte	   imbalance	   could	   manifest	   themselves	   as	   an	  
abnormal	   electrical	   activity.	   In	   channelopathies,	   mutations	   can	   affect	   the	   functional	   or	   accessory	  
subunits	   or	   modulatory	   proteins381.	   In	   this	   thesis	   work,	   two	  models	   of	   NaV1.5	   abnormalities	   are	  
investigated:	  the	  first	  one	  is	  a	  model	  of	  Duchenne	  muscular	  dystrophy,	  where	  the	  NaV1.5	  regulatory	  
protein	  dystrophin	  is	  deficient	  (introduced	  in	  section	  1.2.2);	  whereas	  the	  second	  is	  a	  model	  of	  long-­‐
QT	  syndrome	  (LQTS),	  where	  the	  mutated	  protein	  is	  the	  sodium	  channel	  itself	  (introduced	  in	  section	  
1.4.3).	  	  
Electrocardiographic	   (or	   ECG)	   abnormalities.	   Morphological	   changes	   in	   cellular	   AP	   are	  
translated	  into	  changes	  that	  appear	  on	  the	  body	  surface	  ECG,	  a	  signal	  that	  represents	  the	  vectorial	  
projections	   of	   the	   overall	   cardiac	   spatial	   and	   temporal	   electrical	   gradients	   generated	   at	   different	  
phases	  of	  the	  AP382.	  Atrial	  depolarization	  precedes	  ventricular	  depolarization	  and	  it’s	  manifested	  as	  
a	   low-­‐frequency	   P-­‐wave	   that	   precedes	   the	   peaked	   QRS	   signal,	   the	   latter	   is	   indicative	   of	   the	   high	  
frequency	   components	  of	   the	  bulkier	   ventricular	  muscle	  depolarization1.	  The	  T-­‐wave	   that	   follows	  
the	  QRS	  complex	  represents	  ventricular	  repolarization.	  For	  instance,	  widening	  of	  the	  QRS	  complex	  
beyond	   120ms	   (in	   adult	   humans)	   is	   indicative	   of	   conduction	   slowing	   across	   the	   ventricles.	   ST	  
elevation	   correlates	   with	   increased	   transmural	   voltage	   gradients	   during	   phase	   2	   of	   the	   AP,	   a	  
hallmark	  of	  myocardial	   injury,	   such	  as	   the	  one	  occuring	  during	  an	  acute	  episode	  of	  a	  heart	  attack	  
(myocardial	  ischemia)383.	  APD	  prolongation	  results	  in	  a	  prolonged	  QT	  interval,	  which	  may	  or	  not	  be	  
associated	   with	   T	   wave	   abnormalities,	   considerably	   increasing	   the	   risk	   of	   developing	   lethal	  
arrhythmias,	  syncopexxxiii	  and	  SCD384.	  	  
1.4.3. Genetic mutations of NaV1.5: The Long QT Syndrome 
LQTS	  is	  a	  collection	  of	  cardiac	  disorders	  characterized	  by	  a	  prolongation	  of	  the	  QT-­‐interval	  on	  the	  
ECG	  and	  can	  be	  divided	  clinically	   into	   two	  categories:	  primary	  and	   secondary385.	   Secondary	  LQTS	  
generally	   results	   from	   either	   pharmacological	   interventions	   aiming	   at	   treating	   non-­‐cardiac	   or	  
cardiac	   diseases386,	   electrolytes	   disorders	   (hyperkalemia)387	   or	   acquired	   cardiac	   diseases	  
(cardiomyopathies,	  ischemia)385.	  Primary	  LQTS	  is	  predominantly	  due	  to	  inherited	  genetic	  mutations	  
of	  the	  cardiac	  K+	  and	  Na+	  channels	  (and	  other	  regulating	  proteins),	  and	  so	  far	  more	  than	  ten	  genes	  
have	  been	  implicated	  in	  the	  disease388.	  The	  variant	  3	  of	  LQTS	  (LQTS3)	  is	  caused	  by	  a	  mutation	  in	  the	  
gene	  encoding	  for	  the	  α-­‐subunit	  of	  the	  cardiac	  sodium	  channel389.	  Eighty	  different	  SCN5A	  mutations	  
have	  been	  identified	  in	  LQTS3	  patients	  so	  far390,	  hence	  different	  mechanisms	  were	  described	  trying	  
to	  explain	  QT	  interval	  prolongation.	  	  	  
	  
The	  first	  genetic	  defect,	  positioned	  at	  the	  short	  arm	  of	  chromosome	  3	  (3p21-­‐24)391,	  was	  detected	  in	  
patients	  with	  an	  autosomal	  dominant	  form	  of	  LQTS3392.	  This	  mutation	  is	  severe	  enough	  to	  cause	  a	  
deletion	   of	   nine	   bases	   coding	   for	   lysine-­‐1505,	   proline-­‐1506	   and	   glycine-­‐1507	   in	   the	   DIII-­‐DIV	  
intracellular	   linker392.	   The	   loss	   of	   those	   amino	   acids,	   termed	   as	   the	   ∆KPQ	  mutation393,	   induces	   a	  
disruption	  of	  the	  motif	  crucial	  for	  the	  fast	  inactivation	  of	  NaV1.5,	  hence	  results	  in	  a	  persistent	  non-­‐
inactivating	  current394,	  typically	  ranging	  between	  0.5-­‐2%	  INa,i395,	  396.	  This	  gain	  of	  function	  or	  bursting	  
mutation	  leading	  to	  altered	  gating	  highlights	  the	  critical	  role	  of	   fast	   inactivation	  in	  the	  cardiac	  Na-­‐
channel	   isoform	   in	   the	   preservation	   of	   the	   normal	   electrical	   function,	   when	   compared	   to	   its	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xxxiii	   Cardiac	   syncope	   is	   defined	   as	   sudden	   loss	   of	   consciousness,	   with	   momentary	   premonitory	   symptoms	   or	   without	  
warning,	   due	   to	   cerebral	   anemia	   caused	  by	  obstructions	   to	   cardiac	   output	   or	   arrhythmias	   such	   as	   ventricular	   asystole,	  
extreme	  bradycardia	  (heart	  rate	  <	  45-­‐50),	  or	  ventricular	  fibrillation	  (Webster	  Medical	  Dictionary).	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  Introduction	  
muscular	   or	   neural	   counterparts	   that	   exhibit	   far	   less	   inactivated	   states73.	   First	   and	   foremost,	  
activation	  of	  NaV1.5	  is	  sharply	  voltage-­‐dependent.	  However,	  inactivation	  is	  also	  a	  voltage-­‐dependent	  
process	   and	   some	   of	   these	   channels	   normally	   undergo	   closed-­‐state	   inactivationxxxiv,	   without	   ever	  
opening	   upon	   membrane	   depolarization327.	   When	   membrane	   voltage	   lingers	   at	   depolarizing	  
potentials	  such	  as	  the	  plateau	  phase,	  present	  estimates	  reveal	  that	  99%	  of	  NaV1.5	  are	  expected	  to	  be	  
in	  the	   inactivated,	  non-­‐conducting	  state363,	   395.	  The	  remaining	  1%	  could	  be	  open	  during	  phase	  2	  of	  
the	  AP	  and	  mediate	  the	  late	  inward	  Na-­‐current	  (INa,late)xxxv.	  The	  probability	  of	  NaV1.5	  opening	  during	  
this	   phase	   can	   be	   determined	   by	   the	   overlap	   of	   the	   steady	   states	   activation	   and	   inactivation	  
Boltzman	   curves118.	   This	   voltage	   window	   has	   two	   important	   implications	   on	   the	   kinetics	   and	  
molecular	  contingency	  of	  NaV1.5:	  First,	  there	  exists	  a	  finite	  possibility	  that	  inactivation	  is	  reversible	  
at	   depolarizing	   voltages	   (i.e.	   a	   finite	   population	   of	   inactivated	   channels	   can	   reopen	   during	   the	  
plateau).	   Second,	   an	   upregulation	   of	   the	   window	   current	   or	   INa,late	   could	   inflict	   a	   calamitous	  
prolongation	  of	   the	  AP106.	  This	   small	   amplitude	  current	  has	  been	  described	   in	  normal	  hearts,	   and	  
appears	   to	   be	   amplified	   in	   disease	  models	   such	   as	   heart	   failure397.	   Eminently,	   the	   presence	   of	   an	  
inwardly	   leaking	   INa,late	   will	   counteract	   the	   repolarizing	   reserve,	   thereby	   either	   delaying	  
repolarization	  or	   inducing	  afterdepolarizations309xxxvi.	  However,	   considerable	  details	   regarding	   the	  
nature	  of	   INa,late	  remain	  unresolved.	  Does	  this	  current	  result	   from	  channels	   that	   failed	  to	   inactivate	  
after	   the	  upstroke	  (i.e.	   this	   late	  current	   is	  a	  remnant	  or	  a	  sustained	  component	  of	   the	   fast	   inward	  
INa,f)	  or	  from	  channels	  that	  underwent	  reverse	  inactivation,	  or	  both?	  
	  
Another	   example	   of	   altered	   gating	   was	   proposed	   when	   the	   behavior	   of	   channels	   harboring	   the	  
E1295K	   mutationxxxvii	   didn’t	   seem	   to	   match	   well	   with	   the	   mechanism	   induced	   by	   the	   ∆KPQ	  
mutation398.	   In	   this	  particular	  case	  of	  LQTS3,	  glutamic	  acid	  (E1295)	  was	  mutated	   into	  a	  positively	  
charged	   lysine	   in	   the	  4-­‐amino	  acid	  extracellular	   loop	  connecting	   the	  S3-­‐S4	  segments	  of	  DIII.	   S4	   is	  
one	  of	   the	  voltage	  sensors	   for	  activation	  gating	  process	  of	   the	  channel356,	  and	  E1295	   is	   the	  amino	  
acid	  closest	  to	  DIII-­‐S4326.	  Instead,	  the	  mutation	  induced	  a	  positive	  shift	  in	  the	  half	  maximal	  voltage	  of	  
steady	   state	   inactivation	   and	   activation,	   a	   shift	   of	   the	   window	   current	   to	   voltages	   where	   the	  
repolarizing	   currents	   are	   not	   freed	   from	   their	   rectificationxxxviii	   constraints	   and	   hence	   unable	   to	  
counteract	   the	   effects	   of	   NaV1.5	   reopening398.	   A	   third	   mechanism	   implicated	   in	   LQTS3	   was	  
associated	   with	   the	   I1768V	   mutation,	   which	   also	   didn’t	   point	   to	   a	   bursting	   effect	   of	   the	   NaV1.5	  
channel363,	   399.	   This	   mutation,	   located	   within	   the	   DIV-­‐S6	   transmembrane	   segment,	   results	   in	   the	  
substitution	   of	   valine	   instead	   of	   isoleucine363	   and	   increases	   the	   availability	   of	   NaV1.5	   during	  
repolarization,	  by	  enhancing	  the	  capacity	  of	  the	  channel	  to	  recover	  from	  inactivation	  at	  a	  range	  of	  
membrane	   voltages	   that	   actually	   favors	   the	   activation	   transition,	   i.e.	   at	   diastolic	   membrane	  
potentials400.	  
1.4.4. Spatial Dispersion of Repolarization: An Arrhythmogenic Mechanism 
Studies	  in	  the	  past	  two	  decades	  have	  shed	  the	  light	  on	  the	  natural	  heterogeneity	  that	  exists	  within	  
the	   normal	   ventricular	   wall,	   which	   comprises	   of	   at	   least	   three	   electrophysiologically	   and	  
functionally	   different	   cell	   types:	   epicardial,	   midmyocardial	   and	   endocardial401.	   The	   principal	  
difference	  between	  these	  cells	  is	  believed	  to	  reside	  in	  the	  ionic	  machinery	  available	  for	  each	  type262,	  
402.	  When	  isolated,	  the	  resulting	  APDs	  appear	  to	  deviate	  significantly	  in	  magnitude268.	  However,	  this	  
dispersion	  seems	  to	  smooth	  out	   in	   the	   intact	  myocardium,	  mainly	  due	  to	  electrotonic	   interactions	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xxxiv	  Refer	  to	  section	  1.4.1,	  for	  a	  description	  of	  the	  different	  conformational	  and	  functional	  states	  of	  NaV1.5.	  
xxxv	  Refer	  to	  section	  1.1.4,	  for	  a	  description	  of	  the	  late	  Na-­‐current	  and	  its	  infliction	  on	  AP	  prolongation.	  
xxxvi	  Refer	  to	  section	  1.3.5,	  for	  a	  description	  of	  triggered	  activity	  and	  afterdepolarizations.	  	  
xxxvii	   The	   standard	   nomenclature	   to	   describe	   a	   point	   mutation	   is	   used	   such	   that	   A****B	   describes	   that	   an	   amino	   acid	  
residue	  A	  is	  replaced	  by	  the	  residue	  B	  at	  position	  ****	  (*	  is	  a	  number).	  	  
xxxviii	  Ionic	  current	  rectification	  was	  introduced	  in	  section	  1.1.4.	  
The	  Cardiac	  Sodium	  Channel	  NaV1.5	   	   	   	  	  39	  
between	   the	  different	  cells	   types,	   causing	   the	  gradual	  decrease	   in	  APD	  across	   the	  ventricular	  wall	  
from	  endocardium	  to	  epicardium257.	  It’s	  now	  widely	  accepted	  that	  the	  degree	  of	  electrical	  coupling,	  
in	  addition	  to	  the	  intrinsic	  differences	  in	  APD	  determines	  the	  extent	  to	  which	  spatial	  dispersion	  of	  
repolarization	   (SDR)	   is	   enunciated	   in	   the	   ventricular	  myocardium270.	   One	   of	   the	   arrhythmogenic	  
mechanisms	  proposed	   for	   the	  LQTS	   substrate	   is	   amplification	  of	   the	   SDR,	  which	  when	  present	   in	  
either	   early	   or	   late	   phases	   of	   the	   AP	   can	   lead	   to	   the	   development	   of	   a	   variety	   of	   arrhythmia403.	  
Altered	  SDR	  has	  been	  associated	  with	  arrhythmogenicity	  in	  cases	  of	  electrolytes’	  imbalance	  (such	  as	  
hypokalemia404)	   or	   in	   genetically	   manipulated	   hearts	   lacking	   repolarizing	   K+	   currents405.	  
Amplification	   of	   intrinsic	   heterogeneity	   together	   with	   premature	   impulses	   could	   principally	  
underlie	   the	  mechanistic	   trigger	   for	   ventricular	   arrhythmias	   in	   cardiac	   pathologies	   such	   as	   heart	  
failure271	  and	  “Torsades	  de	  pointes”	  in	  LQTS3406.	  
	  
The	   concept	  of	  heterogeneous	   repolarization,	   as	   a	   facilitator	  of	   arrhythmogenic	   activity,	   has	  been	  
recognized	   for	  more	   than	   four	  decades407-­‐409.	   Even	   in	   the	   absence	  of	   any	   structural	   heterogeneity	  
due	  to	  infarction	  for	  instance,	  intrinsic	  spatial	  variations	  in	  repolarization	  currents	  in	  the	  heart	  have	  
been	   shown	   to	   produce	   spatial	   gradients	   in	   APD410.	   Experimental	   work,	   including	   mapping	  
experiments	  using	  extracellular	  electrodes,	  have	  shown	  significant	  SDR	  in	  arrhythmogenic	  diseases,	  
such	   as	   Long	   QT	   Syndrome	   (LQTS)	   and	   Brugada	   Syndrome261,	   264.	   When	   transmembrane	  
repolarization	   at	   some	   sites	   of	   the	   cardiac	   tissue	   outlasts	   repolarization	   at	   adjacent	   sites,	   local	  
current	  will	  flow	  in	  proportion	  to	  the	  voltage	  gradient	  between	  the	  two	  sites411.	  If	  the	  current	  is	  of	  
sufficient	  magnitude,	   it	   can	  reexcite	   the	  earlier	   repolarizing	  site	  by	  bringing	   the	  cells’	  potential	   to	  
threshold.	  Hence,	  marked	  differences	  in	  APD	  have	  been	  suggested	  to	  induce	  a	  special	  type	  of	  reentry	  
termed	  “focal	  reexcitation”30,	  407,	  412	  and	  “prolonged	  repolarization-­‐dependent	  rexcitation”413	  
1.4.5. Other Mutations of NaV1.5 and Heterogeneous Phenotypes 
A	  distinct	   class,	   previously	   referred	   to	   as	   idiopathic	   ventricular	   fibrillation,	   has	  been	   attributed	   to	  
NaV1.5	   loss	   of	   function	  mutation414,	   and	  underlies	   the	  Brugada	   Syndrome	   (BrS)	   phenotype415.	   BrS	  
has	   characteristic	   ECG	   manifestations	   with	   a	   right	   bundle	   branch	   block	   morphologyxxxix,	   an	   ST-­‐
elevation	  in	  left	  precordial	  leads,	  associated	  with	  ventricular	  tachycardia	  and	  fibrillation	  resulting	  in	  
SCD416.	  Unlike	  LQTS3,	  BrS	  characteristically	  causes	  a	  reduction	  in	  INa,	  which	  occurs	  through	  a	  variety	  
of	  proposed	  mechanisms390:	   reduced	   rates	  of	   recovery	   from	   inactivation	   (which	  decreases	  NaV1.5	  
availability	   for	   subsequent	   beats),	   enhanced	   inactivation	   subsequent	   to	   channel	   opening,	   and	  
protein	   trafficking	   defects	   that	   alter	   NaV1.5	   localization	   in	   the	   sarcolemma417.	   Studies	   on	   the	   BrS	  
NaV1.5	   mutations	   revealed	   that	   a	   particular	   mutation	   (T1620M)	   increased	   the	   tendency	   of	   the	  
channel	   to	   reside	   in	   the	   intermediate	   state	   of	   slow	   inactivation348,	   implying	   a	   loss	   of	   function	  
attributed	  to	  the	  decreased	  availability	  of	  the	  channels	  at	  fast	  heart	  rates418.	  	  
	  
Isolated	  cardiac	  conduction	  disease	  (ICCD)	  is	  a	  phenotype	  tracked	  down	  to	  a	  loss	  of	  function	  SCN5A	  
mutation	   (G514C)	   in	   the	   DI-­‐DII	   interlinker419.	   ICCD	   is	   characterized	   by	   a	   slowing	   of	   conduction	  
throughout	  the	  myocardium,	  which	  manifests	  itself	  by	  a	  widening	  of	  the	  QRS	  complex,	  bradycardia	  
and	   possibly	   syncope419,	   420.	   Heterologous	   expressionxl	   of	   the	   mutated	   channel	   uncovered	   a	  
depolarizing	   shift	   in	   the	   voltage	   dependence	   of	   NaV1.5	   activation;	   hence	   stronger	   depolarization	  
gradients	   are	   required	   to	   open	   the	   channel.	   This	   shift	   could	   likely	   result	   from	   an	   inherited	  
insensitivity	  of	  NaV1.5	  to	  Vmbr	  changes	  delaying	  opening	  of	  the	  channel	  and	  pushing	  the	  peak	  of	  the	  
INa,i	  to	  more	  depolarized	  membrane	  potentials419,	  420.	  Such	  a	  delay	  is	  expected	  to	  cause	  a	  ubiquitous	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xxxix	  Right	  bundle	  branch	  block	  is	  attributed	  to	  a	  decrease	  in	  electrical	  conduction	  velocity	  in	  the	  Purkinje	  fibers	  forming	  
the	  right	  bundle	  branch.	  It	  has	  a	  characteristic	  QRS	  morphology	  on	  the	  ECG.	  	  
xl	  Heterologous	   expression	   is	   to	   express	   a	   gene	  or	   a	  part	   of	   a	   gene	   in	   a	  host	   organism,	  which	  under	  normal	   conditions	  
doesn’t	  express	  this	  particular	  gene	  or	  fragment.	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decrease	   in	   (dV/dt)max,	  which	  most	  probably	  underlies	   the	  15%	  depression	   in	  myocardial	  CV	  and	  
contributes	   to	   the	   bradyarrhythmia	   phenotype419,	   currently	   treated	   with	   implantation	   of	   a	  
pacemaker.	  	  
	  	  
Further	   insights	   into	   the	  heterogeneity	   of	   pathological	  manifestations	   of	   diseases	   associated	  with	  
NaV1.5	   abnormalities	   were	   gained	   from	   individuals	   who	   appeared	   to	   have	   heart-­‐rate	   dependent	  
LQTS	  and	  BrS	   features:	   the	  QT-­‐interval	   is	  prolonged	  at	   slow	  hearts	   and	  a	  distinctive	  ST-­‐elevation	  
occurs	   during	   exercise	   or	   at	   faster	   heart-­‐rates421.	   More	   interestingly,	   a	   single	   NaV1.5	   mutation	  
(179insD)	  with	   an	   aspartic	   acid	   insertion	   in	   the	   carboxylic	   terminal	   was	   shown	   to	   contribute	   to	  
these	  opposite	  effects421,	  by	  affecting	  the	  two	  distinct	  kinetic	  components	  of	  NaV1.5	  inactivation.	  The	  
mutation	   disrupts	   the	   fast	   component	   of	   inactivation,	   generating	   a	   persistent	   Na+	   current	   INa,p	  
(~1.4%	   INa,i)370	   throughout	   the	   plateau,	   hence	   prolonging	   the	   QT-­‐interval	   at	   slow	   heart	   rates.	   In	  
addition,	   it	   simultaneously	   enhances	   the	   intermediate	   kinetics422	   of	   slow	   inactivationxli	   in	  
depolarized	   NaV1.5,	   during	   sustained	   depolarization,	   thereby	   reducing	   the	   availability	   of	   NaV1.5	  
primarily	  at	  rapid	  heart	  rates,	  which	  could	  explain	  ST-­‐elevation	  on	  ECG	  during	  exercise421,	  423.	  	  
	  
Substantial	   increase	   in	   the	   probability	   that	   the	   channel	   would	   slow-­‐inactivate	   at	   depolarization	  
pulses	  within	   the	   cardiac	  APD	   (~100-­‐200ms),	   implies	   that	   fewer	   channels	  would	  have	   recovered	  
from	   inactivation	   at	   rapid	   heart	   rates,	   where	   hyperpolarized	   diastolic	   intervals	   are	   narrow370,	   a	  
characteristic	   finding	   in	   loss	  of	   function	  mutations424.	   	  Notably,	   studies	   involving	  NaV1.5	   gating	   in	  
myocytes	   isolated	   from	   epicardial	   regions	   bordering	   a	   5-­‐day	   infarcted	   zone	   in	   the	   canine	   heart	  
reveal	   a	   delay	   in	   recovery	   from	   inactivation,	   with	   enhancement	   NaV1.5	   loss	   of	   function	   is	   a	  
proarrhythmic	  mechanism,	  which	   is	  not	  restricted	   to	  genetically	   transmitted	  electrical	  diseases	  of	  
the	  heart,	  but	  could	  also	  be	  implicated	  in	  more	  common	  acquired	  forms	  of	  SCD,	  such	  as	  infarction100.	  
1.4.6. Anchoring and Modulating Proteins  
Cardiac	   ionic	  channels	  trafficking,	   the	  mechanisms	  behind	  their	  regulation	  on	  different	  membrane	  
domains	   and	   the	   diverse	   proteins	   modulating	   their	   function	   still	   pose	   largely	   unanswered	  
questions14.	  Multidomain	  membrane	  proteins	  appear	  to	  affect	  NaV1.5,	  indulging	  in	  the	  possibility	  of	  
several	  regulation	  processes	  that	  target	  the	  channel,	  depending	  on	  whether	  it’s	  located	  in	  the	  ID	  or	  
LM425	  (Figure	  3c).	  
	  
SAP97	   (along	  with	   another	   similar	   protein	   SAP90)	  was	   isolated	   initially	   from	   synapses	   in	   the	   rat	  
cerebellum426.	   In	   the	   heart,	   two	   isoforms	   of	   SAP97	   are	   expressed,	   differing	   in	   the	   combination	   of	  
spliced	   insertions	   that	  determine	   the	  subcellular	   localization	  of	   the	  protein427.	   It’s	  present	   in	  both	  
atrial	   and	   ventricular	   myocytes,	   however	   seems	   to	   be	   predominantly	   localized	   towards	   the	  
longitudinal	  ends	  of	  the	  cardiac	  cells,	  near	  or	  at	  the	  ID239.	  Through	  cultured	  adult	  cardiac	  myocytes,	  
where	  specialized	  cell-­‐cell	  contacts	  can	  be	  followed	  in	  vitro,	  much	  evidence	  is	  gathered	  concerning	  
the	  sequence	  of	  events	  that	  leads	  to	  SAP97	  being	  targeted	  to	  particular	  cardiomyocytic	  domains206.	  
Several	  cardiac	  ionic	  channels	  interact	  with	  SAP97239,	  428,	  including	  NaV1.5,	  particularly	  via	  the	  PDZ	  
domain429.	  PDZ	  is	  a	  protein-­‐protein	  interaction	  domain430	  and	  its	  name	  derives	  from	  the	  first	  letters	  
of	  three	  proteins	  where	  this	  domain	  was	  initially	  identified431:	  PSD-­‐95	  (a	  95kDa	  protein	  involved	  in	  
synaptic	   signaling),	  Dlg	   (the	  Drosophilia	  melanogaster	   disk)	  and	  ZO-­‐1	   (zonula	  occludens	   1	  protein	  
involved	  in	  the	  maintenance	  of	  epithelia	  cells	  polarity).	  The	  effect	  of	  SAP97	  on	  the	  cardiac	  sodium	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xli	  In	  the	  report	  by	  Veldkamp	  et	  al.	  (Circ.	  Res.,	  2000),	  the	  authors	  argue	  that	  Nav1.5	  is	  likely	  to	  fill	  the	  intermediate	  state	  of	  
slow	  inactivation	  (IM),	  which	  is	  induced	  by	  longer	  depolarization	  times	  (~100-­‐200ms)	  than	  the	  ones	  used	  to	  detect	  the	  fast	  
inactivation	   behavior	   (~10ms),	   but	   considerably	   shorter	   than	   the	   ones	   used	   to	   describe	   the	   classic	   slow	   inactivated	  
(~60s).	  Hence	  their	  slow	  inactivation	  reporting	  falls	  within	  the	  intermediate	  kinetics	  of	  slow	  inactivation	  rather	  than	  the	  
longer	  timescale	  slow	  inactivation.	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channel	   appears	   so	   far	   to	   be	   functional.	   Heterologous	   expression	   of	   SAP97	   and	   cardiac	   ionic	  
channels	   has	   been	   studied	   and	   their	   associated	   currents	   were	   measured	   using	   patch-­‐clamping	  
techniques.	   Enhancement	   of	   the	   corresponding	   current	   was	   observed	   with	   SAP97	   expression238,	  
however	   this	   effect	   couldn’t	   be	   linked	   to	   changes	   in	   the	   channel’s	   intrinsic	   kinetics,	   since	   SAP97	  
induced	  no	  change	  in	  the	  activation	  of	  the	  channel	  or	  in	  the	  open	  probability240.	  On	  the	  other	  hand,	  
protein	   levels	   detected	   by	   Western	   blot	   assay	   were	   increased	   in	   cardiomyocytes	   co-­‐expressing	  
SAP97,	  indicating	  possibly	  an	  increase	  in	  channel	  density432.	  In	  studies	  where	  SAP97	  expression	  was	  
silenced,	  significant	  decrease	   in	  INa,i	  was	  recorded	  and	  decreased	  membrane	  excitability	  ensued238,	  
239.	   The	   mechanism	   by	   which	   SAP97	   enhances	   the	   functional	   capacities	   of	   the	   NaV1.5	   channel	  
remains	  unknown14.	  	  
	   	  
As	   described	   in	   section	   1.2.2,	   dystrophin	   stabilizes	   the	   DSMC	   in	   the	   LM	   domain221.	   Dystrophin	  
acquires	  multiple	  protein-­‐protein	  interaction	  domains,	  but	  interacts	  with	  NaV1.5	  via	  the	  syntrophin	  
adaptor	   proteins433.	   The	   syntrophin	   protein	   interacts	   with	   a	   domain	   at	   the	   carboxylic	   end	   of	  
dystrophin	  (its	  amino	  end	  interacts	  with	  the	  actin	  filament)	  and	  simultaneously,	  via	  its	  PDZ	  domain,	  
interacts	  with	  the	  carboxylic	  tail	  of	  NaV1.5,	  at	  the	  channel’s	  PDZ	  binding	  motif237.	   In	  the	  context	  of	  
dystrophin	   loss,	   which	   mainly	   affects	   striated	   muscles,	   the	   regulatory	   role	   of	   dystrophin	   in	  
electrophysiology	  was	  therefore	  hypothesized	  to	  be	  more	  substantial.	  Petitprez	  et	  al.	  suggested	  the	  
possible	  existence	  of	   two	  distinct	  subpopulations	  of	  NaV1.5	  channels	  with	   two	  different	  anchoring	  
proteins:	   the	   channels	   located	   in	   the	   ID	   are	   most	   probably	   associated	   with	   SAP97,	   whereas	   the	  
other	  subpopulation	  is	  predominantly	  anchored	  to	  the	  LM	  via	  the	  DSMC238.	  	  
	  
In	  addition	  to	  SAP97	  and	  the	  DSMC,	  studies	  have	  shown	  interactions	  between	  ankyrin	  and	  NaV1.5.	  It	  
was	  previously	  thought	  that	  ankyrin’s	  role	  is	  strictly	  structural,	  anchoring	  membrane	  ionic	  channels	  
and	  other	  ATPases	  to	  the	  cytoskeleton434.	  But	  studies	  in	  the	  last	  ten	  years	  showed	  a	  more	  mediatory	  
role	   of	   this	   protein	   and	   its	   possible	   involvement	   in	   ECC435.	   Both	   ankyrin	   B	   and	   ankyrin	   G	   are	  
expressed	   in	   the	   heart434.	   They	   are	   differently	   localized	   and	   the	   mutations	   of	   which	   lead	   to	  
completely	   different	   phenotypes.	   Ankyrin-­‐B	   is	   found	   at	   the	   level	   of	   the	   M-­‐line	   and	   the	   Z-­‐disk436,	  
while	  ankyrin-­‐G	  was	   localized	  at	   the	   ID	  and	   t-­‐tubules437.	   It	  was	  shown	   that	  many	   transmembrane	  
ionic	  transporters,	  such	  as	  the	  Na-­‐pump	  and	  NCX,	  were	  erroneously	  localized	  in	  cardiomyocytes	  of	  
mice	  expressing	  only	  one	  allele	  of	  the	  ankyrin	  gene438.	  While	  ankyrin	  B	  has	  been	  linked	  to	  several	  
pathologies	   such	   as	   LQTS4,	   atrial	   fibrillation	   and	   SCD,	   hence	   the	   name	   ankyrin-­‐B	   cardiac	  
syndrome439;	   decreased	   ankyrin-­‐G	   expression	   was	   mainly	   associated	   with	   decreased	   NaV1.5	  
expression	  and	  consequently	  a	  decrease	  in	  its	  corresponding	  current.	  No	  such	  effects	  were	  reported	  
for	   ankyrin-­‐B14.	   Nevertheless,	   a	  missense	  mutation	   in	   the	   NaV1.5	   channel	   leading	   to	   the	   Brugada	  
syndrome	  phenotype	  was	  associated	  with	  a	  disruption	  of	  the	  interaction	  between	  the	  channel	  and	  
ankyrin-­‐G440.	  	  
	  
Although	   the	   interaction	   site	   between	   caveolin	   and	   NaV1.5	   is	   still	   unknown14,	   immunostaining	  
images	  show	  a	  colocalization	  of	  those	  two	  proteins198,	  441	  and	  recent	  electrophysiological	  data	  have	  
also	   emphasized	   the	   role	   of	   mutated	   caveolin	   in	   cardiac	   function.	   Caveolin	   is	   a	   transmembrane	  
protein	   that	   recruits	  different	   signaling	  molecules	   and	   is	   an	   important	   constituent	  of	   sarcolemma	  
invaginations,	   the	   caveolae.	   The	   cardiac	   isoform	   Caveolin-­‐3	   (CAV3)	   is	   recently	   described	   as	   a	  
binding	  partner	  for	  the	  dystroglycan	  molecule,	  part	  of	  the	  DSMC442.	  Dystrophin	  was	  shown	  to	  be	  a	  
component	  of	  caveolae,	  raising	  the	  possibility	  of	  an	  indirect	   interaction	  between	  CAV3	  and	  NaV1.5	  
via	  the	  DSMC443.	  Mutations	  in	  the	  cardiac	  caveolin	  isoform	  (CAV3)	  were	  found	  in	  patients	  with	  fatal	  
arrhythmogenic	   phenotypes	   such	   LQTS441,	   sudden	   infant	   death	   syndrome444,	   and	   familial	  
hypertrophic	  cardiomyopathy445.	  When	  NaV1.5	  was	  co-­‐expressed	  with	  mutant	  CAV3,	  the	  persistent	  
inward	   INa,p	   (see	   section	   1.1.4)	   was	   shown	   to	   be	   increased,	   a	   consistent	   finding	   with	   LQTS	  
arrhythmogenic	  mechanism441,	  444.	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In	   this	   section,	   only	   the	   major	   proteins	   that	   potentially	   affect	   NaV1.5	   regulation	   with	   the	  
involvement	   of	   the	  DSMC	  were	   presented.	   For	   a	   complete	   overview	   of	   other	   interacting	   proteins	  
that	  could	  possibly	  modulate	  NaV1.5,	  refer	  to	  the	  extensive	  review	  by	  H.	  Abriel446.	  	  
1.4.7. Pharmacological Interventions: Antiarrhythmic Drugs  
In	   the	   past	   40	   years,	   considerable	   progress	   has	   been	   made	   in	   pharmacological	   therapy	   of	  
arrhythmic	  disturbances	  of	   the	  heart7.	  The	  treatment	  of	  a	   large	  subset	  of	  arrhythmias	   is	  currently	  
well	  managed	  and	  tolerated	  by	  patients133.	  However,	  sudden	  cardiac	  death	  (SCD)	  remains	  a	  major	  
cause	   of	   mortality	   internationally,	   with	   more	   than	   3	   million	   people	   dying	   yearly447.	   Implantable	  
cardioverter-­‐defibrillators	   or	   ICDs	   have	   revolutionized	   the	   approach	   to	   the	   prevention	   of	   SCD	   by	  
delivering	   anti-­‐tachycardia	   pacing	   and	   high-­‐energy	   shocks448.	   The	   availability	   of	   these	   modes	   of	  
treatment	  has	  encouraged	  the	  shift	  to	  these	  devices,	  particularly	  in	  high-­‐risk	  patients448.	  Although,	  
they	   can	   be	   life	   saving,	   they	   can	   also	   deliver	   inappropriate	   shocks.	   Henceforth,	   pharmacological	  
management	   remains	   the	   mainstay	   treatment	   in	   many	   cases	   of	   arrhythmia7,	   and	   as	   an	   adjuvant	  
therapy	  in	  patients	  with	  ICDs449.	  
	  
The	   targets	   of	   many	   antiarrhythmic	   drugs	   (AADs)	   are	   the	   ionic	   channels	   that	   mediate	   the	  
corresponding	  currents	  to	  be	  modulated.	  Their	  side	  effects,	  mainly	  due	  to	  their	   limited	  selectivity,	  
have	  forced	  a	  careful	  examination	  of	  the	  indications	  where	  these	  drugs	  can	  be	  used450.	  For	  instance,	  
many	  NaV1.5-­‐blockers	  are	  not	  pure	  use-­‐dependent	  NaV1.5	  antagonists,	  but	  also	  block	  K+	  and/or	  Ca2+	  
channels451.	   The	   recent	   cloning	   and	   sequencing	   of	  major	   cardiac	   ionic	   channels	   have	   emphasized	  
their	   striking	  similarities.	  Hence,	   it’s	  hardly	   surprising	   that	   these	  drugs	  can	  act	  on	  more	   than	  one	  
channel	   at	   a	   time452.	   This	   poses	   a	   substantial	   challenge	   for	   an	   optimal	   treatment	   using	  
pharmacological	  agents.	  
	  
NaV1.5-­‐blockers	   primarily	   block	   Na+	   influx	   through	   the	   channel.	   This	   is	   usually	  measured	   by	   the	  
reduction	  in	  the	  amplitude	  of	  the	  fast	  inward	  currentxlii	  (INa,f),	  the	  shallower	  upstroke	  velocity,	  and	  
the	  slowing	  of	  conduction	  across	  the	  myocardium453.	  The	  strong	  use-­‐dependence	  blockxliii	  (UDB)	  of	  
some	  NaV1.5	  blocker,	  a	  property	  believed	  to	  be	  at	  the	  core	  of	  their	  proarrhythmic	  effects,	  has	  shifted	  
the	   interest	   of	   investigators	   towards	   K+	   blockers451.	   The	   ideal	   K+	   blocker	   is	   to	   cause	   little	   APD	  
prolongation	   and	   refractoriness	   at	   slow	   hearts,	   while	   producing	   progressively	   greater	   effects	   on	  
those	  parameters	  at	  higher	  heart	  rates	  (use-­‐dependence	  prolongation	  of	  APD	  and	  refractoriness)454.	  
But	  in	  reality,	  most	  available	  K+	  blockers	  display	  the	  opposite	  behavior,	   limiting	  their	  efficacy,	  and	  
predisposing	   patients	   to	   Torsades	   de	   Pointesxliv,	   due	   to	   excessive	   APD	   lengthening	   at	   slow	   heart	  
rates131,	   455.	  To	   further	   illustrate	   the	   challenge	   in	  designing	  AADs,	  K+	  blockers,	   for	  example,	   act	  by	  
altering	  the	  time	  course	  of	  repolarization	  and	  refractory	  period131.	  By	  doing	  so,	   they	  will	   facilitate	  
reentry	  either	  way,	  by	  shortening	  or	  lengthening	  the	  phase	  3xlv	  of	  the	  AP455.	  On	  one	  hand,	  shortening	  
phase	  3	  means	  reducing	  the	  time	  interval	  during	  which	  the	  impulse	  must	  linger	  to	  await	  recovery	  of	  
excitability:	  acetylcholine-­‐mediated	  tachyarrhythmia	  in	  the	  normal	  tissue	  is	  an	  example	  of	  such	  type	  
of	  reentry456,	  457.	  On	  the	  other	  hand,	  prolonging	  phase	  3	  of	  the	  AP	  and	  the	  time	  needed	  for	  recovery,	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xlii	  Refer	  to	  section	  1.1.4	  for	  a	  detailed	  description	  of	  the	  sodium	  current.	  	  
xliii	  Use	  dependence	  block	  is	  a	  term	  used	  to	  describe	  a	  property	  of	  NaV1.5	  blockers	  being	  increasingly	  effective	  with	  frequent	  
pulses	  until	  a	  new	  steady	  state	  is	  reached.	  This	  is	  a	  desirable	  effect,	  particularly	  in	  the	  presence	  of	  ventricular	  tachycardia.	  
However,	   this	   same	   effect	   is	   also	   shown	   to	   be	   proarrhythmic,	   since	   unidirectional	   block	   can	   ensue	   favoring	   reentrant	  
rhythms	  (Reference:	  Clin	  Chem	  (1989)	  35(5):	  748-­‐754).	  
xliv	   Torsades	   de	   Pointes	   was	   first	   reported	   by	   Dessertenne	   in	   1966,	   to	   describe	   a	   particular	   form	   of	   polymorphic	  
ventricular	   tachycardia,	   with	   a	   characteristic	   of	   the	   QRS	   twisting	   around	   the	   isoelectric	   line	   (Reference:	   Am	   J	   Cardiol	  
(1987)	  59:10-­‐18)	  
xlv	  Refer	  to	  section	  1.1.4	  for	  a	  description	  of	  the	  different	  phases	  of	  the	  AP.	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may	   lead	   to	  marked	   APD	   prolongation	   and	   slowing	   of	   conduction	   of	   premature	   impulses,	   which	  
could	  also	  facilitate	  reentry131,	  455.	  
	  
Use-­‐dependence	   of	   NaV1.5	   blockers	   has	   two	   major	   features:	   voltage-­‐dependence	   and	   frequency	  
dependence453.	  A	  drug	  is	  said	  to	  be	  voltage	  dependent,	  if	  its	  effect	  is	  significantly	  dependent	  on	  the	  
resting	  membrane	  voltage	  (Vrmp)453.	  For	  example,	  a	  drug	  might	  be	   less	  effective	   in	  blocking	  NaV1.5	  
channels	   in	   cases	   of	   depolarized	   Vrmp	   (~-­‐65mV)	   compared	   to	   the	   normal	   case	   (~-­‐80mV)xlvi.	  
Conversely,	   frequency-­‐dependence	  means	   that	   the	   drug	   is	   particularly	  more	   effective	   in	   blocking	  
the	  channel	  during	  a	  rapid	  series	  of	  depolarizations,	  rather	   than	  one	  single	   long	  depolarization453.	  
All	  NaV1.5	  blockers	  are	  state-­‐dependent73,	  i.e.	  they	  either	  block	  the	  channel	  in	  its	  open	  or	  inactivated	  
statexlvii.	   Rested	   channels	   are	   assumed	   not	   to	   bind	   any	   drug.	   These	   apparent	   state-­‐dependencies	  
have	  prompted	  a	  series	  of	  investigation	  to	  model	  drug-­‐channel	  interactions.	  Two	  major	  hypotheses	  
attempted	   to	   describe	   this	  mechanism:	   the	  Modulated	  Receptor	  Hypothesis	   (developed	  by	  Hille361,	  
Hondeghem	   and	   Katzung362,	   458	   in	   1977)	   and	   the	   Guarded	   Receptor	   Hypothesis	   (developed	   by	  
Starmer	   et	   al.	   in	   1984459).	   The	   modulated	   receptor	   hypothesis	   proposes	   that	   drugs	   bind	   to	   a	  
channel-­‐associated	   receptor	   with	   state	   specific	   affinities,	   i.e.	   binding	   occurs	   with	   state-­‐specific	  
association	  and	  dissociation	  rate	  constants	  and	  drug-­‐bound	  channels	  do	  not	  conduct	  a	  current	  even	  
if	   activated453.	   According	   to	   this	   model,	   the	   ability	   of	   a	   drug	   to	   bind	   to	   a	   particular	   state	   of	   the	  
channel	   depends	  on	   the	   time	  during	  which	   the	   channel	   occupies	   this	   state	   and	   state-­‐specific	   rate	  
constants453.	   While	   the	   guarded	   receptor	   hypothesis	   assumes	   that	   the	   drug	   binds	   to	   a	   constant-­‐
affinity	   receptor,	   whose	   access	   is	   regulated	   by	   the	   gating	   states	   leading	   to	   apparent	   variable	  
affinities	   as	   the	   channel	   changes	   conformational	   states453.	   It	   shares	   several	   features	   with	   the	  
modulated	  receptor	  hypothesis,	  however	  it	  explicitly	  states	  that	  the	  affinity	  of	  the	  receptor	  site	  for	  
the	   drug	   molecule	   is	   constant	   (i.e.	   conformation	   independent),	   but	   channel	   gates	   restrict	   drug	  
access	   to	   the	   receptor,	   thus	   controlling	   binding	   with	   the	   channel453.	   So	   far,	   both	   remain	   two	  
attractive	   hypotheses	   to	   explain	   drug	   binding	   to	   the	   channel,	   some	   believe	   that	   the	   guarded	  
receptor	   hypothesis	   can	   be	   regarded	   as	   a	  mechanism	   for	   the	   change	   in	   affinity	   proposed	   by	   the	  
modulated	  receptor	  hypothesis454.	  	  
	  
The	   adverse	   arrhythmic	   effects	   are	   not	   restricted	   to	   AADs.	   A	   wide	   variety	   of	   currently	   used	  
pharmacological	   agents	   have	   the	   potential	   to	   be	   proarrhythmic,	   including	   antibioticsxlviii	   such	   as	  
Azithromycin460	   and	   Clarithromycin461,	   462;	   mood	   regulators	   such	   as	   SSRIsxlix463	   and	   antipsychotic	  
agentsl464.	  These	  drugs	  have	  the	  propensity	  to	  prolong	  the	  QT	  interval	  and	  could	  lead	  in	  rare	  cases	  
to	  fatal	  arrhythmias.	  Henceforth,	  improving	  our	  understanding	  of	  molecular	  and	  ionic	  mechanisms	  
underlying	   arrhythmic	   activity	   will	   provide	   opportunities	   towards	   optimizing	   channel	   blocking	  
profile	  and	  improving	  clinical	  efficiency	  and	  safety465.	  
	  
1.5. Proarrhythmic Effects of Antiarrhythmic Drugs 
Flecainide	  acetate	  was	  released	  in	  the	  UK	  in	  1983,	  preceded	  with	  several	  publications	  confirming	  its	  
efficacy	  as	  an	  antiarrhythmic	  agent	  and	  its	  relative	  safety466,	  467.	  Initial	  observations	  with	  Flecainide	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
xlviThis	  can	  occur	  clinically	  during	  hyperkalemia	  for	  instance,	  which	  might	  worsen	  or	  decrease	  the	  action	  of	  some	  AADs.	  
xlvii	  Refer	  to	  section	  1.4.1	  for	  a	  complete	  description	  of	  NaV1.5	  conformational	  states.	  
xlviii	   Among	   the	   different	   classifications	   of	   antibiotics,	  macrolides	   have	   been	  widely	   investigated	   for	   their	   propensity	   to	  
prolong	  the	  QT	  interval	  and	  subject	  patients	  to	  Torsades	  to	  Pointes	  (section	  1.4.7),	  a	  lethal	  type	  of	  ventricular	  arrhythmias	  
(Reference:	  J	  Pharmacol	  Exp	  Ther	  (1998)	  286(2):	  788-­‐93).	  
xlix	  SSRIs	  are	  commonly	  known	  in	  the	  clinical	  practice	  and	  they	  stand	  for	  Selective	  Serotonin	  Reuptake	  Inhibitors.	  
l	   Antipsychotic	   agents	   belong	   to	   a	   class	   of	   psychiatric	  medications,	   also	   known	   as	   neuroleptics,	   primarily	   used	   to	   treat	  
psychosis	   particularly	   in	   schizophrenia	   and	   bipolar	   disorders	   (Reference:	   Pharmacology.	   4th	   Ed.	   (2009)	   Philadelphia:	  
Lippincott	  Williams	  and	  Wilkins).	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have	  been	  confirmed	  on	  numerous	  occasions468,	   469.	  This	  drug	  was	  proven	  to	  be	  highly	  effective	   in	  
the	  treatment	  of	  several	  types	  of	  arrhythmias468.	  Similarly	  to	  other	  AADs,	  Flecainide	  was	  reported	  to	  
have	   side	   effects,	   but	   the	   majority	   was	   minor	   and	   generally	   well	   tolerated470.	   Guidelines	  
recommended	  at	  the	  time	  that	  the	  drug	  be	  used	  with	  caution	  with	  patients	  suffering	  from	  severe	  LV	  
dysfunction,	  due	  to	  the	  drug’s	  negative	  inotropic	  effects,	  that	  would	  be	  detrimental	  if	  CV	  was	  further	  
decreased	  in	  patients	  suffering	  from	  HF471.	  Although	  a	  truly	  controlled	  study	  about	  the	  frequency	  of	  
proarrhythmic	  eventsli	  was	  not	  performed,	  but	  available	  comparative	  data	  suggested	  that	  Flecainide	  
is	  no	  worse	  than	  any	  other	  AAD,	  when	  prescribed	  to	  patients	  with	  ventricular	  arrhythmias472.	  Other	  
reports	   confirmed	   that	   a	   considerable	   number	   of	   patients,	   who	   suffered	   major	   life-­‐threatening	  
arrhythmia,	  were	  responding	  well	  to	  the	  treatment468.	  So	  why	  after	  1989,	  did	  Flecainide	  become	  a	  
subject	  of	  controversy	  and	  intensive	  study?473	  
1.5.1. CAST I: Increased Mortality Rate with Flecainide 
In	   an	   editorial	   discussing	   the	   unexpected	   and	   disappointing	   results	   of	   CAST	   I	   (1989)474,	   John	  
Sanderson	  wrote475:	  “In	  few	  specialties	  of	  medicine	  are	  new	  promising	  drugs	  shown	  to	  be	  so	  much	  
inferior	   to	   placebo	   and,	   even	  worse,	   to	   increase	  mortality”476.	   CAST	   I	   or	   The	   Cardiac	   Arrhythmia	  
Suppression	  Trial	   is	  a	  multicenter	  (in	  the	  USA	  and	  Canada),	  randomized,	  placebo-­‐controlled	  study	  
initiated	  in	  1987,	  and	  designed	  to	  test	  whether	  suppression	  of	  symptomless	  or	  mildly	  symptomatic	  
ventricular	   tachycardias	   occurring	   in	   the	   setting	   of	   myocardial	   infarction	   (MI)lii	   would	   also	   be	  
associated	  with	  a	  reduction	  of	  sudden	  death473.	  Flecainide,	  among	  other	  AADs	  such	  as	  Encainide	  and	  
Moricizine,	  were	  used	  in	  this	  study.	  The	  preliminary	  report	  of	  this	  study	  was	  published	  in	  1989,	  and	  
the	  trial	  was	  terminated	  when	  the	  results	  indicated	  that	  death	  from	  arrhythmia	  was	  3-­‐6	  times	  more	  
common	   in	   the	   treated	   group	   compared	   to	   placebo474.	   Flecainide	   and	   Encainide	   decreased	   the	  
“number	  of	  nonlethal	  acute	  coronary	  events	  in	  CAST	  to	  an	  extent	  that	  corresponded	  to	  the	  increase	  
in	  lethal	  events	  that	  the	  drugs	  produced”474.	  This	  means	  that	  in	  the	  setting	  of	  acute	  ischemia	  these	  
Class	   Ic	   drugs	   caused	   lethal	   pro-­‐arrhythmia	   by	   promoting	   V-­‐Fib,	   transforming	   what	   would	  
otherwise	   have	   been	   nonlethal	   events	   into	   cases	   of	   SCD	   by	   exacerbating	   ischemia-­‐induced	  
conduction	  delay465.	  
	  
The	  outcomes	  of	  this	  large-­‐scale	  clinical	  trial	  not	  only	  were	  unsatisfactory	  to	  investigators,	  but	  they	  
were	  also	  to	  a	  great	  extent	  disconcerting	  and	  even,	  paradoxical.	  Since	  potentially	  fatal	  arrhythmias	  
arise	  from	  ectopic	  stimuli	  that	  can	  alter	  the	  cellular	  synchrony	  in	  the	  heart	  leading	  to	  spontaneous	  
oscillations	  in	  otherwise	  quiescent	  cells300,	  477,	  clinicians	  thought	  that	  depressing	  the	  tissue	  response	  
to	  premature	  excitations	  should	  have	  antiarrhythmic	  properties478.	  CAST	  I	  showed	  that	  Flecainide,	  
among	  other	  AADs	   that	   also	  decreased	  excitability	   and	  extended	   the	   refractory	  period	   in	   isolated	  
cell	   studies479,	   ended	   up	   increasing	   the	   incidence	   of	   SCD	   in	   patients,	   despite	   successfully	  
suppressing	  the	  cardiac	  response	  to	  at	  least	  80%	  of	  PVCs475.	  
1.5.2. Proposed Mechanisms of Flecainide Proarrhythmia 
The	   paradox	   behind	   AADs	   increased	   mortality	   profile	   in	   CAST	   I	   has	   been	   the	   focus	   of	  
electrophysiological	   research	   for	  more	   than	   three	  decades	   so	   far.	  However,	   the	  ability	  of	  AADs	   to	  
induce	  malignant	   tachyarrhythmias	  has	  been	   recognized	  much	  earlier	   than	  1989,	  with	   the	   classic	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  Velebit	  et	  al.	  chose	  the	  following	  criteria	  to	  define	  pro-­‐arrhythmia:	  1)	  a	  four-­‐fold	  increase	  in	  the	  mean	  hourly	  frequency	  
of	  ectopic	  beats	  compared	  with	  control	  period;	  2)	  a	  ten-­‐fold	  increase	  in	  the	  mean	  hourly	  frequency	  of	  ventricular	  couplets	  
or	  ventricular	  tachycardia	  beats,	  or	  both	  compared	  to	  control	  period;	  3)	  the	  first	  occurrence	  of	  sixty	  seconds	  or	  more	  of	  
sustained	  V-­‐Tach	  that	  was	  not	  present	  during	  the	  control	  period	  (Reference:	  Circulation	  (1982)	  65:	  886-­‐894).	  
liiPatients	  recruited	  had	  had	  a	  myocardial	  infarction	  between	  6	  days	  and	  2	  years	  previously.	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report	  by	   Selzer	   and	  Wray	  on	  Quinidineliii-­‐induced	   syncope	   in	  1964480.	  Morganroth	   and	  Horowitz	  
defined	  the	  term	  proarrhythmia	  to	  describe	  either	  the	  aggravation	  of	  an	  existing	  arrhythmia	  or	  the	  
facilitation	   of	   new	   arrhythmias	   by	   means	   of	   AADs481.	   Proarrhythmia	   in	   the	   clinical	   setting	   can	  
appear	  in	  a	  variety	  of	  forms,	  including	  increased	  frequency	  of	  PVCs,	  increased	  ventricular	  response	  to	  
ectopic	   beats,	   facilitation	   of	   V-­‐Tach	   induction	   and	   alterations	   in	   the	   properties	   of	   ventricular	  
arrhythmia	  such	  that	  they	  show	  higher	  resistance	  to	  electrical	  cardioversion482.	  
	  
Following	   CAST474,	   experiments	   were	   designed	   to	   test	   Flecainide	   in	   animals	   with	   prior	  MI483,	   484.	  
Among	  these	  studies,	  were	  the	  ones	  that	  used	  epicardial	  mapping	  using	  extracellular	  electrodes	  to	  
determine	  the	  mechanisms	  by	  which	  Flecainide	  promotes	  V-­‐Fib	  in	  canine	  hearts	  with	  prior	  MI484-­‐486.	  
They	   concluded	   that	   preferential	   transversal	   conduction	   slowing	   or	   block	   in	   the	   infarcted	   zone	  
facilitated	  the	  occurrence	  V-­‐Tach.	  Flecainide	  was	  postulated	  to	  induce	  episodes	  of	  sustained	  V-­‐Tach	  
by	  slowing	  conduction	  in	  the	  ischemic	  zone	  enough	  to	  allow	  the	  electrical	  activity	  to	  reenter485.	   In	  
these	   studies,	   Flecainide	   reduced	   the	   longitudinal	   and	   transversal	   velocity	   proportionately	   in	   the	  
normal	   tissue	   and	   rarely	   induced	   V-­‐Tach	   in	   animal	   hearts	   devoid	   of	  MI484,	   485,	   487.	   The	   prominent	  
effects	  of	  Flecainide	  on	  conduction	   in	   the	   infarct	  zone	  without	  detectable	  effects	  on	  refractoriness	  
set	  the	  basic	  mechanism	  for	  reentry	  and	  it	  became	  widely	  accepted	  that	  infarct	  size	  in	  these	  hearts	  
was	   an	   important	   determinant	   of	   proarrhythmia484.	   As	   acute	   MI	   produces	   a	   variety	   of	  
electrophysiological	  instabilities,	  which	  are	  not	  necessary	  found	  in	  a	  prior	  MI	  model30,	  488,	  additional	  
studies	  focused	  on	  investigating	  the	  response	  of	  the	  cardiac	  tissue	  that	  had	  been	  exposed	  to	  Class	  Ic	  
agents	   during	   an	   ongoing	   MI	   protocol489,	   490.	   One	   study	   emphasized	   on	   the	   substantial	   drug	  
concentration	   in	   the	   ischemic	   myocardial	   zone	   relatively	   to	   the	   remaining	   tissue,	   which	   was	  
believed	  to	  be	  the	  cause	  behind	  excessively	  slowed	  conduction	  and	  block	  in	  that	  region489.	  Another	  
study	   showed	   that	   the	   Class	   Ic	   agent	   amplified	   the	   ischemia-­‐induced	   conduction	   delay	   in	   the	  
myocardium,	  which	  in	  turn	  facilitated	  reentry	  in	  a	   large	  area	  of	  the	  tissue490.	  Carson	  et	  al.	  showed	  
that	  another	  Class	  I	  blocker	  increased	  the	  propensity	  for	  V-­‐Fib	  occurrence	  in	  the	  pig	  heart,	  following	  
coronary	  artery	  ligation,	  with	  a	  rate	  dependence	  mechanism	  that	  favored	  V-­‐Tach	  degeneration	  into	  
a	   sustained	   form	   of	   V-­‐Fib491.	   These	   studies	   highlighted	   that	   the	   mechanism	   of	   Class	   I	   agents	  
proarrhythmia	   is	   by	   promoting	   ischemic	   V-­‐Fib	   secondary	   to	   their	   potent	   effects	   on	   cellular	  
excitability	   and	   impulse	   propagation490-­‐492.	   It	   was	   tempting	   to	   conclude,	   following	   extensive	  
experimental	   literature	  review	  and	   the	  groundbreaking	  results	  of	  CAST	   I,	   that	  acute	   ischemia	  and	  
infarction	   in	   the	  myocardium	  were	  the	  central	   factors	   that	   facilitated	  drug-­‐associated	  mortality	   in	  
large	   clinical	   trials	   such	   as	   CAST493,	   494,	   particularly	  when	   an	   analysis	   of	   non-­‐fatal	   events	   in	   CAST	  
suggested	  that	  Flecainide	  complicated	  what	  would	  otherwise	  have	  been	  non-­‐lethal494.	  
	  
In	  contrast	  to	  the	  experimental	  work	  done	  with	  Flecainide	  in	  the	  setting	  of	  myocardial	  ischemia	  and	  
infarction,	  much	  less	  data	  were	  available	  regarding	  the	  proarrhythmic	  potential	  of	  Flecainide	  in	  the	  
normal	   cardiac	   tissue	   or	   in	   the	   “structurally-­‐normal”	   tissue482.	   Several	   hypothetical	   explanations	  
regarding	   the	   adverse	   affects	   of	   AADs	   were	   postulated,	   after	   experimental	   data	   along	   with	  
numerical	   simulations	   have	   been	   gathered	   to	   clarify	   how	   AADs	   might	   facilitate	   the	   initiation	   of	  
potentially	   life-­‐threatening	  arrhythmias	   in	  the	  normal	  myocardium.	  Nesterenko	  et	  al.	   showed	  that	  
NaV1.5	   blockers	   facilitate	   ventricular	   arrhythmia	   induction	   in	   isolated	   guinea	   pig	   hearts495,	   in	  
consistency	  with	   their	  earlier	  published	  mathematical	  simulations	  describing	   the	  effects	  of	  NaV1.5	  
blockade	  on	   cardiac	   vulnerability	   to	   arrhythmia492.	   Starmer	  et	   al.	   consequently	   hypothesized	   that	  
slowing	   the	   recovery	   of	   NaV1.5	   availability	   might	   be	   associated	   with	   the	   amplification	   of	  
proarrhythmic	   responses	   by	   increasing	   the	   time	   during	   which	   NaV1.5	   availability	   was	   spatially	  
nonuniform,	  a	  time	  interval	  which	  they	  termed	  “vulnerability	  period”475,	   496.	  They	  also	  showed	  that	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
liiiAccording	   to	   the	   Vaughan-­‐Williams	   AADs	   Classification,	   Quinidine	   is	   a	   NaV1.5	   blocker	   agent	   belonging	   to	   Class	   Ia,	  
possessing	  both	  conduction-­‐slowing	  and	  APD	  prolongation	  actions	  (Reference:	  Cardiovasc	  Res	  (1983)	  17:344-­‐352).	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vulnerability	   of	   the	   cardiac	   tissue	   to	   premature	   stimuli	   was	   increased	   in	   the	   presence	   of	   use-­‐
dependence	  block,	  a	  well-­‐documented	  characteristic	  of	  NaV1.5	  blockers	  (Class	  Ic)454,	  459.	  	  
	  
Brugada	   et	   al.	   showed	   that	   Flecainide	   promoted	   V-­‐Tach	   in	   nine	   out	   of	   ten	   thin	   sheets	   of	  
Langendorff-­‐perfused	   rabbit	   epicardium	   created	   after	   a	   transmural	   RV	   endocardial	   cryoablation,	  
with	  no	  tachyarrhythmia	  being	  documented	  in	  any	  of	  the	  thin	  sheets	  prior	  to	  Flecainide	  exposure497.	  
By	   mapping	   the	   epicardial	   surface	   using	   248	   extracellular	   electrodes,	   the	   tissue	   was	   spatially	  
resolved	  to	  2.25mm.	  They	  showed	  that	  Flecainide-­‐induced	  tachyarrhythmia	  was	  based	  on	  reentry	  
around	   an	   “arc	   of	   functional	   block”,	   a	   mechanism	   that	   resembled	   the	   one	   proposed	   for	  
proarrhythmia	  prior	  to	  MI,	  however	  without	  the	  involvement	  of	  a	  fixed	  anatomical	  obstacle497.	  Since	  
no	  particular	  area	  was	  identified	  to	  be	  especially	  prone	  to	  conduction	  block,	  they	  hypothesized	  that	  
Flecainide	   may	   have	   unmasked	   the	   natural	   spatial	   inhomogeneity	   in	   conduction	   properties,	  
resulting	  in	  areas	  of	  long	  conduction	  delays497.	  
	  
Another	   hypothesis	   was	   elegantly	   proposed	   by	   Antzelevitch	   et	   al.,	   who	   suggested	   that	   spatial	  
heterogeneity;	   an	   intrinsic	   property	   of	   the	   cardiac	   muscle	   (section	   1.3.2),	   is	   responsible	   for	   the	  
differential	   responsiveness	   of	   the	   ventricular	   myocardial	   tissue	   to	   NaV1.5	   blocking498.	  
Transmembrane	   potential	   measurements	   were	   carried	   out	   from	   the	   endocardium	   and	   the	  
epicardium	   of	   isolated	   canine	   hearts	   exposed	   to	   Flecainide	   [15μM],	  which	   revealed	   a	   contrasting	  
response	  of	  these	  tissues	  to	  the	  drug,	  the	  reason	  for	  which	  was	  suggested	  to	  be	  in	  part	  due	  to	  a	  more	  
prominent	  Ito	  in	  the	  epicardium	  than	  in	  the	  endocardium499.	  The	  resulting	  transmural	  dispersion	  of	  
repolarization	  can	  form	  regions	  that	  block	  propagating	  wave,	  creating	  therefore	  a	  robust	  substrate	  
for	  reentry262	  (section	  1.4.4).	  
	  
1.6. This Thesis 
Sudden	   death	   often	   follows	   cardiac	   rhythm	   disturbances	   that	   are	   initiated	   by	   excitation	   of	  
electrically	   unstable	   tissue496.	   The	   work	   presented	   in	   this	   thesis	   is	   centered	   on	   characterizing	  
macroscopic	  electrophysiological	  instabilities	  observed	  at	  the	  tissue	  level	  that	  emanate	  from	  
perturbations	   affecting	   essentially	   the	   NaV1.5	   channel	   in	   the	   murine	   heart.	   We	   tried	   to	  
approach	   this	   question	   by	   directly	   targeting	   NaV1.5,	   either	   through	   genetically	   modified	   mouse	  
models	  that	  mirror	  fatal	  pathologies	  observed	  in	  man,	  or	  through	  the	  use	  of	  antiarrhythmic	  drugs	  
that	   principally	   modify	   the	   channel’s	   function	   in	   its	   respective	   environment.	   The	   hallmark	   of	   an	  
unstable	   tissue	   is	   that	   excitability	   is	   spatially	   heterogeneous475;	   hence	   characterizing	   these	  
instabilities	   in	   excitability	   and	   conduction	  will	   require	   a	   technical	   tool	   that	   provides	   the	   spatial-­‐
temporal	   resolution	  necessary	   to	  map	   the	   electrical	   activity	   from	   the	   epicardial	   surface	  of	   the	   in-­‐
vitro	  perfused	  heart.	  Optical	  mapping	  has	  provided	  us	  with	  the	  capacity	  to	  measure	  the	  propagation	  
of	   the	   electrical	  wave	   on	   the	   surface	   of	   the	   intact	   heart,	   with	   a	   spatial	   resolution	   down	   to	   a	   few	  
epicardial	  cardiac	  cells	   in	  one	  pixel	  and	  a	  temporal	  resolution	  more	  than	  ten	  times	  faster	  than	  the	  
time	  it	  takes	  the	  actual	  electrical	  wave	  to	  travel	  across	  the	  epicardium.	  Using	  this	  technique,	  our	  aim	  
was	   to	  measure	  more	   accurately	   a	   set	   of	  biophysical	   parameters	   and	   to	   elucidate	   the	   fundamental	  
relationships	   between	   them	   in	   distinct	   cardiac	   substrates	   and	   within	   different	   pharmacological	  
protocols,	  integrating	  knowledge	  and	  data	  from	  the	  molecular	  ionic	  level	  to	  the	  whole	  organ.	  
	  
To	  fulfill	  this	  aim,	  we	  investigated	  two	  genetically	  modified	  mouse	  models:	  the	  mdx-­‐mouse	  model	  of	  
Duchenne	  muscular	  dystrophy	  (section	  1.2.2)	  and	  the	  ΔKPQ	  mouse	  model	  of	  LQTS3	  (section	  1.4.3),	  
each	  compared	  to	  their	  respective	  WT	  control.	  The	  pathophysiology	  of	  each	  of	  these	  fatal	  diseases	  
has	  been	  described	  in	  their	  respective	  sections.	  We	  adopted	  a	  generic	  approach	  to	  these	  models,	  by	  
focusing	   on	   one	   denominator:	   the	   NaV1.5	   channel	   and	   its	   modulation	   by	   antiarrhythmic	   drugs	  
(Flecainide,	   section	   1.5).	   Although,	   we	   appreciate	   the	   entanglement	   of	   the	   molecular	   pathways	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underlying	  the	  different	  pathologies,	  we	  aimed	  in	  our	  optical	  mapping	  investigations	  at	  describing	  
the	   translational	   axis	   that	   connects	   the	   ion	   channel	   on	   one	   side	   to	   macroscopic	   electrical	  
instabilities	  on	  the	  other	  side.	  We	  adopted	  a	  generic	  approach	  to	  fulfill	  this	  goal,	  by	  subdividing	  the	  
study	  over	  three	  phases	  of	  investigation,	  as	  follows:	  	  
1.6.1.  Conduction Abnormalities in the mdx-mouse: A Model of Lower NaV1.5 
Availability 
The	   monogenetic	   disease	   investigated	   is	   caused	   by	   a	   mutation	   in	   the	   gene	   encoding	   the	   large	  
cytoskeletal	  protein,	  dystrophin500	  (section	  1.2.2).	  A	  recent	  study	  showed	  that	  dystrophin	  regulates	  
the	  cardiac	  sodium	  channel238,	  NaV1.5	  (section	  1.4)	  on	  the	  LM	  of	  the	  cardiomyocyte.	  NaV1.5	  mediates	  
the	  fast	  inward	  sodium	  current	  (section	  1.1.4)	  that	  initiates	  electrical	  excitation	  in	  most	  cardiac	  cells	  
(section	  1.3.6).	  The	  absence	  of	  dystrophin	  is	  associated	  with	  a	  non-­‐uniform	  loss	  of	  NaV1.5	  from	  the	  
plasma	  membrane	   of	   the	   cardiomyocyte238.	   Consequently,	  we	  wanted	   to	   investigate	  whether	   this	  
molecular	   finding	  had	   any	   repercussions	   on	   the	   conduction	   velocity	   in	   the	  medium,	   and	  whether	  
conduction	   abnormalities	   can	   be	   detected	   by	   optically	  mapping	   the	   intact	   mdx	   mouse	   heart	   (the	  
mouse	   model	   harboring	   dystrophin	   deficiency,	   section1.2.2).	   Conduction	   measurements	   were	  
carried	  out	  to	  characterize	  potential	  propagation	  instabilities	  that	  could	  ensue	  in	  a	  cardiac	  substrate	  
of	  lower	  NaV1.5	  availability	  (section	  3.1).	  	  
1.6.2. Implementation and Validation of Analytical Strategies in CV Evaluation 
in the Murine Heart Using Optical Mapping 
The	  use	  of	  murine	  hearts	  for	  gathering	  electrophysiological	  data	  is	  a	  challenging	  task.	  It’s	  faced	  with	  
technical	   difficulties	   that	   start	  with	   the	   rapid	   heart	   rate501,	   the	   undersized	   heart,	   the	   presence	   of	  
heterogeneities474,	   502	  at	  both	  the	  cellular	  and	  structural	   levels503	  (section	  1.3.2),	  and	  the	  restricted	  
time	   for	   the	   spread	   of	   any	   activating	   wave	   front504.	   The	   discrepancies	   found	   in	   the	  
electrophysiological	   data	   justify	   the	   use	   of	   high	   spatial-­‐temporal	   resolution	   techniques,	   such	   as	  
optical	   mapping,	   to	   reassess	   and	   reevaluate	   CV	   measurements	   with	   higher	   accuracy284.	   Optical	  
mapping	  of	  intact	  hearts	  using	  fluorescent	  voltage	  reporter	  dyes	  is	  a	  powerful,	  well-­‐established	  and	  
widely	   used	   technique	   to	   study	   electrical	   patterns	   occurring	   in	   the	   cardiac	   tissue505.	   The	   precise	  
quantification	  of	  CV	  for	  the	  same	  cardiac	  substrate	  is	  often	  controversial284,	  506,	  507.	  Several	  methods	  
have	  been	  implemented	  in	  the	  study	  of	  CV	  in	  mouse	  hearts	  under	  simple238,	   508	  and	  more	  complex	  
activation	  patterns509,	  510.	  While	  they	  are	  appearing	  more	  and	  more	  frequently	  in	  publications,	  their	  
implicit	  assumptions,	  errors	  and	  limitations	  are	  rarely	  subject	  of	  overt	  debate.	  From	  epicardial	  AP	  
spreads,	   we	   obtained	   information	   on	   action	   potential	   (AP)	   generation,	   electrophysiological	  
properties	  of	  the	  cardiac	  substrate	  via	  patterns	  of	  activation	  and	  the	  apparent	  CV	  in	  the	  medium	  of	  
propagation.	  We	   implemented	   three	   different	   strategies	   to	   our	   experimental	   data	   (section	   2.2.4),	  
and	  compared	  the	  outcomes	  of	  each	  method	  and	  validated	  the	  results	  under	  anisotropic	  and	  non-­‐
anisotropic	  conditions	  (section	  3.1.4).	  We	  challenged	  each	  method	  with	  synthetic	  data	  emphasizing	  
on	  the	  effects	  due	  to	  noise	  (section	  3.1.6)	  and	  heterogeneity	  in	  propagation	  (section	  3.1.7).	  	  
1.6.3. Characterization of Spatial-Temporal Heterogeneity Induced by 
Flecainide Using Clinically Valid Concentrations  
Scientists’	   growing	   suspicion	   regarding	   the	   predictive	   capacity	   of	   single	   cell	   measurements	   was	  
triggered	   by	   the	   counterintuitive	   results	   of	   CAST	   I	   in	   1989474.	   Despite	   the	   fact	   that	   the	  
antiarrhythmic	   activity	   of	   NaV1.5-­‐blockers	   has	   been	   demonstrated	   quite	   robustly	   and	  
redundantly458,	  511-­‐513	  over	  more	  than	  three	  decades	  of	  experiments,	  the	  increased	  mortality	  rates	  of	  
CAST	  I	  disproved	  this	  predictive	  potential.	  Flecainide,	  being	  an	  antiarrhythmic	  drug	  known	  for	   its	  
strong	   modulation	   of	   NaV1.5466,	   has	   been	   shown	   to	   evoke	   proarrhythmic	   responses	   in	   cardiac	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tissues	  exposed	  to	  the	  drug474,	  482.	  Since	  then,	  several	  hypotheses	  have	  been	  proposed	  to	  clarify	  the	  
mechanisms	  behind	  the	  electrical	  instabilities	  that	  collectively	  develop	  in	  the	  intact	  tissue495,	  497,	  499.	  	  
We	  investigated	  the	  effects	  of	  this	  drug	  using	  clinically	  valid	  concentrations,	  to	  observe	  and	  measure	  
the	   different	   biophysical	   parameters	   at	   play	   that	   could	   give	   us	   some	   insights	   on	   the	   electrical	  
instabilities	   emanating	   from	   modifying	   the	   channel	   in	   three	   different	   cardiac	   substrates,	   with	   a	  
gradient	   in	  NaV1.5	   functionality:	   one	  with	   lower	  NaV1.5	   availability	   (mdx,	   section	  3.2),	   the	   second	  
one	  with	  a	  normally	  functioning	  channel	  (WT,	  section	  3.2.2)	  and	  the	  last	  one	  with	  a	  hyper-­‐functional	  
channel	  (ΔKPQ,	  section	  3.3).	   In	  this	  regard,	  optical	  mapping	   is	  a	   fundamental	  experimental	   tool	   in	  
the	  study	  of	  spatially	  extended	  electrophysiological	  heterogeneity	  of	  the	  cardiac	  substrate,	  without	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 Chapter 2 
Experimental Methods 
The	  present	  chapter	  details	  the	  methods	  used	  to	  obtain	  the	  experimental	  results	  of	  this	  thesis.	  The	  
main	   experimental	   protocol	   used	   is	   optical	   mapping	   of	   the	   propagating	   electrical	   wave	   on	   the	  
surface	   of	   the	   murine	   left	   ventricular	   (LV)	   free	   wall	   epicardium,	   using	   Di-­‐4-­‐Anepps,	   a	   voltage	  
sensitive	  dye	  (VSD).	  Section	  2.1	  outlines	  the	  details	  the	  optical	  mapping	  setup	  in	  terms	  of	  hardware	  
and	   software	   used:	   vECG	   recordings	   and	   pacing	   electrodes	   (2.1.1),	   the	   details	   of	   murine	   heart	  
isolation	   (2.1.2).	   Optical	  mapping	   of	  membrane	   voltage	  measurements	   were	   performed	   using	   an	  
electromechanical	   decoupler	   and	   a	   VSD	   (2.1.3)	   and	   details	   of	   the	   setup	   are	   elaborated	   in	   section	  
2.1.4.	   Section	   2.2	   outlines	   the	   details	   concerning	   the	   optimization	   of	   signal	   quality	   for	   further	  
analysis	  and	  the	  mathematical	  background	  of	  the	  strategies	  used	  in	  this	  thesis	  to	  evaluate	  the	  CV	  in	  
the	   medium	   of	   propagation.	   Starting	   with	   processing	   the	   raw	   optical	   signal	   and	   the	   creation	   of	  
activation	  maps	  (2.2.1),	  to	  dispersion	  maps	  (2.2.3),	  we	  also	  show	  the	  methodological	  approaches	  in	  
the	  evaluation	  of	  CV	  2.2.4,	  as	  well	  as	  the	  numerical	  data	  used	  to	  simulate	  propagation	  in	  the	  murine	  
heart,	   which	   are	   detailed	   in	   section	   2.2.5.	   Results	   of	   the	   optical	   mapping	   data	   are	   presented	   in	  
Chapter	  3	  and	  are	  further	  discussed	  in	  Chapter	  4.	  
	  
The	  study	  of	  electrophysiological	  properties	  of	   the	  healthy	  and	  diseased	  heart	  provides	   important	  
insights	  into	  the	  understanding	  of	  the	  complex	  electrical	  activity,	  which	  requires	  the	  development	  of	  
mapping	   techniques	   that	   simultaneously	   record	   spatial	   and	   temporal	   information.	   Traditionally,	  
surface	  electrodes	  have	  been,	  and	  continue	   to	  be,	  used	  measure	  extracellular	  cardiac	  potentials514	  
(Figure	  5b).	  However,	  this	  type	  of	  surface	  mapping	  actually	  suffers	  from	  several	  drawbacks,	  such	  as	  
low	  spatial	  resolution	  and	  reduced	  flexibility	  (since	  only	  a	  finite	  number	  of	  electrodes	  can	  be	  placed	  
on	  the	  surface	  of	  one	  heart	  with	  a	  fixed	  spacing	  between	  electrodes	  once	  the	  electrode	  array	  is	  set),	  
low	  depth	  of	  field	  and	  electrical	  (interference)	  artifacts	  from	  stimulating	  electrodes514.	   	  The	  mouse	  
heart	  is	  a	  widespread	  model	  for	  cardiovascular	  studies,	  due	  to	  factors	  like	  the	  existence	  of	  low	  cost	  
technology	  for	  genetic	  engineering	  in	  this	  species515,	  the	  relatively	  fast	  reproduction	  capacity	  of	  the	  
animal	  and	  the	  ease	  of	  handling	  the	  animal	  for	  experimental	  work.	  Nevertheless,	  the	  use	  of	  murine	  
hearts	  for	  gathering	  electrophysiological	  data	  is	  a	  particular	  challenging	  task.	  It’s	  faced	  with	  several	  
technical	   difficulties	   that	   start	  with	   the	   rapid	   heart	   rate501,	   the	   undersized	   heart	   (the	   apico-­‐basal	  
distance	   is	   ~6mm)	   and	   the	   restricted	   time	   for	   the	   spread	   of	   any	   activating	   wave	   front	   (a	  
propagating	   electrical	  wave	   can	   traverse	   the	   entire	   epicardium	   in	   less	   than	  6-­‐8ms)504.	   For	   such	   a	  
small	   heart,	   the	   number	   of	   extracellular	   electrodes	   is	   limited	   by	   spatial	   constraints	   and	   a	   lower	  
number	  of	  detection	  sites	  makes	  the	  electrode	  array	  a	  poor	  choice	  for	  detecting	  complex	  electrical	  
patterns.	  
	  
Optical	  mapping	  with	  VSDs	  has	  made	   it	  possible	   to	  record	  cardiac	  APs	  with	  high	  spatial-­‐temporal	  
resolution	  that	  is	  otherwise	  not	  attainable	  using	  electrode	  arrays505.	  Optical	  techniques	  use	  changes	  
in	  transmitted	   light	   from	  the	  prep	  to	  map	  the	  electrical	  activity.	  VSDs	  are	  compounds	  that	  bind	  to	  
cell	  membranes	   and	   fluoresce	  with	   an	   intensity	   proportional	   to	   the	   local	  membrane	   potential516,	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and	  with	  a	  response	  time	  which	  is	  several	  orders	  of	  magnitude	  faster	  than	  the	  most	  rapid	  changes	  in	  
the	  cardiac	  membrane	  potential517.	  	  VSDs	  can	  produce	  phototoxic	  effects.	  For	  instance,	  Di-­‐4-­‐Anepps,	  
a	  widespread	  used	  VSD	  in	  cardiac	  mapping,	  is	  reported	  not	  to	  be	  toxic	  at	  low	  concentrations	  in	  the	  
absence	  of	   light,	  but	  degrades	  membranes	   in	   the	  presence	  of	   increased	   levels	  of	   light,	  where	   light	  
absorption	   at	   high	   intensities	   can	   cause	   tissue	   heating	   and	   alterations	   in	   electrophysiological	  
parameters518.	  Therefore,	  a	  major	  advantage	  of	  electrode	  arrays	  is	  that	  the	  prep	  is	  not	  subjected	  to	  
potentially	  phototoxic	  effects	  of	  potentiometric	  dyes519.	  In	  addition,	  these	  electrodes	  record	  are	  very	  
fast	   and	   capable	   of	  measuring	   the	   AP	   upstroke	   at	   a	   temporal	   rate	   close	   to	   0.1ms520,	   521.	   Another	  
fundamental	  difference	  between	  electrodes	  and	  optical	  AP	  (OAP)	  recordings	  is	  related	  to	  the	  source	  
of	   these	   signals516.	   Using	   extracellular	   electrodes,	   the	   source	   is	   a	   single	   cell,	   whereas	   an	   OAP	  
originates	  from	  a	  small	  lump	  of	  cells,	  where	  the	  overall	  volume	  depends	  on	  several	  factors	  such	  as	  
optical	   magnification,	   detector	   size,	   light	   transmission	   properties	   of	   the	   cardiac	   tissue516.	   For	  
comprehensive	  reviews	  regarding	  optical	  mapping,	  refer	  to	  the	  reviews	  by	  Girouard	  et	  al.516	  (1996),	  
Efimov505	  (2004),	  Herron	  and	  Jalife514	  (2012).	  	  
	  
2.1. Setup and Tissue Preparation 
Nearly	  all	  mapping	  systems	  consist	  of	  a	  number	  of	  sensitive	  detectors,	   from	  which	  the	  signal	  gets	  
amplified,	  processed,	  displayed	  and	  then	  stored	  for	  further	  analysis.	  	  
2.1.1. vECG and Pacing Electrodes  
vECG	   recordings	   associated	   with	   spontaneous	   sinus	   and	   paced	   rhythms,	   were	   obtained	   steadily	  
throughout	  the	  experiment	  and	  stored	  for	  off-­‐line	  analysis	  (Figure	  5b).	  Signals	  were	  amplified	  and	  
low-­‐pass	  filtered	  at	  200Hz	  using	  an	  electronic	  amplifier	  (HSE,	  Germany)	  and	  digitally	  sampled	  at	  10	  
kHz	   with	   a	   16-­‐bit	   resolution	   using	   the	   NI	   USB-­‐6216	   BNC	   (National	   Instruments)	   digitizer	   and	  
custom-­‐made	  software	  using	  LabView	  (National	   Instruments).	  At	   the	  center	  of	   the	   left	  ventricular	  
wall,	   a	   bipolar	   specialized	   cardiac	   pacing	   electrode	   (50-­‐100	   kOhm,	   FHC,	   USA)	  was	   gently	   placed,	  
stimulating	   the	   preparations	   at	   a	   BCL	   of	   100ms	   at	   2.5 diastolic	   threshold,	   with	   2ms	   impulse	  
duration.	  Capture	  was	  confirmed	  both	  electronically	  and	  optically.	  
2.1.2. Murine Heart Isolation and Langendorff Perfusion 
Mice	  were	  heparinized	  (40	  units)	  and	  anesthetized	  using	  volatile	  100%	  Isoflurane	  (Floren,	  Abbat-­‐
Germany).	   Excised	   through	   a	   sternotomy,	   intact	   hearts	  were	   carefully	   cannulated,	   connected	   to	   a	  
custom-­‐made	  perfusion	  setup	  and	  retrogradely	  perfused	  at	  2.5-­‐3	  mL.min-­‐1	  via	  the	  aorta	  with	  Tyrode	  
solution,	  under	  quasiphysiological	  conditions.	  The	  temperature	  was	  set	  to	  38±1°C,	  oxygen	  content	  
(95%O2	  and	  95%	  CO2),	  pH	  to	  7.4	  and	  ionic	  concentration	  (in	  mmol.L-­‐1):	  NaCl	  130,	  NaHCO3	  24,	  KCl	  4,	  
MgCl2	  1,	  CaCl2	  1.8,	  KH2PO4	  1.2,	  C6H12O6	  	  5.6,	  1%	  albumin	  (Bovine	  Serum	  Albumin,	  Sigma)	  and	  insulin	  
(Insuman	   Rapid,	   Sanofi-­‐Aventis,	   5IU/L).	   Hearts	   were	   immersed	   with	   constantly	   warm	   Tyrode	  
solution,	  within	  a	  custom-­‐made	  glass	  chamber	  that	  ensures	  adequate	  temperature	  throughout	  the	  
experimental	  period,	  where	  the	  solution	  within	  serves	  as	  a	  conducting	  medium	  for	  in-­‐vitro	  custom-­‐
made	  Ag-­‐AgCl	  ECG	  electrodes	  placed	  horizontally	  and	  parallel	  to	  the	  septum,	  at	  a	  distance	  of	  1mm	  
from	   the	   epicardial	   surface.	   Hearts	  with	   a	   spontaneous	   beating	   rate	   exceeding	   450beats/min	   for	  
more	   than	  20min	   after	   connecting	   them	   to	   the	   perfusion	   setup	  were	   exclusively	   used	   for	   further	  
measurements.	  The	  left	  ventricular	  free	  wall	  was	  projected	  with	  maximal	  cross-­‐sectional	  diameter	  
in	   the	  objective	   light	  path	   to	  ensure	   consistent	  mapping	  of	   the	   conduction	   spread,	  by	  maximizing	  
the	  exposed	  stimulated	  area	  to	  the	  exciting	  monochromatic	  beam	  (Figure	  5a).	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2.1.3. Excitation-Contraction Decoupler and VSD Staining 
Of	  the	  limitations	  of	  cardiac	  optical	  mapping	  of	  the	  heart	  are	  imaging	  artifacts,	  caused	  by	  successive	  
contractions.	  Motion	  artifacts	  can	  strongly	  distort	  or	  obscure	  voltage	  optical	  measurements.	  Several	  
strategies	   are	   adopted	   to	   overcome	   this	   obstacle,	   which	   could	   be	   mechanical	   in	   nature,	  
pharmacological	   or	   numerical.	  We	   adopted	   a	   pharmacological	   one	   by	   using	   an	   electromechanical	  
decoupler	   (5µM,	  Blebbistatin,	   Sigma),	  which	   acts	   basically	   as	   a	   specific	  myosin	   II	   inhibitor522,	   but	  
does	   not	   have	   any	   noticeable	   effects	   on	   cardiac	   electrophysiology	   under	   these	   experimental	  
conditions523.	  
	  
Fluorescence	  dye	   can	  be	  divided	   into	   slow	  and	   fast	   acting	  dyes.	   Slow	  dyes	   change	   their	   locations	  
with	   cells	   (i.e.	   move	   between	   intracellular	   and	   extracellular	   compartments)	   in	   response	   to	  












































Figure	   5.	   Experimental	   preparation	  
and	   signal	   samples	   recorded	   during	  
LV	   free	   wall	   pacing	   of	   the	   murine	  
heart.	   a.	   External	   anatomy	   of	  murine	  
heart	   and	   cross	   section	   (cartoon)	  
delineated.	   An	   intact	   murine	   heart	  
cannulated	   and	   installed	   in	   a	  
Langendorff	   retrograde	   perfusion.	  
Dotted	   line	   marks	   the	   borders	   between	  
RV	   and	   LV.	   The	   distance	   endo-­‐epic	   is	  ~	  
2.2mm	   and	   the	   epicardial	   layer	  
estimated	   ~	   0.3-­‐0.5mm	   deep.	   In	   cross	  
section,	   the	   bulky	   LV	   is	   of	   considerable	  
volume	   compared	   to	   RV.	   Annotations	  
on	  figure:	  RA	  =	  Right	  Atrium;	  LA	  =	  Left	  
Atrium,	   PV	   =	   Pulmonary	   Veins;	  
Horizontal	   Scale	   Bar	   =	   1mm.	   (Picture	  
credit	   to:	   Dura,	   M.	   and	   Schröder-­‐
Schetelig,	   J.).	   b.	   Hardware	   and	  
example	   signals.	   The	   light	   source	   is	   a	  
short	  arc	  mercury	  lamp.	  The	  light	  passes	  
through	   a	   shutter	   and	   focused	   on	   filter	  
cube	   that	   homogenizes	   the	   beam	   into	   a	  
green	   monochromatic	   light	   of	  
515±15nm.	   The	   emitted	   fluorescence	   is	  
passed	   through	   a	   dichroic	   mirror	   (DM)	  
of	   570nm,	  which	   is	   further	   long	   passed	  
filtered	  (>590nm).	  The	  light	   is	  projected	  
on	  a	  CMOS	  chip	  of	  100	  by	  100	  pixels,	  and	  
the	   measurements	   are	   temporally	  
sampled	   at	   2kHz.	   Left:	   (above)	   vECG	  
showing	   the	  normal	   sinus	   rhythm	   (here	  
~9Hz);	   (below)	   Monophasic	   AP	  
recording	   (sinus	   rhythm	   corresponding	  
to	   above	   vECG	   signal).	   Right:	   (Above)	  
OAP,	  with	  fractional	  change	  of	  5%,	  paced	  
at	   10Hz.	   (Below)	   Steady	   state	   pacing	  
protocol,	   pulse	   duration	   =	   1.5ms,	   at	   2.5	  
times	   diastolic	   threshold.	   Arrow:	   heart	  
in	   perfusion,	   1:	   vECG	   electrodes,	   2:	  
pacing	  electrode,	  3:	  perfusion	  chamber.	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large	   time	   constants,	   are	   not	   suitable	   for	  mapping	   fast	   activities	   like	   the	   ones	   taking	   place	   in	   the	  
murine	  heart,	  where	  the	  entire	  ventricular	  AP	  starts	  and	  terminates	  in	  ~40ms.	  
Fast	   dyes,	   on	   the	   other	   hand,	   do	   not	   rely	   on	   movement	   back	   and	   forth	   between	   the	   different	  
compartments	  of	  the	  cardiac	  cell,	  but	  change	  their	  optical	  characteristics	  by	  changing	  conformation.	  
These	   dyes	   provide	   rapid	   absorbance	   and	   fluorescence	   responses	   to	   membrane	   potential	   (time	  
constants	  in	  the	  order	  of	  one	  ms)	  and	  are	  capable	  of	  recording	  fast	  AP525.	  Fast	  dyes	  are	  divided	  into	  
different	   categories	   based	   on	   their	   chemistry.	   Several	   mechanisms	   account	   for	   a	   given	   dye’s	  
sensitivity,	  including	  changing	  its	  conformation,	  its	  orientation	  within	  the	  plasma	  membrane	  or	  its	  
charge	   distribution	   (electrochromism)	   within	   the	   plasma	   membrane526.	   The	   rotation-­‐dimer	  
mechanism	  has	  been	  suggested	  as	  a	  variant	  of	  molecular	  motion,	  by	  which	  the	  dye	  switches	  with	  a	  
change	   in	   voltage	   from	   a	   monomeric	   form,	   which	   is	   basically	   oriented	   perpendicular	   to	   the	  
membrane,	  to	  a	  dimer	  oriented	  parallel	  to	  the	  membrane526.	  Electrochromism,	  another	  mechanism	  
explaining	   the	   function	   of	  VSD,	   refers	   to	   the	  direct	   displacement	   of	   charges	  within	   a	  molecule	   by	  
external	   electric	   fields527.	   As	   there	   is	   no	   change	   in	   the	   molecular	   arrangement,	   electrochromic	  
processes	  take	  place	  at	  the	  nanosecond	  time	  scale527.	  Loew	  et	  al.	  have	  provided	  evidence	  that	  Di-­‐4-­‐
ANEPPS	  (the	  VSD	  used	  in	  our	  experimentsliv,	  stock	  solution	  1.25mg/mL,	  aliquots	  of	  100μL)	  respond	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
liv	  In	  the	  mouse	  heart,	  the	  endo-­‐epicardium	  distance	  was	  measured	  to	  be	  around	  2.2mm	  (this	  value	  is	  congruent	  with	  the	  















Figure	   6.	   Steady-­‐state	   pacing	   conditions	  
(10Hz).	  a.	  Optical	  mapping	  signal	  showing	  a	  
sequence	  of	  paced	  APs.	  The	  normalized	  signal	  
is	  shown	  here,	  with	  a	  SNR~20	  and	  FC~5%.	  The	  
red	  dotted	  line	  indicates	  the	  consecutive	  pulses	  
to	   be	   temporally	   averaged	   in	   order	   to	   reduce	  
beat-­‐to-­‐beat	   variability.	   In	   our	   measurements,	  
10	   pulses	   are	   usually	   averaged	   under	   steady	  
state	   conditions	   (here	   only	   6	   are	   shown).	   b.	  
Standard	   deviation	   (STD)	  map	   showing	   the	  
standard	  deviation	  at	  each	  pixel.	  A	  white	  line	  
delineates	  a	  mask	  on	  the	  LV	  free	  wall.	  Since	  all	  
averaged	   AP	   are	   similar	   in	   pixels	   covering	   the	  
LV,	   the	   STD	   is	   near	   0.	   At	   10Hz,	   the	   atria	  
entrained	  by	  the	  sinus	  rhythm	  are	  out	  of	  phase	  
with	   the	   ventricles,	   so	   the	   STD	   is	   high.	   Scale	  
bar	   =1mm.	  c.	   Curves	   showing	   the	   change	   in	  
APD	   at	   different	   numbers	   of	   pulses	   (WT,	  
n=5).	  Biophysical	  parameters	  such	  as	  APD50	  or	  
APD90	   vary	   progressively	   with	   entrainment	  
from	  sinus	  rhythm.	  The	  curves	  show	  APD50	  and	  
APD90	   increasing	   gradually	   to	   reach	   steady	  
state	   values	   at	   20	   pulses,	   beyond	   which	  
additional	   pulses	   didn’t	   affect	   the	   values	  
significantly,	   indicating	   steady	   state	   conditions	  
(these	   curves	  were	  made	  with	  WT	  hearts.	   The	  
same	  procedure	  was	  repeated	   for	  mdx	  hearts).	  	  
d.	   Differential	   of	   the	   curves	   shown	   in	   (c)	  
over	  number	  of	  pulses.	  The	  curves	  cross	  y=0	  
(dotted	   black	   line)	   when	   20	   pulses	   are	   given	  
consecutively	   to	   entrain	   the	   heart	   at	   10Hz.	  
Additional	  pulses	  don’t	  change	   the	  value	  of	  the	  
parameter	  measured.	   From	  these	  experiments,	  
we	   concluded	   that	   20	   pulses	   should	   be	   given	  
before	  optical	  measuring	  starts.	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to	  membrane	  voltage	  changes	  by	  an	  electrochromic	  mechanism,	  i.e.	  by	  charge	  redistribution	  of	  the	  
surface	   of	   the	   molecule527.	   For	   a	   comprehensive	   review	   on	   organic	   dyes,	   their	   chemistry,	  
mechanisms	  and	  sensitivity	  in	  optical	  mapping,	  refer	  to	  the	  book	  chapter	  by	  Loew	  “Design	  and	  Use	  
of	  Organic	  Voltage	  Sensitive	  Dyes”	  (2010)526.	  
2.1.4. 2D Optical Mapping Setup 
After	  the	  heart	  rate	  reached	  steady	  state	  (typically	  20min	  from	  initiation	  of	  retrograde	  perfusion),	  
measurements	  were	  carried	  out	  after	  staining	  the	  heart	  with	  a	  voltage-­‐reporter	  dye	  (Di-­‐4-­‐ANEPPS,	  
Molecular	  Probes,	   Portland,	  OR),	   by	   injecting	   a	   1mL	  bolus	   at	   30μmol.L-­‐1,	   into	   a	   10mL	   compliance	  
chamber	   proximal	   to	   the	   aorta	   (section	   2.1.2).	   Concisely,	   excitation	   light	   from	   a	   100W	   short-­‐arc	  
mercury	   lamp	   (HBO103W/2,	   Olympus,	   Germany)	   was	   collocated,	   using	   an	   upright	   macroscope	  
(MVX10,	   Olympus)	   and	   made	   monochromatic	   using	   an	   interference	   filter	   (515±15nm)	   and	  
dichromatic	   filter	   (570nm),	   then	  collected	  using	  a	   long-­‐pass	   filter	   (>590nm)	  and	  projected	  onto	  a	  
100	   	   100	  pixel	   CMOS	   (Complementary	  Metal	  Oxide	   Semiconductor	   camera,	  Ultima-­‐L,	   SciMedia)	  
recording	  array	  (Figure	  5b).	   Imaging	  with	  Di-­‐4-­‐ANEPPS	  was	  obtained	  at	  a	   frame	  rate	  of	  2	  kHz.	  To	  
reveal	  the	  signal,	  background	  noise	  was	  subtracted	  from	  each	  frame.	  Imaging	  was	  carried	  out	  using	  
a	  0.63 	  objective	  (MVPLAPO	  0.63X,	  NA	  0.15;	  Olympus),	  at	  a	  zoom	  of	  2.5 	  in	  order	  to	  provide	  the	  
largest	  view	  of	  the	   left	  ventricular	   free	  wall	  with	  a	  pixel	  resolution	  of	  100µm.	  Prior	  to	  any	  further	  
analysis,	  the	  optical	  signal	  was	  modified	  in	  order	  to	  optimize	  the	  fluorescence	  change	  and	  increase	  
the	  SNR.	  To	  study	  conduction	  spread	  at	  steady	  state	  pacing	  of	  10Hz,	  preparations	  were	  paced	  using	  
a	  bipolar	  electrode	  (Figure	  5b,	  section2.1.1).	  The	  raw	  data	  collected	  from	  the	  camera	  were	  frame-­‐
selected	  using	  custom-­‐made	  open	  source	  software	  written	  in	  Java	  that	  was	  optimized	  for	  the	  mouse	  
heart,	   constituting	   a	   platform	   input	   into	   another	   custom-­‐made	   routine	   written	   in	   MATLAB	   (the	  
Mathworks)	  for	  further	  analysis.	  
2.1.5. Animal Models Used in the Current Study and Drugs 
Adult	  12-­‐16weeks	  male	  dystrophin-­‐deficientlv	  B6Ros.CG-­‐Dmd(mdx-­‐5cv)/J	  micelvi	   (nlvii=17+7)	  along	  
with	   their	  WT	  gender	  and	  age	  matched	  controls	  C57BL6/J	   (n=17+10);	  and	  20-­‐22	  weeks	  old	  male	  
heterozygous	  ∆KPQ	  micelviii	   (n=3+4)	  with	   their	   corresponding	  WT	   control	   (n=3+4)	  were	   selected	  
for	  the	  following	  studies.	  To	  avoid	  any	  position	  induced	  changes	  in	  fiber	  orientation,	  to	  maximally	  
expose	   the	   region	   of	   fluorescence	   and	   to	   provide	   a	   supposedly	   homogeneous	   area	   of	   conduction	  
spread;	   we	   restricted	   the	   measurements	   to	   the	   LV	   free	   wall	   for	   all	   excised	   hearts.	   Hearts	   were	  
stained	  with	   a	  Di-­‐4-­‐ANEPPS	   and	   activations	  were	   recorded	   as	  waves	   emanated	   from	   the	   tip	   of	   a	  
bipolar	  electrode,	  placed	  at	  the	  centre	  of	   the	  LV	  free	  wall,	  under	  automated	  steady	  state	  pacing	  at	  
BCL=100ms.	   The	   pharmacological	   intervention	   consisted	   of	   perfusing	   the	   cannulated	   hearts	  with	  
the	   regular	   Tyrode	   solution	   (section	   2.1.2)	   containing	   1µM	   Flecainide	   (Flecainide	   Acetate,	   Sigma	  
Aldrich)	   after	   the	   control	   (non-­‐treated)	   measurement	   was	   recorded	   and	   showed	   an	   elliptical	  
behavior.	  Measurements	  with	  Flecainide	  were	  taken	  at	  time	  points	  0,	  1,	  3,	  5,	  7	  and	  10	  min,	  to	  assure	  
close	  monitoring	  of	  activation	  changes	  due	   to	   the	  drug.	  Unlike	   the	  experimental	  protocol	  used	   for	  
the	  mdx	  and	  their	  WT	  counterpart	  that	  lasted	  up	  to	  10min	  exposure	  to	  Flecainide,	  steady	  state	  was	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(Biophys	   J	   (2006)	   90:2938-­‐2945),	   fluorescence	   in	   rabbit	   hearts	   loaded	  with	   Di-­‐4-­‐Anepps	   is	   optimal	   between	   0.5-­‐1mm	  
below	  the	  epicardial	  surface.	  
lv	  Dystrophin-­‐deficiency	  is	  described	  in	  the	  Introduction	  section	  1.2.2.	  	  
lvi	  These	  mice	  will	  be	  referred	  to	  as	  mdx	  (for	  simplicity)	  throughout	  this	  work.	  
lvii	  n	  =	  number	  of	  experiments.	  Two	  major	  experimental	  studies	  were	  conducted	  in	  this	  thesis.	  n	  =	  x	  +	  y	  means	  the	  total	  
number	  of	  animals	  used	  for	  both	  studies,	  where	  x	  indicates	  the	  number	  of	  animals	  used	  in	  the	  study	  that	  investigated	  the	  
different	   analytical	   strategies	   in	   CV	   evaluation	   using	   optical	   mapping,	   and	   y	   indicates	   the	   number	   of	   animals	   used	   to	  
conduct	  the	  heterogeneity	  study	  with	  Flecainide.	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no	   longer	   achievable	   for	   the	   ∆KPQ	   beyond	   5min	   of	   treatment	   (i.e.	   either	   entrainment	   at	   10Hz	  
frequency	  was	  no	  longer	  possible	  or	  consecutive	  APs	  showed	  considerable	  beat-­‐to-­‐beat	  variability	  
which	  prevented	  temporal	  averaging).	  All	  animal	  procedures	  were	  reviewed	  and	  approved	  by	   the	  
Institutional	   Animal	   Care	   and	   Use	   Committee	   of	   the	   University	  Medical	   Center	   Göttingen	   and	   by	  
veterinarian	   state	   authority	   LAVES	   (Niedersächsisches	   Landesamt	   für	   Verbraucherschutz	   und	  
Lebensmittelsicherheit)	  in	  compliance	  with	  the	  humane	  care	  and	  use	  of	  laboratory	  animals.	  
	  
2.2. Analyzing the Optical Signallix  
2.2.1. Signal Processing 
The	  image	  sequence	  was	  filtered	  spatially	  using	  a	  5 5	  uniform	  kernel.	  At	  each	  pixel,	  the	  time	  series	  
was	  filtered	  in	  time	  using	  a	  5 5	  uniform	  kernel,	  baseline	  subtracted,	  normalized	  to	  with	  respect	  to	  
its	  peak	  amplitude	  to	  [0	  1]	  intensity	  values	  and	  inverted	  (Figure	  6a).	  For	  the	  paced	  recordings	  only,	  
the	   optical	   signal	   was	   further	   averaged	   over	   10	   activations	   to	   improve	   SNR	   and	   remove	  
infinitesimal	   beat-­‐to-­‐beat	   variability	   (Figure	   6a).	   The	   cardiac	   excitation	   propagates	   as	   a	   moving	  
wave	  front,	  segregating	  the	  depolarized	  tissue	  from	  the	  quiescent	  tissue;	  consequently	  boundaries	  
at	  0.5ms	  interval	  (corresponding	  to	  the	  sampling	  rate)	  were	  computed	  by	  a	  linear	  interpolation	  of	  
activated	   pixels	   (Figure	   7),	   as	   the	   wave	   front	   propagates	   anisotropically	   from	   the	   tip	   of	   the	  
stimulating	  electrode	  (Figure	  5b).	  	  
	  
Signal	  Analysis.	  In	  this	  section,	  the	  analysis	  of	  the	  optical	  recordings	  will	  be	  described	  in	  detail.	  It	  is	  
based	  on	  the	  recorded	  optical	  signal .	  Note	  that,	  in	  fact,	  only	  the	  set	  of	  values	  
	   	   (1)	  
is	  known.	   	  denotes	  the	  position	  of	  the	   out	  of	   pixels	  in	  the	  x-­‐direction	  and	  the out	  of	  
	  pixels	  in	  the	  y-­‐direction	  and is	  the	  time	  at	  which	  the	   out	  of	   frames	  was	  recorded,	  i.e.	  	  
	   	   	  
	   	   (2)	  
	   	   	  
where	   	  and	   	  are	   the	  space	  and	  time	  resolution	  of	   the	  cameras.	  Whenever	  physical	  units	  are	  
not	  required,	  we	  will	  refer	  to	  the	  value	   	  simply	  as	   .	  Before	  performing	  any	  signal	  
analysis,	   the	   optical	   signal	   is	   averaged	   using	   a	   box	   filter	   of	   5	   pixels	   by	   5	   pixels	   in	   space	   and	   5	  
samples	  in	  time.	  
2.2.2. Activation Maps 
An	   activation	  map	   	   indicates	   the	   time	   of	   the	   first	   activation	   of	   the	   tissue	   at	   position 	  
after	  some	  reference	  time .	  The	  reference	  time	  usually	  corresponds	  to	  the	  time	  of	  a	  stimulus	   in	  
order	  summarize	   the	  wave	  activity	  emerging	   from	  the	  stimulation	  site.	  For	   simplicity,	  we	  assume	  
that	   the	   data	   only	   contain	   the	   response	   to	   one	   stimulus	   and	  hence .	   For	   all 	   and ,	  we	  
define	  the	  normalized	  signal	   	  as:	  
	  
	   (3)	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The	  activation	   time	  can	  be	   thought	  of	  as	   the	   time	  point	  at	  which	   the	  excitation	  wave	   front	  passes	  
through	   the	  myocardial	   cell.	   Since	   the	   originally	   recorded	   optical	   signal	   is	   inverted,	  we	   choose	   a	  
threshold	   ,	  below	  which	  the	  tissue	  should	  be	  regarded	  at	  activated.	  To	  account	  for	  noise,	  we	  only	  
accept	  a	  drop	  of	  the	  signal	  below	  threshold	  as	  an	  activation,	  if	  it	  is	  followed	  by	   	  consecutive	  frames	  
that	   are,	   on	  average	  below	   threshold.	  Thus	   for	   all	   pixels	   ,	   the	   frame	  of	   activation	   	   is	  
defined	  as	  	  
	  
	   	   (4)	  
In	  the	  examples	  shown	  in	  this	  paper,	  we	  use	   	  (Figure	  7a)	  and	   (Figure	  7a).	  To	  get	  a	  sub-­‐
frame	  estimate	  of	  the	  time	  of	  activation,	  we	  linearly	  interpolate 	  between	   	  and	   ,	  
which	  leads	  to	  the	  definition	  	  
	  
	   (5)	  
for	  each	  pixel of	  the	  activation	  map.	  To	  reduce	  noise	  artifacts,	  activation	  maps	  for	  10	  pulses	  of	  
the	  same	  stimulation	  sequence	  are	  averaged	  (Figure	  6a).	  Beat-­‐to-­‐beat	  variability	  can	  be	  monitored	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/-,**" Figure	   7.	   Activation	   times	   and	  
creation	  of	  activation	  maps	  for	  WT	  
and	  mdx.	  	  a.	  3D	  scheme	  of	  the	  wave	  
propagation	   on	   the	   epicardial	  
surface	   (depth~	   0.5	   mm)	   from	   a	  
point	  stimulation	  (P).	   	  The	  numbers	  
(1,	  2,	  3)	  of	  the	  AP	  upstrokes	  on	  the	  left	  
represents	   the	   activity	   in	   the	  
corresponding	   points	   on	   the	   surface	  
(right).	   Activation	   times	   were	  
detected	   whenever	   the	   upstroke	  
crossed	   the	   threshold	   at	   50%	  
fluorescence	   (ΔF)	   for	   more	   than	   10	  
consecutive	   frames.	   Interpolation	   of	  
the	   different	   pixels	   with	   the	   same	  
activation	   time	   formed	   an	   isochronal	  
line.	   The	   points	   (1,	   2	   and	   3)	   are	  
separated	   by	   2	   isochrones,	   i.e.	   a	  
temporal	   interval	   of	   1ms	   (temporal	  
resolution	   =0.5ms).	   b.	   Activation	  
maps	   recorded	   from	   the	  
epicardium	   of	   WT	   (left)	   and	   mdx	  
(right)	   hearts.	   As	   the	   wave	  
propagates	  from	  a	  point	  stimulation,	  a	  
snapshot	   each	   0.5ms	   was	   taken.	   The	  
activated	  pixels	  formed	  an	  ellipse	  that	  
gradually	   increased	   in	   size	   and	   the	  
wave	   reached	   the	   boundaries,	   which	  
delineated	   the	   typical	   anisotropic	  
propagation	   on	   the	   epicardium.	  
Annotations	   in	   figure:	   P=Pacing,	  
Ap=Apex,	  Ao=Aorta,	   L=Left,	  R=Right.	  
Scale	  bar	  =	  0.5mm.	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2.2.3. ROI and Dispersion Maps 
Further	  analysis	  was	  based	  activation	  maps	   	  obtained	  as	  described	   in	   the	  previous	  section.	  
Within	  this	  map,	  we	  define	  a	  region	  of	  interest	  (ROI),	  as	  a	  subset	  of	  pixels	  that	  satisfies	  the	  following	  
criteria	  (Figure	  8b):	  
• A	  homogeneous	   fluorescence	   intensity	   field	  where	   individual	   pixels	   can	  be	   evaluated	   as	   a	  
whole	  and	  are	  assumed	  to	  share	  fairly	  similar	  physiological	  variables528;	  
• Exclusion	  of	  stimulation	  artifacts	  projected	   in	   the	  earliest	  contours	  as	  well	  as	  boundary	  or	  
curvature	  artifacts	   in	   the	   last	   contours	   that	  are	  well	  known	  sources	  of	   inhomogeneities505,	  
529,	  530.	  
	  
Whenever	  the	  analysis	  of	  CV	  or	  upstroke	  velocity	  (dF/dt)max	  is	  founded	  on	  a	  previously	  determined	  
ROI	  (Figure	  8b),	  which	  usually	  includes	  the	  isochrones	  number	  2	  to	  number	  6	  (i.e.	  the	  area	  covered	  
by	  the	  traveling	  wave	  in	  its	  fastest	  speed	  configuration	  over	  a	  time	  interval	  of	  4ms);	  hence	  avoiding	  
pacing	  artifacts	  and	  boundary	  conditions	  (due	  to	  the	  ellipsoid	  shape	  of	  the	  heart	  being	  projected	  on	  
a	   2D	   surface).	   We	   use	   three	   different	   methods	   to	   quantify	   the	   CV	   components,	   parallel	   and	  
perpendicular	  to	  the	  fiber	  direction	  (section	  2.2.4).	  	  
	  
CV,	   (dF/dt)max	   and	   APD	   dispersion	  maps	   are	   typically	   used	   in	   analyzing	   optical	  mapping	   data	   to	  
characterize	  the	  local	  conduction	  velocity,	  upstroke	  velocity	  and	  APD	  at	  each	  pixel,	  respectively.	  	  
2.2.4. Analytical Strategies In CV Analysis 
Least	  Squares	  Ellipsis	  Fitting	  (LSEF)	  Makes	  Use	  of	  Geometry.	  Our	  method	  exploits	  2	  criteria	  of	  
myocardial	  propagation:	  1)	   the	  elliptical	  properties	  of	  activation	   isochrones	  due	   to	  anisotropy;	  2)	  
the	  linear	  relationship	  between	  spatial	  isochronal	  points	  and	  activation	  times	  along	  two	  directions	  
of	   propagation528.	   We	   extract	   contour	   lines	   from	   the	   activation	   map,	   for	   every ,	   ,	  














































Figure	   8.	   APD	   duration	   and	   upstroke	  
velocity	  (dF/dt)max	  analysis	  using	  optical	  
AP	  recordings	  with	  their	  associated	  APD	  
and	   (dF/dt)max	   dispersion	   maps.	   a.	  
Determining	   APD	   and	   (dF/dt)max	   using	  
optical	  AP.	  APD50	  is	  determined	  by	  the	  time	  
interval	   from	   the	   time	   point	   of	   the	   takeoff	  
potential	   (arrow	   with	   0ms)	   till	   the	  
normalized	   AP	   repolarizes	   back	   to	   50%	  
from	   the	   peak.	   The	   amplitude	   between	  
takeoff	  and	  peak	  represents	  100%	  (which	  is	  
similar	   to	   the	   100%	   repolarization	   from	  
peak	   to	   resting	   membrane	   potential).	   Red	  
dotted	   lines	   (upper	   10%	   and	   lower	   10%	  
thresholds)	   cross	   the	   AP	   upstroke	   at	   two	  
locations,	   from	   which	   (dF/dt)max	   can	   be	  
calculated	  (amplitude	  in	  a.u.	  over	  time	  in	  s).	  
b.	  ROI	  between	  isochrones	  2	  and	  6.	  Blue	  
and	   red	   arrows	   represent	   propagation	  
along	   longitudinal	   and	   transversal	  
directions	  (APs	  at	  these	  locations	  are	  picked	  
up	  along	   these	  axes	   for	   further	  analysis).	  c.	  
APD	   and	   (dF/dt)max	   dispersion	   maps	  
showing	   the	   gradually	   changing	   spatial	  
properties	  of	  these	  parameters.	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activation	  times,	  only	  the	  longest	  contour	  line	  at	  each	  frame	  time	   	  is	  kept	  for	  further	  analysis.	  To	  
each	  of	  these	  contours,	  ellipses	  are	  fitted	  which	  yield	  a	  set	  of	  major	  and	  minor	  axis	  lengths 	  and	   	  
respectively.	  Only	  one	  intermediate	  linear	  scaling	  regime	  can	  be	  found	  where	   	  can	  be	  fitted	  to	  
a	   line	   .	   Similarly,	   is	   obtained	   by	   fitting	   	   for	   the	   same	   set	   of	   	  
indices.	   The	   least	   square	   techniques	   recognize	   a	   set	   of	   parameters	   that	   minimize	   the	   distance	  
between	  the	  isochronal	  data	  points	  and	  the	  ellipse531.	  The	  specificity	  of	  the	  fitted	  ellipse-­‐solution	  is	  
monitored	   by	   a	   cost	   function,	   which	   consists	   of	   arbitrary	   unit	   values	   plotted	   against	   time	   that	  
characterize	   the	   closeness	   of	   the	   isochrones	   to	   the	   expected	   ellipse-­‐solution,	   therefore	   relate	   a	  
measure	  of	   the	  goodness	  of	   fit	  of	   the	  particular	  ellipse	   to	   the	  given	  set	  of	  data	  points.	   In	   the	   ideal	  
conditions,	   the	  cost	   function	   is	  anticipated	  to	  be	  constantly	  zero	   for	  all	   times.	  Under	  experimental	  
conditions,	  isochrones	  that	  return	  a	  cost	  function	  lower	  than	  unity	  are	  exclusively	  used	  for	  further	  
analysis.	  	  
	  
Plane	   Fitting	   (PF)	   Evaluates	   Velocities	   Locally.	  This	  method	   is	   based	   on	   averaging	   local	  wave	  
fronts	  velocities,	  which	  are	  extracted	  using	  the	  well-­‐known	  relationship532:	  
	   	   (6)	  
We	  use	   a	  method	  by	  Morley	  et	   al.	   to	   obtain	   	   in	   a	   robust	  way284.	   Instead	   of	   approximating	   the	  
operator	   	  by	  finite	  differences533,	  we	  fit	  a	  plane	  to	  the square	  of	  pixels	  around	  every	  pixel
and	  take	  the	  vector	  with	  the	  steepest	  slope	  of	  this	  plane	  as	   .	  This	  is	  then	  used	  to	  calculate	  
equation	  (6).	  Pixels	  with	  a	  divergence	  of	  the	  velocity	  field	  greater	  than	  2cm.s-­‐1.pixel-­‐1	  were	  excluded	  
and	  they	  correspond	  to	  the	  location	  of	  wave	  initiation,	  which	  yields	  arbitrarily	  high	  wave	  speeds	  by	  
default.	  By	  choosing	  the	  earliest	  activated	  pixels	  as	  a	  geometric	  centre	   	  for	  the	  created	  vector	  
field,	   the	   pixels	   are	   sorted	   into	   bins	   according	   to	   the	   angle	   of	   the	   point	   	  with	   respect	   to	   the	  
centre	   .	  Using	  	   	  bins,	  each	  bin	  has	  a	  width	  of	   	  and	  
the	  angle	  of	  the	   	  bin	  is	   .	  	  After	  this	  procedure,	  each	  angle	  bin	  is	  associated	  
with	  a	  mean	  wave	  speed	  
	   ,	   	   (7)	  
Note	  that	  this	  definition	  only	  makes	  sense	  if	  the	  propagation	  is	  approximately	  symmetric:	  by	  using	  
the	   arctan	   function,	   opposite	   sides	   with	   respect	   to	   the	   point	   of	   wave	   initiation	   are	   implicitly	  
averaged	  into	  one	  angle	  bin.	  The	  fiber	  direction	  is	  then	  the	  angle	   ,	  where	   	  is	  
the	  index	  of	  the	  bin	  with	  the	  largest	  mean	  wave	  speed.	  The	  wave	  speed	  along	  the	  fiber	  direction	  is	  
therefore	   .	  A	  corresponding	  definition	  for	  the	  minimum	  mean	  wave	  speed	  yields	  a	  direction,	  
which	  is	  approximately	  perpendicular	  to	  the	  fiber	  direction	  and	  therefore	  represents	   .	  
	  
Area	  Fitting	  (AF)	  Estimates	  Global	  Course	  of	  Activation.	  This	  method	  estimates	  velocities	  from	  
the	  rate	  of	   increase	  of	  the	  area	  activated	  in	  each	  angle	  bin.	   If	  we	  define	  the	   	  as	  above,	  using	  the	  
activation	  map	  as	  defined	  in	  equation	  (5)	  we	  compute	  the	  area	  activated	  in	  each	  bin	  
	   ,	   ,	  
(8)	  
where	   contains	  all	  the	  points	  with	   .	  The	  resulting	  function	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,	   ,	   (9)	  
where	   	  and	   	  are	  the	  result	  of	  a	  least-­‐square	  fitting	  procedure	  and	  indicate	  the	  velocity	  and	  the	  
apparent	   starting	   time	   (which	  might	  not	  be	   the	   time	  of	  pacing	  due	   to	  pacing	  artifacts)	   associated	  
with	  the	  angle	   ,	  respectively.	  The	  fitting	  is	  restricted	  to	  points	  from	  about	  1.0ms	  to	  3.5	  ms	  after	  
the	   stimulation.	   As	   for	   PF,	   the	   longitudinal	   and	   transversal	   velocities	   are	   then	   estimated	   as	   the	  
maximum	  and	  minimum	  of	   	  with	  respect	  to	   ,	  respectively. 
2.2.5. Synthetic Data Used to Simulate Propagation 
Computer	  Simulation.	  The	  properties	  of	  the	  different	  methods	  were	  verified	  on	  synthetic	  data	  sets.	  
In	  real	  experiments,	  the	  ideal	  anisotropic	  activation	  can	  be	  contaminated	  at	  the	  level	  of	  the	  acquired	  
signal	   by	   measurement	   noise	   and	   at	   the	   level	   of	   the	   cardiac	   substrate	   by	   different	   levels	   of	  
heterogeneity.	   To	   assess	   the	   performance	   of	   each	   of	   the	   methods,	   we	   carried	   out	   a	   series	   of	  
numerical	  simulations	  to	  characterize	  the	  effects	  of	  those	  two	  particular	  parameters	  on	  robustness,	  
accuracy	  and	  precision.	  
	  
Data	  Model.	  Simulations	  were	  done	  on	  a	  two-­‐dimensional,	  rectangular	  domain	  of	  1cm	  x	  1cm	  in	  size	  
using	  the	  Fenton-­‐Karma	  model	  with	  Beeler-­‐Reuter	  parameters534,	   that	  were	  modified	  (gfi	  =	  12	  and	  
and	   ucsi	   =	   0.91)	   to	   yield	   fast	   propagation	   velocities	   and	   a	   shorter	   action	   potential	   durations	  
comparable	  to	  those	  in	  the	  experiments.	  The	  numerical	  resolution	  was	  100µm	  in	  space	  and	  10µs	  in	  
time.	  Centered	  finite	  differences	  and	  a	  simple	  Euler	  step	  were	  used	  in	  space	  and	  time,	  respectively.	  
A	  circular	  region	  with	  a	  radius	  of	  200µm	  in	  the	  center	  of	  the	  domain	  was	  periodically	  stimulated	  at	  
10Hz	  with	  1.5ms	  monophasic	  pulses	   to	   initiate	  outward-­‐travelling	  waves.	  The	   fiber	  direction	  was	  
chosen	  to	  be	  along	  the	  diagonal	  of	  the	  domain,	  in	  order	  to	  allow	  for	  longer	  propagation	  without	  the	  
influence	  of	   the	  no-­‐flux	  condition	  enforced	  at	   the	  boundary.	  Diffusivities	  of	  1cm2.s-­‐1	  and	  0.5cm2.s-­‐1	  
were	   chosen	   parallel	   and	   perpendicular	   to	   the	   fibers,	   respectively.	   The	   total	   length	   of	   the	  
simulations	   was	   5s.	   A	   snapshot	   of	   the	   simulation	   was	   taken	   every	   0.5ms	   (corresponding	   to	   a	  
sampling	   frequency	   of	   2kHz)	   and	   voltage	   data	   were	   inverted	   to	   create	   artificial	   optical	   mapping	  
data.	  
	  
Ideal	  Elliptical	  Propagation.	  We	  simulated	  the	  effect	  of	  perfect	  anisotropy	  in	  the	  cardiac	  tissue	  by	  
an	   activation	   wave	   front	   initiated	   at	   a	   point-­‐stimulation,	   and	   traveling	   to	   the	   boundaries	   as	  
absolutely	   elliptical	   isochrones.	   Both	   maximal	   and	   minimal	   CVs	   were	   evaluated	   by	   the	   three	  
strategies	  simultaneously	  over	  well-­‐defined	  rings	  systematically	  scanning	  the	  entire	  activation	  field.	  
Those	  rings	  are	  ROIs	  containing	  5	  consecutive	   isochrones	  similar	   to	   the	  region	  used	   in	  evaluating	  
velocities	   in	  the	  experimental	  data.	  Conducive	  to	  substantially	  exploit	  all	   the	  simulated	  isochrones	  
(N=23),	  we	  adopted	  the	  notion	  of	  a	  sliding	  interval	  that	  corresponds	  to	  that	  particular	  ROI	  shifted	  at	  
increments	   of	   1	   isochrone,	   starting	   from	   the	   first	   to	   the	   23rd	   contour.	   To	   avoid	   artifacts	   in	   our	  
analysis	   due	   to	   boundary	   effects,	   the	   outermost	   ring	   was	   restricted	   between	   the	   12th	   and	   16th	  
contour	  lines.	  The	  curves	  plotted	  in	  the	  ideal	  case	  will	  serve	  as	  a	  platform	  against	  which	  the	  curves	  
obtained	  from	  the	  non-­‐ideal	  conditions	  will	  be	  contrasted.	  	  
	  
Measurement	   Noise.	   Noisy	   data	   were	   constructed	   from	   the	   ideal	   case	   using	   additive	   Gaussian	  
white	  noise:	  independent	  random	  numbers	  were	  drawn	  from	  a	  Gaussian	  distribution	  with	  standard	  
deviation	   	   and	   added	   to	   each	   pixel	   in	   each	   frame	   of	   the	   artificial	   optical	  mapping	   data.	   The	  
signal-­‐to-­‐noise	  ratio	  (SNR)	  was	  defined	  as	  the	  ratio	   .	  Note	  that	  this	  original	  SNR	  ratio	  is	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Simulated	   Heterogeneities.	   The	   effect	   of	   a	   heterogeneous	   cardiac	   substrate	   was	   implemented	  
using	   a	   gaussian	   random	   field	   	   with	   a	   correlation	   length	   of	   300µm	   and	   amplitudes	  
measured	  as	  the	  standard	  deviation	   of	  the	  ensemble	  of	  all	  points.	  The	  diffusion	  tensor	   	  of	  the	  
simulation	  was	  then	  modified	  according	  to	  
	   ,	   (10)	  
where	   	  was	  chosen	  such	  that	   ,	  i.e.	  a	  constant	  mean	  velocity	  was	  maintained.	  With	  
different	   realizations	   of	   these	   heterogeneous	   diffusion	   tensors,	   the	   numerical	   simulations	   were	  
carried	  out	  as	  indicated	  above.	  
	  
Statistics.	  Data	  are	  presented	  as	  mean	  ±	  SM.	  Differences	  between	  groups	  were	  tested	  for	  statistical	  
























































Figure	   9.	   Depolarization	   (a)	  
wave	   front	   followed	   by	  
repolarization	   (b)	   projected	  
on	  the	  epicardial	  surface	  (gray	  
background)	   of	   the	   LV	   free	  
wall	  of	  a	  murine	  heart	  (WT).	  a.	  
Mapping	   the	   amplitude	   of	   the	  
activation	   wave	   front	   as	   it	  
emanates	   from	   a	   point	  
stimulation	   (pacing	   electrode	  
placed	   at	   the	   center	   of	   the	   LV	  
free	  wall).	  The	  wave	  propagates	  
in	   an	   elliptical	   (anisotropic)	  
fashion	   towards	   the	   LV	  
boundaries	  within	  8ms.	  At	  15ms,	  
all	  pixels	  are	  activated:	  cells	  have	  
depolarized	   and	   entered	   the	  
refractory	  phase	  (i.e.	  they	  are	  no	  
longer	   excitable	   until	  
repolarization	   is	   achieved).	   b.	  
Repolarization	   is	   slower	   than	  
activation	   and	   is	   homogenous	  
throughout	   the	   heart.	   Such	  
repolarization	   pattern	   indicates	  
that	   the	   dispersion	   of	  
repolarization	   in	   normal	   hearts	  
is	   minimal,	   as	   nearly	   all	   cells	  
regain	   excitability	   almost	  
simultaneously.	   Annotations	   in	  
figure:	   Scale	   bar	   =1mm.	   Look-­‐
up-­‐table	   normalized	   signal	  
amplitude	  of	  the	  activation	  wave	  
front.	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 Chapter 3 
Results 
As	   indicated	   in	   the	   section	   1.2.2,	   NaV1.5	   was	   demonstrated	   to	   associate	   with	   the	   dystrophin-­‐
syntrophin	   multiprotein	   complex	   (DSMC)	   in	   cardiac	   cells.	   The	   principal	   active	   molecular	  
determinant	  of	  propagation	   in	  the	  ventricular	  myocardium	  is	  probably	  the	  availability	  of	  NaV1.599,	  
368.	  However,	   the	   role	   of	   changes	   in	   INa	   density	   on	  biophysical	   properties	   remains	   a	   controversial	  
issue289,	   with	   varying	   reported	   effects	   among	   the	   different	   cardiac	   models	   investigated535,	   536.	   As	  
described	   in	   the	   introductionlx,	   the	   ventricular	  wall	   is	   far	   from	  being	   homogeneous	  with	   uniform	  
electrical	  properties.	  In	  concordance	  with	  the	  discontinuous	  nature	  of	  electrical	  propagation	  in	  the	  
heart,	  heterogeneity	  seems	  to	  be	  an	  intrinsic	  property	  of	  the	  ventricle	  that	  is	  not	  only	  observed	  at	  
the	  different	  tissue	  levels	  comprising	  the	  wall262,	  but	  also	  prevails	  subcellularly	  with	  distinct	  profiles	  
of	  activation	  in	  a	  network	  of	  connected	  cells537.	   Interventions,	  whether	  genetic	  (e.g.	  gain	  or	   loss	  of	  
NaV1.5)	   or	  pharmacological	   (e.g.	  NaV1.5	  blockers),	   that	   alter	  propagation	  of	   an	   excitation	  wave	   in	  
multicellular	   cardiac	   network	   may	   additionally	   extend	   the	   range	   over	   which	   many	   functional	  
parameters,	  such	  as	  (dF/dt)max	  and	  APD,	  are	  inhomogeneous.	  Such	  increased	  dispersion	  in	  recovery	  
from	   inactivation	   is	   believed	   to	   facilitate	   re-­‐entrant	   excitation	   and	   renders	   the	   ventricular	   tissue	  
prone	  to	  arrhythmias263,	  538.	  	  
	  
The	  results	  presented	  below	  target	  three	  central	  questions:	  First,	  what	  impact	  does	  losing	  a	  pool	  of	  
NaV1.5	  have	  on	  conduction	  in	  the	  medium	  and	  how	  does	  this	  possibly	  add	  to	  our	  understanding	  of	  
cardiac	   dysfunction	   in	   DMD	   patients?	   Second,	   giving	   the	   importance	   of	   evaluating	   propagation	  
instabilities	  in	  the	  cardiac	  tissue	  and	  its	  implication	  in	  facilitating	  arrhythmic	  patterns,	  how	  accurate	  
are	   the	   existing	   analytical	   and	   numerical	   methods	   in	   detecting	   velocity	   changes	   of	   transient	  
dynamical	  processes	  occurring	  on	  a	  millisecond	  scale?	  Would	  controversy	  regarding	  some	  models	  
of	   cardiac	   electrical	   propagation	   stem	   from	   the	   actual	   limitations	   of	   methods	   used	   in	   optical	  
mapping,	   particularly	   with	   their	   dependence	   on	   geometry,	   signal-­‐to-­‐noise	   ratio,	   initial	   and	  
boundary	  conditions,	  and	  sensitivity	  to	  heterogeneities	  in	  the	  milieu?	  Third,	  a	  hallmark	  of	  reduced	  
conduction	  in	  arrhythmogenic	  models	  is	  the	  simultaneous	  presence	  of	  repolarization	  abnormalities	  
that	  amplify	  the	  electrical	  heterogeneity	  in	  the	  ventricle.	  How	  could	  heterogeneity	  be	  spatially	  and	  
temporally	   characterized	   in	  models	   of	   loss	   or	   gain	   of	  NaV1.5	   function,	   and	  how	  modifiable	   is	   this	  
property	   under	   conditions	   of	   NaV1.5	   blocking?	   Could	   Flecainide’s	   “paradoxical”	   proarrhythmic	  
effects	   at	   the	   multicellular	   level	   be	   dependent	   on	   contrasting	   modulation	   of	   NaV1.5	   in	   different	  
cardiac	  models?	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lx	  Refer	  to	  Introduction	  section	  1.3.2	  
66	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Chapter	  3	  Results	  
In	   this	   context,	   the	   experimental	   framework	   of	   this	   thesis	   focused	   on	   characterizing	   electrical	  
instabilities	   using	   high	   spatial-­‐temporal	   optical	   mapping	   techniques	   in	   models	   harboring	   NaV1.5	  
loss	  (the	  mdx	  mouse	  model)	  or	  NaV1.5	  gain	  of	  function	  (ΔKPQ	  model	  of	  LQTS3),	  each	  group	  with	  its	  
corresponding	  WT	   counterparts,	   in	   ex-­‐vivo	   conditions	  where	   isolated	   hearts	  were	   perfused	  with	  
Flecainidelxi.	  
	  
3.1. Conduction Slowing in Hearts of mdx-Mice 
In	  a	  region	  of	  the	  heart,	  in	  which	  excitability	  and	  conduction	  is	  mainly	  supported	  by	  INa,	  an	  inaugural	  
electrophysiological	  sequel	  of	  losing	  NaV1.5	  from	  the	  LM	  would	  probably	  be	  a	  global	  decrease	  in	  CV	  
across	   the	   ventricle.	   Changes	   in	   anisotropic	   ratiolxii	   (AR)	   due	   to	   clustering	   of	   the	   remaining	  
functional	  NaV1.5	  in	  the	  ID	  are	  less	  certain,	  possibly	  secondary	  to	  the	  dependence	  of	  anisotropy	  on	  
other	  passive	  components,	  such	  as	  gap	  junctions	  (GJ)	  distribution199,	  539,	  which	  hasn’t	  been	  reported	  
so	  far	  to	  be	  altered	  in	  the	  mdx	  model.	  ECG	  recordings	  of	  mdx-­‐mice	  showed	  a	  prolongation	  of	  the	  QRS	  
interval237,	   which	   further	   suggests	   a	   general	   decrease	   in	   wave	   front	   propagation.	   	   In	   order	   to	  
investigate	  whether	   CV	   is	   reduced	   in	   those	   hearts,	   optical	  mapping	   experiments	   of	   intact	  murine	  
hearts	  were	  performedlxiii.	  In	  this	  in-­‐vitro	  experimental	  study,	  the	  LV	  free	  wall	  was	  solely	  exposed	  to	  
the	  optical	  path	  to	  provide	  a	  quasi-­‐homogeneous	  field	  of	  tissue,	  with	  the	  pacing	  electrode	  positioned	  
directly	  in	  the	  center	  to	  ensure	  the	  best	  possible	  elliptical	  configuration	  (Figure	  10a).	  A	  comparison	  
of	  the	  activation	  patterns	  obtained	  from	  WT	  and	  mdx-­‐hearts	  are	  shown	  in	  (Figure	  10b).	  Isochronal	  
maps	  show	  that	  the	  maximal	  CV	  occurred	  in	  nearly	  the	  same	  direction	  in	  WT	  and	  mdx-­‐hearts,	  but	  
the	  activation	  patterns	  between	   the	   two	  groups	  are	  clearly	  non-­‐identical.	   In	  order	   to	  delineate	  an	  
unambiguous	   region	  where	  CV	   can	  be	   safely	   estimated,	   an	   iterative	   test-­‐and-­‐exclude	  process	  was	  
performed	  to	  identify	  isochrones	  with	  points	  on	  the	  distance	  vs.	  time	  graph	  that	  do	  not	  deviate	  from	  
the	   linear	   regime	   (Figure	   10b,	   left).	   Regressions	   of	   the	   selected	   points	   were	   performed	   and	   the	  
slopes	  represented	  the	  velocity	  of	  the	  wave	  front	  in	  that	  particular	  direction.	  In	  contrast	  to	  the	  WT	  
hearts	   (Figure	   10c),	   dystrophin-­‐deficient	   hearts	   showed	   an	   average	   decrease	   of	   31.4%	   in	   the	  
transversal	  direction	  from	  0.51±0.04m.s-­‐1	  to	  0.35±0.06m.s-­‐1	  (WT,	  n=5;	  mdx,	  n=8,	  p<0.001)	  and	  along	  
the	   longitudinal	   direction	   a	   decrease	   of	   17.5%	   from	   0.74±0.08m.s-­‐1	   to	   0.61±0.11m.s-­‐1	   (WT,	   n=5;	  
mdx,	  n=8,	  p<0.05).	  AR	   increased	  on	  average	  by	  almost	  10%	   in	   the	  mdx-­‐group,	  however	  without	  a	  
statistical	   significance	   (Figure	   10c).	   Thus,	   under	   conditions	   mimicking	   the	   physiological	   resting	  
mouse	   heart	   rate	   (~10-­‐12Hz),	   the	  mdx	   ventricle	   showed	   significant	   slowing	   of	   conduction	   in	   all	  
directions,	   in	   concordance	   with	   the	   previously	   reported	   QRS	   widening237.	   The	   fact	   that	   the	  
distribution	   and	   expression	   of	   Cx43	   remains	   unaltered	   in	   the	  mdx	   hearts237,	   238	   may	   explain	   the	  
insignificant	   change	   in	   AR	   in	   those	   hearts.	   Using	   the	   ellipsis-­‐fitting	   method	   we	   published	   these	  
results	  as	  a	  collaborative	  work	  in	  Circulation	  Research	  (2011)238.	  However,	  as	  different	  methods	  to	  
evaluate	  CV	  using	  optical	  mapping	  were	  already	  published284,	  validation	  of	  our	  results	  using	  other	  
methods	  was	  deemed	  necessary.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxi	  Refer	  to	  Introduction	  section	  1.4.7	  for	  a	  complete	  description	  of	  the	  drug.	  
lxii	  Anisotropic	  ratio	  is	  the	  ratio	  of	  the	  longitudinal	  and	  transversal	  velocities.	  	  
lxiii	  Refer	  to	  Experimental	  Methods	  section	  2.1.2	  for	  a	  complete	  description	  of	  procedure.	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Combining	  CV	  measurements	   to	   time	  parameters	   such	   as	   the	  RP	  or	  APD	  of	   a	  moving	  wave	   front,	  
provides	   a	   distance	   parameter	   that	   is	   directly	   associated	   with	   the	   stability	   of	   a	   reentrant	   wave	  
pattern100.	  The	  precise	  quantification	  of	  CV	  for	  the	  same	  cardiac	  substrate	  is	  often	  controversial284,	  
506,	  507.	  Several	  methods	  have	  been	  implemented	  in	  the	  study	  of	  CV	  in	  normal	  or	  genetically	  altered	  
mouse	   hearts	   under	   simple238,	   508	   and	   more	   complex	   activation	   patterns509,	   510.	   While	   they	   are	  
appearing	  more	   frequently	   in	   publications,	   their	   implicit	   assumptions,	   errors	   and	   limitations	   are	  
rarely	   subject	  of	  overt	  debate.	   Instead,	   they	   should	  be	  explicitly	   challenged	  and	  openly	  discussed,	  
for	  if	  they	  are	  underestimated,	  results	  may	  be	  contradictory	  or	  misleading.	  	  
	  
For	  this	  purpose,	  three	  analytical	  strategies	  were	  adopted	  as	  described	  in	  the	  Methods’	  section	  with	  
their	  mathematical	   formulations.	   All	   these	   strategies	   yielded	  plausible	   results238,	   284.	  Despite	   their	  






























Figure	   10.	   LV	   conduction	   slowing	  
in	  mdx-­‐hearts.	   a.	   Paced	   activation	  
recorded	   from	   the	   LV	   free	  wall	   of	  
an	  mdx-­‐mouse	  heart	  at	   0.5ms	   time	  
interval	   shows	   the	   expected	   elliptic	  
spread,	   characteristic	   of	   anisotropy.	  	  
The	   first	   derivative	   in	   time	   of	   the	  
optical	   signal	   is	   calculated	   at	   each	  
pixel,	   and	   as	   the	   wave	   front	  
propagates	   the	   maximum	   of	   the	  
derivative	  is	  colored	  according	  to	  the	  
scale	   bar	   on	   the	   left.	   Gray	   color	  
means	  refractory	   or	  quiescent	   tissue	  
depending	  on	   its	   location	   relative	   to	  
the	   wave	   front.	   b.	   Activation	  maps	  
and	   estimation	   of	   CV	   by	   a	   linear	  
regression.	   Isochronal	  contour	   lines	  
are	   extracted	   from	   the	   activation	  
recordings	   and	   ellipses	   are	   fitted	  
successively	   to	   the	   interpolated	  
pixels	   (left,	   red)	   with	   their	  
corresponding	  data	  points	   (square	  =	  
longitudinal,	  circle	  =	   transversal)	   for	  
WT	   (black)	   and	   mdx	   (blue).	   Filled	  
symbols	   represent	   the	   selected	   data	  
points	  used	  for	  the	  linear	  regression.	  
The	  shallower	  slopes	  for	  the	  mdx	  are	  
indicative	   of	   slower	   conductions.	  
Scale	   bar	  =	   1mm.	   Ap	  =	   Apex,	   Ao	   =	  
Aorta,	   P	   =	   Point	   stimulation,	   R	   =	  
Right,	   L	   =	   Left,	   c.	   Bar	   graphs	  
summarizing	   CV	   and	   AR	   averages.	  
Statistical	  significance	  as	  indicated	  in	  
figure,	  n.s.,	  not	  significant.	  	  
68	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Chapter	  3	  Results	  
could	  seriously	  complicate	  the	  quantitative	  evaluation	  of	  CV.	  The	  least-­‐square	  ellipsis	  fitting	  (LESF),	  
for	  instance,	  has	  a	  strong	  dependency	  on	  geometry.	  An	  overall	  deviation	  from	  the	  elliptical	  pattern	  
will	  easily	  lead	  to	  large	  errors,	  whereas	  the	  vector	  field	  analysis	  (i.e.	  the	  plane	  fitting	  method,	  or	  PF)	  
is	  prone	  to	  pick-­‐up	  local	  heterogeneities	  in	  the	  activation	  medium	  and	  overtly	  estimate	  the	  velocity	  
values,	   in	   addition	   to	   a	   significant	   loss	   in	   precision.	   The	   area	   fitting	   (AF)	   avoids	   dependence	   on	  
geometry	   and	   sensitivity	   secondary	   to	   numerical	   derivatives,	   but	   hasn’t	   been	   implemented	   as	   a	  
potential	   strategy	   to	  measure	   CV,	   possibly	   due	   to	   the	   fact	   that	   it	  mathematically	   returns	   a	   global	  
parameter	   of	   spread,	   rather	   than	   an	   “actual	   velocity”,	   in	   consequence	   it	   does	   not	   invest	   the	   full	  
spatial	   resolution	   offered	   by	   optical	   mapping.	   A	   comprehensive	   comparison	   of	   the	   proposed	  
methods	   concludes	   this	   section.	   The	   validity,	   advantages,	   sensitivity	   and	   limitations	   of	   these	  
methods	   are	   discussed	   in	   the	   next	   chapter.	   However,	   this	   study	   reviews	   evidence	   that	   analytical	  
methods	   may	   not	   always	   be	   applicable,	   and	   when	   they	   are	   not,	   the	   obtained	   results	   may	   be	  
misleading.	  
3.1.1. LSEF: an Anisotropy-Dependent Method 
In	  order	   to	   avoid	   investigator	  bias,	   an	  additional	   component	  was	  added	   to	   the	  LSEF	  method.	  The	  
need	   to	   objectively	   determine	   the	   area	   where	   CV	   can	   be	   safely	   evaluated,	   isochrones	   that	  
particularly	  minimize	   the	   cost	   function	  were	   included,	   and	   their	   corresponding	   data	   points	  were	  
exclusively	   used	   for	   the	   linear	   regression	   to	   evaluate	   the	   CV	   within	   this	   ROIlxiv.	   The	   observed	  
condensation	  of	  isochrones	  in	  the	  mdx-­‐model	  is	  appropriately	  exploited	  by	  LSEF.	  In	  Figure	  11b,	  we	  
notice	  that	  compared	  to	  the	  WT	  activation	  in	  Figure	  11a,	  tightening	  of	  the	  spatial	  map	  for	  the	  mdx-­‐
heart	  is	  translated	  into	  smaller	  slopes	  for	  both	  major	  and	  minor	  directions	  of	  propagation.	  Because	  
first	  isochrones	  are	  prone	  to	  pacing	  artifacts,	  noted	  by	  the	  irregularities	  in	  the	  shape,	  that	  possibly	  
lead	   to	   arbitrarily	   high	   velocities,	   they	  were	   excluded	   from	   the	   linear	   regression	   analysis	   (Figure	  
11b,	  right).	  CV	  using	  LSEF	  was	  reduced	  on	  average	  by	  24.7%	  along	  the	  longitudinal	  (WT,	  n=17;	  mdx,	  
n=17;	   p-­‐value<0.0001)	   and	   21.1%	   along	   the	   transversal	   (p-­‐value<0.0001)	   directions	   in	   the	  mdx-­‐
hearts	  relative	  to	  the	  WT	  control	  group	  (Figure	  11c),	  with	  no	  significant	  change	  in	  AR	  (Figure	  11d).	  
Consequently,	  this	  part	  of	  the	  study	  shows	  that	  the	  number	  of	  experiments	  used	  for	  the	  previously	  
published	   results	   wasn’t	   a	   limiting	   factor.	   The	   percentage	   decrease	   in	   velocities	   was	   within	   the	  
previously	  reported	  ranges	  using	  this	  method.	  Nevertheless,	  the	  higher	  number	  of	  experiments	  has	  
mainly	  strengthened	  the	  statistical	  significance	  of	  our	  results.	  	  
3.1.2. PF: Local Calculation of Velocity Wave Fronts 
The	  colored	  vector	  fields	  in	  Figure	  12a	  and	  b	  show	  the	  anisotropic	  activation	  patterns	  for	  WT	  and	  
mdx-­‐hearts	  respectively,	  both	  representing	  a	  well-­‐behaved	  configuration	  almost	  similar	  to	  the	  ideal	  
simulation	   model.	   Nevertheless,	   Figure	   12b	   reveals	   a	   slower	   propagation	   in	   the	   mdx-­‐hearts	  
reflected	  by	  a	  longer	  time	  of	  activation	  when	  compared	  to	  the	  WT.	  Each	  vector	  combines	  a	  direction	  
and	   amplitude	   at	   each	  pixel.	   The	   vectors	   emanate	   from	   the	  pacing	   site	   in	   an	   anisotropic	  manner,	  
regardless	  of	  the	  direction	  of	  the	  underlying	  epicardial	  fibers.	  Only	  within	  the	  ROI	  delineated	  above	  
(i.e.	   between	   t1=0.5ms	  and	   t6=2.5ms),	   the	   assumption	  of	   homogeneous	   symmetrical	   fields	   around	  
the	  pacing	  site	  stands.	  Therefore	  the	  resulting	  vectors	  are	  binned	  based	  on	  a	  geometric	  center	  that	  
coincides	   with	   the	   tip	   of	   the	   pacing	   electrode,	   leading	   to	   a	   continuous	   set	   of	   mean	   velocities	  
spanning	  the	  directions	  from	  90°	  to	  270°	  (Figure	  12a	  and	  b)	  from	  which	  the	  fastest	  and	  slowest	  CV	  
in	   the	  medium	   are	   picked	   up.	   This	  method	   reported	   a	   significant	   CV	   decrease	   of	   24%	   along	   the	  
maximal	   (p-­‐value<0.0001)	   and	   19.5%	   along	   the	  minimal	   (p-­‐value<0.0001)	   directions	   in	   the	  mdx-­‐
hearts	  relative	  to	  the	  WT	  group	  (Figure	  12c),	  with	  no	  change	  in	  AR	  (Figure	  12d).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxiv	  Refer	  to	  Experimental	  Methods	  section2.2.3	  and	  Figure	  8	  for	  the	  current	  definition	  of	  ROI	  in	  this	  context.	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3.1.3. AF: An Estimation of Global Conduction Method 
As	   the	   cardiac	   excitation	   propagates	   from	   the	   tip	   of	   the	   pacing	   electrode,	   it	   separates	   the	  
depolarized	   and	   quiescent	   myocardium.	   The	   temporal	   evolution	   of	   the	   activated	   area	   can	   be	  
visualized	   in	   Figure	   13a	   and	   b	   (left)	   for	   both	  WT	   and	  mdx-­‐hearts	   respectively,	   where	   the	   white	  
region	   spreads	   over	   the	   resting	   black	  myocardium.	   The	   symmetry	   around	   the	   pacing	   site	   is	   still	  
conserved	  at	  t6	  =	  2.5ms,	  which	  allows	  for	  a	  symmetrical	  segmentation	  of	  the	  map	  along	  16	  different	  
directions	  of	  propagation,	  evaluated	  in	  pairs	  resulting	  in	  8	  time	  series	  (panels	  a	  and	  b,	  middle),	  to	  
each	  of	  which	  a	  quadratic	  function	  is	  fitted.	  This	  function	  returns	  8	  effective	  velocity	  measures	  from	  
















Figure	   11.	   Least-­‐square	   ellipsis	  
fitting	  method	   (LSEF).	   a.	   From	   the	  
WT	   activation	   map	   we	   extract	  
isochronal	  contour	   lines;	  ellipses	  are	  
successively	   fitted	   (on	   the	   left,	   in	  
red)	  to	  the	  interpolated	  pixels,	  which	  
return	  a	  set	  of	  major	  and	  minor	  axes	  
lengths.	   The	   center	   of	   the	   ellipses	  
coincides	   with	   the	   actual	   point	   of	  
stimulation	   (P).	   Longitudinal	  
(square)	   and	   transversal	   (circle)	  
isochronal	   points,	   deduced	   from	   the	  
bilaterally	  averaged	  major	  and	  minor	  
axes	   of	   the	   ellipses	   respectively,	   are	  
plotted	   in	   a	   distance	   vs.	   time	   graph	  
(middle).	   In	   an	   exclusively	  
intermediate	   linear	   scaling	   regime	  
(filled	   symbols),	   isochronal	   points	  
are	   fitted	   along	   the	   direction	   of	  
propagation,	   yielding	   the	   respective	  
velocity	   value.	   Points	   that	   deviate	  
from	   the	   linear	   behavior	   (open	  
symbols)	   were	   excluded	   from	   the	  
regression.	   Vmax	   =	   0.72m.s-­‐1;	   Vmin	   =	  
0.35m.s-­‐1.	   The	   goodness	   of	   fit	   for	  
each	  of	  the	  ellipses	  is	  estimated	  using	  
a	   cost	   function	   (right).	   Ellipses	   that	  
return	  a	  cost	  function	  value	  less	  than	  
1	   are	   exclusively	   considered	   for	  
further	  analysis.	  Scale	  bar	  =	  0.5mm.	  
Ap=Apex;	   Ao=Aorta;	   R=Right,	  
L=Left.	   b.	   Same	   analysis	   used	   for	  
mdx-­‐activation	  map.	  Estimated	  Vmax	  
=	   0.54	  m.s-­‐1;	   Vmin	  =	   0.30m.s-­‐1.	  c.	  Box	  
plots	   with	   whiskers	   showing	  
significantly	   reduced	   longitudinal	  
and	   transversal	   CV.	   d.	   Bar	   graphs	  
showing	  no	  difference	  in	  AR,	  n.s.	  not	  
significant	  as	  indicated.	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global	   velocity	   decrease	   of	   24%	   along	   the	   fastest	   (p-­‐value<0.0001)	   and	   17.5%	   along	   the	   slowest	  
directions	  (p-­‐value<0.01)	  between	  the	  2	  experimental	  groups.	  
	  
These	   results	   consistently	   show	  a	  CV	  decrease	   in	   the	  mutated	  group.	  Nonetheless,	   in	   all	   previous	  
measurements,	  activations	  were	  carefully	  selected	  not	  to	  deviate	  from	  anisotropy,	  which	  in	  return	  
might	   be	   introducing	   a	   bias	   component	   in	   restricting	   the	   analysis	  within	   the	   safety	  margins	   of	   a	  
well-­‐defined	   geometric	   propagation.	   Hence,	   this	   agreement	   between	   the	   methods	   needs	   to	   be	  




























Figure	   12.	   Plane	   fitting	   method	  
(PF).	   a.	   and	   b.	   Vector	   fields	  
calculated	   from	   the	   previously	  
shown	   activation	   maps	   for	   WT	   and	  
mdx	   hearts	   respectively.	   Each	   black	  
vector	   is	   characterized	   with	   both	   a	  
direction,	   which	   corresponds	   to	   the	  
direction	   of	   propagation	  of	   the	   local	  
wave	   front	   and	   a	   scalar	   amplitude,	  
which	   corresponds	   to	   the	   CV	   at	   that	  
particular	   pixel.	   The	   pacing	   site,	  
taken	   to	   be	   the	   geometric	   center	   of	  
the	  vectorial	  map,	  coincides	  with	  the	  
center	   of	   the	   polar	   plot	   (right).	  
Vectors	   are	   projected	   into	   24	  
different	   orientations	   going	   from	   0°	  
to	  360°	  at	  a	  bin	  width	  of	  15°.	  Average	  
velocities	   (blue	   line)	   along	   with	   the	  
standard	   deviations	   (red	   dotted	  
lines)	  are	  calculated	  in	  each	  direction	  
by	   averaging	   each	   bin	   and	   its	  
diametrically	   opposite	   counterpart,	  
yielding	   velocity	   vectors	   oriented	  
from	   90°	   to	   270°,	   from	   which	   the	  
maximum	   and	   minimum	   scalar	  
amplitudes	  (the	  large	  and	  small	  black	  
arrows	   in	   the	   polar	   plots)	   are	  
automatically	   picked	   up	   and	  
represent	  the	  fastest	  and	  slowest	  CVs	  
in	  the	  medium	  respectively.	  WT:	  Vmax	  
=	   0.7±0.05	   m.s-­‐1;	   Vmin	   =	   0.35±0.04	  
m.s-­‐1.	   mdx:	   Vmax	   =	   0.55±0.08	   m.s-­‐1;	  
Vmin	   =	   0.31±0.03	   m.s-­‐1.	   For	   clarity,	  
only	  1	  out	  of	  2	  calculated	  vectors	  are	  
drawn	   here.	   Horizontal	   scaling	  
arrow	   (upper,	   left),	   magnitude	   =	   1	  
m.s-­‐1.	   Scale	  bar	  =	  1mm.	   Color	   scale	  
bar	  =	   time	   scale	   of	   activation	   in	  ms	  
[0	   10].	   Ap=Apex;	   Ao	   =Aorta;	  
R=Right,	   L=Left.	   c.	   Box	   plots	   with	  
whiskers	   showing	   significantly	  
reduced	   CV	   along	   the	   maximal	   and	  
the	  minimal	  directions	  between	  the	  2	  
experimental	   groups.	   d.	   Bar	   graphs	  
showing	  no	  difference	  in	  AR,	  n.s.	  not	  
significant	  as	  indicated.	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does	  not	  reveal	  a	  direct	  comparison	  between	  them,	  nor	  it	  does	  show	  how	  well	  the	  methods	  would	  
agree	  in	  more	  complicated	  activation	  patterns.	  	  
	  
	  
3.1.4. Deviation from Anisotropy: Failure of Methods’ Convergence 
Three	   experiments	   were	   further	   performed	   with	   the	   ∆KPQ	   mice	   and	   maps	   with	   an	   initial	  
anisotropic	  spread	  were	  exclusively	  chosen.	  Similar	  outcomes	  were	  reproduced	  with	  these	  NaV1.5	  
mutated	   hearts,	   as	   the	   previous	   two	   experimental	   groups:	   As	   expected,	   the	   methods	   yielded	  
comparable	  results	  under	  anisotropic	  conditions	  (Figure	  14a).	  The	  reported	  Vmax	  using	  PF	  is	  almost	  
10%	   higher	   than	   the	   ones	   by	   LSEF	   and	   AF	   because	   the	   method	   was	   chosen	   to	   explore	   the	   full	  
circumference	   of	   the	   ROI,	   without	   symmetry	   consideration	   around	   the	   geometric	   center	   (as	  
















Figure	   13.	   	   Area	   Fitting	   method	  
(AF).	   a	   and	   b.	   The	   temporal	  
evolution	  of	  the	  area	  activated	  by	  the	  
propagating	   wave	   from	   the	   point	   of	  
stimulation	  (red	  dot)	  at	  the	  center	  of	  
the	  LV	  to	  the	  boundaries	  for	  WT	  and	  
mdx	   hearts	   respectively	   (left).	   For	  
simplicity,	  snapshots	  of	  the	  activated	  
area	   are	   shown	   at	   1ms	   intervals.	  
Scale	   bar	   =	   3mm.	   The	   isochronal	  
map	   is	   segmented	   into	   16	   bins	   of	  
different	   angles	   of	   propagation.	   By	  
evaluating	   simultaneously	   each	   bin	  
with	  its	  contralateral	  side,	  a	  total	  of	  8	  
time	   series	   are	   derived	   (middle),	  
created	   from	   the	   extracted	  
isochronal	   points	   as	   the	   activated	  
area	   expands	   in	   those	   particular	  
orientations.	   A	   quadratic	   function	  
(blue	  line)	  is	  fitted	  to	  selected	  points	  
in	   each	   of	   the	   time	   series	   (red	  
symbols),	   yielding	   an	   effective	  
velocity	   measure	   representing	   a	  
global	   course	   of	   activation	   in	   that	  
particular	   direction;	   from	  which	   the	  
fastest	   and	   slowest	   rates	   of	  
activation	   are	   selected	   (right).	   WT:	  
Vmax=	  0.70m.s-­‐1;	  Vmin=	  0.32m.s-­‐1.	  mdx:	  
Vmax=	   0.53m.s-­‐1;	   Vmin=0.29m.s-­‐1.	   c.	  
Box	   plots	   with	   whiskers	   showing	  
significantly	  reduced	  velocities	  along	  
the	  fastest	  and	  slowest	  directions.	  d.	  
Bar	   graphs	   showing	   no	   change	   in	  
AR,	  n.s.	  not	  significant.	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expected	  to	  pick	  up	  the	  maximal	  velocity	  from	  the	  bin	  with	  the	  highest	  calculated	  mean.	  For	  a	  quick	  
check,	  binning	  both	  sides	  returned	  Vmax=0.84±0.02m.s-­‐1	   instead	  of	  0.95±0.02m.s-­‐1,	  which	   is	  almost	  
identical	   to	   the	   values	   reported	   by	   LSEF	   and	   the	   AF	   (See	   caption).	   Application	   of	   Flecainide	  
distorted	   anisotropy	   (Figure	   14b)	   and	   pushed	   the	  methods	   to	   diverge	   considerably	   in	   their	   final	  
results.	  The	  distortion	  seen	  in	  the	  activation	  map	  is	  not	  due	  to	  pacing	  artifacts,	  because	  deviations	  
from	  anisotropy	  were	  reproducible	  in	  the	  other	  two	  ∆KPQ	  hearts	  treated	  with	  this	  NaV1.5-­‐blocking	  
agent.	  Quantitatively,	  this	  deviation	  is	  characterized	  by	  the	  high	  values	  of	  the	  cost	  function	  and	  the	  
irregular	  shape	  of	   the	  mean	  velocities	   line	   in	   the	  polar	  plot	  along	  with	  their	  respective	  high	  SD	   in	  
























Figure	  14.	   Inaccuracy	   in	  evaluating	  CV	  
due	  to	  a	  heterogeneous	  activation	  after	  
5	   min	   of	   treating	   ∆KPQ	   heart	   with	  
Flecainide.	  a.	  Under	  control	  conditions,	  
∆KPQ	   shows	   an	   elliptical	   activation;	  
Scale	   bar	   =	   1mm.	   LSEF:	   nicely	   fitted	  
ellipses	  (up,	  middle)	  return	  near	  0	  values	  
for	   cost	   function.	   Scale	   bar=0.5mm.	   The	  
linear	   fit	   (right)	   returns	   Vmax	   =	  
0.85±0.01m.s-­‐1;Vmin	   =	   0.38±0.01m.s-­‐1.	  
(bottom,	   left).	   Vectors	   within	   ROI	   are	  
emanating	   from	  the	  point	  stimulation.	  1st	  
isochrone	   not	   included	   in	   ROI,	   hence	  
empty	   center	   in	   vector	   field.	  Horizontal	  
arrow	   (magnitude	   for	   scale)	   =	   1m.s-­‐1.	  
Scale	   bar	   =1mm.	   Polar	   plot	   (bottom,	  
middle)	   of	   velocity	   values	   (blue)	  
calculated	   within	   15°bin	   (based	   on	  
geometric	  angle,	  see	  text)	  running	  from	  0	  
to	  2π	  and	  their	  respective	  SD	  (red	  dotted	  
line).	   Note	   the	   almost	   elliptical	   shape	   of	  
the	   blue	   line,	   i.e.	   an	   anisotropic	  
distribution	   of	   velocities:	   Vmax	   =	  
0.95±0.02m.s-­‐1;Vmin	   =0.35±0.01m.s-­‐1.	   AF	  
(bottom,	   right)	   returns	   Vmax	   =0.82m.s-­‐1;	  
Vmin	   =0.34m.s-­‐1.	   b.	   Induced	   activation	  
pattern	   heterogeneity	   in	   substrate	  
after	  5min	  drug	  perfusion.	  Distortion	  of	  
AM	  (up,	  left)	  disables	  a	  good-­‐fit	  of	  ellipses	  
(middle)	   that	   increases	   the	  cost	   function,	  
rendering	  LSEF	  inaccurate	  despite	  a	  good	  
linear	   fit	   of	   data	   points	   in	   distance	   vs.	  
time	   graph	   (up,	   right)	   with	   Vmax	   =	  
0.72±0.09m.s-­‐1;	   Vmin	   =	   0.32±0.05m.s-­‐1.	  
Scale	  bar	  =	  0.5mm.	  Vectors	  (bottom,	  left)	  
blow	   up	   in	   concordance	   with	   spaced	  
isochrones	   in	   the	   longitudinal	   direction.	  
Horizontal	   arrow	   (magnitude	   for	   scale)	  
=	   1m.s-­‐1.	   Scale	   bar	   =1mm.	   Note	   the	  
irregular	   star-­‐shaped	   blue	   line	   in	   polar	  
plot,	   with	   widening	   of	   SD	   curve:	   Vmax	   =	  
1.4±0.12m.s-­‐1;Vmin=0.34±0.08m.s-­‐1.	   AF	  
returns	  middle	  values	  between	  LSEF	   and	  
PF	   for	  Vmax	   (0.9m.s-­‐1),	   however	   a	   smaller	  
Vmin	  (0.16m.s-­‐1).	  Ap	  =	  Apex,	  Ao=	  Aorta,	  P=	  
pacing,	  R	  =	  Right,	  L=	  Left.	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In	  order	  to	  determine	  the	  relationship	  between	  the	  different	  outcomes	  of	  the	  methods	  and	  how	  well	  
the	   values,	   which	   also	   include	   the	   errors	   associated	   with	   the	   methods,	   are	   correlated,	   velocity	  
values	  are	  plotted	  on	  a	  graph	  that	  combines	  two	  methods	  at	  a	  time,	  separating	  Vmax	  and	  Vmin	  being	  
the	  two	  variables	  extracted	  with	  each	  method.	  In	  the	  most	  ideal	  conditions	  (i.e.	   ideal	  methods	  and	  
ideal	   substrates),	   both	   the	   determination	   coefficient	   (R2)	   and	   slopes	   of	   all	   combinations	  must	   be	  
strictly	  equal	  to	  unity.	  If	  the	  methods	  were	  independently	  estimating	  the	  velocities	  (i.e.	  non	  biased)	  
but	  still	  correlated	  well,	  both	  R2	  and	  slopes	  should	  be	  close	  to	  one.	  Mixing	  the	  two	  groups	  (WT,	  mdx)	  
and	   treating	   them	   as	   one	   population	   considerably	   increases	   the	  magnitude	   of	   the	   determination	  
coefficient	  R2	   in	  almost	  all	  combinations	  of	  methods,	  mainly	   for	  the	  Vmax,	   than	  when	  each	  group	  is	  
treated	  separately	  (Figure	  46).	  This	  could	  be	  due	  to	  increasing	  the	  number	  of	  variables	  in	  the	  plot	  
on	  one	  hand.	  On	  the	  other	  hand,	  the	  WT	  and	  mdx	  represent	  two	  sets	  with	  completely	  independent	  
measurements,	  and	  the	  velocities	  in	  each	  group	  show	  sizeable	  statistical	  differences	  for	  all	  methods.	  
When	  the	  magnitude	  of	  the	  R2	  is	  high,	  the	  slope	  is	  also	  substantially	  close	  to	  1,	  an	  expected	  finding	  
for	  independently	  working	  methods.	  Some	  exceptions	  are	  relevant:	  the	  first	  is	  found	  in	  the	  plot	  that	  
combines	  the	  Vmin	  values	  of	  PF	  vs.	  LSEF	  (with	  R2=0.59	  and	  slope	  =	  0.57±0.08;	  Figure	  15,	  bottom,	  left)	  
and	   the	   second	   in	   the	   plot	   combining	   Vmin	   values	   of	   the	   AF	   vs.	   PF	   (with	   R2	   =	   0.65	   and	   slope	   =	  
0.99±0.15;	  Figure	  15,	  bottom,	  right).	  In	  the	  first	  plot,	   if	  the	  slope	  were	  the	  only	  determinant	  of	  the	  
agreement	  between	  the	  methods,	  then	  PF	  will	  constantly	  return	  a	  lower	  value	  than	  LSEF.	  However,	  
considerable	  point	  scattering	  indicates	  that	  large	  errors	  in	  the	  measurements	  are	  non-­‐correlated.	  In	  
the	   second	   plot,	   intermingled	   data	   points	   (low	   R2)	   suggest	   that	   either	   the	   methods	   randomly	  
disagree	  over	  the	  same	  actual	  velocity	  value	  (hence,	  the	  slope	  is	  almost	  one),	  or	  the	  measurements	  
and	   their	   errors	   are	   completely	  uncorrelated.	  A	   third	  possibility	   could	  be	  due	   to	   the	   fact	   that	   the	  
natural	   variability	   of	   Vmin	   is	   smaller	   than	   the	   one	   of	   Vmax;	   hence	   harder	   to	  measure	   by	   default.	   In	  
summary,	  these	  methods	  show	  unbiased	  behavior	   is	  estimating	  velocities	  along	  with	  uncorrelated	  



















Figure	  15.	  Correspondence	  among	  
LSEF,	   PF	   and	   AF	   methods.	  
Regressions	   lines	  (red)	  are	  drawn	  
through	  velocity	  values	  for	  a	  direct	  
comparison	   between	   the	   methods’	  
outcomes	  Vmax	  (up,	  squares)	  and	  Vmin	  
(bottom,	   circles)	   from	   both	   WT	  
(black)	   and	  mdx	   (blue)	   groups.	   For	  
high	   values	   of	   the	   coefficient	   of	  
determination	   (R2>0.85)	   the	  
majority	   of	   dots	   assumes	   a	   long	  
narrow	   pattern,	   with	   a	   target	   slope	  
~1.	  Two	  cases	  where	  R2	   is	  relatively	  
low	  appear	  in	  the	  graphs	  correlating	  
Vmin	   values:	   First,	   between	   the	   PF	  
and	   LSEF	   with	   a	   slope	   considerably	  
far	   from	  1	   (bottom	   left)	   and	  second,	  
between	   AF	   and	   PF	   (bottom,	   right)	  
with	   a	   slope	  ~1.	   	   These	  correlations	  
mainly	   show	   that	   the	   methods	   are	  
independent	   and	   non-­‐biased	   in	  
estimating	   velocity	   values	   in	   the	  
same	  preparation.	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The	   working	   range	   of	   the	   three	   methods	   was	   further	   challenged	   using	   synthetic	   data	   sets.	   The	  
dependence	  of	  the	  LSEF	  and	  PF	  on	  the	  capacity	  to	  produce	  valid	  activation	  maps	  is	  not	  the	  case	  for	  
AF,	  which	  is	  completely	  independent	  of	  such	  an	  assumption.	  This	  means,	  keeping	  other	  parameters	  
fixed,	   increasing	   noise	   levels	  would	   limit	   the	   reasonable	   use	   of	   LSEF	   and	   PF,	  without	   necessarily	  
causing	  similar	  effects	  on	   the	  behavior	  of	  AF	  method.	  The	   fact	   that	  all	  methods	  perform	  plausibly	  
well	   under	   homogeneously	   and	   fairly	   anisotropic	   conditions	   cannot	   be	   extended	   to	   include	   non-­‐
homogeneous	   conditions	  without	   challenging	   the	  methods	  with	   increasing	   level	   of	   heterogeneity.	  
LSEF	   being	   restricted	   to	   a	   linear	   regime	   and	   the	   AF	   to	   an	   overall	   area	   increase	   are	   intrinsic	  
properties	  that	  would	  limit	  the	  sensitivity	  of	  these	  methods	  to	  heterogeneity.	  In	  contrast,	  PF	  has	  the	  
intrinsic	  property	  of	  evaluating	  velocity	  vectors	  locally,	  hence	  can	  incorporate	  progressively	  higher	  
SDs	  to	  the	  calculated	  velocities	  as	  a	  measure	  of	  increasing	  heterogeneity.	  
3.1.5. Simulating the Ideal Condition 
In	  both	  Figure	  16a	  and	  Figure	  17a	   (outmost	   left	   column),	   activation	  contours	  are	   calculated	   from	  
the	   simulation	  of	   a	  perfectly	  homogeneous	  and	  anisotropic	  medium.	  The	   fitted	  ellipses	   in	   red	  are	  
perfectly	   superimposed	   on	   the	   simulated	   isochrones.	   The	   calculated	   vectors	   in	   all	   pixels	   are	  
protruding	   outward	   from	   the	   point	   of	   stimulation	   in	   an	   almost	   parallel	   fashion	   in	   each	   direction	  
(Figure	  16a,	  outmost	  left	  column,	  bottom).	  In	  the	  polar	  plot	  (similar	  to	  the	  polar	  plot	  in	  Figure	  14),	  
average	  velocities,	  when	   spanning	   angles	   from	  0	   to	  2π	  within	   the	  ROI,	   form	  a	  perfect	   elliptically-­‐
shaped	   line,	  with	  near	  0	  standard	  deviation	  values	   for	   the	  mean	  velocities	   in	  all	  bins	   (Figure	  17b,	  
right).	  This	  indicates	  an	  ideal	  distribution	  of	  velocities	  with	  the	  highest	  possibly	  acquired	  precision	  
by	  the	  method.	  In	  light	  of	  these	  findings,	  all	  curves	  representing	  the	  calculated	  velocities	  by	  each	  of	  
the	   three	  methods	   are	   almost	   congruent	   point-­‐by-­‐point	   (Figure	  18a,	   left).	   It	   can	  be	   assumed	   that	  
this	  highly	  organized	  pattern	  offers	  an	  ideal	  basis	  for	  a	  straightforward	  comparison	  of	  the	  CVs	  over	  
each	  interval	  of	  interest	  in	  the	  activation	  medium,	  for	  all	  the	  methods	  combined;	  hence	  providing	  a	  
confirmation	  for	  the	  observed	  agreement	  between	  the	  methods	  for	  the	  experimental	  data.	  
3.1.6. Robustness to Noise 
Estimating	  CV	  is	  adjoined	  with	  the	  challenge	  of	  accurately	  distinguishing	  activation	  wave	  fronts.	  In	  
Figure	  16a,	   the	  noise	   level	  was	  systematically	  added	  at	  each	  pixel	   in	  order	   to	  assert	   the	  methods’	  
ability	   to	   cope	   with	   high	   noise	   levels.	   Isochronal	   contours	   become	   more	   rugged	   as	   the	   SNR	  
decreases,	  despite	  the	  applied	  smoothing	  and	  filtering	  processes,	  with	  appearance	  of	  “dark	  spots”	  or	  
“buds”	   at	   SNR	   =	   0.03,	   due	   to	   misdetection	   of	   activation	   times	   in	   a	   random	   fashion	   leading	   to	  
spurious	   isochronal	   lines	   between	   neighboring	   pixels.	   These	   small-­‐scale	   irregularities	   seem	   to	  
average	   out,	   keeping	   the	   overall	   geometry	   readily	   detectable	   by	   the	   ellipse	   fitting	   algorithm,	  
observed	  in	  the	  stability	  of	  the	  fitted	  ellipses.	  The	  PF	  remains	  robust,	  with	  slowly	  increasing	  but	  still	  
insignificant	  deviations	  in	  vectors’	  directions,	  keeping	  amplitude	  fluctuations	  in	  a	  comparable	  range	  
with	  both	  the	  LSEF	  and	  AF	  (Figure	  18a,	  right).	  Except	  for	  the	  earlier	  points	  (SNR	  =	  0.03),	  the	  velocity	  
curves	   eventually	   converge.	   The	   first	   4	   points	   in	   the	   graph	   diverge,	   due	   to	   different	   velocities	  
calculated	  over	  these	  intervals.	  Both	  the	  LSEF	  and	  AF	  underestimate	  the	  mean	  CV	  compared	  to	  the	  
ideal	   case,	   with	   a	   15%	   decrease	   along	   the	   longitudinal	   direction	   and	   9%	   along	   the	   transverse	  
direction	   for	   the	  LSEF,	  and	  5%	  decrease	  along	   the	  maximal	  direction	  and	  12%	  along	   the	  minimal	  
direction	  for	  the	  AF.	  The	  PF	  reports	  very	  similar	  results	  for	  the	  mean	  velocities	  at	  SNR=0.03,	  when	  
compared	  to	  the	  ideal	  condition.	  However,	  the	  noise	  effect	  is	  reflected	  in	  the	  increasing	  SD,	  reaching	  
11%	  in	  the	  noisy	  set	  compared	  to	  1-­‐2%	  in	  the	  ideal	  case.	  When	  SNR	  reaches	  0.01,	  the	  wave	  spread	  
is	   completely	  blurred	  with	  noise,	   leading	   to	  utterly	   random	  detections	  of	   activation	   times	  at	   each	  
pixel	   (Figure	   16a,	   rightmost	   column).	   Failure	   to	   delineate	   any	   geometry	   in	   the	   activated	   pixels	  
causes	  a	  chaotic	  plotting	  of	  ellipses.	  The	  PF	  shows	  overtly	  larger	  and	  smaller	  amplitude	  vectors	  in	  a	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patchy	  configuration	  that	  doesn’t	  correlate	  well	  with	  the	  “real”	  underlying	  activation,	  mainly	  due	  to	  
the	   arbitrarily	   small	   and	   large	   activation	   time	   differences	   between	   the	   neighboring	   pixels	  
respectively.	   Surprisingly,	   only	   the	   AF	   illustrates	   the	   real	   activation	   pattern	  with	   this	   noise	   level,	  
clearly	  separating	  the	  activated	  area	  from	  the	  resting	  medium	  as	  the	  wave	  propagates	  (Figure	  16b).	  
However,	   a	   correction	   is	  needed	   to	   restore	   the	   geometric	   center	  onto	   the	   starting	  position	  of	   the	  
real	  depolarization.	  The	  random	  noise-­‐induced	  detection	  of	  activated	  pixels	  before	   t=5.5ms	  didn’t	  
contribute	   to	   the	   evaluation	   of	   velocity,	   since	   the	   total	   activated	   area	   remained	   near	   0	   in	   the	  
corresponding	   time	   series	   for	   several	   frames	   before	   the	   slopes	   take	   off	   and	   the	   real	   activation	  
dominates	  (refer	  to	  Figure	  13	  for	  an	  illustration	  of	  these	  time	  series).	  
3.1.7. Sensitivity to Heterogeneity in the Milieu of Propagation 
In	  the	  presence	  of	  random	  spatial	  (structural)	  or	  temporal	  heterogeneity,	  analytical	  strategies	  might	  
return	   velocity	   values,	   which	   are	   not	   representative	   of	   the	   whole	   medium,	   an	   effect	   that	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Figure	   16.	   Comparing	   the	  
methods	   using	   computational	  
modeling	   for	   increasing	   noise.	   a.	  
Fitting	   of	   ellipses	   and	   planes	   to	  
activation	  maps	  with	   incremental	  
noise.	   Notice	   the	   increasing	  
roughness	   in	   the	   isochronal	   lines	  
due	   to	   variable	   detection	   of	  
activation	   times.	   Small-­‐scale	  
deformities	   are	   well	   tolerated	   by	  
LSEF.	   As	   SNR	   degrades	   to	   0.03,	   the	  
algorithm	   is	   incapable	   of	   detecting	  
with	   enough	   precision	   the	   AP	  
upstroke	  at	  each	  pixel,	  which	  favors	  
a	  continuous	   loop	  of	  activation	   time	  
misdetections,	   causing	   black	   dots	  
that	   “bud”	   from	   the	   isochrones.	   As	  
for	   PF,	   apparent	   deviations	   in	   the	  
resulting	   vectors	   at	   each	   pixel	   are	  
balanced	   out	   by	   binning.	   The	  
contours	   become	   entirely	   obscured	  
with	   “budding”	   artifacts	   when	   SNR	  
drops	   to	   0.01,	   the	   level	   at	   which	  
both	   LSEF	   and	   PF	   fail	   to	   return	  
reliable	   results.	  Horizontal	   scaling	  
arrow	  =	  vector	  magnitude	  =	  1m.s-­‐1.	  
Scale	   bar	   (in	   all	   maps)	   =	   1mm.	   b.	  
Global	   activation	   pattern	   seen	   at	  
SNR=0.01.	   Images	   from	   0.5ms	   to	  
4.5ms	   show	   randomly	   activated	  
pixels	  due	   to	  noise-­‐induced	   random	  
detection	   of	   activation	   times	   before	  
activation	   actually	   starts	   at	   5.5ms.	  
The	   red	   dot	   should	   hypothetically	  
denote	   the	   start	   of	   depolarization,	  
i.e.	  the	  location	  of	  pacing.	  The	  green	  
arrow	   shows	   the	   spatial	   translation	  
needed	   to	   correct	   for	   the	   center	   of	  
the	   activation	   (green	   star),	   which	  
otherwise	   might	   incorrectly	   affect	  
velocities.	  Scale	  bar	  =	  3mm.	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inadvertently	   challenges	   the	   accuracy	   of	   the	   obtained	   result.	   Using	   simulated	   data,	   a	   gradual	  
increase	  of	  spatial	  heterogeneity	  on	  the	  excitable	  medium	  is	  implemented	  and	  manifests	  itself	  by	  an	  
increase	   in	   the	  severity	  of	   the	  contour	   lines’	  deformations	   (Figure	  17a),	   creating	   therefore	  patchy	  
configurations	   where	   the	   isochronal	   invaginations	   and	   the	   protrusions	   correspond	   to	   areas	   of	  
slower	  and	  faster	  conduction	  respectively.	  
	  
These	   simulations	   tried	   to	  mimic	   the	   activations	   observed	   for	   the	  ΔKPQ	  hearts	   that	  were	   treated	  
with	  a	  NaV1.5-­‐blocker.	  For	  low	  to	  moderate	  heterogeneity	  level	  (e.g.	  σG	  12	  or	  below),	  the	  LSEF	  and	  
AF	   seem	   to	  work	   rather	  well,	   compared	   to	   the	   PF.	   The	   velocity	   vs.	   sliding	   interval	   graph	   (Figure	  
18b)	  offers	  the	  possibility	  to	  detect	  the	  varying	  transitions	  in	  the	  estimation	  of	  velocity	  at	  constant	  
time	   intervals	   but	   variable	   spatial	   distributions	   (the	   outward	   emanating	   wave	   from	   a	   point	  
stimulation	  progressively	  increases	  in	  size	  as	  it	  moves	  away	  towards	  the	  boundaries).	  Each	  colored	  
curve	  corresponds	  to	  one	  analytical	  method	  and	  each	  point	  is	  the	  outcome	  of	  evaluating	  the	  velocity	  
at	  a	  particular	  zone	  of	  the	  map.	  As	  it	  can	  be	  seen	  from	  the	  graph	  on	  the	  left,	  the	  LSEF	  returns	  a	  Vmax	  








Figure	  17.	  Comparison	  of	  LSEF	  and	  
PF	   methods	   using	   computational	  
modeling	   for	   heterogeneity.	   a.	  
Fitting	   of	   ellipses	   and	   planes	   to	  
activation	  maps	   with	   incremental	  
heterogeneity	   level	   (σG).	   The	  
isochronal	  distortions	  are	  introduced	  
by	   locally	   varying	   the	   diffusion	  
constant,	   while	   maintaining	   a	  
constant	   velocity	   of	   propagation.	  
Irregularities	   in	   the	   activation	  
patterns	   lead	   to	   progressive	  
deviations	   from	   the	   expected	  
anisotropic	   behavior.	   LSEF	   becomes	  
an	   inferior	   choice	   for	   CV	   evaluation	  
due	   to	   poor	   incorporation	   of	   non-­‐
uniformity	   in	   the	   calculated	   CV	  
values	   that	   are	   averaged	   out	   by	   the	  
fitted	   ellipses	   and	   the	   linear	  
regression;	   whereas	   with	   PF	   the	  
gradual	   effect	   of	   heterogeneity	   is	  
well	   demonstrated	  with	   the	   vectors’	  
local	   divergence	   in	   direction	   and	  
amplitude.	   Horizontal	   scaling	  
arrow	  =	  vector	  magnitude	  of	  1	  m.s-­‐1.	  
Scale	   bar	   (in	   all	   maps)	   =	   1mm.	   b.	  
Anisotropy	   estimated	   by	   the	  
closeness	   of	   the	   isochronal	   contours	  
to	   the	   elliptical	   geometry	   (left),	   a	  
property	  which	  is	  well-­‐monitored	  by	  
the	   cost	   function,	   which	   returns	  
increasingly	   higher	   values	   as	  
anisotropy	   is	   altered.	   (Right)	   The	  
increase	   in	   heterogeneity	   is	  
incorporated	   as	   a	   statistical	  
component	   in	   the	   PF	   method,	  
reflected	   by	   the	   gradual	   increase	   in	  
the	   SD	   of	   the	   CV	   within	   each	   bin,	  
which	   signifies	   loss	   of	   precision	   in	  
determining	  the	  CV.	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Excluding	   this	  point,	   the	  remaining	  points	  don’t	  show	  a	  variation	   that	  exceeds	  7%.	   It’s	  also	  worth	  
mentioning	  that	  for	  the	  same	  heterogeneity	  level,	  several	  realizations	  were	  simulated	  and	  analyzed	  
accordingly,	  in	  principal	  to	  guarantee	  dependence	  of	  the	  curves	  on	  heterogeneity,	  rather	  than	  on	  a	  
particular	   isochronal	   configuration.	   The	   graph,	   on	   the	   right	   in	   Figure	   18b,	   reveals	   deviations	   of	  
more	   than	   20%	   among	   the	   mean	   velocities	   at	   different	   ROIs	   with	   maps	   embodying	   higher	  
heterogeneity	   levels	   (e.g.	   σG	   24).	   At	   this	   level,	   the	   curves	   do	   not	   show	   consistency	   among	   the	  
different	   realizations.	   The	   behavior	   is	   expected,	   where	   experimentally	   this	   could	   represent	  
completely	   distinct	   substrates.	   Heterogeneity	   and	   uncertainty	   due	   to	   the	   associated	   error	   will	  
ultimately	   influence	   the	   velocity	  measured	   and	   its	   significance.	   A	   global	   estimate	   of	   velocity	  will	  
deviate	   from	   the	   local	   one,	   once	   the	   heterogeneity	   in	   the	  medium	   creates	   an	   activation	   complex	  
enough	  to	  alter	  the	  morphology	  of	  the	  propagation	  pattern.	  Since	  only	  PF	  provides	  local	  calculations	  
of	  velocity,	   small	   local	  heterogeneities	  are	   readily	  accessible	   for	   further	  analysis,	  where	   the	  mean	  
velocity	  within	  the	  heterogeneous	  bin	  can	  be	  contrasted	  to	  the	  average	  velocity	  in	  the	  medium.	  	  To	  
further	  explore	  this	  prevailing	  hypothesis,	  the	  effect	  of	  heterogeneity	  on	  the	  SD	  is	  plotted	  in	  Figure	  
17b.	   The	   PF	   tends	   to	   incorporate	   inhomogeneity	   into	   its	   statistics.	   Therefore	   the	   progressive	  
increase	   in	   SD	   values	   within	   each	   bin,	   at	   almost	   all	   orientations,	   reflects	   the	   sensitivity	   of	   the	  
method	   in	   picking	   up	   heterogeneities	   in	   the	  medium	   (Figure	   17b,	   right).	   The	   LSEF	   and	   AF	   can’t	  
provide	   such	   a	   feature.	   Nevertheless,	   an	   indirect	   measure	   of	   heterogeneity	   can	   be	   provided	   as	  
deviations	   of	   the	   isochrones	   from	   the	   elliptical	   geometry,	  which	   can	   be	   quantified	   using	   the	   cost	  
function:	  as	  the	  heterogeneity	  strength	  progressively	  increases,	  the	  cost	  function	  faithfully	  mirrors	  








Figure	  18.	  Plot	  of	  the	  maximal	  and	  minimal	  
velocities	   vs.	   sliding	   interval.	   a.	   Methods	  
correspondence	  with	  increasing	  noise.	  Each	  
interval	   [x,	   x+4]	   corresponds	   to	   one	   ring	   of	  
inner	   circumference	   formed	   by	   the	   xth	  
isochrone	   and	   outer	   circumference	   by	   the	  
(x+4)th	   isochrone.	   This	   ring	   is	   a	   well-­‐defined	  
ROI	  where	  the	  minimal	  and	  maximal	  CVs	  were	  
calculated.	   	   By	   sliding	   this	   ring,	   curves	   that	  
scan	   through	   the	   entire	   activation	   map	   are	  
obtained,	   revealing	   the	   deviations	   from	   the	  
ideal	   configuration	   observed	   as	   velocities	   are	  
calculated	   by	   the	   three	   different	   methods.	  
Evidently,	   all	   methods	   show	   robustness	   to	  
noise	  with	   very	   comparable	   behavior	   (except	  
for	   early	   isochrones)	   until	   complete	  
misdetection	   of	   activation	   times	   at	   SNR<0.03	  
for	   LSEFP	   and	   PF	   (Figure	   16).	   b.	   Methods	  
correspondence	   with	   increasing	  
heterogeneity.	   The	   observed	   fluctuations	   in	  
velocity	   values	   reported	   by	   the	   methods	   are	  
due	   to	   the	   continuous	   increase	   in	  
heterogeneity	   level.	   Discernible	   divergence	  
among	   the	   values	   is	   detected	   where	  
anisotropy	  is	  largely	  disturbed	  (right). Square	  
filled	   symbol:	   maximal	   CV;	   Circular	   filled	  
symbol:	   minimal	   CV;	   black:	   LSEF;	   blue:	   PF;	  
red:	  AF.	  
78	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Chapter	  3	  Results	  
3.2. Flecainide Proarrhythmia Scaled-Down in the mdx-Model  
Pharmacological	   management	   of	   clinical	   arrhythmias	   remains	   empiric	   at	   best,	   a	   trial-­‐and-­‐error	  
process	   actualized	   on	   a	   case-­‐by-­‐case	   basis	   and	   guided	   by	   one’s	   clinical	   acumen540,	   541.	   The	  
preeminent	   reason	   remains	   our	   deficiency	   in	   understanding	   the	   complex	   pathophysiological	  
mechanisms	  that	  govern	  electrical	  cardiac	  rhythm	  disturbances542,	  543.	  	  
	  
In	   most	   cardiac	   cells,	   NaV1.5	   provides	   the	   ionic	   current	   required	   to	   initiate	   and	   sustain	   a	  
propagating	   wave.	   Their	   nonlinear	   responses	   to	   changes	   of	   membrane	   potential	   allow	   them	   to	  
switch	   between	   conducting	   and	   non-­‐conducting	   states.	   	   These	  membrane	   proteins	   appear	   today	  
more	   intricate	   than	   previously	   thought.	   The	   emergence	   of	   lethal	   diseases	   solely	   based	   on	   the	  
possibility	  of	  existing	  flaws	  in	  their	  switching	  behavior	  puts	  into	  perspective	  our	  previous	  deficiency	  
in	  appreciating	  the	  complexity	  of	  the	  protein.	  Genetic	  mutations,	  cardiac	  remodeling	  and	  drugs	  are	  
famous	  modulators	  of	  NaV1.5	  function.	  For	  instance,	  class	  I	  agents	  are	  among	  the	  most	  widely	  used	  
antiarrhythmic	  drugs	  (AADs)478.	  They	  are	  further	  grouped	  into	  three	  different	  subclasses541,	  544	  (the	  
Vaughan	  Williams	  Classification)	  given	  their	  different	  interactions	  (kinetics,	  channel	  binding	  state…	  
etc.)	  with	  their	  molecular	  target.	  The	  electrophysiological	  effects	  of	  NaV1.5-­‐blockers	  have	  generally	  
been	  thought	  to	  be	  uniform,	  straightforward,	  hence	  well-­‐understood478,	  479,	  511.	  Extrapolating	  cellular	  
findings	   to	  a	  whole	  organ	   is	  now	  considered	  at	  best	   “ambitious”.	   “Block	  of	   conduction	  at	  one	   site	  
may	   be	   antiarrhythmic	   but	   become	   proarrhythmic	   at	   another	   site”454.	   Possibly…	   But,	   how	   far	  
spatially	   are	   these	   two	   different	   sites	   exactly?	   What	   defines	   anti-­‐/proarrhythmic	   activity	   in	   a	  
multicellular	   network?	   How	   should	   we	   alter	   our	   experimental	   methodologies	   to	   improve	   the	  
predictive	  outcome	  -­‐with	  more	  certainty-­‐	  of	  any	  means	  of	  treatment?	  
	  
In	  the	  last	  two	  decades,	  multi-­‐electrode	  arrays	  followed	  by	  optical	  mapping	  experiments	  of	  animal	  
hearts	  showed	  that	   these	  drugs	  could	  produce	  divergent	  and	  sometimes	  contrasting	  effects	   in	   the	  
multicellular	   tissue,	   as	   opposed	   to	   the	   clearly	   well	   defined	   effects	   in	   isolated	   cells36,	   545.	   This	  
paradoxical	   association	   between	   Flecainide	   (a	   Class	   IC	   NaV1.5	   blocker)	   and	   its	   proarrhythmic	  
responses	   in	   a	  multicellular	   network	   of	   cells	   is	   investigated	   in	   the	   next	   sets	   of	   experiments	  with	  
cardiac	   substrates	   that	   have	   one	   common	   denominator:	   abnormalities	   in	   NaV1.5.	   My	   approach	  
includes	   observing	   the	   effects	   of	   targeting	   NaV1.5	   in	   the	  whole	   organ	   (mouse	   heart)	  with	   a	   drug	  
(Flecainide)	  using	  concentrations	  within	  the	  therapeutic	  range	  ([1μM])	  and	  characterizing	  through	  
whole	   heart	   ex-­‐vivo	   optical	   mapping	   the	   spatial-­‐temporal	   heterogeneity	   that	   could	   arise	   from	  
pharmacologically	  modulating	  the	  function	  of	  this	  protein	  under	  pathological	  (mdx,	  ΔKPQ	  models)	  
and	  normal	  (WT)	  conditions.	  	  	  
3.2.1. (dF/dt)max and CV: Indexes of NaV1.5 Availability and Conductance? 
Two	  active	  factors	  affect	  the	  propagation	  of	  the	  cardiac	  impulse:	  The	  magnitude	  of	  the	  fast	  inward	  
INa	   and	   the	   time	   required	   to	   reach	   its	   peak99.	   A	   decrease	   in	   this	   current	   would	   be	   expected	   to	  
decrease	  both	  the	  maximum	  rate	  of	  rise	  of	  the	  AP	  upstroke	  (dF/dt)max	  and	  the	  conduction	  velocity	  
(CV).	   It	   has	   been	   assumed	   that	   the	   effects	   exerted	   by	  AADs,	   particularly	   the	   Class	   I	   drugs,	   on	   CV	  
correlate	   well	   with	   their	   effects	   on	   (dF/dt)max,	   because	   of	   their	   direct	   modification	   of	   INa92,	   362.	  
Nonetheless,	   it	   doesn’t	   mean	   that	   the	   relationship	   governing	   changes	   between	   any	   of	   the	   three	  
components	   should	   necessarily	   be	   linear96,	   546,	   547.	   The	   results	   presented	   in	   section	   3.1	   certainly	  
show	   that	   under	   quasi-­‐physiological	   conditions	   where	   anisotropy	   is	   preserved,	   the	   mdx	   heart,	  
which	   is	   a	  model	   deficient	   in	   NaV1.5,	   sustains	   an	   electrical	   activity	   of	   lower	   velocity	   than	   its	  WT	  
counterpart	  does.	  Nevertheless	  further	  blocking	  of	  INa,	  through	  a	  commonly	  used	  AAD	  (Flecainide)	  
does	  not	  compulsorily	  alter	  CV	  and	  (dF/dt)max	  in	  a	  predictable	  fashion	  in	  any	  of	  the	  substrates.	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After	  processing	  and	  filtering,	  the	  conditioned	  optical	  signal	   is	  used	  for	  further	  analysis.	  Figure	  19	  
above	  shows	  remarkable	  morphological	  differences	  between	  the	  optical	  APs	  (OAPs)	  recorded	  from	  
the	   LV	   epicardium	  of	   the	  WT	  heart	   (left)	   and	  mdx	   (black,	   right)	   under	   control	   conditions	   (i.e.	   no	  
drug	  is	  added),	  stimulated	  with	  a	  BCL=100ms.	  Prior	  to	  normalization,	  both	  signals	  were	  checked	  for	  
equal	   fractional	   change	   (FC%	  =	  ∆F/F)	  and	  amplitude.	  Normalizing	  a	  weaker	   signal	   to	  another	  one	  
with	  larger	  amplitude	  could	  lead	  to	  erroneous	  prolongation	  of	  the	  earliest	  repolarization	  phases	  of	  
OAP,	   an	   artifact	   that	   could	   cause	   the	   APD	   to	   “appear”	   prolonged	   at	   these	   levels.	   The	  mdx	   AP	   is	  
superimposed	  on	  a	  dotted	   representation	  of	   the	   same	  WT	  AP	  on	   the	   left	   for	  a	  direct	   comparison.	  
The	   major	   findings	   can	   be	   summarized	   as	   follows:	   the	   less	   prominent	   notch	   is	   caused	   by	   the	  
shortened	  phase	  1,	  which	  is	  preceded	  by	  a	  slightly	  depressed	  upstroke.	  The	  plateau	  phase	  therefore	  
starts	  at	  more	  positive	  voltages	  in	  the	  mdx	  than	  it	  does	  in	  the	  WT.	  The	  plateau	  phase	  in	  the	  mouse	  
heart	   is	   normally	   short	   (<15ms)	   due	   to	   the	   eminent	   IK,to	   in	   these	   hearts	   that	   favors	   a	   fast	   early	  
repolarization	   to	   more	   negative	   potentials	   and	   the	   kick-­‐in	   of	   the	   delayed	   rectifier	   repolarizing	  
currents	   brings	   the	   membrane	   potential	   back	   to	   the	   resting	   state501.	   In	   the	   mdx	   heart,	   the	   AP	  
appears	  prolonged	  in	  the	  early	  stages	  following	  the	  depolarization	  upstroke.	  However,	  recovery	  is	  
fast	   enough	   to	   compensate	   for	   the	   previous	   delays	   in	   repolarization	   and	   brings	   the	  mdx	   AP	   to	  
resting	  potentials	  at	  almost	  the	  same	  time	  point	  as	  its	  WT	  counterpart.	  	  
	  
Once	  activation	   times	  at	  all	  pixels	  are	  assigned,	   isochronal	  maps	  are	  generated.	  They	  describe	   the	  
activation	   pattern	   of	   the	   electrical	   wave	   elicited	   at	   the	   LV	   free	   wall	   center,	   with	   a	   spatial	   and	  
temporal	   resolution	  of	  100µm	  and	  0.5ms,	   respectively.	  Since	   the	  waves	   travel	  periodically	   (10Hz)	  
across	   the	  myocardium	   in	   all	  measurements,	   a	   time	  window	   can	   be	   selected	  within	   steady	   state	  
conditions.	   In	   Figure	   20a,	   the	   maps	   reproduce	   the	   effects	   detected	   previously	   concerning	  
conduction	   slowing	   in	   the	   mdx	   heart	   in	   all	   directions.	   After	   t10=10min	   of	   Flecainide	   perfusion,	  
isochrones	   are	   considerably	   tightened	   in	   both	   maps	   (Figure	   20b).	   Qualitatively,	   differences	   in	  
conduction	  become	  more	  challenging	  to	  observe	  between	  the	  two	  substrates.	  The	  appearance	  of	  the	  
darker	  blue	  color	  in	  the	  mdx	  map	  means	  that	  a	  longer	  time	  is	  needed	  for	  the	  wave	  to	  travel	  almost	  
the	   same	   distance,	   suggesting	   a	   slower	   conduction	   in	   the	  mdx	   heart.	   Despite	   overall	   decrease	   of	  
conduction,	   an	   area	  of	   faster	   conduction	   emerges	   on	   the	  upper	   right	   corner	   of	   the	  WT	  map.	  This	  
effect,	  previously	   thought	   to	  be	  an	  artifact	  due	   to	  boundary	   conditions,	   is	   reported	   in	  6	  out	  of	  10	  












Figure	   19.	   Optical	   epicardial	  
APs	   show	   morphological	  
differences	   at	   control	  
conditions.	  mdx	   AP	   (right,	   black)	  
when	   superimposed	   on	   WT	  
(dotted,	   pink)	   shows	   a	   slightly	  
shallower	   upstroke,	   a	   decreased	  
notch	   and	   a	   higher	   plateau.	   Full	  
recovery	   however	   is	   achieved	   at	  
almost	   the	  same	  time	  point	  as	   the	  
WT.	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From	  comparing	  the	  different	  analytical	  strategies	  used	  to	  evaluate	  CV	  in	  the	  previous	  subsection,	  
the	  PF	  method	  was	  identified	  as	  the	  most	  sensitive	  in	  picking	  up	  CV	  fluctuations,	  due	  to	  its	  built-­‐in	  
capacity	   in	   evaluating	   velocity	   vectors	   locally.	   The	   aim	  of	   the	   current	   study	   is	   to	   characterize	   the	  
effects	  of	  blocking	  NaV1.5	  on	  the	  macroscopic	  component	  of	  propagation	  (i.e.	  CV)	  on	  one	  hand.	  On	  
the	   other	   hand,	   we’d	   like	   to	   know	   whether	   CV	   continues	   to	   correlate	   well	   with	   the	   maximum	  
upstroke	   rise	   of	   the	   APs	   (dF/dt)max	   in	   every	   direction,	   at	   all	   experimental	   time	   points	   of	   the	  
treatment	   (i.e.	   at	   0,	   +1,	   +3,	   +5,	   +7	   and	   +10min).	   Using	   the	   PF	  method,	   CV	   dispersion	  maps	  were	  
therefore	   produced	   within	   the	   ROI	   previously	   describedlxv.	   In	   Figure	   21a	   (upper,	   left),	   velocity	  
values	  are	  distributed	  along	  the	  axes	  of	  maximum	  and	  minimum	  propagation,	  as	  depicted	  from	  their	  
corresponding	  maps.	  The	  faster	  velocities	  in	  orange	  red	  appear	  in	  the	  WT	  map	  at	  both	  sides	  of	  the	  
pacing	  point,	  with	  the	  lower	  velocities	  arranged	  perpendicularly.	  The	  same	  effect	  can	  be	  seen	  in	  the	  
mdx	  CV	  dispersion	  map	  (Figure	  21a,	  upper	  right),	  however	  with	  diminished	  velocities,	  as	  expected.	  
After	  t10	  of	  drug	  perfusion,	  histograms	  (Figure	  21b)	  reveal	  a	  shift	  of	  velocity	  distribution	  to	  the	  left,	  
particularly	   for	   the	  WT	  heart,	  where	   the	   number	   of	   counts	   for	   the	   velocity	   values	   below	  0.5m.s-­‐1	  
increased	  significantly.	  The	  overall	  decrease	   in	  transversal	  velocities	   in	  this	  example	   is	  ~26%	  and	  
~34%	  for	  WT	  and	  mdx	  respectively.	  While	  the	  velocities	  along	  the	  longitudinal	  direction	  is	  overall	  
decreased	  in	  the	  mdx	  by	  ~35%,	  only	  one	  side	  showed	  a	  decrease	  of	  ~32%,	  whereas	  an	  increase	  of	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  







































Figure	  20.	  Activation	  maps	  from	  
WT	   and	   mdx	   LV	   free	   wall	  
epicardium.	   a.	   At	   Control	  
conditions	   (+0min	   Flecainide).	  
Isochronal	   lines	   in	   the	  mdx	   (right)	  
are	  more	   closely	   spaced	   than	  WT,	  
suggestive	   of	   conduction	   slowing.	  
From	   the	   LV	   center,	   the	   electrical	  
wave	   propagates	   toward	   the	  
boundaries	   anisotropically.	   b.	  
t10=10min	   Flecainide	   [1µM].	  
Activation	   maps	   of	   both	   hearts	  
show	   further	   slowing	   of	  
conduction,	   and	   isochronal	  
tightening	   around	   the	   source	   of	  
stimulation.	   The	   propagation	  
remains	   anisotropic	   however	   its	  
axis	   appears	   shifted	  
counterclockwise	   in	   both	   maps	  
compared	  to	  control	  conditions.	  In	  
the	   upper	   right	   side	   of	   the	   WT	  
map,	   an	   area	   of	   increased	  
conduction	   emerges,	   through	   the	  
increased	   spacing	  of	   isochrones	   in	  
that	   region.	   Look-­‐up-­‐table:	  
Activation	  time	  range	  in	  ms	  [0	  20].	  
Scale	   bar	   =	   0.5mm.	   Anatomical	  
annotations:	   Ao	   =	   Aorta,	  
Ap=Apex,	  L=Left,	  R=Right.	  P=Point	  
stimulation.	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~57%	   in	   velocity	   occurred	   on	   the	   diametrically	   opposite	   side.	   The	   vectors	   with	   higher	   velocity	  
norms	  are	  depicted	  in	  the	  velocity	  histograms	  below	  (Figure	  21b,	  left).	  	  
	  
Four	  velocities	  -­‐corresponding	  to	  mean	  velocities	  in	  each	  of	  the	  4	  different	  15˚	  bins	  (2	  bins	  located	  
along	  the	   longitudinal	  axis	  and	  the	  2	  others	  along	  the	  transversal	  axis)-­‐	  were	  extracted	   from	  each	  
velocity	  dispersion	  map	  and	  included	  in	  bar	  graphs	  (Figure	  22),	  in	  order	  to	  compare	  the	  changes	  in	  
velocity	   for	  WT	   (N=20)lxvi	   and	  mdx	   (N=14)	   in	   the	   longitudinal	   (Figure	  22,	   upper)	   and	   transversal	  
(Figure	   22,	   lower)	   directions	   as	   the	   treatment	  with	   Flecainide	   progresses.	   Statistical	   significance	  
was	   calculated	   using	   the	   unpaired	   t-­‐test.	   The	   major	   findings	   can	   be	   summarized	   as	   follows:	  
Flecainide	  causes	  a	  slowing	  in	  conduction	  in	  both	  directions	  of	  propagation	  for	  both	  groups.	  For	  the	  
WT	   group,	   the	   standard	   deviation	   (SD)	   increases	   to	   become	   twice	   as	   large	   at	   7	   and	   10	   min	   of	  
treatment	  compared	  to	  the	  control	  value,	  particularly	  for	  the	  longitudinal	  velocities	  (Average	  Vmax	  =	  
0.75±0.11m.s-­‐1	  at	  control	  conditions,	  Vmax	  =	  0.53±0.22m.s-­‐1	  at	  t10,	  Figure	  22,	  upper).	  This	  increase	  in	  
SD	  is	  probably	  due	  to	  the	  one-­‐sided	  increase	  in	  Vmax,	  thus	  enhancing	  the	  discrepancy	  in	  the	  values	  
within	  the	  same	  group.	  Even	  when	  the	  velocity	  is	  overall	  decreased	  at	  t10	  compared	  to	  control,	  Vmax	  
reached	   its	   lowest	  attainable	  value	  on	  average	  at	  5min	  post	   treatment	  with	  Vmax	  =	  0.49±0.12m.s-­‐1	  
(Figure	   22,	   upper).	   The	   minimal	   velocities	   in	   the	   WT	   group	   show	   less	   fluctuation	   in	   terms	   of	  
amplitude	   and	   SD	   than	   the	  maximal	   velocities	   (Vmin	   =	   0.38±0.06m.s-­‐1	   at	   control	   conditions,	   Vmin	   =	  
0.23±0.09m.s-­‐1	   at	   t10,	   Figure	   22,	   lower).	   The	   gray	   bars	   show	   a	   SD	   of	   ~10%	   at	   all	   time	   points,	  
suggesting	  a	  more	  homogeneous	  distribution	  of	  values	  within	  the	  mdx	  group	  (Figure	  22,	  upper	  and	  
lower)	  with	  a	  progressive	  and	  continuous	  decrease	  to	  reach	  the	  lowest	  values	  at	  t10	  post	  treatment	  
(Average	  Vmax	  =	  0.52±0.10m.s-­‐1,	  Vmin	  =	  0.26±0.04m.s-­‐1	   at	   control	   conditions;	  Vmax	  =	  0.33±0.08m.s-­‐1,	  
Vmin	  =	  0.18±0.04m.s-­‐1	  at	  t10).	  With	  a	  Vmin	  value	  of	  only	  5%	  less	  in	  the	  mdx,	  the	  increase	  in	  SD	  in	  the	  
WT	   to	   9%	   abolished	   the	   statistical	   significance	   of	   Vmin	   at	   t10	   between	   the	   two	   groups	   (Figure	   22,	  
lower,	  last	  two	  bars).	  
	  
Since	   (dF/dt)max	   is	   regarded	  as	  one	  of	   the	  most	   important	   factors	  determining	  propagation	   in	   the	  
mammalian	  heart,	  the	  relationship	  between	  upstroke	  velocity	  and	  CV	  has	  been	  so	  widely	  accepted	  
that	   several	   studies	   only	   offered	  measurements	   of	   (dF/dt)max	   as	   evidence	   for	   changes	   in	   CV99	   at	  
normal	  values	  of	  resting	  membrane	  potential	  (Vrmp	  ~	  -­‐70mV)92.	  This	  proposed	  relationship	  became	  
questionable	   in	   light	   of	   noticeable	   examples548,	   549,	   that	   (dF/dt)max	   has	   been	   further	   probed	   to	  
whether	   it	   could	   actually	  be	  used	  as	   an	   index	  of	  proportionality	   to	  CV	  or	   availability	  of	  NaV1.5	   at	  
take-­‐off	  potentials.	  The	  following	  results	  investigate	  the	  sort	  of	  CV	  dependency	  on	  (dF/dt)max	  under	  
normal	   conditions,	   but	   also	   reexamine	   (dF/dt)max	   as	   a	   determinant	   of	   CV	   in	   conditions	   of	   NaV1.5	  
blocking,	  where	  measurements	  of	  (dF/dt)max	  appear	  to	  be	  of	   little	  predictive	  value	  with	  respect	  to	  
CV.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxvi	  For	  the	  WT	  group,	  the	  number	  of	  experiments	  is	  n=10.	  Since	  two	  velocity	  points	  were	  extracted	  along	  the	  longitudinal	  
axis	  and	  two	  others	  along	  the	  transversal	  axis,	  the	  overall	  number	  of	  velocity	  points	  in	  one	  direction	  is	  N=20	  (used	  in	  the	  
bar	  graphs).	  The	  same	  goes	  for	  the	  mdx	  hearts	  where	  n=7,	  but	  N=14	  was	  used	  to	  make	  the	  bar	  graphs.	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In	  Figure	  23,	  (dF/dt)max	  is	  calculated	  for	  each	  pixel	  within	  the	  same	  ROI	  chosen	  for	  the	  velocity	  maps	  	  
(Figure	  21).	  This	  approach	  will	  identify	  at	  one-­‐pixel	  resolution	  how	  the	  upstroke	  velocities	  react	  to	  
the	  NaV1.5-­‐blocking	  protocol	  and	  whether	  they	  mimic	  the	  CV	  fluctuations	  detected	  in	  the	  WT	  hearts.	  
Under	   control	   conditions,	   both	   WT	   (Figure	   23a,	   upper	   left)	   and	   mdx	   (Figure	   23b,	   upper	   left)	  
upstroke	  velocities	  maps	  faithfully	  reproduce	  the	  CV	  patterns:	  the	  highest	  (dF/dt)max	  match	  well	  the	  
Vmax	   distribution	   along	   the	   longitudinal	   axis,	   and	   the	   lowest	   (dF/dt)max	   along	   the	   transversal	   one.	  
The	  mdx	  heart	  that	  has	  a	  lower	  CV	  profile	  is	  also	  characterized	  with	  (dF/dt)max	  in	  the	  lower	  range.	  
The	  steady	  loss	  of	  the	  original	  higher	  upstroke	  values	  with	  Flecainide	  perfusion	  is	  consistent	  with	  a	  
homogeneous	  distribution	  of	  the	  drug	  to	  the	  tissue	  during	  measurements,	  as	  seen	  in	  both	  sequences	  
(Figure	  23a	  and	  b).	  The	  peculiar	  increase	  in	  CV	  seen	  in	  the	  WT	  heart	  at	  t10	  (Figure	  21a,	  bottom	  left)	  
however,	   doesn’t	   seem	   to	   be	   present	   in	   the	   (dF/dt)max	   map	   (Figure	   23a,	   bottom	   right).	   In	   this	  
example,	   the	   location	   of	   fast	   propagation	   is	   indeed	   identified	   in	   an	   area	   of	   relatively	   higher	  
(dF/dt)max	   compared	   to	   the	   rest	   of	   the	  ROI,	   however	   it	   is	   certainly	   not	   high	   enough	   to	  match	   the	  



































































Figure	   21.	   Velocity	   dispersion	  
maps	   and	   histograms.	   a.	  
Evaluation	  of	  velocities	  within	  ROI	  
at	  t0	  and	  t10	  Flecainide.	  Velocities	  in	  
the	  WT	   control	   map	   are	   distributed	  
along	   the	   respective	   axes	   of	   wave	  
propagation.	   The	   faster	   velocities	  
(red	   orange)	   are	   almost	  
perpendicularly	  located	  to	  the	  slower	  
ones	   (blue).	   The	   same	   anisotropic	  
distribution	   is	   seen	   for	   the	   mdx	  
(upper,	   right),	   with	   a	   lower	   velocity	  
range.	   Treating	   the	   hearts	   with	  
Flecainide	  lead	  to	  an	  overall	  decrease	  
in	   velocity	   values	   in	   both	   groups.	   A	  
focus	   of	   faster	   conduction	   (1.2m.s-­‐1)	  
appeared	   one-­‐sided	   along	   the	  
longitudinal	   direction.	   Such	   a	   focus	  
doesn’t	  appear	  in	   the	  mdx,	  where	  CV	  
monotonically	  decreased	  as	  NaV1.5	  is	  
blocked	   by	   the	  drug.	   The	  map	   at	   t10	  
shows	   a	  homogenous	  distribution	  of	  
velocities	   (bottom,	   right).	   Scale	   bar	  
=	  0.5mm.	  Look-­‐up	  table:	  CV	  [0	  1.2]	  in	  
m.s-­‐1.	   Annotations	   in	   figure:	   Ao=	  
Aorta,	   Ap	   =	   Apex,	   R=Right,	   L=Left,	  
P=Point	   stimulation.	   	  b.	  Histograms	  
of	   velocities	   of	   the	   above	  
dispersion	  maps.	  A	  uniform	  shift	   to	  
the	   left	   is	   seen	   in	   both	   groups	   with	  
Flecainide.	   The	   focus	   of	   faster	  
conduction	   is	   represented	   by	  
dispersed	  high	  velocity	  values	   in	   the	  
WT,	  but	  not	  in	  the	  mdx.	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correspond	  to	  a	  (dF/dt)max	  value	  near	  1	  a.u.ms-­‐1	  (based	  on	  previous	  measurements).	  By	   looking	  at	  
upstroke	   velocities	   dispersion	   maps,	   we	   conclude	   on	   one	   hand	   that	   they	   correlate	   well	   with	   CV	  
maps	  under	  control	  conditions	  and	  in	  the	  early	  stages	  of	  NaV1.5	  blocking,	  where	  the	  OAP	  upstroke	  
at	   each	   pixel	   becomes	   less	   steep.	   On	   the	   other	   hand,	   upstroke	   velocity	   maps	   obviously	   do	   not	  
explain	  the	  outbreak	  of	  CV	  heterogeneity	  at	   later	  stages	  of	  NaV1.5	  blocking.	  Therefore	  they	  do	  not	  
predict	  CV	  distribution	  at	  the	  level	  of	  the	  tissue	  under	  these	  conditions.	  	  	  	  
	  
In	   a	   similar	   fashion	   to	   the	   CV,	   (dF/dt)max	   data	   points	  were	   compared	   using	   bar	   graphs	   along	   the	  
longitudinal	  (Figure	  24a)	  and	  transversal	  (Figure	  24b)	  axes.	  The	  results	  described	  in	  the	  dispersion	  
maps	   correspond	   well	   with	   the	   decrease	   in	   (dF/dt)max	   in	   the	   bar	   graphs.	   In	   contrast	   to	   the	   CV,	  
(dF/dt)max	   don’t	   show	   any	   effect	   related	   to	   an	   enhanced	   scattering	   between	  high	   and	   low	   values,	  
hence	  no	  sudden	  increase	  in	  (dF/dt)max	   is	  found	  at	   later	  time	  points	  of	  Flecainide	  perfusion	  in	  any	  
group.	  It’s	  important	  to	  be	  reminded	  here	  that	  the	  values	  reported	  by	  the	  upstroke	  velocities	  do	  not	  
represent	   the	   “absolute”	   membrane	   voltage	   values	   at	   the	   upstroke	   phase.	   Hence,	   its	   unit	   is	   not	  
represented	  in	  V.s-­‐1	  as	  in	  isolated	  cells	  studies,	  rather	  in	  a.u.ms-­‐1	  (a.u.	  stands	  for	  “arbitrary	  units”).	  	  
Figure	  22.	   Bar	   graphs	   of	   Vmax	   and	  
Vmin	   for	   WT	   (N=20)	   and	   mdx	  
(N=14)	   under	   control	   and	  
different	  time	  points	  of	  Flecainide	  
perfusion.	   (Upper)	   Decrease	   in	  
Vmax	   is	   consistent	   for	   both	   groups	  
until	  later	  time	  points:	  A	  maximum	  
decrease	  of	  33%	  for	  WT	  (at	  5min)	  vs.	  
36%	   decrease	   for	  mdx	   (at	   t10).	   The	  
increase	   in	  CV	  at	  +7min	  and	  +10min	  
of	   Flecainide	   perfusion	   is	   typically	  
seen	  in	  6	  out	  of	  10	  WT	  experiments.	  
No	   such	   fluctuation	   was	   detected	   in	  
the	  mdx	  group.	  The	  increase	  in	  SD	  at	  
t7	   and	   t10	   is	   relevant	   due	   to	   the	  
enhanced	  scattering	  of	  Vmax	  values	  in	  
the	  WT.	   (Lower)	  Gradual	  decrease	  
in	   Vmin	   with	   Flecainide:	   A	   total	   of	  
39%	   and	   30.5%	   decrease	   in	   Vmin	  
were	   measured	   for	   WT	   and	   mdx	  
respectively.	   The	   differences	  
between	   velocities	   at	   all	   times	   is	  
statistically	   significant	   (unpaired	   t-­‐
test),	  except	  for	  the	  Vmin	  at	  t10,	  where	  
the	   difference	   between	   mean	  
velocities	   (<5%)	   is	   covered	   by	   the	  
increase	  in	  SD	  of	  the	  WT	  group	  (9%).	  
Annotations	   in	   figure:	   	   #	   (p<	  
0.0001);	  ***	  (p<0.001);	  **	  (p<0.01);	  *	  
(p<0.05);	  n.s.	  not	  significant.	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Indeed	   the	   optical	   AP	   has	   been	   validated	   as	   a	   linear	   translation	   of	   the	   changes	   in	   membrane	  
voltage550,	  however	  the	  data	  regarding	  upstroke	  velocities	  must	  be	  carefully	  represented.	  Another	  
way	  of	  estimating	  the	  changes	  in	  (dF/dt)max	  during	  NaV1.5	  blocking	  is	  to	  look	  at	  the	  “relative	  change”	  
of	   (dF/dt)max	   at	   any	   time	   point	   of	   Flecainide	   treatment	   compared	   to	   the	   control	   conditions.	   This	  






























Figure	   23.	   Dispersion	   maps	  
within	   the	   ROI	   showing	  
(dF/dt)max	   changes	   with	  
Flecainide.	   Starting	   from	   a	  
nicely	  anisotropic	  distribution	  of	  
upstroke	   velocities	   (property	   of	  
propagation,	  where	  not	  only	  the	  
CV	   is	  anisotropic,	  but	  so	  are	   the	  
upstroke	   velocities	   in	   the	  
tissue),	   the	   drug	   progressively	  
decreases	   the	   steepness	   of	   the	  
upstroke	   at	   each	   pixel.	   a.	  
Progression	   in	   the	   WT	   heart	  
(from	   Control	   (t0)	   to	   +1min	  
(t1),	   +5min	   (t5)	   and	   +10min	  
(t10)	   drug	   perfusion).	   The	   red	  
areas	   are	   gradually	   replaced	   by	  
blue,	   suggesting	   a	   shift	   of	   the	  
upstroke	   velocities	   towards	  
lower	   values.	   At	   t10,	   the	  
distribution	   of	   (dF/dt)max	  
remains	  homogenous,	  except	  for	  
the	  upper	  side	  of	  the	  ROI,	  with	  a	  
clear	   green	   coloration.	   The	  
values	  of	  (dF/dt)max	  however	  do	  
not	  explain	   the	   fast	  CV	  detected	  
in	   that	   area.	   b.	   Progression	   in	  
the	   mdx.	   The	   unremarkable	  
changes	   in	   (dF/dt)max	   appear	  
consistent	   with	   the	   changes	   in	  
CV	   reported	   previously.	   Aside	  
from	  the	  gradual	  decrease	  in	  the	  
upstroke	   velocities	   throughout	  
the	   ROI,	   the	   maps	   appear	  
homogeneous	   and	  
unremarkable.	   Scale	   bar	   =	  
0.5mm.	   Look-­‐up	   table:	  
(dF/dt)max	   	   in	  a.u.ms-­‐1	  =	  [0	  0.8].	  
Annotations	   in	   figure:	   Ao=	  
Aorta,	   Ap	   =	   Apex,	   R=Right,	  
L=Left,	  P=Point	  stimulation.	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Figure	   25	   shows	   the	   upstroke	   velocities	   at	   each	   time	   point	   normalized	   to	   the	   control	   value	   in	  
percentage.	   At	   time	   0,	   (dF/dt)max	   is	   represented	   by	   the	   highest	   values	   recorded	   along	   the	  
longitudinal	  and	  transversal	  directions	  for	  each	  preparation,	  corresponding	  to	  100%	  in	  the	  plot.	  As	  
the	   treatment	   progresses	   and	   the	   value	   of	   the	   upstroke	   velocity	   decreases,	   the	   following	   values	  
represent	  a	  certain	  percentage	  of	  the	  control	  values.	  Each	  variable	  in	  the	  decay	  curve	  is	  the	  mean	  of	  
percentage	   values	   of	   (dF/dt)max	   at	   a	   particular	   time	   point	   of	   the	   treatment	   protocol	   (bars	   =	   SD).	  
Figure	  25a	  clearly	  demonstrates	  that	  despite	  the	  lower	  starting	  values	  of	  the	  upstroke	  velocities	  in	  
the	  mdx	   ventricular	   tissue,	   the	   fit	   of	   the	   one	   phase	   exponential	   decay	   is	   comparable	   to	   its	   WT	  
counterpart.	   The	   red	   squares	   (mdx)	   are	   almost	   superimposable	   over	   the	   blue	   squares	   (WT).	   The	  
decay	   rates	   below	   (Figure	   25b)	   are	   in	   agreement	  with	   the	   fit,	  with	   corresponding	   rate	   constants	  
KWT,Long	   =	  0.21±0.07min-­‐1	   and	  Kmdx,Long	   =	  0.19±0.09min-­‐1	   .	   The	   congruence	   in	  decay	   curves	   indicate	  
that	  (dF/dt)max	  of	  the	  mdx	  along	  the	  longitudinal	  direction	  has	  almost	  the	  same	  “sensitivity”	  as	  the	  
WT’s	  to	  NaV1.5	  blocking.	  The	  plot	  on	  the	  right	  shows	  the	  decay	  of	  (dF/dt)max	  along	  the	  transversal	  
direction	  with	  drug	  perfusion	  times.	  In	  contrast	  to	  the	  previous	  plot	  on	  the	  left,	  the	  WT	  curve	  shows	  




Figure	  24.	  Bar	  graphs	  representing	  
gradual	   changes	   in	   (dF/dt)max	  with	  
Flecainide	  between	  WT	  (N=20)	  and	  
mdx	   (N=14).	   Progressive	   changes	   in	  
upstroke	   velocities	   are	   visible	   at	   all	  
time	   points	   of	   drug	   perfusion.	   a.	  
Changes	   along	   the	   longitudinal	  
direction.	   b.	   Changes	   along	   the	  
transversal	  direction.	  As	  reported	  in	  
cellular	   studies,	   blocking	   Nav1.5	   will	  
lead	   to	  decrease	   in	   the	   rate	   of	   rise	   of	  
the	   AP.	   This	   effect	   is	   perfectly	  
reproducible	   in	   the	   optical	   AP.	   At	  
control	   conditions,	   the	   mdx	   with	  
initially	   lower	  Nav1.5	  has	  a	  shallower	  
(dF/dt)max.	   These	   values,	   although	  
describe	   the	   differences	   observed	  
between	   WT	   and	   mdx	   at	   each	   time	  
point,	   they	   poorly	   represent	   the	  
“relative”	   changes	   at	   each	   point	   from	  
the	  initial	  starting	  point,	  and	  whether	  
differences	   in	   the	  decay	  of	   (dF/dt)max	  
exist	   between	   the	   two	   experimental	  
groups.	  Annotations	  in	  figure:	  	  #	  (p<	  
0.0001);	  ***	   (p<0.001);	  **	  (p<0.01);	  *	  
(p<0.05);	  n.s.	  not	  significant.	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By	   looking	   at	   the	   WT	   values,	   KWT,Trans	   is	   not	   only	   twice	   as	   large	   as	   Kmdx,Trans	   (0.34±0.05min-­‐1	   vs.	  
0.17±0.05min-­‐1	  respectively)	  but	  also	  ~13%	  larger	  than	  KWT,Long,	  which	  indicates	  that	  responses	  to	  
NaV1.5-­‐blocking	  is	  not	  uniform	  in	  the	  cardiac	  tissue.	  This	  result	  could	  be	  attributed	  to	  alterations	  in	  
active	  and	  passive	  electrical	  properties	  of	  the	  ventricular	  tissue,	  which	  play	  a	  role	  in	  excitation	  and	  
conduction.	  The	  notably	  slower	  decay	  of	   (dF/dt)max	   in	   the	  mdx	   substrate	  (compared	  to	  WT)	  along	  
the	  transversal	  direction	  suggests	  an	  impaired	  ability	  of	  Flecainide	  to	  modify	  the	  excitability	  profile	  
in	  this	  direction.	  This	  likely	  suggests	  that	  the	  loss	  NaV1.5	  from	  the	  LM	  in	  the	  mdx	  could	  play	  a	  role	  in	  
preventing	   modulation	   of	   the	   channel	   pharmacologically,	   which	   translates	   as	   a	   form	   of	   drug	  
resistance	  in	  the	  cardiac	  tissue.	  
	  
A	  useful	  way	  of	  comparing	  how	  the	  alterations	  in	  (dF/dt)max	  and	  CV	  correlate	  is	  to	  plot	  them	  against	  
each	  other	  (Figure	  26)	  by	  dividing	  them	  into	  four	  groups	  according	  to	  their	  direction	  of	  propagation	  	  
(longitudinal,	   transversal)	  and	  according	   to	   the	   two	  experimental	  groups	  (WT,	  N=20;	  mdx,	  N=14).	  
Each	  plot	  contains	  20	  Vmax	  (square,	  blue)	  and	  20	  Vmin	  (circle,	  blue)	  values	  for	  the	  WT,	  as	  well	  as	  14	  
Vmax	  (square,	  red)	  and	  14	  Vmin	  (circle,	  red)	  values	  for	  the	  mdx,	  each	  velocity	  with	  its	  corresponding	  
(dF/dt)max.	   Starting	   with	   control	   conditions	   (upper	   left),	   it	   can	   be	   deduced	   that	   the	   relationship	  
governing	  (dF/dt)max	  and	  CV	  is	  not	  exigently	  linear.	  The	  fact	  that	  data	  points	  within	  each	  ensemble	  
occupy	   a	   particular	   zone	   of	   the	   plot	   suggests	   an	   overall	   interdependence	  mechanism	   among	   the	  
groups,	  where	  fast	  CVs	  are	  associated	  with	  high	  (dF/dt)max,	  and	  slower	  velocities	  with	  lower	  values	  
of	  (dF/dt)max	  (as	  can	  be	  depicted	  from	  the	  distribution	  of	  blue	  squares	  and	  red	  circles	  for	  instance).	  
Other	  areas	  of	  the	  control	  plot,	  however,	  could	  be	  harder	  to	  explain.	  
Figure	   25.	   Fractional	   (dF/dt)max	   decay	   with	   Flecainide	   perfusion.	   a.	   Plots	   show	   disparate	   responses	   to	   NaV1.5-­‐
blocking,	   depending	   on	   the	   substrate	   and	   direction	   of	   propagation.	  The	   variables	   represent	   the	  mean	   of	   fractional	  
values	  at	   a	  specific	   time	  point	   of	   the	  protocol.	  The	  bars	   represent	   the	   SD.	  The	  data	   are	   fitted	  using	   the	   one-­‐phase	  decay	  
equation:	  y(t)=(Y0-­‐A)e(-­‐t/τ)+A,	  where	  τ	  is	  the	  time	  constant,	  A	  the	  plateau	  (i.e.	  y	  value	  at	  infinite	  times)	  and	  Y0	  is	  the	  initial	  
value	   at	   time	  0.	   (Left)	  mdx	   and	  WT	  acquire	  similar	  decay	   curves	  with	  almost	   superimposable	  points,	  when	   (dF/dt)max	   is	  
measured	   in	   the	   longitudinal	   direction.	   The	   plateaus	   reached	   are	   also	   within	   the	   same	   range	   of	   values	   where	  
AWT,Long=40.3±8.2%	   and	   Amdx,Long=39.1±10.0%.	   (Right)	   Transversely,	   (dF/dt)max	   curve’s	   sharper	   decline	   in	   the	  WT	   at	   the	  
early	  stages	  indicates	  the	  presence	  of	  a	  spatial	  component	  in	  modulating	  Nav1.5	  blocking,	  which	  is	  deterred	  in	  the	  mdx.	  This	  
could	  possibly	  be	  due	  to	  the	  loss	  of	  Nav1.5	  on	   the	  LM	  in	   the	  mdx,	  which	  dampens	  down	  the	  sensitivity	  of	   the	  substrate	  to	  
Flecaninde	  in	  this	  direction.	  Despite	  a	  faster	  decay	  in	  the	  early	  phases	  of	  treatment,	  the	  curves	  are	  expected	  to	  intersect	  at	  
some	  point	  beyond	  10min,	  if	  the	  tissues	  remain	  excitable,	  with	  a	  higher	  plateau	  value	  for	  the	  WT:	  AWT,Trans=46.8±2.4%	  and	  
Amdx,Trans=41.9±9.1%.	  b.	  Table	  of	  the	  decay	  parameters	  for	  both	  experimental	  groups,	  in	  the	  two	  directions.	  K	  =	  Rate	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The	  highest	  velocity	  ranges	  (blue	  squares,	  WT	  Vmax)	  are	  interspersed	  in	  the	  upper	  right	  side	  of	  the	  
plot.	  Points	  that	  differ	   in	   less	  than	  2%	  in	  the	  (dF/dt)max	  are	  associated	  with	  velocity	  values	  almost	  
40%	  in	  difference.	  For	  more	  than	  6	  data	  points,	  the	  red	  squares	  (which	  symbolize	  Vmax	  in	  mdx)	  are	  
almost	   horizontally	   aligned,	   which	  means	   that	   a	   steady	   (dF/dt)max	   value	   correlates	  with	   a	  whole	  
range	  velocities	   (span	  ~20%).	   Similarly,	   the	  distribution	  of	  blue	   circles	   (i.e.	  Vmin	   in	  WT)	   is	   almost	  
vertical	  for	  more	  than	  8	  data	  points,	  which	  suggests	  that	  the	  same	  CV	  can	  be	  determined	  by	  a	  range	  
of	   	   (dF/dt)max	  values.	  As	   shown	   in	   the	   remaining	  panels	  of	  Figure	  26,	   as	  Flecainide	  blocks	   further	  
NaV1.5,	  the	  data	  points	  shift	  to	  the	  lower	  left	  corner	  of	  the	  plot,	  indicative	  of	  an	  overall	  decrease	  in	  




Figure	   26.	   (dF/dt)max	   vs.	   CV	  
correlation	  plots	  at	  different	  times	  
of	   Flecainide	   (1μM)	   perfusion	  
protocol.	   The	   clustering	   of	   data	  
points	   in	   specific	   zones	   with	  
relatively	   little	   overlapping	   (control)	  
suggests	   a	   dependency	   between	   the	  
two	   parameters	   of	   interest,	   even	  
though	   no	   linearity	   can	   be	   deduced.	  
At	  +1min,	  data	  points	  show	  a	  shift	  to	  
the	   left	   lower	   corner	   of	   the	   plot,	  
which	   means	   that	   for	   all	   points,	  
NaV1.5-­‐blocking	  caused	  a	  decrease	  in	  
both	  (dF/dt)max	  and	  CV.	  The	  widened	  
scattering	   simultaneously	   in	   all	  
groups	   can	   be	   attributed	   to	   the	  
general	   state	   of	   the	   system	   in	  
transient	  phases	  (also	  seen	  at	  +3min)	  
between	   a	   control	   drug-­‐free	  
condition	  to	  a	  state	  of	  steady	  NaV1.5-­‐
blocking	   (at	   +5min).	   At	   5min,	   the	  
points	   occupy	   the	   lower	   left	   side	   of	  
the	   plot,	   where	   the	   lower	   scattering	  
is	   indicative	   that	   a	   new	   steady	   state	  
is	   achieved	   in	   the	   presence	   of	  
Flecainide.	   Beyond	   5min	   of	  
treatment,	   the	   previously	   described	  
faster	   CV	   foci	   kick-­‐in	   and	   induce	   a	  
widening	  of	  the	  zone	  occupied	  by	  the	  
WT	   longitudinal	   data	   points,	   where	  
fast	   CVs	   correlate	   with	   lower	  
(dF/dt)max	   values.	   At	   this	   point,	   it’s	  
obvious	   that	   heterogeneity	   in	  
propagation	  occurs	  mainly	  along	   the	  
longitudinal	   direction,	   where	  
increases	   in	  Vmax	  no	   longer	   correlate	  
with	   (dF/dt)max.	   The	   transverse	  
direction	   appears	   to	   be	   independent	  
of	  such	  effects.	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scattering	  is	  occurring	  in	  all	  groups,	  it	  means	  that	  it’s	  independent	  of	  the	  direction	  of	  propagation	  or	  
the	   substrate	   at	   hand;	   rather	   it	   depends	   on	   the	   overall	   state	   of	   the	   system	   (cardiac	   tissue)	   being	  
acutely	   exposed	   to	   a	  NaV1.5	   blocking	  process.	   A	   new	   steady	   state	   is	   achieved	   at	   5min,	  where	   the	  
data	   points	   occupy	   the	   lower	   left	   region	   of	   the	   plot,	   indicative	   of	   a	   comprehensive	   decrease	   in	  
propagation	   velocity	   and	   (dF/dt)max.	   Beyond	   5min,	   all	   groups	   appear	   in	   clusters	   of	   points	  
particularly	   obvious	   in	   the	  Vmax	   (WT).	   If	   an	   imaginary	   line	   is	   drawn	  parallel	   to	   the	   x-­‐axis	   (y=0.2),	  
blue	   squares	   could	   share	   the	   same	   (dF/dt)max	   =0.2,	   but	   could	   acquire	   velocities	   varying	   between	  
0.4m.s-­‐1	   and	   0.8m.s-­‐1.	   In	   global	   terms,	   (dF/dt)max	   dispersion	  maps	   (Figure	   23)	   and	   CV	   dispersion	  
maps	   (Figure	   21)	   appear	   reciprocal	   and	   interdependent.	   In	   local	   terms,	   this	   relationship	   is	  
misleading	  since	  point	  selection	  (with	  some	  spatial	  preferences	  along	  fiber	  directions)	  reveals	  that	  
the	   predictive	   potential	   of	   (dF/dt)max	   is	   quantitatively	   weak.	   This	   becomes	   more	   obvious	   when	  
prediction	   completely	   fails	  with	   the	  onset	   of	   heterogeneous	   elements	   in	   the	  propagating	  medium	  
(Figure	  21a,	   lower	   left	  panel)	   that	   increase	  Vmax,	  along	  with	  a	  simultaneous	  decrease	   in	  (dF/dt)max	  
(Figure	  23a,	  lower	  right	  panel).	  In	  other	  words,	  the	  adopted	  rationale	  behind	  the	  creation	  of	  NaV1.5	  
blocking	  agents	  was	  in	  principle	  based	  on	  the	  outcomes	  of	  isolated	  single	  cell	  studies,	  which	  in	  light	  
of	   these	   results	   is	   no	   longer	   justified.	   Henceforth,	   the	   conjectures	   of	   these	   studies	   need	   to	   be	  
reevaluated,	  taking	  into	  account	  the	  behavior	  of	  the	  drug	  in	  a	  multicellular	  network.	  
	  
Cell	  size204,	  geometry551	  and	  intercellular	  coupling204	  are	  all	  well-­‐defined,	  structural	  determinants	  of	  
anisotropy.	   However,	   anisotropy	   is	   not	   a	   static	   entity,	   it	   is	   subjected	   to	   modifications	   by	   non-­‐
structural	   (functional)	   parameters	   such	   as	   frequency	   of	   stimulation552.	   Factors	   that	   alter	   CV	   in	   a	  
direction	  dependent	  manner	  are	  expected	  to	  change	  the	  AR.	  In	  the	  results	  presented	  in	  the	  section	  
3.1,	  the	  change	  in	  AR	  between	  WT	  and	  mdx	  is	  not	  statistically	  significant.	  To	  recall,	  CV	  was	  evaluated	  
using	   three	  different	  methods,	  and	   the	  decrease	   in	  both	  Vmax	  and	  Vmin	   is	   comparable	  secondary	   to	  
the	  loss	  of	  NaV1.5	  in	  the	  mdx	  heart	  (Figure	  11d,	  Figure	  12d,	  Figure	  13d).	  However,	  with	  addition	  of	  
Flecainide,	  Vmin	  showed	  a	  steady	  decrease	  (in	  mdx	  and	  WT),	  whereas	  Vmax	  started	  to	  increase	  beyond	  
5	  min	  of	  treatment	  in	  the	  WT	  group	  only.	  In	  Figure	  27a,	  the	  AR	  bar	  graphs	  show	  that	  under	  control	  
conditions	   till	   3	  min	  of	   treatment,	   both	   velocities	  were	   changing	   in	   a	   comparable	   fashion	   in	  both	  
groups,	  without	   altering	   the	   AR	   (At	   t0,	   ARWT	   =1.9±0.3	   and	   ARmdx	   =2.0±0.3,	  p-­‐value=0.75).	   Beyond	  
5min,	  the	  increase	  in	  Vmax	  with	  the	  steady	  decrease	  in	  Vmin	  (Figure	  22)	  leads	  to	  an	  increase	  in	  the	  AR	  
of	  the	  WT	  group	  only	  (Figure	  27).	  Since	  Vmax	  increase	  always	  occurs	  one-­‐sidedly	  (Figure	  21a,	  lower	  
left),	   the	   same	  WT	   preparation	   shows	   a	   high	   and	   regular	   value	   of	   AR,	   leading	   to	   a	   simultaneous	  
increase	   in	   the	   SD	   (at	   t7,	   ARWT	   =	   2.4±0.5;	   at	   t10,	   ARWT	   =	   2.2±0.7).	   Since	   CV	   wasn’t	   subjected	   to	  
heterogeneity	   in	   the	  mdx,	   the	   AR	   remains	   unchanged	  within	   the	   group	   over	   the	  whole	   period	   of	  
treatment	  (at	  t7,	  ARmdx	  =	  1.9±0.3;	  at	  t10,	  ARmdx	  =	  1.8±0.3).	  
	  
In	   order	   to	   estimate	   the	   propagation	   “speed”	   in	   the	   heart	   at	   later	   times	   of	   treatment	   without	  
stumbling	  over	  the	  heterogeneity	  picked	  up	  by	  Vmax,	  we	  measured	  the	  global	  time	  (Δtact)	  it	  took	  the	  
wave	   to	   cover	   the	  LV	  epicardium	   from	   the	  point	  of	   stimulation	   to	   the	  boundaries.	  Δtact	   is	   a	  broad	  
measure	  of	  time,	  hence	  less	  likely	  to	  be	  affected	  by	  the	  heterogeneity	  in	  local	  conduction,	  since	  the	  
propagation	   at	   both	   sides	   of	   the	   pacing	  will	   average	   out	   in	   time.	   Bar	   graphs	   (Figure	   27b)	   of	   Δtact	  
show	  that	  under	  control	  conditions	  significantly	  more	  time	  was	  needed	  for	  the	  wave	  to	  cover	  the	  LV	  
in	   the	   mdx	   heart	   (n=7)	   than	   in	   the	   WT	   heart	   (n=10)	   with	   Δtact,mdx	   =12.0±1.6ms	   and	   Δtact,WT	  
=8.9±0.8ms	  respectively	  (p-­‐value<0.0001).	  At	   t10	  of	  Flecainide	  perfusion,	  an	   increase	  of	  ~107%	  in	  
time	  was	   achieved	   in	   the	  WT	  heart	   vs.	   an	   increase	   of	   only	   56%	   in	   the	  mdx,	   leading	   to	   an	   almost	  
similar	   time	   window	   needed	   for	   the	   depolarization	   wave	   to	   cover	   both	   epicardia	   (Δtact,WT	  
=18.5±3.2ms	   vs.	   Δtact,mdx	   =18.8±3.1ms,	   p-­‐value=0.88).	   The	   overall	   decrease	   in	   (dF/dt)max	   at	   t10	   of	  
Flecainide	  was	   also	   estimated	   in	   percentage	   value	   along	   both	   directions	   (Figure	   27c)	   in	   the	  mdx	  
(N=14)	   and	   WT	   (N=20).	   As	   expected	   from	   the	   exponential	   graph	   (Figure	   25),	   the	   decrease	   in	  
(dF/dt)max	   shows	   a	   significant	   difference	   between	   the	   groups	   exclusively	   along	   the	   transversal	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direction,	   with	   52.3±10.1%	   and	   39.4±6.2%	   for	  WT	   and	  mdx	   respectively	   (p-­‐value<0.001).	   In	   the	  
longitudinal	   direction,	   the	   decrease	   in	   (dF/dt)max	   was	   comparable	   between	   the	   groups	   with	  
51.8±16.9%	  decrease	  in	  the	  WT	  and	  44.3±9.5%	  in	  the	  mdx	  (p-­‐value=0.15).	  Interestingly	  in	  the	  WT	  
heart,	  the	  overall	  percentile	  changes	  in	  (dF/dt)max	  at	  t10	  are	  analogous	  regardless	  of	  fiber	  direction,	  
despite	  the	  initially	  faster	  decay	  along	  one	  of	  the	  directions	  (Figure	  25a	  and	  b).	  These	  results	  are	  at	  
odds	  with	  the	  ones	  published	  by	  Iida	  et	  al.	  (1996),	  where	  Flecainide	  (0.1-­‐1μM)	  appears	  to	  decrease	  
the	  maximum	  upstroke	  velocity	  in	  the	  rabbit	  heart	  preferentially	  along	  the	  longitudinal	  direction553.	  
The	   reason	   behind	   this	   discrepancy	   might	   lie	   in	   the	   methodology	   at	   the	   time	   by	   using	   bipolar	  
extracellular	   electrodes	   to	   examine	   CV,	   and	   the	   inability	   to	   sufficiently	   resolve	   the	   cardiac	   tissue	  
spatially	  and	  temporally,	  as	  offered	  nowadays	  by	  optical	  mapping.	  
3.2.2. Symmetry Breaking:  A Proarrhythmic Mechanism of Flecainide 
Regional	  differences	  in	  action	  potential	  duration	  (APD)	  contribute	  to	  spatial	  non-­‐homogeneities	  in	  
the	  three	  dimensional	  structure	  of	  the	  ventricular	  myocardium.	  Functional	  electrical	  asymmetry	  of	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Figure	  27.	  Bar	  graphs	  show	  changes	  in	  
AR,	   the	   increase	   in	   Δtact	   and	   the	   total	  
%-­‐decrease	   in	   (dF/dt)max	   at	   t10	   of	  
Flecainide	   perfusion	   for	  mdx	   and	   WT	  
hearts.	  a.	  Apparent	   increase	   in	  AR	  due	  
to	   heterogeneity	   in	   conduction	  
properties.	  With	  the	  increase	  in	  Vmax	  and	  
the	   steady	   decrease	   in	   Vmin	   in	   the	   WT	  
heart	   with	   Flecainide,	   the	   ratio	   of	  
velocities	   is	   expected	   to	   increase	   in	   the	  
WT.	   It	   remains	   unchanged	   in	   the	   mdx	  
increasing	   the	  differences	   in	  AR	  between	  
the	   two	   groups	   beyond	   5min.	   	  b.	   A	   total	  
increase	   of	   107%	   in	   Δtact,WT	   vs.	   a	  
moderate	   increase	   in	   Δtact,mdx	   (56%)	  
abolishes	   the	   difference	   in	   global	  
depolarization	   time	   between	   the	   two	  
groups	   at	   t10	   Flecainide.	   c.	   Bar	   graphs	  
show	   that	   the	   total	   percentage	   decrease	  
in	   (dF/dt)max	   between	   t0	   and	   t10	   of	  
Flecainide	   along	   the	   longitudinal	  
direction	   is	   comparable	   between	   WT	  
(51.8±16.9%)	  and	  mdx	  (44.3±9.5%).	  This	  
difference	   becomes	   more	   significant	  
along	   the	   transversal	   direction	   with	  
52.3±10.1%	   (WT)	   and	   39.4±6.2%	   (mdx).	  
Annotations	   in	   figure:	   	   #	   (p<	   0.0001);	  
***	   (p<0.001);	   **	   (p<0.01);	   *	   (p<0.05);	  
n.s.	  not	  significant.	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the	  cardiac	  AP	  and	  dispersion	  of	  repolarization,	  often	  enhanced	  by	  intrinsic	  heterogeneities	  of	  the	  
tissue	   electrical	   properties,	   can	   facilitate	   unidirectional	   block407	   in	   the	   absence	   of	   conduction	  
changes	   or	   an	   anatomical	   obstacle,	   solely	   based	   on	   temporal	   differences	   in	   recovery	   of	  
excitability477.	   Experimental	   studies	   conducted	   on	   particularly	   high	   arrhythmogenic	   substrates264,	  
such	   as	   Long	   QT-­‐	   and	   Brugada	   syndromes,	   have	   reported	   significant	   dispersion	   in	   recovery	   of	  
excitability.	   While	   differences	   in	   APD	   have	   shown	   to	   naturally	   exist	   across	   the	   heart262	   (e.g.	   the	  
apico-­‐basal	  or	  transmural	  epicardium-­‐endocardium	  axes),	  these	  gradual	  transitions	  are	  improbable	  
to	  form	  substrates	  for	  arrhythmia	  under	  normal	  conditions.	  Distinct	  repolarization	  times	  are	  likely	  
to	   become	   arrhythmogenic	  when	   their	   corresponding	   locations	   are	   “adjacent	   enough”554.	  Most	   of	  
the	   heterogeneities	   in	   repolarization	   have	   been	   characterized	   in	   the	   time	   domain,	   whereas	  
knowledge	   concerning	   the	   spatial	   extent	   of	   these	   APD	   gradients	   is	   relatively	   less	   certain254.	   The	  
increasing	   resolution	   provided	   by	   optical	   mapping	   techniques555,	   in	   combination	   with	  
computational	   simulations270,	   556,	   currently	   allows	   for	   a	   more	   precise	   analysis	   of	   the	   spatial-­‐
temporal	   extent	   of	   repolarization	   heterogeneity	   in	   the	   cardiac	   tissue	   and	   the	   elucidation	   of	  
biophysical	  mechanisms	  possibly	  involved	  in	  promoting	  reentry.	  	  
	  
APD	  dispersion	  maps	  are	  typically	  used	  to	  characterize	  spatial	  dispersion	  of	  repolarization	  (SDR)550.	  
Although	   intrinsic	   cellular	  heterogeneity	  has	  been	  well	   characterized	   in	   isolated	   cells,	   taken	   from	  
distinct	   areas	   of	   the	   heart266,	   402,	   electrotonic	   interactions	   are	   also	   known	   to	   modulate	  
repolarization257	   over	   large	   spatial	   extents402,	   557.	   The	   latter	   may	   have	   a	   relatively	   considerable	  
impact	   on	   small	   size	   hearts,	   where	   functional	   dispersion	   of	   repolarization	   was	   found	   to	   be	  
diminished556.	   The	   latter	   might	   render	   small	   animals	   (e.g.	   mouse)	   less	   favorable	   models	   for	   the	  
investigation	   of	   APD	   dispersion	   in	   arrhythmogenic	   substrates	   compared	   to	   larger	   animals	   (e.g.	  
rabbit,	  pig).	  At	  any	  rate,	  the	  cellular	  basis	  of	  ventricular	  wall	  heterogeneity	  is	  in	  principle	  based	  on	  
the	   presence	   of	   three	   distinct	   types	   of	   cells	   that	   differ	   with	   respect	   to	   their	   early	   and	   late	  
repolarization	  phases402.	  The	  response	  of	  each	  type	  of	  cells	   to	  AADs	   is	   therefore	  expected	  to	  vary,	  
henceforth	  widens	   the	  underlying	   electrophysiological	  differences	   in	   the	  myocardium,	   a	  plausible	  
mechanism	   into	   the	   proarrhythmic	   effects	   of	   AADs.	   As	   for	   activation	   times,	   APD	   from	   the	   optical	  
signal	   can	   be	   calculated	   within	   each	   pixel	   and	   APD	   dispersion	   maps	   can	   be	   used	   to	   elucidate	  
simultaneously	   temporal	   gradients	   in	   repolarization	   and	   their	   spatial	   extent	   in	   the	   region	   of	  
interest.	  	  
	  
In	   the	   next	   sets	   of	   results,	   we	   report	   how	   NaV1.5	   blocking	   with	   Flecainide	   using	   clinically	   valid	  
concentrations	   can	   produce	   opposite	   effects	   on	   APD–and	   repolarization–within	   the	   same	  
population	  of	  cells	  (LV	  free	  wall	  epicardial	  cells)	  in	  the	  murine	  heart,	  under	  anisotropic	  conduction	  
spread	  and	  steady-­‐state	  entrainment	  conditions.	  We	  describe	  the	  temporal	  gradient	  and	  the	  spatial	  
extent	  of	  such	  an	  effect,	  the	  repolarization	  inhomogeneity	  as	  it	  occurred	  consistently	  and	  exclusively	  
in	  the	  WT	  group	  under	  the	  current	  experimental	  conditions.	  Interestingly,	  the	  mdx	  group	  with	  lower	  
available	   NaV1.5	   channels	   appeared	   to	   be	   resistant	   to	   the	   drug-­‐induced	   heterogeneity	   in	   APD.	  
Following	  the	  presented	  arguments	  above,	  a	  substantial	  SDR	  has	  hardly	  been	  expected	  to	  occur	  in	  
small	   sized	   hearts,	   not	   to	  mention	   the	   exclusivity	   of	   the	   symmetry	   breaking	   effect	   to	   the	   normal	  
hearts	   sparing	   the	   hearts	   with	   initially	   lower	   NaV1.5	   channels.	   This	   effect	   hasn’t	   been	   reported	  
before	   in	   murine	   hearts,	   nor	   has	   the	   response	   of	   the	   dystrophic	   substrate	   to	   Flecainide	   been	  
characterized.	   The	  molecular	  mechanism	   behind	   this	   observation	   remains	   to	   be	   fully	   elucidated;	  
however	  it	  could	  provide	  insights	  into	  the	  electrophysiological	  process	  underlying	  why	  Flecainide	  is	  
among	  the	  most	  arrhythmogenic	  and	  proarrhythmic	  of	  antiarrhythmic	  agents483,	  492,	  558,	  559.	  




































Figure	   28.	   	   APs	   and	   APD50	   dispersion	  maps	   for	  WT	   (a)	   and	  mdx	   (b)	   hearts	   at	   t0,	   t1,	   t5	   and	   t10	   of	   NaV1.5-­‐
blocking.	  a.	  Symmetry	  breaking	  evident	  at	  t10	  with	  an	  APD50	  gradient	  ~35ms.	  APs	  consistently	  selected	  from	  4	  	  
sites	  for	  all	  measurements	  on	  the	  map	  longitudinally	  (white	  dots,	  numbers:	  1,3;	  corresponding	  blue	  colored	  APs	  on	  
the	  left)	  and	  transversely	  (red	  dots,	  numbers:	  2,4;	  red	  APs	  on	  the	  left)	  perfectly	  overlap	  at	  t0.	  APD50	  dispersion	  maps	  
are	  shown	  on	  the	  right	  of	  the	  APs.	  At	  t0,	  the	  map	  shows	  a	  homogeneous	  distribution	  of	  APD	  values	  in	  the	  tissue,	  with	  
prolongation	  at	  the	  pacing	  site	  (P).	  APD50	   is	  defined	  as	  the	  duration	  between	  the	   times	  at	  which	  the	  green	  dotted	  
line	   crosses	   the	  AP	   (the	  10%	   lower	   threshold)	   to	   the	  50%	   repolarization	   from	   the	  peak	   (pink	  dotted	   line).	  APD	  
prolongation	  is	  noticeable	  as	  Flecainide	  progresses	  (the	  gray	  dotted	  line	  within	  the	  APs	  at	  t1,	  t5	  and	  t10	  represents	  
the	   initial	  AP	  at	   t0).	  The	  map	   shows	  a	   steady	  APD	  prolongation	  manifested	  by	   the	  appearance	  of	   the	   lighter	  blue	  
color.	  A	  striking	  APD50	  distribution	  appears	  at	   t10,	  where	   the	  LV	  epicardium	  embeds	  simultaneously	  an	  area	  with	  
prolonged	  APs	  (red)	  abutting	  another	  area	  with	  paradoxically	  shortened	  APs	  (blue).	  This	  bistability	  is	  also	  reflected	  
in	   the	   selected	   APs	   that	   clearly	   separate	   into	   2	   groups	   (prolonged	   and	   shortened),	   independent	   of	   direction	   of	  
propagation.	  b.	  APD	  prolongation	  in	  the	  mdx	  is	  not	  associated	  with	  a	  symmetry	  breaking	  process	  at	  t10.	  The	  
mdx	   APs	   prolong	   with	   Flecainide.	   Homogeneously,	   the	   dispersion	   maps	   manifest	   this	   prolongation	   without	  
diverging	   from	   the	   circular	   distribution.	   Consequently,	   all	   APs	   remain	   superimposable.	  Annotations	   in	   figure:	  
Ao=Aorta,	  Ap=Apex,	  R=Right,	  L=Left,	  P=Pacing,	  PE=Pacing	  electrode.	  Scale	  bar	  map=1mm.	  Scale	  bar	  AP=20ms.	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In	  Figure	  28,	  APs	  and	  APD50	  dispersion	  maps	  for	  WT	  (a)	  and	  mdx	  (b)	  at	  t0,	  t1,	  t5	  and	  t10	  of	  Flecainide	  
[1μM]	  are	  shown.	  The	  same	  mask	  of	  the	  LV	  free	  wall	  has	  been	  repeatedly	  used	  for	  the	  same	  heart	  
preparation	   to	   reproduce	   the	  maps	   at	   different	  measurements	   as	   the	   drug	   treatment	   progresses.	  	  
The	   APs	   were	   selected	   from	   4	   different	   locations	   on	   the	   map,	   chosen	   along	   the	   longitudinal	  
direction	  of	  propagation	  (white	  dots	  on	  map,	  numbered	  as	  1	  and	  3,	  corresponding	  blue	  colored	  APs	  
on	  the	  left)	  and	  the	  transversal	  direction	  (red	  dots	  on	  map,	  numbered	  as	  2	  and	  4,	  corresponding	  red	  
colored	  APs	  on	  the	  left).	   	  The	  AP	  morphological	  changes	  were	  monitored	  at	  t1,	   t5	  and	  t10	  as	  NaV1.5	  
blocking	   progressedlxvii.	   For	   a	   direct	   comparison,	   an	   underlying	   control	   AP	   is	  marked	   in	   a	   dotted	  
gray	  line.	  The	  corresponding	  APD	  dispersion	  maps	  appear	  at	  the	  right	  side	  of	  the	  AP	  at	  all	  times.	  At	  
t0	   (Figure	  28a,	  upper	   right),	  APs	  perfectly	  overlap	  and	   the	  dispersion	  map	  shows	  a	  homogeneous	  
distribution	  of	  APD50,	  with	  higher	  values	  at	  the	  stimulation	  site,	  where	  current-­‐induced	  electrotonic	  
imbalance	  possibly	  causes	  a	  local	  increase	  in	  APD	  values.	  APD	  for	  the	  mouse	  heart	  is	  maximal	  at	  the	  
pacing	  site	  and	  dispels	  in	  all	  directions	  as	  the	  wave	  moves	  away	  elliptically	  from	  the	  pacing	  site	  to	  
the	   boundaries	   (the	   last	   sites	   of	   activation	   in	   a	   2D	   projection).	   This	   circular	   distribution	   of	   APD	  
values	  appears	  in	  all	  dispersion	  maps	  where	  breaking	  of	  symmetry	  did	  not	  kick	  in.	  Henceforth,	  AP	  
sites	  were	  chosen	  along	  the	  longitudinal	  and	  transversal	  directions	  as	  to	  avoid	  the	  high	  electrotonic	  
imbalance	  due	  to	  pacing	  at	  the	  center	  of	  the	  ventricle	  and	  the	  effects	  due	  to	  the	  boundaries	  (in	  the	  
2D	  map).	  Dispersion	  maps	  where	  the	  sinus	  rhythm	  (8.3Hz)	  prevailed	  (not	  shown)	  were	  devoid	  from	  
such	   a	   ramification.	   Therefore,	   the	   heart	   curvature	   (the	   heart	   being	   an	   ellipsoid-­‐like	   object)	  was	  
eliminated	   as	   a	   potential	   cause	   for	   the	   spatial	   APD	   distribution	   in	   this	   context.	   In	   addition	   to	  
visualizing	  the	  gradient	  in	  APD	  values,	  histograms	  can	  be	  extracted	  from	  these	  maps	  (Figure	  29)	  in	  
order	  to	  quantify	  APD	  dispersion	  (ΔAPD)	  from	  the	  difference	  between	  the	  95th	  and	  5th	  percentile	  of	  
the	  APD	  distribution560.	  For	  instance,	  from	  the	  WT	  histogram	  at	  t0	  (Figure	  29b,	  left),	  ΔAPD50,WT	  was	  
calculated	  as	  95%-­‐5%	  of	  the	  distribution	  =	  36.7-­‐24.5=12.2ms,	  with	  a	  median	  =6.2ms.	  
	  
At	  1min	  post-­‐treatment	   initiation,	   the	  overlapping	  APs	  already	  show	  a	  prolongation	  starting	   from	  
phase	   1,	   a	   higher	   plateau	   phase	   then	   down	   to	   complete	   repolarization.	   The	  map	   shows	   a	   steady	  
prolongation	  of	  APD50	  manifested	  by	  the	  appearance	  of	  the	  lighter	  blue	  color.	  Further	  stretching	  of	  
the	  APD	  occurs	   at	   t5,	  with	   the	  map	   showing	   continuous	   elongation	  of	   the	  depicted	  values	   at	   each	  
pixel.	  The	  histograms	  of	   the	  map	  at	   t5	   (not	  shown)	   form	  a	  Gaussian	  distribution	  with	  a	  median	  at	  
44.8ms	  and	  ΔAPD50,WT	  =30.7ms.	  These	  values	  confirm	  that	  the	  APD	  in	  all	  pixels	  did	  indeed	  prolong,	  
with	  a	  shift	  of	  the	  median	  of	  ~15ms	  to	  the	  right	  and	  a	  widening	  of	  the	  unimodal	  distribution	  base	  by	  
~150%	  compared	  to	  the	  value	  at	  t0.	  A	  striking	  APD50	  pattern	  appears	  at	  t10,	  where	  the	  LV	  free	  wall	  
epicardium	  is	  observed	  to	  simultaneously	  accommodate	  two	  juxtaposed	  zones	  as	  a	  response	  to	  the	  
same	  steady-­‐state	  entrainment	  frequency	  (10Hz).	  This	  symmetry	  breaking	  effect	  is	  characterized	  by	  
two	  adjacent	  zones:	  One	  with	  prolonged	  APDs	  (red)	  and	  another	  with	  paradoxically	  shortened	  APDs	  
(blue)	  separated	  by	  a	  borderline	  of	  middle	  APD	  values.	  Although	  histograms	  are	  not	  sensitive	  to	  the	  
spatial	  distribution	  of	  APDs,	  particularly	  when	  the	  heterogeneity	  is	  global	  and	  involves	  large	  areas	  
of	  the	  LV,	  they	  revealed	  that	  the	  Gaussian	  distribution	  previously	  observed	  at	  t5	  had	  separated	  into	  a	  
bimodal	   one	   with	   a	   wider	   base	   (Figure	   29b,	   left).	   At	   t10,	   the	   calculated	   median	   =	   38.7ms	   and	  
ΔAPD50,WT	  =	  35.8ms	  (~193%	  wider	  than	  ΔAPD50,WT	  at	  t0).	  The	  APD50	  map	  at	  t10	  for	  the	  sinus	  rhythm	  
(dropped	  to	  5Hz	  after	  10min	  of	  Flecainide)	  reveals	  longer	  and	  shorter	  APDs	  with	  the	  same	  pattern	  
as	   the	   paced	   rhythm	   (10Hz).	   Hence	   this	   effect	   is	   pacing-­‐independent	   and	   this	   functional	   APD	  
heterogeneity	  is	  characteristic	  of	  the	  substrate.	  Along	  with	  a	  shallower	  upstroke	  (dotted	  gray	  line),	  
this	  bistability	  was	  also	  apparent	  in	  the	  selected	  APs	  (Figure	  28a,	  lower	  right)	  that	  clearly	  separated	  
into	  two	  groups	  (prolonged	  and	  shortened)	  towards	  the	  end	  of	  phase	  1,	  prior	  to	  the	  plateau	  phase	  
independent	  of	  the	  direction	  of	  propagation.	  The	  APs	  with	  the	  contracted	  plateau	  approach	  the	  non-­‐
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxvii	  Refer	  to	  the	  Experimental	  Methods	  section	  2.2.3,	  where	  calculation	  of	  the	  APD	  and	  the	  creation	  of	  APD	  dispersion	  maps	  
are	  fully	  described.	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treated	  AP	  dotted	  line	  at	  the	  time	  of	  50%	  repolarization	  despite	  an	  initially	  shallower	  upstroke	  and	  
a	  widened	  notch,	  to	  break	  away	  afterwards	  with	  a	  protracted	  repolarization	  until	  resting	  potential	  
is	  reached,	  resulting	  in	  a	  marked	  abbreviation	  of	  the	  epicardial	  response	  at	  50%	  repolarization.	  
	  
	  
The	  changes	  in	  the	  mdx	  heart	  with	  Flecainide	  are	  less	  complex	  (Figure	  28b).	  At	  t0	   in	  this	  example,	  
qualitatively	  the	  map	  is	  homogeneous	  with	  prolonged	  APDs	  mainly	  at	  the	  site	  of	  pacing.	  This	  is	  also	  
evident	   from	   the	  Gaussian	   distribution	   of	  APD50	   values	   in	   Figure	   29b	   (right).	   The	   histograms	   are	  
centered	  at	  31.7ms,	   and	  have	  a	  13.1ms	  dispersion,	   a	   slightly	  higher	  value	   that	   the	  one	  of	   the	  WT	  
heart	  at	   the	  same	  conditions	  (ΔAPD50,WT	  =	  12.2ms).	  As	   for	  the	  mdx	  APs	  (Figure	  28b,	   left),	   they	  are	  
characterized	  by	  a	  more	  flattened	  “notch”	  of	  the	  early	  repolarization	  phase	  (compared	  to	  WT	  APs	  at	  










































































Figure	   29.	   Histograms	  
extracted	   from	   APD	   maps	   at	  
different	   repolarization	   rates	  
for	  mdx	   and	  WT,	   at	   t0	   and	   t10	  
of	   Nav1.5	   blocking.	   a.	   APD25	  
peaks	   at	   6.2ms	   and	   8.9ms	   at	   t0	  
for	   WT	   and	   mdx	   respectively.	  
ΔAPD25,mdx	   approximates	   to	  
10.2ms	   at	   t0	   and	   increases	   to	  
30.9ms	   at	   t10.	  This	  dispersion	   is	  
considerably	  larger	  than	  the	  one	  
calculated	   for	   the	   WT	   (evident	  
from	   the	   widening	   of	   the	  
distribution	   base),	   where	  
ΔAPD25,WT	   =	   14.6ms	   at	   t10.	   b.	  
APD50	  distributions	  at	  t0	  do	  not	  
differ	   between	   WT	   and	   mdx.	  
Indeed	   their	   respective	   median	  
values	   (WT	   =	   30.5ms,	   mdx	   =	  
31.7ms)	   and	   ΔAPD50	   (WT	   =	  
12.2ms,	   mdx	   =	   13.1ms)	   are	  
comparable.	   The	   bistability	  
profile	   in	   the	  WT	  heart	   induced	  
by	   Flecainide	   at	   t10	   is	   reflected	  
by	   a	   bimodal	   distribution	   of	  
values	   with	   a	   significant	  
expansion	   of	   the	   dispersion	  
parameters	  (ΔAPD50,WT	  =	  34.8ms	  
,	   ΔAPD50,mdx	   =	   25.6ms).	   The	  
distribution	   in	   the	  mdx	   remains	  
one-­‐peaked,	   due	   to	   the	   absence	  
of	   symmetry	   breaking	   as	   in	   the	  
WT.	  	  c.	  APD75	  histograms	  show	  
almost	   the	   same	   response	   as	  
APD50,	   however	   the	   dispersion	  
at	   t0	   of	   the	  mdx	   values	   is	   larger	  
(ΔAPD75,mdx	   =	   20.4ms	   vs.	  
ΔAPD75,WT	  =	  	  13.5ms).	  A	  bimodal	  
pattern	  appears	  in	  the	  WT	  at	  t10,	  
similar	   to	  the	  one	  of	  APD50	  with	  
ΔAPD75,WT	   =	   33.1ms.	   No	   such	  
configuration	   appears	   in	   the	  
mdx	   heart	   at	   t10,	   where	  
ΔAPD75,mdx	   (=24.8ms)	   is	   smaller	  
as	  well.	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termination	  as	  the	  WT	  APs.	  The	  bar	  graphs	  in	  Figure	  30	  -­‐	  (a)	  APD50	  along	  the	  longitudinal	  direction,	  
(b)	  APD50	  along	   the	   transversal	  direction	  –	   show	  that	  no	  significant	  difference	  exists	  between	   the	  
APD50	   values	   of	   WT	   (N=20)	   and	  mdx	   (N=14)	   at	   t0,	   with	   APD50,WT=	   27.2±5.2ms	   and	   APD50,mdx	   =	  
28.1±5.6ms	  longitudinally;	  APD50,WT=30.1±6.4ms	  and	  APD50,mdx	  =	  29.5±3.8ms	  transversally.	  
	  
	  
Consistently	   with	   the	   WT	   heart,	   the	   dystrophic	   heart	   also	   shows	   an	   overall	   prolongation	   of	   the	  
APD50	  at	   t1.	   In	  this	  example,	   the	  prolongation	  starts	  at	  a	  more	  delayed	  phase	  than	  observed	  in	  the	  
WT	   and	   involves	   primarily	   the	   parts	   of	   the	   AP	   that	   follow	   the	   plateau.	   The	   dark	   blue	   color	   is	  
concentrated	  towards	  the	  apex	  and	  the	  base	  of	  the	  heart	  (Figure	  29b,	  upper	  right).	  Monitoring	  these	  
areas	  over	  time	  revealed	  that	  prolongation	  of	  the	  APs	  occurred	  at	  a	  lower	  rate	  than	  the	  remaining	  of	  
the	  map.	  At	   this	   time	  point	  of	   the	  experiment,	  APD50,mdx	  acquired	  different	  statistics	  depending	  on	  
the	  direction	  of	  propagation	  compared	  to	  its	  WT	  counterpart.	  Although	  at	  t1	  for	  example,	  APD50,WT	  
(Long.)	  =	  38.8±9.8ms	  and	  APD50,WT	  (Trans.)	  =	  40.8±9.8ms	  are	  analogous	  on	  average,	  evident	  of	  no	  
directional	   bias	   in	   the	   prolongation	   process	   of	   the	   APD,	   the	   difference	   between	   the	  WT	   and	  mdx	  
groups	  became	  statistically	  significant,	  possibly	  because	  of	   the	  smaller	  SD	   in	   the	  mdx	   group	  along	  
!"
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Figure	  30.	   Bar	   graphs	   show	  no	   significant	  
difference	   in	   the	   progression	   of	   APD50	  
between	   WT	   and	   mdx.	   a.	   Longitudinally,	  
APD50	   values	   in	   both	   groups	   show	   a	  
prolongation	   with	   Flecainide.	   The	   initial	  
comparability	  (at	   t0)	   between	  WT	  and	  mdx	   is	  
maintained	   in	   all	   following	   measurements.	  
APD50,WT	  appears	  to	  prolong	  on	  average	  more	  
than	   APD50,mdx	   at	   t1	   and	   t3,	   but	   the	   latter	  
become	   slightly	   more	   prolonged	   on	   average	  
afterwards.	   The	   increase	   in	   the	   SD	   at	   later	  
stages	   accounts	   for	   the	   symmetry-­‐breaking	  
effect	  seen	  in	  the	  WT	  hearts	  (SD	  at	  t0	  =	  5.2ms	  
vs.	  SD	  at	  t10	  =10.5ms).	  The	  percentile	  increase	  
in	   APD50	   between	   t10	   and	   t0	   is	   ~65%	   and	  
~70%	   for	   the	   WT	   and	  mdx	   respectively.	   	   b.	  
Transversally,	   a	   transient	   non-­‐
symmetrical	  surge	   in	  APD50,WT	  occurs	  only	  
in	   the	   early	   few	   minutes	   of	   treatment.	  
Initially,	   the	   WT	   and	   mdx	   don’t	   show	   any	  
difference	  in	  the	  APD50	  values.	  The	  significant	  
difference	  between	  the	  two	  groups	  appears	  at	  
t1	  and	  t3	  due	  to	  the	  inability	  of	  the	  APD50,mdx	  to	  
cope	   with	   	   the	   APD50,WT	   prolongation	   pace.	  
When	   comparing	   the	   longitudinal	   and	  
transversal	   APD50,WT,	   they	   are	   analogous	   at	  
these	  two	  time	  points,	  which	  means	  that	  there	  
are	   no	   directional	   preferences	   in	   the	   APD	  
prolongation	   in	   the	   WT	   (see	   text).	   This	   is	  
followed	   by	   an	   offset	   at	   t5,	   where	   the	   two	  
groups	   seem	   to	   reach	   a	   similar	   steady	  
prolonged	   state	   (from	   t5	   to	   t10).	   The	   SD	   is	  
however	   larger	   in	   the	   WT	   group	   at	   t10	  
(APD50,WT	   =	   48.1±9.4ms	   vs.	   APD50,mdx	   =	  
49.9±4.8ms).	  The	  percentile	  increase	  in	  APD50	  
between	  t10	  and	  t0	  is	  ~60%	  and	  ~69%	  for	  the	  
WT	   and	   mdx	   respectively.	   Annotations	   in	  
figure:	  *	  (p<0.05);	  n.s.	  not	  significant.	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the	  transversal	  direction,	  at	  these	  consecutive	  time	  points	  (t1	  and	  t3).	  The	  APs	  at	  t5	  present	  with	  a	  
distinctive	  form	  (compared	  to	  the	  APmdx	  at	  control	  conditions,	  marked	  by	  the	  dotted	  gray	  line	  with	  
the	  APs	   at	   t5),	  where	   the	   shallower	  upstroke	  merges	  with	   a	  dissolved	  notch	   followed	  by	  a	  higher	  
plateau	   and	   extended	   repolarization.	   Importantly,	   NaV1.5	   blocking	   appears	   to	   affect	   all	   APs	  
symmetrically,	   in	  such	  a	  way	  that	  the	  map	  maintains	  its	  circular	  distribution	  of	  APD50	  and	  the	  APs	  
(on	  the	  left)	  remain	  superimposable.	  At	  t10,	  the	  map	  and	  APs	  configurations	  show	  no	  evidence	  of	  a	  
bistability	   or	   a	   symmetry	   breaking	   pattern	   despite	   continuous	   prolongation	   of	   the	   APs.	   This	  
observation	  was	  consistent	  throughout	  all	  mdx	  experiments	  (n=7).	  As	  an	  illustration,	  the	  histograms	  
extracted	  from	  the	  APD50,mdx	  map	  at	  t10	  return	  a	  symmetrical	  distribution	  of	  APD50	  values,	  centered	  
at	   46.1ms	  with	   ΔAPD50,mdx	   =	   25.6ms	   (~95%	   increase	   in	   the	  width	   of	   ΔAPD50,mdx	   compared	   to	   t0).	  
Ostensibly,	  the	  dispersion	  of	  the	  APD50,mdx	  is	  considerably	  smaller	  than	  the	  one	  recorded	  for	  the	  WT	  
dual	   peaks	   distribution	  with	   ΔAPD50,WT	   =	   35.8ms	   at	   t10	   (which	   accounts	   for	   an	   actual	   increase	   of	  
~190%	  in	  the	  WT	  case).	  	  
	  
The	  APs	  presented	  in	  Figure	  29a	  indicate	  that	  the	  splitting	  at	  t10	   is	  not	  a	  global	  effect	  on	  the	  time-­‐
scale	  of	  an	  AP.	  It’s	  rather	  confined	  to	  defined	  phases:	  All	  epicardial	  WT	  APs,	  whether	  abbreviated	  or	  
prolonged,	  share	  similar	  shallow	  upstrokes	  and	  a	  uniform	  increased	  delay	  between	  phase	  0	  and	  2.	  
The	   differential	   responsiveness	   to	   Flecainide	   commenced	   at	   the	   beginning	   of	   phase	   2,	  where	   the	  
dome	  (plateau)	  was	  almost	  completely	   lost	   in	   the	  APs	   that	   retracted.	  One	  may	   therefore	  question	  
the	   degree	   at	   which	   Ca2+	   could	   possibly	   be	   involved	   in	   this	   mechanism,	   tipping	   a	   network	   of	  
epicardial	  cells	  to	  either	  acquire	  a	  prolonged	  or	  a	  protracted	  APD.	  Preceding	  the	  plateau	  phase,	  all	  
APs	   share	   the	   same	   morphological	   properties.	   APD25	   maps	   and	   histograms	   were	   therefore	  
necessary	   to	   confirm	   the	   spatial	   distribution	  of	   the	   values	   and	   their	   corresponding	   statistics.	   The	  
shortened	  APs	  however	  don’t	  perfectly	  overlap	  with	   the	  control	  AP	  at	   later	  stages	  either	   (beyond	  
50%	  repolarization,	  Figure	  29a,	  lower	  right).	  Therefore,	  whether	  the	  APs	  decided	  to	  keep	  a	  dome	  or	  
lose	   it	  with	  Flecainide,	   the	   later	  stages	  of	  repolarization	  remained	  prolonged	  compared	  to	  control	  
conditions.	  This	  being	  said,	  AP	  responsiveness	  at	  25%	  and	  75%	  repolarization	  is	  shown	  in	  Figure	  31	  
(a.	  WT	  and	  b.	  mdx).	  In	  panel	  (a),	  APD25	  (upper,	  right)	  dispersion	  map	  at	  t10	  displays	  a	  homogeneous	  
pattern	  with	  the	  highest	  APD	  at	  the	  pacing	  site,	  a	  similar	  configuration	  to	  the	  control	  conditions	  (t0),	  
however	  with	  more	  extended	  APD25	  values	  in	  all	  directions.	  Histograms	  of	  t0	  and	  t10	  APD25	  maps	  are	  
shown	   in	   Figure	   29a	   (left).	   The	   narrow	   high-­‐peak	   histograms	   at	   t0	   are	   centered	   at	   6.1ms	  with	   a	  
dispersion	  that	  doesn’t	  exceed	  6.2ms.	  With	  Flecainide,	  this	  distribution	  widens	  at	  t10	  to	  incorporate	  
higher	  APD25	   values	   resulting	   in	   a	  median	  of	  10.2ms,	  with	   a	  dispersion	  of	  14.6ms	   (~135%	  wider	  
compared	  to	  t0).	  In	  contrast,	  APD75	  map	  at	  t10	  (Figure	  31a,	  lower	  right)	  imitates	  the	  bimodal	  pattern	  
observed	   for	   APD50,	   possibly	   with	   a	   smaller	   gradient	   between	   the	   high	   and	   low	   values.	   The	  
histograms	  follow	  the	  map	  with	  a	  two-­‐peaks	  pattern	  and	  a	  more	  extended	  dispersion	  (at	  t0,	  median	  
=	  39.7ms,	  ΔAPD75,WT	  =	  13.5ms;	  at	  t10,	  median	  =	  55ms,	  ΔAPD75,WT	  =	  33.1ms,	  i.e.	  an	  overall	  increase	  of	  
~140%	  in	  ΔAPD75,WT).	  	  
	  
The	  mdx	   maps	   in	   Figure	   31b	   show	   a	   homogeneous	   distribution	   of	   APD25	   and	   APD75	   at	   control	  
conditions.	  The	  circular	  pattern	  of	  APDs	  persisted	  in	  both	  maps	  after	  10min	  of	  exposing	  the	  hearts	  
to	  Flecainide,	  with	  no	  emergence	  of	  heterogeneity	  patterns	  at	  either	  level	  of	  repolarization.	  In	  this	  
example,	  the	  values	  displayed	  in	  the	  APD25,mdx	  map	  are	  considerably	  larger	  than	  the	  ones	  of	  the	  WT’s	  
(t10)	  and	  more	  diverse.	  It’s	  expected	  that	  the	  mdx	  histograms	  contain	  higher	  APD25	  values	  (median	  
at	  t10	  =	  18.7ms	  vs.	  WT	  median	  at	  t10	  =	  10.2ms)	  with	  a	  wider	  dispersion	  (at	  t10:	  ΔAPD25,mdx	  =	  25.9ms	  
vs.	  ΔAPD25,WT	  =	  14.6ms).	  Between	  the	  experimental	  groups,	  APD25	  remained	  significantly	  higher	  in	  
the	  mdx	  group	  over	  all	  time	  point	  measurements	  (Figure	  32a,	  where	  longitudinal	  APD25	  values	  are	  
displayed	  in	  bar	  graphs.	  The	  transversal	  values	  reported	  the	  same	  statistical	  findings).	  It’s	  obvious	  
that	   the	   SD	   considerably	   increases	   in	   both	   groups	   (WT,	   N=20	   and	  mdx,	   N=14)	   as	   the	   treatment	  
proceeds.	  	  For	  instance	  at	  t0,	  APD25,WT	  =6.0±0.8ms	  and	  APD25,mdx=9.5±1.9ms	  (p-­‐value<0.0001).	  These	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values	  increase	  to	  17.6±8.5ms	  and	  24.4±8.6ms	  respectively	  at	  t10	  (p-­‐value<0.05).	  The	  effect	  doesn’t	  
reflect	   a	   heterogeneity	   component	  with	   each	  heart	   (as	   for	   the	   SD	  of	   the	  APD50,WT	   at	   t10),	   since	  no	  
symmetry	  breaking	  occurs	  neither	  in	  the	  mdx,	  nor	  in	  the	  WT	  at	  this	  level	  of	  repolarization.	  Instead	  it	  
accounts	  for	  the	  widely	  spread	  values	  within	  each	  of	  the	  WT	  and	  mdx	  groups	  over	  all	  experiments.	  	  
	  
	  
Measuring	  APD25	   in	   the	   context	   of	  NaV1.5	   blocking	   appears	   “labile”	   regardless	   of	   the	   investigated	  
substrate	   (WT	   or	  mdx).	   On	   one	   hand,	   some	   hearts	   responded	   acutely	   to	   Flecainide,	   once	   it	   was	  
introduced	  in	  the	  medium.	  Prolongation	  was	  perceived	  starting	  t1	  or	  t3	  and	  was	  maintained	  across	  
the	   next	   following	   measurements.	   On	   the	   other	   hand,	   some	   hearts	   showed	   a	   more	   conservative	  
prolongation	  of	   their	  APD	  at	  25%	  repolarization,	  compared	  to	   the	  effect	  of	  Flecainide	  observed	  at	  
50%	   or	   75%	   repolarization	   levels.	   These	   hearts	   maintained	   lower	   APD25	   values	   throughout	   the	  
entire	   experimental	   protocol.	   Pooling	   the	   data	   gathered	   over	   all	   experiments	   revealed	   a	   sparse	  



















































Figure	  31.	   APs	   and	   APD25/75	  
dispersion	  maps	   for	  WT	   (a)	  
and	  mdx	   (b)	  hearts	  at	  t0	  and	  
t10	   of	   NaV1.5-­‐blocking.	   a.	  
Symmetry	   breaking	   evident	  
at	   t10	  only	   in	  the	  APD75	  map	  	  
with	   a	   gradient	   ~33ms.	   APs	  
on	   the	   left	   of	   each	   map	  
represent	   the	   4	   sites	   on	   the	  
map	   from	   which	   they	   were	  
evaluated	   (See	   caption	   of	  
Figure	   28).	   At	   t10,	   symmetry	  
breaking	   occurs	   before	   the	  
commencement	   of	   the	   AP	  
plateau.	  Hence	   the	  APD25,WT	   is	  
devoid	  of	  the	  bimodal	  pattern,	  
which	   is	   depicted	   instead	   in	  
the	   APD75,WT	   dispersion	   map.	  
ΔAPD75,WT	  (at	   t10)	  =	  	  33.1ms,	  a	  
value	   ~20ms	   larger	   than	   the	  
one	   at	   t0.	   b.	   APD	  
prolongation	   and	   widening	  
of	   the	   dispersion	   values	   in	  
the	   mdx	   heart	   is	   devoid	   of	  
any	   	   	   heterogeneity	   break-­‐
up	   in	   the	   medium.	   (Upper,	  
right)	   Prolongation	   of	   APD25	  
values	   in	   the	   mdx	   heart	   is	  
evident	   at	   t10,	   associated	  with	  
ΔAPD25,mdx	   =	   25.9ms.	   The	  
dispersion	   in	   APD75,mdx	   values	  
at	   t10	   is	   slightly	   higher	  
(24.8ms)	   than	   the	   calculated	  
one	  at	  t0	  (20.4ms).	  The	  pattern	  
remains	   circular	   and	  
unremarkable	   (lower,	   right).	  
Annotations	   in	   figure:	   Ao	   =	  
Aorta,	   Ap	   =	   Apex,	   R	   =	   Right,	  
L=Left,	  P	  =	  Pacing,	  PE	  =	  Pacing	  
electrode.	   Scale	   bar	   map	   =	  
1mm.	  Scale	  bar	  AP	  =	  20ms.	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It’s	  obvious	  that	  all	  APDs	  (at	  all	  repolarization	  levels,	  here	  in	  terms	  of	  duration,	  not	  dispersion)	  were	  
affected	  by	  Flecainide.	  The	  variability	  of	  APDs	  are	  a	  response	  to	  the	  drug	  was	  however	  not	  identical.	  
Both	   APD50	   and	   APD75	   increased	   with	   the	   drug	   and	   did	   not	   show	   any	   directional	   bias	   in	   either	  
experimental	  group	  (i.e.	   the	   increase	   in	  APD	   in	  one	  direction	   is	   comparable	   to	   the	   increase	   in	   the	  
other	   direction).	   In	   the	  WT,	   APD50,Long	   prolongs	   by	   ~65%	   and	   APD50,Trans	   ~	   60%.	   Almost	   similar	  
values	   were	   picked	   up	   for	   the	  mdx	   with	   an	   increase	   in	   APD50,	   Long	   ~70%	   and	   APD50,Trans	   ~	   69%	  
between	   t0	   and	   t10.	   APD75	   in	   WT	   and	  mdx	   prolonged	   by	   ~40%	   in	   both	   directions.	   Furthermore,	  
APD90	   showed	   an	   analogous	   increase	   in	   the	  WT	   and	  mdx	   of	   ~30%	   in	   either	   direction.	   It	   can	   be	  
inferred	  that	  not	  only	  the	  later	  stages	  of	  repolarization	  are	  less	  affected	  than	  the	  early	  ones,	  but	  also	  
APD	  prolongation	  secondary	  to	  Flecainide	  use	  becomes	  more	  direction-­‐	  and	  substrate-­‐	  independent	  
as	   the	   AP	   approaches	   full	   repolarization.	   APD25	   exhibited	   the	   strongest	   susceptibility	   to	   NaV1.5-­‐
blocking,	  with	   remarkable	   differences	   in	   direction	  within	   the	   same	   group	   and	   among	   the	   groups.	  
The	  WT	   longitudinal	  APD25	  scores	   the	  highest	  relative	  change	  between	   t0	  and	   t10	  with	  an	   increase	  
that	  exceeds	  190%.	  The	  transversal	  APD25	  (WT)	  increases	  by	  ~170%.	  These	  effects	  are	  significantly	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Figure	   32.	   Bar	   graphs	   showing	   the	  
progression	  of	  APD25	  (a)	  and	  APD75	  (b)	  
with	  Flecainide	  in	  both	  WT	  (N=20)	  and	  
mdx	   (N=14).	   Both	   graphs	   contain	   the	  
values	   picked	   along	   the	   longitudinal	  
direction	  only,	  since	   the	   transversal	  ones	  
acquire	   a	   similar	   behavior.	   a.	   APD25	  
remains	  significantly	  higher	  in	  the	  mdx	  
group	  for	  all	  drug	  treatment	  points.	  At	  
t0,	   APD25,WT	   =	   6.0±0.8ms	   vs.	   APD25,mdx	   =	  
9.6±1.9ms.	   These	   values	   increased	   by	  
~190%	   and	   by	   ~155%	   respectively	   to	  
reach	   an	   APD25,WT	   =	   17.6	   ±	   8.5ms	   and	  
APD25,mdx	   =	   24.4	   ±	   8.6ms	   at	   t10.	   The	  
statistical	   differences	   along	   the	  
transversal	  directional	   for	   the	  APD25	  (not	  
shown)	   are	   similar	   to	   the	   ones	   reported	  
here.	  However,	   the	   changes	   in	   the	   values	  
between	   t0	   and	   t10	   are	   not	   comparable	  
(see	   text).	   b.	   A	   transitory	   non-­‐
symmetrical	  rise	   in	  APD75,WT	  occurs	   in	  
the	  early	  minutes	  of	   treatment	  (t3	  and	  
t5).	   Initially,	   the	  WT	  and	  mdx	   don’t	  show	  
any	   difference	   in	   APD75	   (similarly	   as	  
APD50,	   Figure	   30).	   The	   significant	  
difference	   between	   the	   two	   groups	  
appears	   at	   t1	   and	   t3	   where	   the	   APD75,WT	  
appears	   to	   prolong	   faster	   than	   the	  
APD75,mdx.	  This	  sudden	  increase	  in	  the	  WT	  
is	  followed	  by	  an	  upturn	  at	  t5,	  where	  the	  2	  
groups	   seem	   to	   reach	   a	   similar	   steady	  
prolonged	   state	   (at	   t10:	   APD75,WT	   =	  
64.5±6.6ms	   vs.	   APD75,mdx	   =	   64.7±5.3ms);	  
after	   the	   increase	   in	   APD75,WT	   recoils,	  
providing	   enough	   time	   for	   the	  mdx	   heart	  
to	   catch	   up.	   This	   corresponds	   to	   an	  
overall	   increase	   of	   ~40%	   in	  both	   groups	  
(see	   text).	  Annotations	   in	   figure:	   	  #	   (p<	  
0.0001);	  *	  (p<0.05);	  n.s.	  not	  significant.	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reduced	  in	  the	  mdx	  heart	  with	  ~155%	  and	  110%	  prolongation	  in	  APD25	  along	  the	  longitudinal	  and	  
transversal	   directions	   respectively	   (Table	   in	   Figure	   34).	   These	   dominant	   changes	   account	   for	   the	  
continuous	  statistical	  difference	  between	  the	  two	  groups	  notably	  seen	  in	  APD25,	  at	  each	  and	  every	  
time	   point	   of	   the	   treatment.	   Contrastingly,	   APD	   dispersion	   may	   not	   be	   quantitatively	   deduced	  
directly	   from	   the	   APD	   changes	   acquired	   with	   Flecainide;	   even	   though	   the	   SD	   increase	   at	   t10	   for	  
either	   group	   reflects	   a	   degree	   of	   inhomogeneity	   in	   the	   population.	   For	   instance,	   the	   mere	  
observation	   that	  no	  statistically	  significant	  difference	  exists	  between	  WT	  and	  mdx	   at	   t10	   for	  APD50	  
(Figure	  30)	  and	  APD75	  (Figure	  32b)	  does	  not	  eliminate	  the	  possibility	  that	  differences	  in	  dispersion	  
maps	   are	   qualitatively	   and	   quantitatively	   more	   pronounced	   between	   the	   two	   groups	   at	   these	  
repolarization	   levels	   (Figure	   28,	   Figure	   29).	   Indeed,	   the	   symmetry	   breaking	   effect	   arising	   with	  
Flecainide	   at	   t10	   in	   both	   APD50	   and	   APD75	  WT	  maps	   was	   reflected	   with	   a	   widening	   of	   the	  maps’	  
respective	  histograms	  by	  ~190%	   (ΔAPD50,WT)	   and	  ~140%	   (ΔAPD75,WT),	  whereas	   the	  dispersion	   in	  
the	   mdx	   maps	   didn’t	   exceed	   90%	   and	   20%	   for	   ΔAPD50,mdx	   and	   ΔAPD75,mdx	   respectively.	   These	  
numbers	  cannot	  have	  been	  concluded	  from	  APD	  values	  alone.	  
	  
We	  suspect	  from	  the	  previous	  examples	  that	  the	  discrepancy	  detected	  in	  the	  expansion	  of	  APDxx	  and	  
ΔAPDxx	   (xx:	   repolarization	   level,	  25%,	  50%	  or	  75%)	  with	  NaV1.5	  blocking	  could	  be	  present	   in	   the	  
other	  data	   sets,	  which	  necessitated	  analysing	  dispersion	   in	  all	  maps	  as	  a	   separate	  entity	   from	  the	  
APDs.	   Figure	   33	   contains	   bar	   graphs	   where	   APD	   dispersion	   is	   compared	   to	   the	  WT	   (n=10)	   and	  
dystrophic	   substrates	   (n=7)	   at	   different	   repolarization	   levels	   under	   control	   and	   drug	   exposure	  
conditions.	  At	   t0,	  only	  ΔAPD25	   is	  significantly	   larger	   in	   the	  mdx	   group,	  with	  ΔAPD25,WT	  =	  8.4±1.7ms	  
and	   ΔAPD25,mdx	   =	   13.1±4.0ms	   (p-­‐value<0.01).	   Interestingly,	   the	   dispersion	   of	   APD50	   maps	   is	   on	  
average	  larger	  than	  the	  one	  calculated	  for	  the	  mdx,	   though	  the	  difference	  between	  the	  two	  groups	  
isn’t	   significant	   (ΔAPD50,WT=	   28.3±6.8ms;	   ΔAPD50,mdx=24.5±6.4ms;	   p-­‐value=0.15).	   At	   75%	  
repolarization,	  both	  WT	  and	  mdx	  return	  almost	  identical	  values	  for	  their	  respective	  APD	  dispersion	  
with	   ΔAPD75,WT	   =	   26.4±4.9ms	   and	   ΔAPD75,mdx=	   32.2±5.8ms.	   All	   ΔAPDxx	   increase	   at	   t10	   Flecainide,	  
except	  for	  ΔAPD75,mdx	  which	  remains	  almost	  unchanged	  at	  t10	  (ΔAPD75,mdx	  =27.3±3.7ms).	  The	  increase	  
in	  ΔAPD75,WT	  (33.2±5.8ms)	  with	  almost	  no	  concomittant	  change	  in	  the	  mdx	  counterpart	  gave	  rise	  to	  
the	  statitistically	  significant	  difference	  between	  the	  two	  groups	  at	  t10	  (p-­‐value<0.05).	  The	  change	  in	  
Figure	   33.	   Effects	   of	   Flecainide	  
on	   APD	   dispersion	   for	   WT	   and	  
mdx	   at	   25%,	   50%	   and	   75%	   AP	  
repolarization.	  APDxx	  is	  calculated	  
for	   each	   prep	   at	   t0	   and	   t10	   as	   the	  
difference	  between	  the	  95th	  and	  5th	  
percentile	   of	   APDxx	   distribution.	   It	  	  
shows	   a	   significant	   difference	   in	  
dispersion	   for	  APD50	   and	   APD75	   at	  
t10	   as	   a	   result	   of	   symmetry	  
breaking	   that	   widens	   the	   APD	  
distribution	   in	   their	   respective	  
maps.	   The	   disperison	   of	   APD25,mdx,	  
unlike	  later	  repolarization	  levels,	  is	  
significantly	   larger	   than	   the	   WT’s	  	  
at	   t0.	   This	   difference	   dissipates	  
with	   NaV1.5	   blocking	   despite	   a	  
widening	  of	  ~200%	  and	  ~120%	  of	  
ΔAPD25	   for	   the	   WT	   and	   mdx	  
respectively.	   Annotations	   in	  
figure:	   **	   (p-­‐value	   <0.01);	   *	   (p-­‐
value<0.05);	  n.s.	  not	  significant.	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ΔAPD25	  is	  by	  far	  the	  most	  remarkable	  with	  an	  increase	  that	  exceeds	  200%	  in	  the	  WT	  and	  120%	  in	  
the	   mdx	   (at	   t10:	   ΔAPD25,WT	   =25.6±6.6ms;	   ΔAPD25,mdx	   =29.3±7.1ms,	   p-­‐value	   =0.29).	   Ideally,	   the	  
decrease	  in	  upstroke	  velocity	  and	  AP	  amplitude	  secondary	  to	  NaV1.5	  blocking	  anticipiates	  a	  degree	  
of	  encrochement	  on	  APD25,	  due	  to	  the	  temporal	  and	  voltage	  dependence	  of	  the	  succeding	  currrents	  
(Ito,1	  and	  ICa)	  on	  upstroke	  kinetics.	  In	  other	  words,	  if	  Flecainide	  were	  an	  ideal	  NaV1.5-­‐blocker,	  it	  will	  
exert	  its	  influence	  more	  prominently	  on	  the	  early	  phases	  of	  the	  AP,	  rather	  than	  the	  later	  ones.	  This	  
correlation	  is	   further	  delineated	  in	  Figure	  35,	  where	  concurrent	  changes	   in	  AP	  parameters	  (APD25	  
vs.	   (dF/dt)max)	   are	   plotted	   during	   the	   progressive	   development	   of	   NaV1.5	   blocking.	   While	   APD25	  
remains	  significantly	  more	  prolonged	   in	   the	  mdx	  with	  Flecainide	  compared	  to	   the	  WT	  at	  all	   times	  
(Figure	  32a),	  dispersion	  doesn’t	  seem	  to	  exactly	  adopt	  this	  behavior.	  This	  can	  be	  partly	  explained	  by	  
the	  fact	  that	  dispersion	  additionally	  has	  a	  spatial	  component	  that	  surpasses	  the	  local	  effects	  of	  the	  
upstroke,	   in	   consequence	   cannot	   be	   precisely	   predicted	   by	   simply	   monitoring	   changes	   in	   the	  
upstroke,	  as	  it	  might	  be	  the	  case	  for	  APD25	  in	  physiological	  conditions.	  
	  
	  
The	  two-­‐states	  system	  that	  erupts	  in	  the	  WT	  heart	  at	  t10	  manifests	  itself	  by	  the	  significant	  increase	  
in	  ΔAPD50,WT	   (40.9±5.0ms)	  and	  ΔAPD75,WT	   (33.2±5.8ms)	   that	  outruns	  any	  change	  happening	   in	   the	  
mdx	  heart	  (Figure	  33),	  which	   is	  devoid	  of	  symmetry	  breaking	  (ΔAPD50,mdx=	  32.7±6.2ms,	  ΔAPD75,mdx	  
=27.3±3.7ms).	  The	  widening	  of	  histograms’	  base	  in	  the	  corresponding	  WT	  APD50	  and	  APD75	  maps	  is	  
a	   result	   of	   rather	   than	   a	   trigger	   for	   this	   bistable	   state.	   The	   assumption	   behind	   this	   lies	   in	   the	  
observation	  that	  the	  acquired	  high	  spatial	  gradient	  between	  the	  two	  adjacent	  zones	  of	  the	  WT	  heart	  
after	  10min	  exposure	  to	  Flecainide	  has	  only	  become	  more	  obvious	  at	   later	  phases	  of	  the	  AP	  (i.e.	  at	  
50%	  and	  75%	  repolarization).	  At	  these	  levels,	  Flecainide,	  being	  an	  open	  state	  channel	  blocker,	  has	  
actually	  little	  -­‐if	  any-­‐	  effect	  on	  NaV1.5	  channels561,	  562.	  We	  believe	  that	  if	  the	  mechanistic	  trigger	  for	  
this	  bistability	  is	  a	  NaV1.5-­‐dependent	  phenomenon	  (i.e.	  an	  aftermath	  of	  NaV1.5	  inhibition),	  it	  shall	  lie	  
most	   probably	   somewhere	   in	   the	   earlier	   phases	   of	   the	   AP,	   within	   a	   time	   interval	   limited	   to	   the	  
maximum	  upstroke	   velocity	   on	   one	   side	   and	   the	   genesis	   of	   plateau	  phase	   on	   the	   other	   side.	   This	  
time	  interval	  is	  wrapped	  within	  APD25.	  	  
	  
To	  elucidate	  how	  the	  different	  phases	  of	   the	  epicardial	  AP	  could	   influence	  one	  another	  during	  the	  
gradual	   development	   of	   NaV1.5	   blocking,	   we	   examined	   the	   correlation	   between	   the	   decrease	   in	  
maximum	   upstroke	   velocities	   (dF/dt)max	   and	   the	   concomitant	   changes	   in	   APD25	   as	   Flecainide	  
proceeded.	   The	   values	   in	   Figure	   35	   were	   obtained	   from	   APs	   at	   4	   different	   locations	   on	   the	   LV	  
epicardium	   (2	   along	   the	   longitudinal	   axis	   of	   propagation	   and	   2	   others	   along	   the	   transversal,	   as	  
previously	   described)	   for	   WT	   (N=20)	   and	   mdx	   (N=14).	   Figure	   35a	   shows	   that	   under	   control	  
conditions,	  the	  relationship	  between	  APD25	  and	  (dF/dt)max	  is	  not	  linear.	  The	  clustering	  of	  the	  points	  
is	  well	   delineated	  within	   each	   group,	   indicating	   a	   specific	   influence	   of	   the	   upstroke	   velocities	   on	  
determining	   APD25,	   although	   this	   influence	   isn’t	   quantitatively	   explicit.	   However,	   for	   fast	   enough	  
upstrokes,	  the	  times	  scales	  of	  the	  processes	  occurring	  afterwards	  are	  so	  small	  that	  APD25	  is	  brief.	  It’s	  
also	   tempting	   to	   speculate	   that	   for	   faster	   upstroke	   velocities	   APD25	   will	   become	   tangential	   to	   a	  
minimum,	  beyond	  which	  no	  further	  dependence	  on	  the	  upstroke	  can	  be	  assessed.	  Since	  the	  number	  















Figure	   34.	   Table	   summarizing	   the	   percentage	   increase	   in	  
APD25	   between	   t0	   and	   t10	   with	   Flecainide,	   along	   with	   the	  
corresponding	   increase	   in	   dispersion.	   The	   mdx	   heart	   with	  
lower	   NaV1.5	   shows	   a	   more	   restrained	   increase	   in	   its	   APD	  
parameters	   compared	   to	   its	  WT	   counterpart.	  More	   importantly,	  
the	   increase	   in	   dispersion	   in	   the	   WT	   heart	   exceeds	   the	  
prolongation	  of	  the	  APD	  in	  either	  direction,	  whereas	  in	  the	  mdx,	  it	  
doesn’t.	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opening	  probability	  of	  these	  channels	  once	  threshold	  is	  reached.	  This	  returns	  a	  finite	  value	  for	  the	  
fast	   inward	   INa	   and	   upstroke	   velocity	   measured	   at	   the	   level	   of	   the	   cell.	   Although	   the	   increase	   in	  
membrane	   voltage	   (Vmbr)	   activates	   L-­‐type	   Ca2+	   channels	   during	   the	   upstroke563,	   ICa,L	   does	   not	  
contribute	  substantially	  to	  the	  rising	  phase	  of	  the	  AP	  (partly	  due	  to	  much	  slower	  kinetics	  of	  the	  Ca2+-­‐
channels	  compared	  to	  NaV1.5)74.	  Ito,1	  with	  its	  outward	  rectification	  properties	  has	  voltage-­‐	  and	  time-­‐
dependencies	  on	  the	  preceding	  upstroke	  amplitude	  and	  velocity.	  The	  time	  scales	  of	  these	  processes	  
are	  also	  finite	  and	  can	  be	  modulated	  by	  the	  same	  factors	  that	  modify	  the	  upstroke’s	  properties.	  In	  a	  
virtual	   cell,	   where	   all	   NaV1.5	   channels	   open	   simultaneously	   (when	   Vmbr>Vthr),	   APD25	   would	   still	  
acquire	   a	   finite	   value	   not	   lower	   than	   the	   time	   scales	   needed	   for	   Ito,1	   and	   ICa	   activation	   (middle	  
processes	   in	   action).	   Following	   this	   line	   of	   thought,	   the	   blue	   squares	   appear	   as	   if	   forming	   a	   line	  
parallel	  to	  the	  x-­‐axis,	  where	  further	  increments	  in	  (dF/dt)max	  only	  shorten	  APD25	  by	  a	  value	  limited	  
to	  measurement	  error	  (0.5ms).	  	  
Figure	   35.	   Plots	   illustrating	   the	  
correlation	   between	   concurrent	   changes	  
in	   APD25	   and	   (dF/dt)max	   during	   the	  
gradual	   development	   of	   NaV1.5	   blocking.	  
a.	   At	   t0,	   the	   points	   within	   each	   group	  
cluster	   in	   a	   well-­‐demarcated	   fashion.	  
Points	   with	   high	   (dF/dt)max	   correspond	   	   to	  
shorter	   APD25.	   As	   the	   upstroke	   velocity	  
decreases,	   APD25	   progressively	   increases.	   b.	  
At	   t5,	   all	   points	   shift	   to	   the	   left	   and	  
upward,	  indicating	  a	  continuously	  increasing	  
APD25	  with	  lower	  (dF/dt)max.	  The	  capacity	  of	  
(dF/dt)max	   to	   influence	   APD25	   values	   is	   still	  
consistent	  and	  not	  completely	  lost	  until	  5min	  
later	   (c)	  where	   the	   intermingled	  data	  points	  
in	   different	   patterns	   illustrate	   a	   pronounced	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As	  the	  values	  of	  (dF/dt)max	  are	  lower	  along	  the	  transversal	  direction,	  APD25	  increases	  slightly	  with	  a	  
maximal	   deviation	   of	   3ms	   compared	   to	   the	   ones	   measured	   in	   the	   direction	   perpendicular	   to	   it	  
(mean	  values	  at	  t0:	  APD25,WT	  (Long)	  =	  6.0±0.8ms	  	  and	  APD25,WT	  (Trans)	  =	  7.5±1.5ms).	  Loss	  of	  NaV1.5	  
in	  the	  mdx	   leads	  to	  a	  global	  slowing	  of	  the	  upstroke	  velocities	  that	  seemingly	  associate	  with	  larger	  
APD25	  values.	   In	  Figure	  35a,	   red/pink	  symbols	  occupy	  the	   left	  side	  and	  upward.	  The	   thin	  blue	   tail	  
relates	  well	  with	  the	  fact	  that	  SD	  in	  APD25,WT	  is	  smaller	  than	  the	  one	  observed	  in	  the	  mdx	   in	  either	  
direction	  (mean	  values	  at	  t0:	  APD25,mdx	  (Long)	  =	  9.6±1.9ms	  	  and	  APD25,mdx	  (Trans)	  =	  12.2±2.4ms).	  The	  
latter	  translates	  into	  a	  wider	  distribution	  of	  the	  red/pink	  symbols	  on	  the	  left	  side	  of	  the	  plot.	  With	  
Flecainide	  exposure,	  all	  points	  move	  further	  to	  the	  left	  and	  spread	  over	  a	  wider	  area	  (Figure	  35b).	  
This	  is	  consistent	  with	  a	  decrease	  in	  (dF/dt)max	  in	  all	  preps	  and	  corresponds	  to	  a	  global	  prolongation	  
in	  APD25	   associated	  with	   an	   increase	   in	   SD	  within	   each	   group.	  As	   (dF/dt)max	   becomes	  weaker,	   its	  
capacity	   to	   regulate	   APD25	   is	   also	   impaired	   and	   the	   time	   scales	   of	   the	  middle	   processes	   become	  
progressively	  more	  important.	  At	  t10,	  as	  the	  rising	  part	  of	  AP	  takes	  considerably	  more	  time	  to	  reach	  
its	   peak,	   (dF/dt)max	   modulation	   of	   APD25	   is	   almost	   lacking	   and	   the	   middle	   processes	   take	   over	  
(Figure	  35c).	  As	   the	  points	   from	  all	  groups	   intermingle	   in	  disorganized	  patterns,	  a	  direct	  coupling	  
between	  APD25	  and	  (dF/dt)max	  becomes	  ambiguous	  and	  doubtful.	  As	  illustrated	  previously	  in	  Figure	  
26,	   Flecainide	   gradually	   diminishes	   the	   extent	   to	  which	   the	   upstroke	   velocity	   could	  modulate	   CV	  
until	  t10,	  where	  local	  heterogeneity	  in	  the	  medium	  breaks	  out	  decoupling	  (dF/dt)max	  and	  CV	  almost	  
entirely.	  
	  
3.3. Expatiated Pathophysiological Heterogeneity in ΔKPQ 
Among	   the	   different	   pathologies	   classified	   under	   LQTS	   is	   a	   subgroup	   of	   genetic	   defects	   that	   are	  
linked	  to	  mutations	  in	  NaV1.5392	  (LQTS3).	  One	  of	  the	  most	  severe	  defects	  so	  far	  studied	  is	  a	  deletion	  
mutation	   of	   nine	   bases	   that	   code	   for	   Lysine-­‐1505,	   Proline-­‐1506	   and	   Glutamine-­‐1507	   in	   the	  
intracellular	   linker	   between	  DIII	   and	  DIV	  of	  NaV1.5	  α-­‐subunit	   (SCN5a-­‐ΔKPQ)393,	   395,	   396.	  One	   of	   the	  
widely	   accepted	   arrhythmia-­‐facilitating	   mechanisms	   in	   LQTS3	   is	   failure	   of	   NaV1.5	   to	   inactivate	  
properly,	   hence	   it’s	   a	   gain-­‐of-­‐function	   mutation.	   Could	   AADs	   that	   target	   INa,f	   have	   a	   potential	  
therapeutic	   effect	   through	   indirect	   modulation	   of	   INa,p,	   possibly	   decreasing	   the	   propensity	   for	  
arrhythmia	  in	  LQTS3?	  Foremost,	  the	  existing	  NaV1.5	  blockers	  remain	  up-­‐to-­‐date	  non-­‐ideal	  and	  their	  
proarrhythmic	   side	   effects	   have	   overshadowed	   their	   therapeutic	   potentials	   in	   many	  
circumstances36,	  474.	  Therefore	  it	  would	  be	  legitimate	  to	  assume	  that	  the	  outcome	  of	  pharmacological	  
interventions	  with	  mutated	  channels	  would	  be	  fairly	  unpredictable.	  
	  
Interactions	   of	   NaV1.5	   with	   pharmacological	   molecules	   could	   be	   dramatically	   altered,	   whether	  
mutations	   involve	  parts	   of	   the	   channel	   proximal349	   or	   distant	   from	   the	   receptor	   site564.	   The	   ever-­‐
increasing	  complexity	  of	  the	  relationship	  between	  NaV1.5	  genetic	  mutations	  and	  clinical	  phenotypes	  
muddles	   the	  ability	   to	  predict	  whether	  defective	  channels	  could	  behave	  similarly	   to	   the	  wild	   type	  
ones	  in	  the	  presence	  of	  blocking	  agents,	  inevitably	  when	  mutations	  alter	  the	  time	  a	  channel	  resides	  
in	  a	  particular	  conformational	  state385.	  In	  this	  regard,	  NaV1.5	  blockade	  with	  Flecainide	  in	  the	  context	  
of	  mutated	  channels	  remains	  highly	  controversial420,	  565,	  566.	  Some	  studies	  reveal	  that	  Flecainide	  has	  
possible	   therapeutic	   prospects	   in	   the	  management	   of	   arrhythmia	   in	   LQTS3	   patients,	   since	   it	  was	  
shown	  to	  normalize	  the	  QT-­‐interval	  on	  ECG567-­‐569.	  In	  other	  cases,	  Flecainide	  was	  reported	  to	  induce	  
Brugada-­‐like	   signs	   (ST	   segment	   elevation)	   in	   LQTS3	  patients,	   henceforth	   increasing	   their	   risk	   for	  
SCD570.	   In	   Brugada	   Syndrome	   (BS),	   the	   use	   of	   Flecainide	   is	   recommended	   as	   a	   diagnostic	   tool	   to	  
unmask	  asymptomatic	  probands,	   since	   the	  drug	  evokes	  ST-­‐elevation	  on	  ECG	  with	  high	   sensitivity	  
and	  specificity416,	  566.	  
	  
Recent	  experimental	  findings	  have	  revealed	  preferential	  blockade	  by	  Flecainide	  of	  INa,p	  in	  the	  ΔKPQ	  
model565.	  It	  was	  found	  that	  Flecainide	  has	  a	  more	  potent	  interaction	  with	  the	  carboxylic	  terminal	  of	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the	   mutated	   channel	   than	   with	   the	   WT	   counterpart,	   leading	   to	   the	   correction	   of	   the	   disease	  
phenotype398,	  566.	  The	  precise	  mechanism	  for	  this	  preferential	  block	  in	  the	  mutated	  channel	  remains	  
unclear,	  hence	  a	  subject	  for	  speculations.	  The	  authors	  suggested	  a	  shift	  of	  NaV1.5	  availability	  in	  the	  
hyperpolarizing	  direction	  might	  have	  enhanced	  Flecainide	  block	   in	   this	   substrate566.	  On	   the	  other	  
hand,	   Flecainide,	   being	   an	   open	   state	   blocker561	   of	   the	   WT	   channel,	   can	   become	   trapped	   during	  
repolarization,	  i.e.	  closure	  of	  the	  activation	  gate	  may	  trap	  the	  drug	  molecule	  within	  the	  channel	  by	  
blocking	  the	  exit	  pathway,	   independently	  of	  inactivation	  properties454.	  Hyperpolarization	  has	  been	  
shown	   to	   slow	   down	   recovery	   from	   block	   in	   case	   of	   trapping,	   consequently	   leading	   to	   an	  
enhancement	   of	   Flecainide’s	   blocking	   effects571.	   Therefore,	   the	   effect	   of	   the	   mutation	   on	   the	  
channel’s	  interaction	  with	  the	  drug	  molecule	  is	  yet	  to	  be	  clarified.	  
	  
In	  the	  next	  set	  of	  experiments,	  ΔKPQ	  murine	  hearts	  were	  subjected	  to	  the	  same	  treatment	  protocol	  
that	  was	  followed	  for	  the	  WT	  and	  mdx	  heart	  (section	  3.2).	  Over	  a	  period	  of	  5min,	  the	  mutated	  hearts	  
(n=4)	   and	   their	   WT	   counterparts	   (n=4)	   were	   perfused	   with	   Flecainide	   [1μM].	   The	   same	  
experimental	   conditions	   used	   previously	  were	   reproduced	   in	   the	   treatment	   of	   ΔKPQ	   hearts.	   The	  
exposure	   to	   the	   drug	   was	   limited	   to	   5min	   only	   (half	   the	   exposure	   time	   in	   the	   previous	   sets	   of	  
experiments),	   due	   to	   difficulty	   in	   entraining	   the	  mutated	   hearts	   into	   a	   10Hz	   steady	   state	   pacing	  
beyond	   5min.	   From	   the	   previous	   experiments,	   the	   increased	   sensitivity	   of	   the	   WT	   group	   to	  
Flecainide	   compared	   to	   a	   substrate	   with	   lower	   availability	   of	   NaV1.5	   was	   a	   major	   finding.	   This	  
sensitivity	   was	   translated	   into	   a	   symmetry	   breaking	   effect	   that	   lead	   to	   the	   coexistence	   of	   two	  
adjacent	  stable	  zones	  entrained	  by	  the	  same	  frequency.	  As	  the	  outcomes	  of	  Flecainide	  exposure	  are	  
yet	   to	   be	   clarified,	   activation,	   functional	   heterogeneity	   profile	   and	   drug	   proarrhythmia	   are	  
investigated	  next,	  since	  a	  NaV1.5	  blocker	  might	  turn	  to	  be	  completely	  ineffective	  or	  overly	  effective	  in	  
interacting	  with	  the	  mutant	  channel.	  	  
3.3.1. Atypical Activation Spread in ΔKPQ with Flecainide 
The	  ΔKPQ	  mutation	  destabilizes	  inactivation,	  as	  previously	  explained.	  Wang	  et	  al.	  measured	  INa	  from	  
a	   whole	   cell	   voltage	   clamp	   using	   ΔKPQ	  mutated	   cardiac	   cells	   and	   reported	   that	   the	   steady	   state	  
activation	  curve	  was	  slightly	  (~6mV)	  shifted	  towards	  depolarizing	  voltages	  compared	  to	  the	  WT395.	  
In	   addition,	   the	   fractional	   amplitude	   of	   the	   fast	   component	   of	   the	   INa,f	  was	   actually	   greater	   in	   the	  
ΔKPQ	  cells	  than	  the	  WT.	  The	  recovery	  from	  inactivation	  kinetics	  was	  also	  considerably	  faster	  for	  the	  
mutated	   cells:	   in	   the	   WT	   the	   largest	   fraction	   (77%)	   of	   channels	   seem	   to	   have	   recovered	   from	  
inactivation	  with	  a	  time	  constant	  of	  τWT	  =6.7ms	  vs.	  59%	  in	  ΔKPQ	  at	  τΔKPQ	  =2.1ms395.	  Based	  on	  these	  
cellular	   results,	   and	   assuming	   that	   the	   resting	   membrane	   potential	   (Vrmp)	   in	   both	   substrates	   is	  
unaltered,	  we	  do	  not	  expect	  the	  maximum	  upstroke	  velocity	  (dF/dt)max	  to	  be	  modified	  in	  ΔKPQ.	  As	  
we	   have	   seen	   in	   the	   previous	   WT	   and	  mdx	   study,	   (dF/dt)max	   may	   represent	   an	   index	   of	   NaV1.5	  
availability	  in	  some	  conditions,	  however	  may	  not	  necessarily	  give	  an	  accurate	  prediction	  of	  the	  CV	  
in	  the	  medium.	  
	  
In	   Figure	   36a,	   the	   optical	  APs	   (OAP)	  were	  measured	   from	   the	   LV	   free	  wall	   of	   the	  WT	   and	  ΔKPQ.	  
Prior	  to	  normalization,	  the	  OAPs	  were	  compared	  for	  amplitude	  and	  FC%	  (as	  previously	  described).	  
The	  APΔKPQ	  is	  superimposed	  over	  the	  dotted	  WT	  representation	  (same	  as	  the	  APWT,	  left)	  for	  a	  direct	  
comparison.	  On	   the	  right,	   the	  slightly	  shallower	  upstroke	   is	   followed	  by	  a	  hampered	  notch,	  which	  
precedes	   a	   plateau	   phase	   at	  more	   positive	   voltages.	   Unlike	   the	   APmdx	   (Figure	   19,	   left),	  where	   the	  
early	  prolongation	  phases	  are	  compensated	  with	  strong	  enough	  repolarization	  currents	   leading	  to	  
an	   almost	   normal	   termination	   of	   the	   AP,	   the	   APΔKPQ	   is	   characterized	   by	   a	   continuous	   non-­‐
compensated	   prolongation	   and	   a	   considerably	   delayed	   repolarization.	   In	   that	   regard,	   the	   APΔKPQ	  
appears	  comprehensively	  prolonged	  compared	  to	  the	  APWT	  in	  all	  phases	  (Figure	  36a,	  right).	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Assigning	   activation	   times	   to	   all	   pixels	   gives	   rise	   to	   the	   activation	  maps	   in	   Figure	   36b	   and	   c.	   At	  
control	  conditions	  (t0),	  both	  WT	  and	  ΔKPQ	  propagation	  patterns	  spread	  anisotropically	  from	  the	  tip	  
of	   the	   pacing	   electrode	   to	   boundaries	  within	   almost	   the	   same	   allotted	   time,	   although	   isochrones	  
along	  the	  transversal	  direction	  appear	  imperceptibly	  more	  compacted	  than	  in	  the	  WT	  map.	  Indeed	  
from	   the	   activation	  maps	   in	   this	   example	   at	   t0,	   conduction	   was	   evaluated	   along	   the	   longitudinal	  
direction	   where	   Vmax,WT	   =	   0.74±0.03m.s-­‐1	   vs.	   Vmax,ΔKPQ	   =	   0.69±0.08m.s-­‐1	   and	   along	   the	   transversal	  













































Figure	   36.	   Changes	   in	   AP	   and	  
activation	   maps	   changes	   with	  
NaV1.5	   mutation	   and	   exposure	  
to	   Flecainide	   [1μM].	   a.	  
Morphological	   changes	   due	   to	  
AP	   prolongation	   detected	  
optically	   in	   the	   ΔKPQ	   heart	  
(BCL=100ms).	   As	   the	   APΔKPQ	   is	  
superimposed	   over	   the	   dotted	  
APWT,	  the	  upstroke	  of	  the	  mutated	  
AP	   appears	   shallower.	   The	  
cascade	  of	  ionic	  events	  promotes	  a	  
more	   flattened	   notch,	   a	   higher	  
plateau	  phase	  and	  prolongation	  of	  
the	   APΔKPQ	   in	   all	   phases	   until	  
repolarization	   is	   terminated.	  
Scale	   bar	   =	   20ms.	   ΔF/F	   =	  
fractional	   change	   of	   the	  
fluorescent	   signal.	   b.	   Activation	  
maps	   at	   control	   conditions.	  
From	   a	   point	   stimulation	   P,	   the	  
electrical	   wave	   anisotropically	  
propagates	  across	  the	  LV	  free	  wall	  
to	   the	   boundaries.	   Latency	   in	  
propagation	   and	   compaction	   of	  
isochronal	   lines	   in	   the	  ΔKPQ	  map	  
indicate	   a	   decrease	   in	   CV	   under	  
control	   (t0)	   conditions.	   c.	  
Activation	  maps	   at	   5min	   (t5)	   of	  
Flecainide	   exposure.	   While	  
activation	  spread	   in	   the	  WT	  heart	  
remains	   anisotropic,	   the	   mutated	  
heart	   adopts	   an	   atypical	  
propagation.	  As	  the	  position	  of	  the	  
electrode	   remains	   unaltered,	   the	  
wave	   emanating	   from	   the	   point	  
stimulation	   shifts	   to	   the	   left	   and	  
spreads	   quasi-­‐elliptically.	   The	  
wave	  fronts	   in	   the	  red	  area	   travel	  
faster	   than	   the	   ones	   in	   the	  
direction	   of	   the	   apex,	   where	  
severe	   conduction	   slowing	  
prevails.	   Annotations	   in	   figure:	  	  
Scale	   bar=1mm,	   Ao=Aorta,	  
Ap=Apex,	   L=Left,	   R=Right,	  
P=Pacing.	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After	   5min	   exposure	   to	   Flecainide	   (t5),	   qualitative	   differences	   between	   the	   two	   maps	   reveal	   an	  
atypical	   pattern	   of	   activation	   in	   the	   mutated	   heart.	   Meanwhile,	   the	   WT	   map	   maintains	   a	   global	  
anisotropic	  propagation	  with	  slower	  components	  compared	  to	  t0	  (at	  t5:	  Vmax,WT	  =	  0.62±0.05m.s-­‐1	  and	  
Vmin,WT	  =	  0.21±0.03m.s-­‐1).	  As	  the	  position	  of	  the	  pacing	  electrode	  remains	  unchanged	  (Figure	  45),	  the	  
wave	  clearly	  emanates	  from	  the	  tip	  of	  the	  electrode	  where	  the	  pacing	  current	  is	  introduced	  into	  the	  
tissue.	  However	  it	  acquires	  a	  preferential	  shift	  towards	  the	  base	  where	  conduction	  is	  clearly	  faster	  
(the	  first	  isochrone	  is	  located	  towards	  the	  aortic	  side),	  maintains	  an	  elliptical	  shape	  until	  the	  convex	  
ends	  along	  the	  major	  axis	  of	  the	  ellipses	  reach	  the	  right	  and	  left	  boundaries	  of	  the	  heart	  (within	  the	  
red	  colored	  area	  of	   the	  map),	   then	   resumes	  propagation	   towards	   the	  apex	   in	  quasi-­‐planar	  waves.	  
From	  the	  movie	  of	  the	  measurement	  (Figure	  44	  and	  Figure	  45),	  an	  artifact	  due	  to	  electrode	  position	  
change	  was	  ruled	  out.	  This	  pattern	  appears	  to	  be	  generic	  for	  all	  ΔKPQ	  preps	  treated	  with	  Flecainide	  
at	  t5	  (n=4)	  in	  this	  study.	  The	  cause	  of	  such	  activation	  is	  unknown.	  Hence,	  it’s	  tempting	  to	  speculate	  
that	   the	   mechanism	   behind	   the	   deviation	   from	   global	   anisotropy	   (to	   partial	   anisotropy)	   could	  
possibly	  be	  due	  to	  a	  source-­‐sink	  mismatch.	  A	  point	  stimulation,	  unlike	  a	  line	  stimulation,	  creates	  an	  
elliptical	  pattern	  of	  activation	  founded	  on	  fiber	  orientation;	  principally	  due	  to	  “facilitation”	  of	  spread	  
in	   the	   direction	   parallel	   to	   the	   fiber’s	   long	   axis	   and	   increased	   “discontinuities”	   in	   the	   direction	  
perpendicular	   to	   it254.	   In	   addition,	   planar	  waves	   have	   the	   propensity	   to	   travel	   faster	   than	   convex	  
ones572,	   due	   to	   more	   efficient	   distribution	   of	   depolarizing	   charges	   as	   the	   wave	   front	   crosses	   the	  
medium573.	   	   Since	   the	   depolarizing	   current	   was	   introduced	   into	   the	   epicardium	   from	   a	   point	  
stimulation,	   it	  will	   give	   rise	   to	  ellipses	  with	   convex	  wave	   fronts.	  For	  unknown	  reasons,	   the	  upper	  
half	   (from	  LV	   free	  wall	   center	   to	  base)	   of	   the	  heart	   appears	   to	   facilitate	   conduction	   and	  becomes	  
fully	  activated	  within	  15ms	  of	  pulse	  induction	  (Vmax,ΔKPQ=0.44±0.04m.s-­‐1).	  The	  remaining	  half	  (center	  
to	  the	  apex)	  requires	  an	  additional	  15ms	  to	  fully	  activate	  (Vmin,ΔKPQ=0.11±0.02m.s-­‐1).	  In	  consequence,	  
even	  if	  conduction	  block	  is	  not	  yet	  present	  here,	  double	  this	  time	  was	  still	  needed	  to	  reach	  the	  apex.	  
As	   the	   elliptical	   activation	   terminates	   in	   the	   upper	   half	   of	   the	   heart,	   a	   quasi-­‐planar	  wave	   front	   is	  
formed,	  more	  capable	  of	  surpassing	  the	  electrical	  load	  across	  the	  remaining	  epicardium	  to	  the	  apex	  
than	  the	  originally	  expected	  convex	  wave.	  
	  
The	   difference	   in	   CV	   between	   the	   two	   groups	   as	   Flecainice	   proceeds	   is	   shown	   in	   Figure	   37.	   Bar	  
graphs	  for	  Vmax	  (N=8,	  per	  group)	  and	  Vmin	  (N=8,	  per	  group)	  indicate	  a	  decrease	  in	  velocities	  in	  both	  
substrates	  with	  an	  overall	   change	   (between	   t0	   and	   t5)	  of	  32%	  and	  26%	   in	  Vmax	   for	  WT	  and	  ΔKPQ	  
respectively;	  40%	  and	  39%	  in	  Vmin	  for	  WT	  and	  ΔKPQ	  respectively.	  It’s	  noteworthy	  to	  emphasize	  that	  
at	   this	   time	  point	  of	   the	  current	  protocol,	   the	  values	  reached	   in	   the	  WT	  group	  are	  consistent	  with	  
what	   was	   reported	   in	   the	   previous	   section	   for	   the	   control	   group	   of	   the	  mdx	   (during	   the	   10min	  
protocol),	  where	  at	   t5,	  Vmax,WT	   	  and	  Vmin,WT	  decreased	  by	  33%	  and	  39%	  respectively	  (Figure	  22).	  At	  
control	  conditions,	  the	  velocities	  recorded	  for	  the	  ΔKPQ	  substrate	  are	  globally	  15-­‐18%	  lower	  than	  
the	  ones	  of	  the	  WT.	  The	  difference	  at	  that	  stage	  is	  significant	  between	  the	  two	  groups	  with	  Vmax,WT	  =	  
0.78±0.10m.s-­‐1,	   Vmax,ΔKPQ	   =	   0.66±0.06m.s-­‐1	   (p-­‐value<0.05);	   and	   Vmin,WT	   =	   0.37±0.08m.s-­‐1,	   Vmin,ΔKPQ	   =	  
0.31±0.03m.s-­‐1	   (p-­‐value<0.05).	   As	  NaV1.5	   blocking	   proceeds,	   both	   velocities	   in	   the	   two	   substrates	  
start	   to	   decrease,	   until	   t5	   where	   the	   difference	   in	   velocities	   between	   the	   groups	   vanishes.	   The	  
percentage	  decrease	  Vmax	  is	  slightly	  higher	  for	  the	  WT	  group	  than	  it	  is	  for	  the	  ΔKPQ,	  but	  Vmin	  seems	  
to	  be	  similarly	  affected	   in	  both	  groups	  at	   t5.	   In	   the	  10min	  protocol	  used	   to	  compare	  mdx	   and	  WT,	  
patchy	   high	   velocity	   (or	   supernormal	   conduction)	   zones	   erupt	   at	   t10	   in	   the	   WT	   group	   along	   the	  
longitudinal	  direction.	  In	  the	  current	  results,	  the	  protocol	  was	  stopped	  at	  5min,	  without	  an	  area	  of	  
supernormal	  conduction	  being	  detected	  in	  either	  group.	  	  
	  
In	  Figure	  38,	  (dF/dt)max	  is	  calculated	  at	  each	  pixel	  for	  each	  of	  the	  maps	  presented	  in	  Figure	  36.	  This	  
approach	  is	  necessary	  to	  identify	  how	  NaV1.5	  blocking	  alters	  (dF/dt)max	  in	  the	  ΔKPQ	  substrate	  and	  
whether	  the	  fluctuations	  detected	  in	  CV	  are	  reproducible	  for	  (dF/dt)max	  .	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In	   a	   similar	   fashion	   to	   CV,	   WT	   and	   ΔKPQ	   (dF/dt)max	   dispersion	   maps	   show	   a	   decrease	   in	   all	  
directions	  with	  Flecainide	  (Figure	  38a).	  The	  maps’	  corresponding	  histograms	  are	  shown	  in	  Figure	  
40c.	  In	  the	  leftmost	  panel,	  the	  WT	  upstroke	  velocities	  have	  a	  bimodal	  distribution	  with	  two	  peaks	  at	  
~0.31	  and	  ~0.44	  ms-­‐1,	  suggestive	  of	  the	  presence	  of	  longitudinal	  and	  transversal	  clusters.	  The	  ΔKPQ	  
map	   also	   shows	   a	   semi-­‐bimodal	   configuration	   at	   control	   conditions,	   with	   the	   majority	   of	   values	  
lingering	  in	  the	  lower	  range	  compared	  to	  WT	  peaking	  at	  ~0.28ms-­‐1	  and	  a	  tail	  of	  higher	  values	  in	  the	  
vicinity	   of	   0.36ms-­‐1.	  With	   Flecainide	   (at	   t5),	   histograms	   shift	   to	   the	   left	   indicating	   lower	   range	   of	  
values	  in	  the	  two	  substrates:	  the	  WT	  maintains	  the	  bimodal	  distribution	  with	  the	  highest	  frequency	  
around	  0.24ms-­‐1	  and	  a	  smaller	  peak	  towards	  0.35ms-­‐1;	  whereas	  the	  ΔKPQ	  histograms	  concentrate	  to	  
the	  left	  with	  a	  high	  peak	  around	  0.1ms-­‐1	  and	  another	  smaller	  one	  around	  0.16ms-­‐1.	  	  
	  
On	   average,	   the	   shallower	  upstrokes	   in	   the	  mutated	   substrate	   (upstroke	  =	  0.43±0.03	   a.u.ms-­‐1)	   do	  
not	  reveal	  a	  significant	  difference	  to	  their	  WT	  counterpart	  at	  t0	  (0.47±0.10	  a.u.ms-­‐1)	  with	  p-­‐value	  =	  
0.34	  (Figure	  38b).	  The	  sharper	  decrease	  in	  the	  ΔKPQ	  heart	  with	  Flecainide	  alters	  this	  difference	  in	  
favor	   of	   considerably	   larger	   values	   in	   the	  WT	   with	   ~71%	   decrease	   in	   ΔKPQ	   in	   the	   longitudinal	  
direction	  (WT:	  0.31±0.08	  a.u.ms-­‐1;	  ΔKPQ:	  0.15±0.04	  a.u.ms-­‐1;	  p-­‐value<0.05),	  and	  ~60%	  decrease	  in	  
ΔKPQ	  in	  the	  transversal	  direction	  (WT:	  0.25±0.08	  a.u.ms-­‐1;	  ΔKPQ:	  0.14±0.04	  a.u.ms-­‐1;	  p-­‐value<0.05).	  
The	  decrease	  in	  the	  WT	  upstrokes,	  unlike	  the	  ΔKPQ	  substrate,	  doesn’t	  show	  directional	  differences,	  
in	  such	  a	  way	  that	   the	  total	  change	   in	  (dF/dt)max	   is	  almost	  similar	   in	  the	   longitudinal	  (~36%)	  and	  
transversal	  (~38%)	  directions.	  
!"
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Figure	   37.	   Bar	   graphs	   of	   Vmax	   and	   Vmin	   for	  
WT	   (N=8)	   and	   ΔKPQ	   (N=8)	   at	   t0	   and	  
different	   time	   points	   of	   Flecainide	   [1μM]	  
perfusion.	   a.	  Decrease	   in	  Vmax	   is	   consistent	  
for	  both	  groups.	  At	  t5,	  a	  maximum	  decrease	  of	  
~32%	   was	   recorded	   in	   the	   WT	   group	   vs.	  
~26%	   in	   the	   ΔKPQ	   (To	   note:	   a	   similar	   value	  
was	   recorded	   in	   the	   previous	   set	   of	  
experiments	   in	   the	  mdx	   control	  group	   (N=22)	  
at	   t5	   with	   a	   decrease	   of	   33%,	   Figure	   22).	  
Despite	   a	   larger	   percentage	   decrease	   in	   the	  
WT,	   both	   groups	   have	   almost	   identical	  
velocities	   at	   t5	   (Vmax,WT	   =	   0.53	   ±	   0.12m.s-­‐1	   ;	  
Vmax,ΔKPQ	  =	  0.49	  ±	  0.11m.s-­‐1).	  The	  initially	  larger	  
velocity	  in	  the	  WT	  group	  at	  t0	  accounts	  for	  the	  
larger	   decline	   (Vmax,WT	   =	   0.78	   ±	   0.10m.s-­‐1,	  
Vmax,ΔKPQ	  =	  0.66	  ±	  0.06m.s-­‐1,	  p-­‐value	  <	  0.05).	  b.	  
A	   gradual	  decrease	   in	  Vmin	  with	  Flecainide.	  
A	   total	   of	   ~41%	   and	   ~39%	   decrease	   in	   Vmin	  
was	   recorded	   for	   WT	   and	   ΔKPQ	   at	   t5	  
respectively.	   Starting	  with	  Vmin,WT	  =	   0.37±0.08	  
m.s-­‐1	   and	   Vmin,ΔKPQ	   =	   0.31	   ±	   0.03m.s-­‐1	   (p-­‐
value<0.05),	   the	   difference	   between	   the	   two	  
groups	   becomes	   statistically	   insignificant	   at	  
5min	   of	   Flecainide	   perfusion	   (Vmin,WT	   =	  
0.22±0.03	  m.s-­‐1	  and	  Vmin,ΔKPQ	  =	  0.19±0.03m.s-­‐1).	  
Annotations	   in	   figure:	   *	   (p-­‐value<0.05),	   n.s.	  
not	  significant.	  	  

























Figure	  38.	  Dispersion	  maps	  showing	  at	  one	  pixel	  resolution	  the	  changes	  in	  (dF/dt)max	  with	  Flecainide	  [1μM]	  in	  WT	  
(N=8)	  and	  ΔKPQ	  (N=8)	  and	   their	  respective	  bar	  graphs.	  a.	  Anisotropic	  (dF/dt)max	  distribution	  with	  a	  consistent	  
decrease	   under	   NaV1.5	   blocking.	   At	   t0,	   higher	   values	   are	   more	   widely	   spread	   in	   the	   WT	   than	   the	   ΔKPQ.	   However	  
(dF/dt)max	   distribution	   remains	   anisotropic.	   At	   t5,	   the	   ΔKPQ	   substrate	   reveals	   an	   area	   of	   higher	   upstroke	   velocities	  
proximal	   to	   the	  base	  and	  towards	   the	   right	   side,	  whereas	   the	   area	   towards	   the	   apex	   indicates	  dramatically	   diminished	  
(dF/dt)max,	   as	   observed	   in	   the	   activation	   map.	   The	   WT	   map	   at	   t5	   reveals	   slower	   upstrokes,	   with	   an	   unremarkable	  
distribution.	  Look-­‐up-­‐table:	  (dF/dt)max	  [0	  0.8].	  Scale	  bar	  =1mm.	  Ao	  =	  Aorta,	  Ap	  =	  Apex,	  R	  =	  Right,	  L	  =Left,	  P	  =	  Pacing,	  PE	  
=	  Pacing	  Electrode.	  (b,c).	  Bar	  graphs	  showing	  the	  gradual	  change	  in	  (dF/dt)max	  in	  longitudinal	  (b)	  and	  transversal	  
(c)	  directions.	  At	  t0,	  the	  shallower	  upstroke	  in	  ΔKPQ	  is	  on	  average	  not	  significantly	  different	  from	  its	  WT	  counterpart.	  The	  
sharper	  decrease	  in	  the	  ΔKPQ	  upstroke	  velocity	  (d)	  in	  both	  directions	  longitudinal	  and	  transversal	  leads	  to	  a	  deviation	  in	  
the	   values	   between	   the	   two	   groups	   at	   t5	   (see	   text).	   d.	   Overall	   decrease	   in	   (dF/dt)max	   between	   t0	   and	   t5	   exceeds	  
70.8±4.8%	  in	  ΔKPQ	  (vs.	  35.8±11.2%	  in	  WT)	  longitudinally	  and	  59.8±7.1%	  	  transversely	  in	  ΔKPQ	  (vs.	  38.1±9.4%	  in	  WT).	  
Annotations	  in	  figure:	  #	  (p-­‐value<0.0001),	  ***	  (p-­‐value<0.001),	  **	  (p-­‐value<0.01),	  *	  (p<0.05),	  n.s.	  not	  significant.	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A	  decrease	  in	  (dF/dt)max	  was	  reported	  for	  the	  WT	  group	  with	  the	  10min	  Flecainide	  protocol	  in	  the	  
previous	   section,	   where	   (dF/dt)max	   maximally	   dropped	   by	   ~52%	   on	   average	   in	   either	   direction	  
(Figure	   27c).	   Meanwhile,	   it’s	   noteworthy	   to	   recall	   that	   the	  mdx	   substrate	   showed	   a	   significantly	  
smaller	  drop	  in	  (dF/dt)max	  at	  t10	  compared	  to	  its	  WT	  counterpart	  particularly	  along	  the	  transverse	  
direction	   (with	   a	   total	   decrease	   of	   ~39%).	   Contrastingly,	   ΔKPQ	   achieves	   a	   significantly	   larger	  
decrease	   in	   (dF/dt)max	   compared	   to	   the	  WT	  group	   (at	   t5),	  which	  could	   indicate	   that	   the	   change	   in	  
upstroke	  velocities	  (including	  the	  transversal	  ones)	  with	  Flecainide	  is	  possibly	  substrate	  dependent.	  
Although,	   both	   CV	   and	   (dF/dt)max	   decreased	   with	   Flecainide	   in	   the	   WT	   and	   ΔKPQ,	   their	  
characteristic	   differences	   do	   not	   match	   at	   control	   conditions,	   and	   their	   response	   to	   Flecainide	  
further	  consolidates	  this	  contrast.	  While	  Vmax	  and	  Vmin	  are	  significantly	  larger	  in	  the	  WT	  group	  at	  t0	  
compared	   to	   ΔKPQ,	   their	   corresponding	   (dF/dt)max	   are	   almost	   similar	   (no	   significant	   difference).	  
Similarly,	  the	  effects	  at	  t5	  are	  reversed:	  the	  velocities	  become	  almost	  comparable	  between	  the	  two	  
groups	   in	   either	   direction,	   whereas	   their	   corresponding	   upstroke	   velocities	   considerably	   differ.	  
Indeed	  in	  these	  two	  groups,	  CV	  and	  (dF/dt)max	  appear	  to	  behave	  characteristically	  different	  with	  or	  
without	  Flecainide.	  	  
3.3.2. Flecainide Exacerbates Intrinsic Heterogeneity in ΔKPQ 
One	  of	  the	  arrhythmogenic	  mechanisms	  proposed	  for	  the	  LQTS	  substrate	  is	  amplification	  of	  the	  SDR,	  
which	  when	  present	  in	  either	  early	  or	  late	  phases	  of	  the	  AP	  can	  lead	  to	  the	  development	  of	  a	  variety	  
of	  arrhythmias403.	  Amplification	  of	  intrinsic	  heterogeneity	  together	  with	  premature	  impulses	  could	  
principally	  underlie	  the	  mechanistic	  trigger	  for	  ventricular	  arrhythmias	  in	  cardiac	  pathologies	  such	  
as	   heart	   failure271	   and	   “torsade	   de	   pointes”	   in	   LQTS3406.	   Gene-­‐specific	   therapy	   includes	   a	   2-­‐hit	  
approach:	   The	   first	   is	   linking	   the	   genetic	  mutation	   to	   the	   ionic	   channel	   dysfunction,	  whereas	   the	  
second	   is	   identifying	   the	   pharmacological	   agents	   that	   can	   modulate	   the	   mutated	   channels	   in	   a	  
differential	  manner281.	  
	  
The	  response	  of	  arrhythmogenic	  LQTS3	  substrate	  to	  AADs	  remains	  the	  subject	  of	  strenuous	  debate.	  
Schwartz	  et	  al.	  and	  others	  reported	  that	  NaV1.5	  blocker	  Mexiletine	  (a	  Class	  IB	  AAD)	  is	  more	  effective	  
in	  shortening	  the	  QT-­‐interval	  in	  LQTS3	  patients	  than	  other	  LQTS	  due	  to	  K+-­‐channel	  mutations282,	  574.	  
Shimizu	  et	  al.	  showed	  that	  a	  K+	  channel	  opening	  agent	  (Nicorandil)	  abbreviated	  the	  QT-­‐interval	  and	  
the	   monophasic	   AP	   duration	   in	   LQTS1	   patients281.	   Shortening	   of	   QT	   interval	   isn’t	   necessarily	  
harmonious	   with	   decreasing	   or	   preventing	   arrhythmia	   risk	   in	   these	   patients281,	   since	   a	   direct	  
validation	  of	  the	  QT	  interval	  as	  a	  measure	  of	  APD	  spatial	  dispersion	  is	  still	  lacking575.	  On	  the	  other	  
hand,	  NaV1.5	  blocking	  agents	  haven’t	  been	  reported	  to	  be	  ineffective	  in	  treating	  LQTS3	  only576,	  but	  
also	  dangerously	  proarrhythmic570,	   sometimes	  despite	   a	  normalized	  QT-­‐interval	  on	  ECG577.	  Hence	  
normalizing	  the	  QT-­‐interval	  is	  not	  necessarily	  congruent	  with	  decreased	  SCD	  risk.	  
	  
We	   show	   in	   the	   following	   results	   that	   exaggerated	   SDR	   is	   predominantly	   observed	   in	   the	   ΔKPQ	  
mouse	   upon	   exposure	   to	   Flecainide	   at	   clinically	   valid	   concentrations,	   which	   could	   make	   it	   a	  
plausible	   mechanism	   in	   increasing	   arrhythmia	   susceptibility	   in	   LQTS3	   patients	   managed	   with	  
NaV1.5	  blockers.	  

























































Figure	  39.	  APs	  and	   APD25	   (a),	   APD50	   (b)	  dispersion	  maps	   for	  WT	   and	   ΔKPQ	  at	   t0	   and	   t5	   of	  NaV1.5	  blocking.	   a.	  
Symmetry	   breaking	   at	   t5	  with	  multiple	   zones	   of	   abbreviated,	   intermediate,	   and	   prolonged	   APs	   across	   the	   LV	  
epicardium	   in	   ΔKPQ.	   APD25,WT	   map	   prolongs	   homogeneously,	   while	   the	   APs	   remain	   superimposable	   after	   5min	   of	  
exposure	   to	   Flecainide.	   The	   initial	   APD25	   configuration	   in	   the	   ΔKPQ	   substrate	   cannot	   be	   considered	   homogeneous	  
(compared	  to	  the	  WT	  map	  above).	  Some	  heterogeneity	  component	  exists	  at	  t0,	  which	  might	  have	  been	  amplified	  in	  the	  
presence	  of	  Flecainide,	  giving	  rise	  to	  the	  multiple	  distinctive	  APD25	  zones	  in	  the	  dispersion	  map.	  b.	  Symmetry	  breaking	  
remains	  identifiable	  for	  APD50	  at	  t5	  in	  the	  ΔKPQ	  epicardium.	  The	  effects	  observed	  for	  APD50	  are	  similar	  to	  the	  ones	  
described	   at	   25%	   repolarization.	   The	   circular	   distribution	   of	  APD50,WT	   is	  maintained	   at	   t5,	   however	   associated	  with	   a	  
homogeneous	  prolongation	  of	  APD	  values.	  The	  pattern	  observed	  at	  t5	  for	  the	  APD50,ΔKPQ	  map	  differs	  from	  the	  APD25,ΔKPQ	  
by	  the	  amplitude	  of	  the	  gradient	  separating	  the	  lower	  and	  upper	  ranges	  of	  APD50,	  which	  is	  limited	  to	  ~20ms,	  as	  shown	  
also	  by	  the	  APs	  on	  the	   left.	  Annotations	  in	  figure:	  Map	  scale	  bar	  =1mm,	  AP	  scale	  bar	  =20ms,	  Ao	  =	  Aorta,	  Ap=Apex,	  
R=Right,	  L=Left,	  PE=	  Pacing	  electrode,	  P=Point	  stimulation.	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In	  Figure	  39,	  APs	  and	  their	  corresponding	  APD	  dispersion	  maps	  (APD25	  (a),	  APD50	  (b))	  for	  WT	  and	  
ΔKPQ	  at	  t0	  and	  t5	  of	  Flecainide	  [1μM]	  are	  shown.	  As	  previously	  described,	  the	  same	  mask	  of	  the	  LV	  
free	  wall	  was	  repeatedly	  used	  for	  the	  same	  prep	  to	  reproduce	  the	  maps	  at	  different	  time	  points	  of	  
exposure	   to	   the	   drug.	   The	  APs	   on	   the	   left	   are	   chosen	   from	   the	   located	   points	   in	   the	  maps	  where	  
white	   dots	   reside	   along	   the	   longitudinal	   direction	  with	   corresponding	   blue	   colored	   APs,	   and	   red	  
dots	   along	   the	   transversal	   direction	   with	   corresponding	   red	   colored	   APs.	   Measurements	   were	  
conducted	  at	  t0,	  t1,	  t3	  and	  t5,	  but	  only	  t0	  and	  t5	  are	  shown	  in	  the	  figure.	  The	  morphological	  changes	  in	  
OAPs	  are	   tracked	  by	  superimposing	  the	  APs	  at	   t5	  over	   their	  control	  AP	  (in	  dotted	   line).	  APWT	  at	   t0	  
perfectly	   overlap,	   and	   their	   corresponding	   APD25	   map	   further	   confirms	   the	   homogeneity	   of	   the	  
cardiac	   tissue	   under	   these	   conditions.	   The	  map’s	   associated	   histograms	   are	   shown	   in	   Figure	   40a	  
(leftmost	   panel).	   The	   unimodal	   distribution	   of	   APD25,WT	   values	   are	   centered	   around	   7.2ms	  with	   a	  
dispersion	  of	  ΔAPD25,WT	  =	  7.9ms.	  The	  average	  dispersion	   in	   the	  WT	  group	   (n=4,	  Figure	  41)	  under	  
control	   conditions	   is	   8.7±1.7ms.	   In	   contrast,	   the	   APD25,ΔKPQ	   map	   (Figure	   39a,	   below	   left)	   shows	  
patchy	  regions	  of	  more	  prolonged	  APs	  across	  the	  LV	  free	  wall	  (lighter	  blue),	  with	  reduced	  APs	  found	  
mainly	  at	  the	  basal	  side.	  The	  distribution	  of	  the	  APD25,ΔKPQ	  values	  is	  centered	  around	  13.5ms,	  has	  a	  
wider	  base	  than	  its	  WT	  counterpart	  with	  ΔAPD25,ΔKPQ	  =	  16.2ms	  (Figure	  40a,	  right).	  In	  conclusion,	  at	  
t0	  when	  Flecainide	  is	  not	  yet	  in	  perfusion,	  not	  only	  APD25,ΔKPQ	  in	  terms	  of	  values	  is	  significantly	  larger	  
(Figure	   42a,	   right	   and	   left	   panels),	   but	   also	   ΔAPD25,ΔKPQ	   (n=4)	   is	   significantly	   wider	   than	   its	   WT	  
counterpart	   (ΔAPD25,WT	   =	   8.7±1.7ms;	   ΔAPD25,ΔKPQ	   =	   14.9±4.1ms,	   p-­‐value<0.05,	   Figure	   41),	  
corresponding	  to	  the	  appearance	  of	  sketchy	  clusters	  of	  longer	  APDs	  in	  the	  mutated	  substrate.	  	  
	  
At	  t5,	  the	  APWT	  have	  shallower	  upstrokes	  with	  a	  decreased	  notch,	  followed	  by	  an	  increase	  in	  the	  APD	  
mainly	  at	  later	  repolarization	  phases.	  While	  the	  map	  shows	  a	  homogenous	  prolongation	  in	  APD25,WT	  
values,	  the	  histograms	  at	  t5	  (Figure	  40a,	  left)	  conserve	  a	  high	  peak	  centered	  at	  10.2ms	  with	  a	  longer	  
tail,	  causing	  an	  increase	  in	  base	  width	  (ΔAPD25,WT	  =	  17.4ms	  in	  this	  example).	  On	  average,	  ΔAPD25,WT	  
increased	  in	  total	  of	  ~120%	  to	  reach	  a	  value	  of	  19.7±5.1ms	  by	  t5	  (Figure	  41).	  The	  response	  of	  the	  
ΔKPQ	  tissue	  to	  Flecainide	  at	   t5	  however	  appears	  more	  dramatic,	  with	  multiple	  adjacent	  regions	  of	  
shorter,	  intermediate,	  and	  prolonged	  APD25	  allocated	  between	  the	  base	  and	  apex	  of	  the	  LV	  free	  wall	  
(Figure	  39a,	  bottom,	  right).	  On	  the	  left	  side	  of	  the	  map,	  the	  APs	  selected	  from	  4	  different	  locations	  
within	   the	  ventricle	  display	  gradual	   loss	  of	   their	  notch,	   followed	  by	  a	  proportional	   increase	   in	   the	  
APD.	  By	  looking	  at	  the	  position	  of	  each	  of	  the	  APs,	  it	  becomes	  obvious	  that	  epicardial	  cells	  that	  once	  
displayed	   almost	   superimposable	  APs	   at	   t0	   (for	   instance	   locations	  1	   and	  3,	   along	   the	   longitudinal	  
direction)	  are	  separated	  by	  an	  APD25	  gradient	  exceeding	  30ms	  after	  5min	  exposure	  to	  Flecainide.	  A	  
direct	  comparison	  of	  the	  APD25,ΔKPQ	  maps	  at	  t0	  and	  t5	  reveals	  the	  possibility	  that	  the	  patterns	  formed	  
at	   t5	   may	   be	   the	   result	   of	   amplification	   of	   intrinsic	   heterogeneity	   found	   within	   the	   mapped	  
epicardial	  layer,	  indicated	  by	  the	  patchy	  arrangement	  of	  APD25	  initially	  found	  at	  t0.	  Nevertheless,	  it’s	  
not	  yet	  clear	  whether	  the	  patterns	  that	  appeared	  with	  Flecainide	  can	  potentially	  be	  predicted	  from	  
the	   initial	   conditions	   at	   t0.	   The	   histograms	   of	   the	   corresponding	   map	   no	   longer	   display	   any	  
particular	   peak	   and	   nicely	   span	   a	   whole	   range	   of	   values	   with	   a	   dispersion	   ΔAPD25,ΔKPQ	   =	   35.7ms	  
(Figure	  40a,	  right).	  From	  the	  bar	  graphs	   in	  Figure	  41,	   it	  becomes	  evident	   that	  APD25	  dispersion	   is	  
significantly	  larger	  in	  the	  ΔKPQ	  substrate	  at	  either	  t0	  or	  t5,	  with	  an	  increase	  of	  ~120%	  and	  ~135%	  in	  
ΔAPD25,WT	  and	  ΔAPD25,ΔKPQ	  respectively	  between	  t0	  and	  t5	  (Figure	  43).	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The	   effects	   observed	   in	  APD25	   are	   translated	   to	   later	   phases	   of	   the	  AP	   (Figure	   39b).	   The	   circular	  
pattern	  with	  slightly	  protracted	  APDs	  at	  the	  site	  of	  pacing	  with	  a	  smoothing	  of	  APD	  value	  towards	  
the	  boundaries	  persists	  for	  the	  WT	  APD50	  map	  at	  t0	  with	  an	  additional	  homogeneous	  prolongation	  of	  
the	   APD	   in	   all	   pixels	   at	   t5.	   In	   this	   example	   under	   control	   conditions,	   dispersion	   of	   APD50,WT	   is	  
calculated	  to	  be	  ΔAPD50,WT	  =34.8ms	  (Figure	  40b,	  leftmost),	  which	  further	  increases	  to	  50.3ms	  at	  t5.	  
With	  the	  current	  configuration	  of	  APD50,ΔKPQ	  at	  t0,	  the	  histograms	  indicate	  a	  unimodal	  distribution	  of	  
values	  centered	  at	  41.5ms	  and	  with	  a	  dispersion	  ΔAPD50,ΔKPQ	  =	  35.8ms.	  On	  average,	  the	  dispersion	  of	  
APD50	  values	  is	  not	  found	  to	  be	  significantly	  different	  between	  WT	  and	  ΔKPQ	  at	  control	  conditions.	  
Only	  after	   the	  development	  of	  symmetry	  breaking	   in	   the	  ΔKPQ	  substrate	  at	   t5,	   that	   this	  difference	  
becomes	  statistically	  significant	  (Figure	  41).	  Counterintuitively,	   the	  dispersion	  in	  APD50	  values	  are	  
considerably	  larger	  in	  the	  WT	  group,	  despite	  the	  presence	  of	  symmetry	  breaking	  exclusively	  in	  the	  
ΔKPQ	   hearts	   at	   t5,	   with	   ΔAPD50,WT	   =47.2±5.0ms;	   ΔAPD50,ΔKPQ	   =	   36.3±7.2ms	   (p-­‐value<0.05).	  
Importantly,	  by	  looking	  at	  the	  bar	  graphs	  (Figure	  41),	  ΔAPD50,WT	  undergoes	  ~45%	  increase	  in	  width	  










































































Figure	   40.	   Histograms	   extracted	   from	  
APD	   maps	   at	   different	   repolarization	  
rates	  (25%	  and	  50%)	  and	  (dF/dt)max	  for	  
WT	   and	   ΔKPQ,	   at	   t0	   and	   t5	   of	   NaV1.5	  
blocking.	   a.	   APD25	   peaks	   at	   7.2ms	   and	  
13.5ms	  at	  t0	  for	  WT	  and	  ΔKPQ	  respectively.	  
ΔAPD25,ΔKPQ	   approximates	   to	   16.2ms	   at	   t0	  
and	   increases	   to	   35.7ms	   at	   t5.	   This	  
dispersion	   is	   considerably	   larger	   than	   the	  
one	   calculated	   for	   the	   WT	   (evident	   from	  
the	  substantial	  widening	  of	  the	  distribution	  
base),	   where	  ΔAPD25,WT	  =17.4ms.	  The	   loss	  
of	  the	  unimodal	  distribution	  in	  the	  mutated	  
group	  at	  t5,	  which	  also	  spans	  a	  whole	  range	  
of	   APD25	   values,	   accounts	   for	   the	  multiple	  
adjacent	   zones	   of	   notably	   different	   APD	  
across	   the	   LV	   free	   wall.	   b.	   APD50	  
distribution	  at	  t0	  is	  wider	  in	  the	  WT	  group	  
in	   this	   particular	   example,	   where	  
considerably	   more	   pixels	   returned	   APD	  
values	   in	   the	   lower	   range.	   APD50,WT	   peaks	  
around	  28.1ms,	  with	  a	  ΔAPD50,WT	  =	  34.8ms.	  
The	  latter	  further	  increases	  to	  50.3ms	  at	  t5.	  
Despite	   the	  WT	  being	  devoid	  of	   symmetry	  
breaking,	  ΔAPD50,WT	   is	   notably	   larger	   than	  
the	  one	  calculated	   in	   the	  ΔKPQ	  heart	  at	   t5,	  
where	   symmetry	   breaking	   actually	   takes	  
place	   (ΔAPD50,ΔKPQ	   =35.7ms).	   c.	   Upstroke	  
velocities	   distribution	   of	   the	   maps	   in	  
Figure	  38.	  The	  bimodal	  distribution	  of	  WT	  
(dF/dt)max	   at	   t0	   is	   compressed	   into	   one	  
larger	   peak	   at	   t5,	   due	   to	   loss	   of	   high	  
upstroke	  values	  with	  Flecainide.	  A	  stronger	  
shift	   to	   the	   left	   is	   noticeable	   for	   the	  
histograms	   of	   ΔKPQ	   with	   Flecainide,	  
indicating	  a	  considerable	  loss	  of	  previously	  
existing	  higher	  (dF/dt)max	  at	  t0.	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While	  some	  heterogeneity	  is	  still	  observed	  at	  repolarization	  levels	  beyond	  50%,	  it’s	  less	  prominent	  
than	   the	   one	   detected	   at	   25%	   and	   50%	   (maps	   not	   shown	   here).	   The	   dispersion	   of	   APD75	   values	  
(Figure	   41)	   is	   not	   significantly	   different	   between	   the	   two	   groups	   at	   t0	   (ΔAPD75,WT	   =24.6±4.3ms;	  
ΔAPD75,ΔKPQ	   =	   28.4±8.3ms;	   p-­‐value=0.44),	   nor	   at	   t5	   (ΔAPD75,WT	   =	   33.9±7.2ms;	   ΔAPD75,ΔKPQ	   =	  
30.2±3.3ms;	  p-­‐value=0.39).	  	  
	  
In	   addition	   to	   dispersion	   analysis,	   APDs	   at	   different	   levels	   of	   repolarization	   were	   analyzed	   and	  
compared	  between	  WT	  and	  ΔKPQ	  at	  different	  time	  points	  of	  Flecainide	  exposure	  (Figure	  42).	  While	  
APD25,	  APD50	  and	  APD75	  show	  statistically	  significant	  differences	  at	  control	  conditions	  (t0)	  between	  
the	   experimental	   groups,	   exposure	   to	   Flecainide	   caused	   a	   consistent	   prolongation	   of	   all	   APDs	  
abolishing	  at	  almost	  all	  time	  points	  the	  existing	  differences	  between	  them.	  
	  
The	   effect	   AP	   abbreviation	   or	   prolongation	   has	   on	   spatial	   dispersion	   has	   not	   been	   quantitatively	  
well	   determined.	   It’s	   strongly	   believed	   however	   that	   asymmetrical	   AP	   prolongation	   in	   the	   heart	  
leads	  to	  increased	  spatial	  dispersion,	  enhancing	  medium	  susceptibility	  for	  arrhythmic	  activity.	  From	  
my	   current	   data,	   the	   correlation	   between	   APDxx	   and	   ΔAPDxx	   (xx	   standing	   for	   any	   percentage	  
repolarization)	   could	   by	   itself	   provide	   a	   quantitative	   indicator	   for	   the	   possible	   occurrence	   of	  
symmetry	   breaking	   in	   the	   ventricle.	   Following	   the	   previous	   analysis	   of	   ΔAPD	   (Figure	   41),	   APD	  
values	   were	   compared	   between	   WT	   (N=8)	   and	   ΔKPQ	   (N=8).	   APD25	   (along	   longitudinal	   and	  
transversal	  directions,	  Figure	  42a),	  APD50	  (longitudinal	  only,	  Figure	  42b),	  APD75	  (longitudinal	  only,	  
Figure	  42c)	  bar	  graphs	  are	  displayed.	  The	  ΔKPQ	  heart	   for	  all	  APDs	  at	   t0	  shows	  significantly	   larger	  
values	   than	   its	  WT	   counterpart.	   For	   instance,	   APD25,WT	   (Long.)	   =	   6.0±1.0ms,	   APD25,ΔKPQ	   (Long.)	   =	  
10.0±4.1ms	   (p-­‐value	   <0.05).	   The	   transversal	   APD25	   are	   particularly	   shown	   here	   because	   of	   their	  
distinct	  changes	  with	  Flecainide	  (when	  comparing	  the	  groups)	  relatively	  to	  the	  longitudinal	  values,	  
which	  is	  not	  the	  case	  for	  the	  APD50	  or	  APD75	  therefore	  only	  longitudinal	  values	  are	  displayed	  in	  the	  
figure.	  Similarly,	  APD50,WT	  =	  27.7±5.6ms,	  APD50,ΔKPQ	  =	  36.1±6.1ms	  (p-­‐value<0.05),	  whereas	  APD75,WT	  =	  
46.7±6.9ms,	  APD75,ΔKPQ	  =	  54.2±5.7ms	  (p-­‐value<0.05).	  	  
Figure	  41.	  Effects	  of	  Flecainide	  
on	  APD	  dispersion	  for	  WT	  and	  
ΔKPQ	   at	   25%,	   50%	   and	   75%	  
AP	   repolarization.	   APDxx	   is	  
calculated	   for	   each	   prep	   at	   t0	  
and	  t5	  as	  the	  difference	  between	  
the	   95th	   and	   5th	   percentile	   of	  
APDxx	   distribution.	   The	  
difference	   in	   ΔAPD25	   at	   t0	   is	  
further	   amplified	   with	  
Flecainide,	   by	   an	   increase	   of	  
120%	   and	   135%	   for	   WT	   and	  
ΔKPQ	   respectively.	   Despite	   this	  
latter	   comparable	   increase,	  
symmety	   breaking	   occurs	   only	  
in	   the	   mutated	   heart	   at	   this	  
experimental	   time	   point.	   The	  	  
increase	  of	  ~45%	   	   in	  ΔAPD50,WT	  
vs.	  ~5%	   in	  ΔAPD50,ΔKPQ	   changed	  
the	   statistics	   at	   t5.	   The	   changes	  
in	   ΔAPD75	   remain	   statistically	  
insignificant	   between	   the	   2	  
groups.	   Annotations	   in	   figure:	  
*	   (p-­‐value<0.05);	   **	   (p-­‐
value<0.01);	  n.s.	  not	  significant.	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As	   all	   APDs	   prolong	   with	   Flecainide	   in	   both	   groups	   (WT	   and	   ΔKPQ),	   the	   maximal	   increase	   is	  
naturally	  observed	  in	  APD25,	  being	  the	  initially	  smallest	  entity	  measured.	  The	  total	  increase	  in	  APD25	  
along	  both	  directions	  is	  not	  only	  compared	  among	  the	  groups,	  but	  also	  contrasted	  to	  the	  increase	  in	  
ΔAPD25	  between	  t0	  and	  t5	  (Figure	  43).	  To	  recall	  from	  previous	  experiments	  done	  on	  the	  mdx	  heart	  
with	  its	  WT	  control,	  symmetry	  breaking	  occurs	  only	  in	  the	  WT	  heart	  at	  t10	  but	  didn’t	  take	  place	  in	  
the	   mdx	   heart.	   The	   total	   increase	   (percentage	   wise)	   in	   APD25	   was	   significantly	   larger	   in	   WT	  
(summarized	   in	   Figure	   43)	   in	   either	   direction	   compared	   to	   the	   changes	   detected	   in	   the	   mdx.	  
Contrastingly,	   comparing	   the	   percentage	   prolongation	   in	   APD25	   at	   t5	   between	   ΔKPQ	   and	  WT,	   the	  
latter	   has	   shown	   a	   considerably	   larger	   increase	   along	   the	   longitudinal	   direction	   (the	   transversal	  
APD25	  increase	  is	  100%	  for	  either	  group),	  yet	  symmetry	  breaking	  took	  place	  in	  the	  ΔKPQ	  ventricle	  
and	  not	  the	  WT.	  Therefore,	  it	  seems	  that	  the	  extent	  of	  APD	  prolongation	  between	  control	  and	  end	  of	  
treatment	  conditions	  alone	  cannot	  predict	  loss	  of	  symmetry	  in	  APD	  patterns.	  
!"
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Figure	  42.	  Bar	  graphs	  showing	  the	  progression	  of	  APD25	  (a),	  APD50	  (b)	  and	  APD75	  (c)	  with	  Flecainide	  in	  both	  WT	  
(N=8)	  and	  ΔKPQ	  (N=8).	  Only	  for	  the	  APD25,	  both	  longitudinal	  (left)	  and	  transversal	  (right)	  are	  shown.	  For	  the	  remaining	  
APD50	  and	  APD75,	  bar	  graphs	  contain	  values	  picked	  along	   the	  longitudinal	  direction	  only.	  At	   initial	  conditions,	   the	  ΔKPQ	  
substrate	  shows	  a	  consistent	  prolongation	  of	   its	  APDs	  compared	  to	  its	  WT	  counterpart.	  As	  Flecainide	  proceeds	  to	  5min,,	  
the	   significant	   difference	   between	   the	   groups	   is	   abolished	   except	   in	   APD25	   (transversally),	   where	   the	   APDs	   remain	  
significantly	  higher	   in	  the	  mutated	  at	  all	  experimental	  time	  points.	  The	  overall	   increase	  in	  APD	  values	  between	  t0	  and	  t5	  
can	   be	   summarized	   as	   such:	   (Long.)	   150%	   in	   APD25,WT	   vs.	   105%	   in	   APD25,ΔKPQ.	   (Trans.)	   100%	   in	   both	   APD25,WT	   and	  
APD25,ΔKPQ	  .	  55%	  in	  APD50,WT	  vs.	  43%	  in	  APD50,ΔKPQ.	  33%	  in	  APD75,WT	  vs.	  30%	  in	  APD75,ΔKPQ.	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As	   mentioned	   earlier,	   symmetry	   breaking	   has	   occurred	   in	   8	   out	   of	   10	   WT	   hearts	   at	   10min	   of	  
Flecainide	  exposure,	  and	  in	  4	  out	  of	  4	  experiments	  in	  ΔKPQ	  hearts	  at	  only	  half	  that	  time.	  None	  of	  7	  
mdx	  experiments	  has	  exhibited	  such	  a	  heterogeneous	  distribution	  at	  any	  experimental	  time.	  If	  this	  
pattern	   formation	   is	   a	   generic	   property	   of	   the	   cardiac	   tissue	   that	   manifests	   itself	   at	   specific	  
experimental	   and	  electrophysiological	   conditions,	   one	  or	   several	   functional	  parameters	   combined	  
could	  bring	  forward	  particular	  requirements	  that	  might	  expedite	  its	  appearance.	  
	  
	  
Such	  a	  symmetry	  breaking	  pattern	   is	   likely	   to	  be	  arrhythmogenic,	  especially	   if	  a	  steep	  gradient	   in	  
repolarization	  exists	  over	  very	  short	  distances,	  as	  in	  the	  mouse	  heart	  experiments	  presented	  in	  this	  
thesis	  work.	  Targeting	  NaV1.5	  is	  fundamental	  in	  Class	  I	  drugs,	  the	  mechanism	  of	  action	  of	  which	  has	  
long	   been	   considered	   well	   understood	   and	   fairly	   straight	   forward.	   The	   race	   to	   understand	   the	  
proarrhythmic	   effects	   of	   AADs	   has	   started	  more	   than	   two	   decades	   ago	   after	   the	   groundbreaking	  
results	   of	   CAST	   and	   till	   now,	   the	  mechanisms	   of	   arrhythmia	   trigger	   and	   sustenance	   are	   not	   fully	  
elucidated.	   These	   results	  map	   a	   detrimental	   side	   effect	   of	   Flecainide	   of	   potentially	   strong	   clinical	  
significance:	   clinically	   valid	   concentrations	   of	   Flecainide	  were	   sufficient	   to	   induce	   a	   steep	   spatial	  
dispersion	  of	  repolarization	  in	  small	  hearts,	  where	  electrotonic	  conduction	  is	  normally	  sufficiently	  
high	  to	  smooth	  out	  functional	  heterogeneities.	  Such	  patterns	  formation	  in	  larger	  hearts,	  where	  more	  
structural	  heterogeneity	  prevails,	  could	  be	  several	  orders	  of	  magnitude	  more	  dangerous	  and	  lethal.	  
In	  cardiac	  tissues,	  where	  electrical	  excitation	  and	  conduction	  across	  coupled	  cells	  is	  maintained	  by	  
Na+,	   pharmacological	   interventions	   through	  NaV1.5	  blocking	  have	   the	  potential	   to	   amplify	   cardiac	  
instability	  by	  decoupling	  universal	  parameters	  of	  excitability	  and	  conductivity,	  including	  weakening	  
electrical	  depolarization,	  slowing	  conduction,	  increasing	  repolarization	  time	  and	  finally	  splitting	  the	  































2$! !2"$! Figure	   43.	   Table	   summarizing	   the	   percentage	   increase	   in	  
APD25	   between	   t0	   and	   t10	   of	   Flecainide	  exposure	   for	  WT	   and	  
mdx,	  and	  between	  t0	  and	  t5	   for	  WT	  and	  ΔKPQ;	  along	  with	  the	  
corresponding	  increase	  in	  dispersion	  (ΔAPD25).	  From	  t0	  àt10:	  
the	  mdx	   heart	   shows	   a	  more	   restrained	  prolongation	  of	   APD25	   in	  
either	  direction	  compared	  to	  the	  WT.	  More	  importantly	  unlike	  the	  
mdx,	   the	   increase	   in	   ΔAPD25,WT	   exceeds	   the	   total	   prolongation	   in	  
APD25	   itself	   in	   either	  direction.	  From	   t0	  à 	   t5:	   Although	  APD25,WT	  
shows	   a	   larger	   prolongation	   with	   Flecainide	   than	   the	   ΔKPQ,	   the	  
total	   increase	   in	  dispersion	  was	   inferior	   to	   the	   total	   prolongation	  
in	   APD25,WT.	   Despite	   a	   more	   constricted	   increase	   in	   APD25,ΔKPQ,	  
symmetry	  breaking	  erupted	  in	  the	  ΔKPQ.	  Only	  in	  substrates	  where	  
the	   global	   increase	   in	   ΔAPD25	   (pink	   cells)	   exceeds	   the	   total	  
prolongation	   of	   its	   respective	   APDs	   (green,	   blue),	   symmetry	  
breaking	  flared	  up.	  




















Figure	   44.	   Activation	   (a)	  
followed	   by	   repolarization	  
(b)	  from	  intact	  epicardium	  of	  
a	   ΔKPQ	   mouse	   heart	   in	   the	  
absence	  of	  Flecainide.	  From	  a	  
point	   stimulation	   (pacing	  
electrode	   aiming	   at	   the	   center	  
of	  the	  LV	  free	  wall),	  an	  elliptical	  
wave	   propagates	   towards	   the	  
boundaries.	   The	   repolarization	  
pattern	   is	   not	   homogeneous	  
compared	   to	   the	   WT	   example	  
shown	   in	   the	  Methods’	  section.	  
Patchy	   distribution	   of	  
prolonged	   APDs	   prevents	   a	  
congruent	   repolarization	   and	  
increases	   spatial-­‐functional	  
heterogeneity.	   Scale	   bar	   =	  
1mm.	  	  




















Figure	   45.	   Activation	   (a)	  
followed	   by	   repolarization	  
(b)	  from	  intact	  epicardium	  of	  
a	   ΔKPQ	   mouse	   heart	   after	  
5min	  	  of	  Flecainide	  exposure.	  
From	   a	   point	   stimulation	  
(pacing	   electrode	   remaining	   at	  
exact	   same	   position	   as	   in	  
Figure	  44),	  activation	  is	  slower	  
and	  asymmetrical	  on	  the	  apico-­‐
basal	   axis.	   Multiple	   adjacent	  
zones	   of	   inconsistent	  
repolarization	   properties	  
amplify	   spatial-­‐temporal	  
heterogeneity	   and	   SDR,	  
rendering	   the	   tissue	   a	   highly	  
susceptible	   substrate	   for	  
arrhythmia.	  Scale	  bar	  =	  1mm.	  











x-axis y-axis Slope ± error Correlation 
coef. (R!) 
LSEF PF 0.55±0.17 0.41 
LESF PF 0.59±0.20 0.41 
PF AF 0.97±0.14 0.75 
LSEF PF 0.67±0.15 0.58 
LESF PF 0.75±0.14 0.64 
PF AF 0.97±0.12 0.82 
LSEF PF 0.87±0.05 0.90 
LESF PF 0.89±0.05 0.92 
PF AF 0.99±0.03 0.97 
LSEF PF 0.66±0.07 0.86 
LESF PF 0.97±0.11 0.84 
PF AF 1.33±0.17 0.82 
LSEF PF 0.72±0.13 0.67 
LESF PF 0.97±0.20 0.62 
PF AF 1.20±0.20 0.75 
LSEF PF 0.57±0.08 0.59 
LESF PF 0.91±0.06 0.87 






































Figure	   46.	   Table	   summarizing	   the	   slopes	   and	   determination	   coefficients	   (R2)	   extracted	   from	   the	   linear	  
regressions	  of	  the	  velocities	  (analysis	  done	  in	  Figure	  15).	  The	  methods’	  outcomes	  being	  Vmax	  (Longitudinal	  CV)	  
and	  Vmin	  (Transversal	  CV)	  are	  initially	  separated	  into	  two	  categories.	  The	  methods	  are	  plotted	  against	  each	  other	  for	  
a	  direct	  comparison.	  The	  substrates	  (WT	  and	  mdx)	  being	  two	  different	  entities	  were	  treated	  each	  aside	  first,	  then	  
merged.	  R2	  consistently	  scored	  higher	  values	   in	  merged	  sets	  (linear	  regressions	   in	  Figure	  15	  contain	  the	  merged	  
data	  points)	   than	   in	   each	   set	   aside	  particularly	   for	  Vmax	   values.	   The	   slopes	   of	  merged	  sets	  are	   closer	   to	  unity	  (in	  
blue)	  except	   for	  the	  value	  in	  pink,	  where	  the	  slope	  is	  not	  close	  to	  one,	  but	  associated	  with	  a	  low	  R2	  value	  as	  well.	  
Values	  in	  red	  show	  sporadic	  unity	  slopes	  and	  in	  green	  slopes	  higher	  than	  one	  occurring	  when	  each	  of	  the	  WT	  and	  
mdx	  sets	  are	  treated	  separately.	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 Chapter 4 
Discussion 
Microscopic	   components	   derived	   from	   active	   ionic	   and	   passive	   membrane	   properties,	   and	  
macroscopic	   discontinuities	   reflecting	   branching	   anatomical	   features	   or	   other	   structural	  
heterogeneities,	   can	   produce	   changes	   in	   the	   shape	   of	   the	   AP	   and	   CV,	   characteristics	   of	   cardiac	  
conduction	   that	   cannot	   be	   predicted	   by	   continuous	   propagation	   models256.	   Discontinuous	  
propagation	  implies	  that	  a	  delicate	  local	  source-­‐sink	  balance	  governs	  successful	  conduction	  across	  
the	  tissue,	  where	  the	  amount	  of	  charges	  supplied	  by	  the	  source	  proximally	  must	  at	  least	  be	  equal	  to	  
the	  charges	  required	  to	  excite	  the	  cardiac	  membrane	  at	  the	  sink	  distally257.	  At	  the	  cellular	  level,	  this	  
is	  controlled	  by	  membrane	  excitability	  followed	  by	  the	  state	  of	  electrical	  coupling	  between	  cells.	  In	  
the	  ventricular	  myocardium,	  the	  principal	  active	  determinant	  of	  excitability	  is	  probably	  the	  cardiac	  
NaV1.5lxviii,	  where	   the	  magnitude	  of	   INa,f	   plays	  a	  decisive	   role	   in	   the	   subsequent	  propagation	  of	   the	  
electrical	   wave	   from	   the	   source	   location	   further	   down	   the	   multicellular	   network.	   Meticulous	  
opening	   and	   closing	   of	   the	   cardiac	   ion	   channels	   results	   in	   the	   generation	   of	   the	   AP,	   ensures	   its	  
successful	  propagation,	  maintains	  the	   intricate	  coupling	  of	  electrical	  and	  mechanical	  activities	  and	  
orchestrates	   the	   sequence	  of	   ionic	   channels	   to	  bring	   about	   the	   lucrative	   termination	  of	   the	  AP260.	  
Henceforth,	   abnormalities	   of	   NaV1.5	   expression,	   regulation	   or	   kinetics	   will	   translate	   into	   cardiac	  
instabilities	   that	   induce	   electrical	   vulnerability	   and	   precipitate	   rhythm	   disturbances.	   How	   could	  
NaV1.5	  perturbations	  influence	  the	  stability	  of	  the	  entire	  cardiac	  tissue?	  	  
	  
In	  this	  thesis	  work,	  two	  models	  of	  NaV1.5	  abnormalities	  were	  investigated,	  and	  further	  modulation	  
of	  NaV1.5	  was	  resumed	  through	  pharmacological	  interventions.	  The	  results	  of	  this	  thesis	  have	  tried	  
to	  answer	  the	  questions	  proposed	  in	  the	  last	  section	  of	  the	  Introductionlxix	  by:	  	  
1. Characterizing	   electrical	   instabilities	   in	   conduction	   in	   a	   model	   where	   NaV1.5	   is	   lost	  
exclusively	  from	  the	  LM	  of	  the	  cardiomyocyte.	  
2. Implementing	   and	   validating	   different	   analytical	   strategies	   to	   evaluate	   conduction	  
velocity	  in	  a	  medium	  with	  anisotropic	  and	  atypical	  spatial-­‐temporal	  patterns	  of	  activation.	  	  
3. Investigating	   a	   circumstantiated	   proarrhythmic	   mechanism	   of	   Flecainide	   (NaV1.5	  
blocker)	  in	  normal	  heart	  tissues	  using	  clinically	  valid	  concentrations.	  	  
4. Providing	   adminicular	   evidence	   that	   a	  model	   harboring	   a	   LQTS3	  mutation	   is	  exceedingly	  
destabilized	  in	  the	  presence	  of	  Flecainide.	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxviii	  Detailed	  description	  of	  the	  two	  models	  of	  propagation	  is	  found	  in	  the	  Introduction	  section	  1.3.1.	  	  
lxix	  Refer	  to	  Introduction	  section	  1.6	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4.1. AP Conduction in the Murine Cardiac Tissue 
Some	   of	   the	   determinants	   of	   impulse	   propagation	   in	   the	   cardiac	   tissue	   include	   excitability	   of	  
individual	   cells,	   impulse	   transmission	   between	   neighboring	   cells	   and	   structural	   geometry56,	   551.	  
Abnormalities	   in	   any	   of	   these	   components	   have	   been	   known	   in	   the	   general	   sense	   to	   facilitate	  
reentrant	   arrhythmia	   for	   almost	   over	   a	   century578.	   By	   reducing	   membrane	   depolarization	  
properties,	   such	   as	   excitability,	   CV	   is	   affected.	   The	   most	   important	   determinant	   of	   reduced	  
excitability	  is	  the	  reduced	  availability	  of	  NaV1.5	  leading	  to	  a	  reduction	  in	  INa,f368.	  Several	  pathological	  
states	  could	  entail	  loss	  of	  functional	  NaV1.5	  such	  as	  acute	  ischemia579,	  580,	  electrolyte	  disturbances581,	  
genetic	   mutations390,	   remodeling	   processes582	   and	   treatment	   with	   AADs315.	   However,	   our	  
knowledge	   of	   how	   exactly	   each	   component	   contributes	   to	   reentry	   is	   still	   deficient,	   and	   our	  
predictive	  potential	  of	  the	  trigger	  and	  sustenance	  of	  arrhythmia	  remains	  at	  best	  fairly	  unreliable.	  
	  
It	  has	  been	  realized	  that	  the	  relationship	  between	  active	  (membrane	  excitability)	  and	  passive	  (cell-­‐
cell	  coupling)	  components	  of	  cellular	  propagation	  and	  CV	  is	  far	  more	  complex,	  the	  characterization	  
of	  which	  requires	  high	  resolution	  mapping	  techniques	  and	  computational	  models	  with	  the	  capacity	  
to	   incorporate	  experimental	  data	  acquired	  at	  molecular,	  cellular	  and	  whole-­‐organ	   levels246.	   In	   this	  
regard,	  optical	  mapping	  has	  proven	  to	  be	  a	  fundamental	  experimental	  tool	  in	  the	  study	  of	  spatially	  
extended	  electrophysiological	  heterogeneity	  of	  the	  cardiac	  substrate,	  without	  which	  appreciation	  of	  
the	   complexity	   of	   arrhythmogenic	   models	   wouldn’t	   have	   been	   possible.	   Whether	   slowing	   of	  
conduction	   is	   a	   necessary	   condition	   or	   not	   for	   reentry,	   experimental	   and	  numerical	   data	   indicate	  
that	  it’s	  not	  sufficient.	  Additional	  factors	  (such	  as	  spatial-­‐temporal	  heterogeneity	  for	  example)	  might	  
be	  as	  crucial	  as	  conduction	  slowing	  to	   increase	  the	  propensity	  of	  the	  cardiac	  tissue	  for	  developing	  
arrhythmic	  patterns.	  
4.1.1. Impulse Conduction Slowing in the Dystrophin-Deficient Heart 
In	  a	  collaborative	  work,	  we	  showed	  through	  high	  spatial-­‐temporal	  resolution	  mapping	  experiments	  
suitable	  for	  the	  mouse	  heart	  that	  CV	  is	  significantly	  altered	  in	  the	  mdx	  LV	  free	  wall	  (Figure	  10)238.	  As	  
NaV1.5	   staining	   remains	   unchanged	   at	   the	   IDs	   in	   these	   hearts,	   reduction	   in	   INa,f	   as	   well	   as	   the	  
decrease	  in	  CV	  have	  been	  attributed	  to	  the	  particular	  loss	  of	  NaV1.5	  from	  the	  LM	  of	  the	  dystrophin-­‐
deficient	  heart.	  The	  latter	  finding	  was	  sufficient	  to	  decrease	  NaV1.5	  protein	  by	  50%	  (Western	  blot),	  
and	   total	   INa,f	   current	   by	   29%	   (patch	   clamp)237.	   Macroscopically,	   these	   molecular	   findings	   were	  
translated	   into	  CV	  decrease	   in	  both	  directions	  with	  Vmax,mdx	   =	  0.55±0.08m.s-­‐1	   (decrease	  of	  20-­‐25%	  
compared	  to	  Vmax,WT)	  and	  Vmin,mdx	  =	  0.31±0.03m.s-­‐1	  (decrease	  of	  17-­‐21%	  compared	  to	  Vmin,WT)	  (Figure	  
11a,	   Figure	  22	  Control)	  without	   a	   significant	   change	   in	  AR	  =	  1.9±0.2	   (Figure	  27a,	  Control).	  These	  
results	  agree	  with	  a	  previous	  study	  reporting	  altered	  NaV1.5	  expression	  and	  reduced	  excitability	  in	  
the	  mdx	  mouse583.	  Although	  the	  authors	  partly	  attributed	  these	  results	  to	  the	  reorganization	  of	  Cx43	  
(a	   major	   protein	   in	   GJlxx)583,	   others	   and	   we	   couldn’t	   confirm	   the	   presence	   of	   an	   ongoing	   Cx43	  
remodeling	  in	  the	  in	  mdx	  heart238,	  584.	  	  Decreased	  NaV1.5	  availability	  can	  be	  achieved	  experimentally	  
with	   other	   conditions	   that	   increase	   the	   resting	   membrane	   potential	   (such	   as	   hyperkalemia581,	  
anoxia581	   and	   acute	   ischemia580)	   or	   with	   NaV1.5	   blockers315	   (TTXlxxi	   or	   AADs).	   Several	   studies	  
reported	  an	  abrupt	  CB	   that	  occurred	   from	  relatively	  high	  enough	  velocities:	   from	  ~0.25m.s-­‐1	  with	  
AADs,	  ~0.2-­‐0.35m.s-­‐1	  with	  hyperkalemia	  protocols	  and	  ~0.2-­‐0.3m.s-­‐1	   in	  acute	   ischemia.	  Numerical	  
studies,	   used	   to	   investigate	   conduction	   properties	   in	   cardiac	   tissues	   in	   the	   context	   of	   diminished	  
excitability,	   revealed	   that	   reduced	  membrane	   excitability	   does	   not	   easily	   support	   ultimately	   slow	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxx	  GJ	  =	  Gap	  Junctions	  
lxxi	  TTX	  is	  introduced	  in	  section	  1.4	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conductions	   (~0.17m.s-­‐1)lxxii,	   rather	   the	   transition	   to	  CB	   is	   abrupt	  and	  occurs	   from	  a	   range	  of	  CVs	  
that	   are	   relatively	   fast585.	   For	   extreme	   reduction	   in	   NaV1.5	   availability	   (<11%),	   the	   generated	  
depolarizing	   charge	   was	   reported	   to	   be	   no	   longer	   sufficient	   to	   depolarize	   the	   membrane	   to	  
excitation	  threshold,	  so	  CB	  ensues585.	  Our	  values	  for	  the	  WT	  heart	  correspond	  well	  with	  the	  values	  
reported	  in	  literature.	  In	  the	  direction	  of	  the	  long	  axis,	  the	  highest	  velocity	  values	  were	  recorded	  in	  
the	  specialized	  tract	  of	  the	  ventricular	  conduction	  system586,	  587	  with	  Vmax	  ~	  2.1±0.4m.s-­‐1,	  while	  the	  
lowest	  values	  were	  measured	  in	  the	  bulk	  ventricular	  muscle321,	  580,	   588	  (~0.5±0.1m.s-­‐1).	  Amongst	  all	  
regions	  in	  the	  heart,	  where	  AR	  was	  calculated,	  the	  lowest	  is	  found	  in	  the	  ventricular	  muscle190	  with	  
AR~2;	  the	  highest	  being	  in	  the	  crista	  terminalis	  (~10)190,	  551.	  
	  
Propagation	  velocities	  were	  measured	  simultaneously	  along	  the	  longitudinal	  and	  transversal	  axes	  of	  
cardiac	  fibers	  in	  the	  LV	  free	  wall.	  The	  anisotropic	  distribution	  of	  propagation	  velocities	  shows	  that	  
both	  velocities	  decreased	  by	  the	  same	  factor	  without	  causing	  a	  detectable	  change	  in	  AR	  in	  the	  mdx.	  
Spach	  et	  al.	  assumed	  in	  their	  model	  of	  anisotropic	  propagation	  that	  the	  AR	  of	  velocities	  should	  not	  
be	   altered	   when	   changes	   in	   membrane	   properties	   are	   considered	   uniform319.	   The	   loss	   of	   NaV1.5	  
exclusively	   at	   the	   LM	   is	   a	   clear	   non-­‐uniformity	   in	   the	   membrane	   ionic	   properties.	   Hence	   this	  
hypothesis	  cannot	  explain	  the	  unchanging	  AR	  in	  the	  mdx.	  On	  the	  other	  hand,	  a	  possible	  explanation	  
can	   be	   provided	   by	   the	   discontinuous	   theory	   of	   conduction,	   which	   postulates	   that	   electrical	  
anisotropy	  at	  the	  cellular	  level	  is	  affected	  by	  a	  sufficiently	  large	  number	  of	  factors,	  such	  as	  the	  shape	  
and	   size	   of	   anisotropic	   cell,	   the	   amount	   and	   distribution	   pattern	   of	   GJ,	   and	   the	   anisotropic	  
distribution	  of	  ionic	  channels537.	  As	  intracellular	  propagation	  is	  found	  not	  to	  be	  homogeneous	  in	  the	  
cardiac	  cell	  and	  with	  the	  absence	  of	  change	  in	  intercellular	  coupling	  (GJ	  properties)	  in	  the	  mdx,	  the	  
observed	   asymmetry	   in	   the	  distribution	  of	  NaV1.5	   in	   the	  mdx	   cell	   should	   have	   resulted	   in	   a	  much	  
larger	  percentage	  decrease	  in	  the	  transversal	  direction,	  causing	  a	  significant	  change	  in	  the	  AR.	  	  
	  
Here,	  we	  hypothesize	  that	  the	  most	  likely	  explanation	  of	  this	  lack	  of	  effect	  is	  the	  smaller	  size	  murine	  
cardiac	   celllxxiii.	   In	   studies	   evaluating	  macroscopic	   conduction,	   little	   significance	   was	   given	   to	   the	  
effects	  of	  size	  and	  geometry,	  before	  Spach	  et	  al.	  demonstrated	  that	  cellular	  scaling	  is	  as	  important	  as	  
changes	  in	  other	  passive	  components	  (such	  as	  GJs)	   in	  determining	  the	  properties	  of	  conduction	  in	  
the	  cardiac	   tissue589.	   Indeed,	   the	  smaller	  cell	   size	  and	  the	  relatively	  smaller	  cytoplasmic	  pathways	  
are	  predicted	  to	  render	  intracellular	  dynamics	  less	  discontinuous590.	  The	  whole	  murine	  cell	  will	  be	  
expected	  to	  depolarize	  as	  one	  unit,	   independently	  of	  the	  detailed	  distribution	  of	  its	  ionic	  channels,	  
which	   would	   otherwise	   (i.e.	   in	   larger	   cardiac	   cells)	   alter	   subcellular	   electrical	   loading	   with	  
significant	  effects	  on	  anisotropic	   conduction	  properties589.	  Consequently,	   it	   can	  be	  safely	  assumed	  
that	  in	  conditions	  where	  CV	  is	  fast	  enough,	  the	  exclusive	  reduction	  of	  NaV1.5	  from	  the	  LM	  in	  the	  mdx	  
cell	   causes	   a	   reduction	   of	   the	   overall	   depolarizing	   current	   entering	   the	   cell,	   decreasing	   CV	  
monotonically	  independently	  of	  the	  axis	  of	  propagation	  and	  keeping	  the	  AR	  unchangedlxxiv.	  
4.1.2. Possible Implications of LM NaV1.5 Loss in mdx: Contribution of LM to 
the Stability of Conduction 
Under	  physiological	  conditions,	  GJ	  conductance	  is	  not	  constant	  as	  excitation	  conduction	  takes	  place.	  
The	   dynamical	   GJ	   model	   was	   first	   proposed	   by	   Vogel	   and	   Weingart	   (1998)258,	   who	   described	   a	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxxii	  In	  contrast	  to	  the	  effects	  due	  to	  reduced	  excitability,	  Tsumoto	  et	  al.	  investigated	  the	  effects	  of	  intercellular	  coupling	  on	  
AP	  conduction	  and	  confirmed	  through	  a	  mathematical	  study	   that	  even	   in	   the	  absence	  of	  GJ	  coupling,	  conduction	  can	  be	  
maintained	  at	  velocities	  as	  slow	  as	  0.14m.s-­‐1	  (Refer	  to	  section	  4.1.2)	  	  
lxxiii	  An	  adult	  canine	  cardiac	  cell	  has	  a	  length	  of	  ~150μm,	  whereas	  the	  length	  of	  a	  murine	  cardiomyocyte	  approximates	  to	  
70μm.	  Canine	  neonatal	  cells	  are	  much	  smaller	  than	  canine	  adult	  cells	  (~30μm)	  with	  distinct	  intercellular	  coupling.	  
lxxiv	  The	  lack	  of	  directional	  preferences	  on	  the	  properties	  of	  conduction	  between	  WT	  and	  mdx	  was	  further	  challenged	  with	  
Flecainide,	   where	   increasing	   the	   time	   scale	   of	   the	   upstroke	   and	   decreasing	   CV	   amplified	   the	   effects	   due	   to	   NaV1.5	  
asymmetry	  in	  the	  mdx	  cell	  exposed	  to	  NaV1.5	  blocking	  (section	  4.3).	  
122	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Chapter	  4	  Discussion	  
mathematical	   model	   for	   the	   voltage-­‐	   and	   time-­‐	   dependency	   observed	   in	   junctional	   conductance	  
changes	  measured	  in	  cell	  pairs591,	  592.	  A	  simulation	  study	  based	  on	  this	  model	  later	  investigated	  the	  
effects	  of	  dynamical	   junctions	  on	   the	  shape	  and	  CV	  of	   the	  propagating	  AP593,	  where	   it	  was	  shown	  
that	   GJ	   conductance	   increases	   moderately	   after	   the	   passage	   of	   the	   wave	   front.	   Therefore	   GJ	   can	  
normally	  represent	  discrete	  resistive	  barriers	  for	  the	  flow	  of	  current,	  where	  increased	  resistance	  at	  
these	   locations	   results	   in	   a	   discontinuous	   pattern	   of	   conduction	   at	   the	   cellular	   level244.	   Two	  
mechanisms	   are	   currently	   proposed	   to	   explain	   AP	   propagation	   across	   GJs:	   the	   Gap-­‐Junctional	  
mechanism	   (GJM)	   and	   the	   Electric	   Field	   mechanism	   (EFM).	   The	   former	   states	   that	   modifying	  
connexons’	  conductance	  (connexons	  are	  the	  structures	  forming	  the	  electrical	  connections	  between	  
the	  cytoplasmic	  chambers	  of	  contiguous	  cells198,	  594,	  595)	  can	  have	  significant	  impacts	  on	  intercellular	  
coupling596,	   597.	   Experimental	   findings598,	   reinforced	   with	   numerical	   studies599,	   have	   showed	   that	  
reduced	  GJ	  coupling	  is	  indeed	  associated	  with	  CV	  slowing.	  However,	  the	  GJM	  failed	  to	  fully	  explain	  
other	  experimental	  observations:	  Using	  genetically	  engineered	  cardiac-­‐restricted	  Cx43	  conditional	  
KO	  mice,	   a	  decrease	   to	  <10%	  of	  WT	  GJ	   conductance	  was	   associated	  with	  only	   a	  50%	  decrease	   in	  
CV600.	  Henceforth,	   it	  became	  more	  obvious	  that	  other	  mechanisms	  maintain	  AP	  propagation,	  when	  
GJM	  is	  dramatically	  impaired.	  
	  
The	  EFM	  was	  first	  suggested	  by	  Sperelakis	  et	  al.	  and	  postulates	  that	  during	  AP	  propagation,	  INa,f	  on	  
the	  proximal	   side	   of	   the	   intercellular	   cleft	   of	   neighboring	   cardiac	   cells	   generates	   a	   large	   negative	  
extracellular	  cleft	  potential,	  which	   in	  turn	  triggers	  the	  activation	  of	   the	   inward	  INa,f	   in	  the	  adjacent	  
cells	   on	   the	   distal	   side	   of	   the	   cleft601.	   NaV1.5	   extensively	   clusters	   in	   the	   IDs	   (or	   the	   junctional	  
membranes	  proximal	  and	  distal	   to	  the	  extracellular	  cleft)242,	   602,	  but	   is	  also	  expressed	  in	  the	  LM238,	  
603.	  In	  that	  regard,	  Tsumoto	  et	  al.	  elegantly	  investigated	  the	  role	  of	  subcellular	  NaV1.5	  distribution	  in	  
AP	  conduction,	  where	  they	  elucidated	  the	  physiological	  significance	  of	  NaV1.5	  in	  the	  LM	  in	  securing	  
the	   stability	   of	   AP	   propagation,	   under	   conditions	   where	   cell-­‐cell	   coupling	   is	   severely	  
compromised604.	   They	   showed	   that	   NaV1.5	   located	   in	   the	   IDs	   and	   LM	   play	   different	   roles	   in	   CV	  
modulation.	  In	  normal	  intercellular	  coupling	  conditions,	  the	  effects	  of	  NaV1.5	  in	  the	  LM	  are	  limited	  
compared	   to	   the	   ones	   clustered	   at	   the	   IDs.	   However	  when	   conductance	   through	   GJ	  was	   severely	  
diminished,	  the	  EFM	  became	  unstable	  with	  the	  absence	  of	  NaV1.5	  from	  the	  LM	  and	  AP	  propagation	  
was	   unsustainable.	   Contrastingly,	   the	   presence	   of	   NaV1.5	   at	   the	   LM	   reinforced	   the	   EFM	   and	  
compensated	  for	  the	  CV	  slowing	  and	  propagation	  remained	  successful	   in	  cases	  of	  dramatic	   loss	  of	  
cell-­‐cell	  coupling	  via	  GJs.	  
	  
Our	   investigation	  of	  propagation	   in	  the	   in	  the	  mdx	  mouse	  along	  with	  these	  studies	  could	  nicely	   fit	  
into	  a	  clinical	  translation	  regarding	  the	  pathological	  progression	  of	  the	  cardiac	  phenotype	  in	  DMD.	  
Cardiac	   involvement	   becomes	   clinically	   detectable	   only	   shortly	   before	   death	   with	   marked	  
interstitial	   fibrosis	   and	   progression	   into	   dilated	   cardiomyopathy	   (DCM)605,	   606,	   which	   precipitates	  
heart	   failure606,	   607.	  At	  early	  stages	  of	   the	  disease,	   loss	  of	  NaV1.5	   from	  the	  LM	  (although	   it	  causes	  a	  
decrease	   in	   CV	   in	   all	   directions)	   doesn’t	   compromise	   electrical	   activity	   spread	   in	   the	   presence	   of	  
normal	   cell-­‐cell	   coupling.	   As	   the	   disease	   progresses,	   intercellular	   coupling	   is	   severely	   reduced608	  
due	   to	   extensive	   fibrosis.	   We	   speculate	   that	   as	   the	   propagation	   across	   the	   weakened	   junctions	  
becomes	   unsustainable,	   the	   absence	   of	   NaV1.5	   from	   the	   LM	   fails	   to	   provide	   homeostasis	   of	   AP	  
propagation,	  therefore	  possibly	  facilitating	  conduction	  block	  and	  reentry,	  events	  known	  to	  occur	  in	  
DMD	  patients	  at	  later	  stages	  of	  the	  disease.	  
4.1.3. Methodological Approaches in Measuring CV 
Imaging	   techniques	   are	   widely	   used	   to	   investigate	   the	   spatial-­‐temporal	   dynamics	   of	   biological	  
systems,	   including	   excitable	   media	   such	   as	   the	   heart508,	   510,	   609.	   Optical	   mapping	   has	   become	   an	  
increasingly	   important	   tool	   to	  study	  the	  electrophysiological	  properties	  of	   the	  heart.	  With	   its	  high	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spatial-­‐temporal	   resolution,	   cardiac	   mapping	   has	   helped	   advancing	   knowledge	   of	   arrhythmias610	  
and	  electrophysiological	  remodeling	  in	  diverse	  pathologies	  in	  the	  past	  two	  decades292,	  611.	  Principles	  
and	  techniques	  of	  cardiac	  optical	  mapping	  have	  been	  extensively	  reviewed505,	  514.	  Multiple	  methods	  
are	  used	  to	  process	  OAP	  and	  analyzing	  optical	  data,	  however	  no	  specific	  method	  has	  been	  reported	  
to	  be	  optimal.	   Inappropriate	  processing	  of	   the	  data	  can	   lead	   to	  erroneous	  results	  and	  conclusions	  
regarding	  the	  electrophysiology	  of	  the	  prep	  can	  be	  misleading550.	  
	  
One	  advantage	  of	  optical	  mapping	  over	  other	  experimental	  electrophysiological	  techniques	  resides	  
mainly	  in	  its	  ability	  to	  record	  electrical	  activity	  from	  more	  than	  10,000	  pixels	  simultaneously	  with	  a	  
temporal	  resolution	  that	  exceeds	  2kHzlxxv.	   In	  our	  experiments,	   isochronal	  maps	  reveal	  that	  a	  point	  
stimulation	   from	   a	   site	   near	   the	   center	   of	   the	   left	   ventricle	   (LV)	   creates	   anisotropic	  wave	   fronts,	  
indicating	  that	  directional	  differences	  in	  conduction	  are	  characteristic	  of	  the	  cardiac	  tissue612.	  From	  
epicardial	  measurements,	   AP	   generation	   and	   other	   electrophysiological	   properties	   of	   the	   cardiac	  
substrate	   can	   be	   obtained	   via	   patterns	   of	   activation	   and	   the	   apparent	   CV	   in	   the	   medium	   of	  
propagation.	  Direction	  and	  speed	  of	  propagation	  are	  used	   to	  characterize	   the	  electrophysiological	  
properties	   of	   the	   cardiac	   substrate,	   from	   which	   CV	   is	   an	   important	   parameter	   to	   statistically	  
describe	  the	  path	  of	  the	  electrical	  activity	  on	  the	  epicardium532,	  613.	  
	  
CV	   depends	   on	   tissue	   properties	   and	   fiber	   orientation,	   the	   latter	   also	   depends	   on	   location614.	  
Although	   epicardial	   CV	   can	   be	   quantified	   by	   different	   analytical	   strategies	   (Figure	   11,	   Figure	   12,	  
Figure	   13),	   caution	   was	   necessary	   while	   interpreting	   the	   results.	   Apparent	   epicardial	   CV	   is	   an	  
accurate	  representative	  of	  the	  actual	  CV	  in	  the	  medium,	  only	  when	  wave	  fronts	  travel	  nearly	  parallel	  
to	  the	  epicardial	  surface	  and	  to	  the	  field	  of	  view514.	  Therefore,	  we	  aimed	  at	  choosing	  constantly	  the	  
activation	  interval	  (ROI)	  spanning	  a	  time	  window	  of	  2.5-­‐3ms	  within	  the	  activation	  map	  (Figure	  11a,	  
for	   example)	   excluding	   the	   first	   isochrone	   (in	   order	   to	   eliminate	   pacing	   artifacts)	   and	   last	  
isochrones	   (affected	  by	   boundary	   conditions),	   therefore	   creating	   a	   region	   that	   essentially	   reflects	  
the	  actual	  epicardial	  conduction	  (Figure	  21a).	  Under	  quasi-­‐physiological	  conditions	  (including	  pH,	  
temperature,	  O2),	  with	  mid-­‐wall	  epicardial	  pacing	  of	   the	  WT	  LV	  (10Hz),	  all	  measured	  velocities	   in	  
the	  absence	  of	  Flecainide	  varied	  between	  0.70-­‐0.82m.s-­‐1	  along	  the	  longitudinal	  direction	  and	  0.38-­‐
0.50m.s-­‐1	   transversally.	   Although	   velocity	   is	   a	   frequency-­‐dependent	   parameter,	   these	   results	   are	  
compatible	  with	  other	  optical	  mapping	  velocity	  measurements	  in	  the	  mouse	  heart	  using	  epicardial	  
pacing	  with	  frequencies	  varying	  between	  8-­‐11Hz284,	  615,	  616.	  In	  the	  sinus	  rhythm,	  activation	  occurred	  
in	   a	   complex	   breakthrough	   pattern	   across	   the	   LV	   free	   wall.	   Since	   our	   optical	   mapping	   setup	  
corresponds	   to	   projecting	   a	   3D	   epicardium	   on	   a	   2D	   surface,	   transmural	   components	   would	  
complicate	  directional	  velocity	  estimates.	  Indeed,	  velocity	  maps	  were	  harder	  to	  compute	  due	  to	  the	  
large	  area	  covered	  by	  the	  wave	  in	  relatively	  brief	  time	  intervals,	  causing	  the	  norms	  of	  the	  velocity	  
vectors	  to	  blow	  up.	  These	  measurements	  were	  avoided	  in	  our	  analysis,	  and	  the	  reported	  velocities	  
correspond	  to	  the	  paced	  rhythms	  that	  were	  initiated	  in	  the	  middle	  of	  the	  LV	  free	  wall	  in	  all	  preps.	  
	  
The	   methodological	   study	   conducted	   after	   the	   initial	   finding	   in	   the	   mdx	   mouse	   aimed	   at	  
investigating	  the	  working	  range	  of	  each	  of	  the	  analytical	  strategies	  implemented	  in	  measuring	  CV	  in	  
the	  mouse	  heart	  using	  optical	  mapping.	  Interestingly,	  our	  experimental	  data	  reveal	  that	  all	  methods	  
yielded	  consistently	   the	   initially	  observed	   findings	   (Figure	  11,	  Figure	  12,	  Figure	  13),	   confirming	  a	  
similarity	   to	   the	   results	   we	   published	   for	   the	  mdx	   mice,	   where	   the	   Least	   Square	   Ellipsis	   Fitting	  
(LSEF)	  method	  was	   implemented	  Figure	  10)238.	  Exposure	  of	   the	  ∆KPQ	  heart	   to	  Flecainide	   (Figure	  
14b)	   caused	   the	   activation	   to	   deviate	   from	   the	   expected	   anisotropic	   pattern.	   Regardless	   of	   the	  
underlying	   molecular	   mechanism,	   complex	   patterns	   in	   the	   cardiac	   substrate	   aren’t	   always	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxxv	  The	  recording	  chip	  of	  the	  CMOS	  camera	  contains	  100	  by	  100	  pixels	  offering	  a	  spatial	  resolution	  of	  100μm.	  The	  frame	  
rate	  was	  set	  to	  2kHz	  when	  measuring	  with	  Di-­‐4-­‐Anepps.	  Refer	  to	  Experimental	  Methods	  (section	  2.1.4)	  for	  further	  details.	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avoidable.	   In	   such	   cases,	   activation	   patterns	   aren’t	   comparable,	   because	   the	   heterogeneity	   effect	  
cannot	  be	  predicted	  from	  the	  initial	  conditions	  imposed	  by	  pacing.	  The	  CV	  values	  will	  be	  expected	  to	  
deviate	  not	   in	  between	  analytical	  strategies	  only,	  but	  also	  on	  a	  prep-­‐by-­‐prep	  basis.	  That	  said,	  care	  
should	  be	  taken	  while	  interpreting	  these	  results,	  due	  to	  the	  loss	  of	  predictability	  and	  to	  the	  fact	  that	  
the	   methods	   are	   conceptually	   different.	   The	   condensation	   of	   early	   isochrones	   seen	   in	   the	   ∆KPQ	  
hearts	   with	   Flecainide,	   is	   probably	   due	   to	   a	   severe	   epicardial	   conduction	   decrease	   around	   the	  
pacing	  electrode.	  Cardiac	  layers	  are	  reported	  to	  react	  differently	  to	  NaV1.5-­‐blocking	  agents492,	  499,	  503.	  
Hence,	  we	   speculate	   that	   the	   isochrones	   become	   largely	   spaced,	   due	   to	   a	   stronger	   3D	   intramural	  
component	   at	   the	   pacing	   site,	   which	   lead	   to	   the	   reappearance	   of	   the	   epicardial	   wave	   near	   the	  
boundaries	   at	   later	   time	   points,	   an	   effect,	  which	   simulates	   an	   increase	   of	   the	   apparent	  mean	   CV,	  
when	   the	   electrical	   excitation	   is	   mapped	   on	   a	   2D	   plane.	   No	   such	   effect	   was	   seen	   in	   the	   WT	  
measurements	   at	   5min,	   treated	   with	   the	   same	   protocol	   as	   the	   ∆KPQ.	   Gradual	   decrease	   in	   CV,	  
without	   alteration	   in	   the	   elliptical	   behavior	   was	   the	   only	   detected	   effect	   with	   WT	   at	   similar	  
measurement	  times	  in	  terms	  of	  isochronal	  maps.	  
	  
The	   fact	   that	   all	   methods	   performed	   well	   with	   homogeneous	   elliptical	   propagation	   cannot	   be	  
extrapolated	   in	   a	   straightforward	   manner	   to	   include	   success	   of	   these	   methods	   with	   more	  
complicated	  patterns.	  Whether	  the	  complexity	  is	  due	  to	  the	  substrate	  heterogeneity	  (Figure	  17)	  or	  
noise	  embedded	  in	  the	  signal	  (Figure	  16),	  these	  factors	  can	  complicate	  the	  analysis	  of	  conduction	  in	  
murine	  hearts.	  	  Measurement	  noise	  can	  replicate	  non-­‐homogeneous	  activations,	  due	  to	  misdetection	  
of	  the	  appropriate	  activation	  times,	  a	  complication	  primarily	  due	  to	  technical	  errors	  rather	  than	  the	  
nature	  of	  the	  cardiac	  substrate	  itself.	  On	  the	  other	  hand,	  dissimilarities,	  induced	  by	  manipulating	  the	  
diffusion	   properties	   of	   the	   medium	   at	   the	   level	   of	   each	   pixel,	   impose	   an	   increasing	   level	   of	  
heterogeneities	   in	   the	  medium,	   a	   proposed	  mechanism	   in	   the	   initiation	   of	   arrhythmia502.	   This	   is	  
considered	   a	   characteristic	   of	   the	   investigated	   substrate	   at	   hand.	   We	   showed	   how	   these	   factors	  
could	  significantly	  alter	  CV	  depending	  on	  the	  method	  of	  analysis.	  
	  
Effect	   of	   Measurement	   Noise:	   Area	   Fitting	   (AF)	   is	   the	   most	   robust.	   Activation	   maps	   were	  
completely	  disrupted	  as	  the	  SNR	  deteriorated	  (Figure	  16).	  Although	  the	  algorithm	  is	  automated	  to	  
detect	   precisely	   activation	   times,	   as	   in	   the	   case	   of	   the	   experimental	   data,	   detection	   became	  
increasingly	  ambiguous	  for	  the	  surrogate	  noisy	  data	  (Figure	  16a,	  upper	  row).	  The	  LSEF	  depends	  on	  
the	  ability	  to	  fit	  ellipses	  to	  data	  points.	  When	  isochrones	  became	  globally	  ill	  defined	  for	  any	  reason,	  
fitting	   ellipses	   become	   a	   random	  process	   (Figure	   16a,	  middle	   row).	  However	   even	   at	   lower	   pixel	  
SNR	  a	  linear	  regime	  could	  still	  be	  sporadically	  found	  for	  some	  maps,	  where	  the	  linear	  fitting	  method	  
could	  give	  considerably	  different	  regression	   lines,	   leading	   to	  arbitrarily	  velocity	  values.	   	  Using	   the	  
Plane	  Fitting	  (PF)	  method,	  the	  ability	  to	  compute	  a	  gradient	  for	  any	  field	  stands	  at	  low	  SNR	  (Figure	  
16a,	  third	  row).	  Nevertheless,	  it’s	  difficult	  to	  judge	  the	  validity	  of	  these	  results	  since	  the	  vector	  field	  
isn’t	  reliable,	  with	  random	  amplitude	  vectors	  pointing	   in	  random	  directions.	  AF,	   in	  contrast	  to	  the	  
previous	  two	  methods,	  overcomes	  misdetection	  of	  activation	  times.	  The	  extreme	  noise	  level	  didn’t	  
hinder	  the	  potential	  for	  detecting	  the	  area	  that	  activated	  and	  quantifying	  the	  activation	  speed.	  The	  
erroneous	  detection	  of	  APs	  when	  there’s	  none–due	  to	  an	  ill-­‐defined	  absolute	  zero,	  i.e.	  the	  arbitrary	  
time	  point	   between	  2	   pulses–lead	   to	   few	   activated	  pixels	   per	   image	   in	   the	   earlier	   frames	   (Figure	  
16b,	   times	  up	   to	  5.5ms).	  However,	  when	   the	  real	  activation	  eventually	  dominated,	   the	   time	  series	  
increased	   accordingly	   (as	   presented	   for	   the	   experimental	   data	   in	   Figure	  13a	   and	  b,	   right	   panels).	  
This	  method	  doesn’t	  have	  an	  inherent	  problem	  and	  is	  spatially	   independent.	  The	  higher	  the	  noise,	  
the	   higher	   the	   number	   of	   pixels	   that	   could	   be	   erroneously	   detected	   as	   activated,	   rendering	   the	  
absolute	   zero	   time	   of	   actual	   activation	   harder	   to	   specify.	   Nevertheless,	   with	   the	   appropriate	  
correction	   of	   the	   initial	   time	   (t0)	   the	   method	   ably	   detected	   the	   real	   activation	   (Figure	   16b)	   and	  
quadratic	   functions	   were	   reliably	   fitted	   to	   the	   time	   series.	   Hence,	   plausible	   value	   for	   anisotropy	  
could	   still	   be	   quantified.	   In	   summary,	   the	   inability	   to	   have	   a	   well-­‐defined	   activation	   map	   at	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extremely	  low	  SNR	  (SNR<0.01)	  eliminated	  the	  plausible	  use	  of	  the	  LSEF	  and	  PF	  in	  these	  conditions.	  
AF	  can	  falsely	  detect	  the	  earliest	  pixel	  due	  to	  noise.	  However,	  carrying	  these	  corrections	  allows	  AF	  
to	  be	  the	  method	  of	  choice	   in	  evaluating	  CV	  in	  the	  presence	  of	  very	   low	  SNR	  without	  contributing	  
significant	  changes	  to	  the	  activation	  other	  than	  the	  physiological	  process	  of	  interest.	  
	  
PF	   Quantifies	   Regional	   Differences	   in	   Propagation.	   In	   simple	   experimental	   conditions,	   while	  
measuring	   the	   epicardial	   activation,	   the	   assumption	   that	   the	   epicardium	   could	   be	   treated	   as	   a	  
homogeneous	   and	   continuous	   medium	   fairly	   stands613.	   Investigating	   disease	   models	   or	  
pharmacological	   interventions	   could	   impose	   variable	   activation	   configurations,	   which	   by	  
significantly	   deviating	   from	   the	   expected	   elliptical	   spread,	   necessitate	   statistical	   calculations	  
embedded	  within	   the	   returned	   values	   of	   velocities.	   PF	   displays	   velocity	   estimates	   as	   vectors	   that	  
locally	  characterize	   the	  speed	  and	  direction	  of	  propagation	  qualitatively	  and	  quantitatively	  during	  
simple	   patterns	   or	   activations,	   even	   where	   anisotropy	   is	   completely	   lost.	   It	   offers	   an	   efficient,	  
quantitative	   strategy	   in	   constructing	   vector	   fields	   that	   fully	  make	  use	  of	   the	   local	   inter-­‐isochronal	  
information284,	  a	  possibility	  that	  isn’t	  offered	  by	  the	  LSEF,	  nor	  the	  AF.	  These	  latter	  methods	  describe	  
the	  conduction	  in	  the	  medium	  only	  globally.	  Despite	  its	  independence	  of	  geometry,	  the	  outcome	  of	  
AF	  can	  be	  used	  only	  as	  an	  “effective”	  velocity	  measure,	  a	  rate	  of	  wave	  propagation	  in	  many	  different	  
orientations,	  rather	  than	  an	  “actual”	  velocity.	  LSEF	  shows	  to	  be	  insensitive	  to	  local	  changes,	  making	  
it	  a	  poorer	  choice	  as	  the	  level	  of	  asymmetry	  adds	  up	  (Figure	  17a,	  middle	  row).	  The	  LSEF	  (and	  AF	  to	  
a	  lesser	  extent)	  fails	  as	  well	  to	  adequately	  represent	  the	  complexities	  of	  the	  activation	  pattern	  in	  the	  
final	  results.	  The	  effect	  of	  heterogeneity	  is	  well	  illustrated	  with	  PF	  (as	  seen	  in	  polar	  plots,	  comparing	  
Figure	  14a	  and	  b)	  that	  captured	  these	  important	  fluctuations	  in	  the	  medium	  and	  incorporated	  them	  
as	  a	  statistical	  component	  within	  each	  bin,	  by	  progressively	  increasing	  the	  SD,	  a	  value	  associated	  by	  
default	  with	  the	  velocity	  value	  (Figure	  17b,	  right	  panel).	  However,	  this	  latter	  could	  also	  be	  regarded	  
as	  a	  disadvantage:	  Based	  on	  numerical	  derivatives,	  overestimating	  mean	  CV	  is	  a	  risk	  and	  increasing	  
SD	   means	   loss	   of	   precision,	   because	   knowing	   the	   “real”	   velocity	   in	   the	   medium	   is	   simply	   not	  
available.	   Henceforth,	   caution	   in	   interpreting	   results	   is	   necessary.	   This	  method	   is	   independent	   of	  
geometry,	  so	  regardless	  of	  the	  underlying	  fiber	  orientation;	  the	  maximal	  and	  minimal	  velocities	  are	  
picked	  up	  from	  binning	  local	  vectors.	  	  
	  
LSEF	   is	  a	  Poorer	  Choice	  as	   the	  Degree	  of	  Asymmetry	   Increases.	  The	  use	  of	   geometric	  models	  
allows	  for	  a	  fast	  and	  robust	  assessment	  against	  outliers	  in	  data	  points.	  The	  cost	  function	  reasonably	  
characterizes	  the	  goodness	  of	  fit	  of	  the	  fitted	  ellipses	  to	  the	  different	  isochrones,	  hence	  objectively	  
reports	  deviations	  of	  the	  activation	  contours	  from	  the	  expected	  anisotropy.	  Such	  a	  model	  takes	  into	  
account	  the	  anisotropic	  spread	  in	  the	  heart	  and	  shows	  robustness	  in	  averaging	  out	  small-­‐scale	  non-­‐
uniformities	  in	  the	  morphology	  of	  the	  propagating	  wave	  front	  that	  may	  otherwise	  cause	  divergence.	  
On	  the	  other	  hand,	  the	  same	  intrinsic	  properties	  make	  this	  method	  particularly	  a	  poorer	  choice,	  as	  
the	  anisotropy	   in	   the	   cardiac	   tissue	   is	  disrupted.	  First,	   only	   the	   isochrones	   that	   show	  an	  elliptical	  
propagation	   from	   a	   point	   stimulation	   are	   valid	   for	   analysis	   (Figure	   10a,	   Figure	   11a	   and	   b).	   This	  
method	   assumes	   symmetry	   about	   the	   pacing	   point,	   making	   it	   inappropriate	   for	   any	   asymmetric	  
configuration,	   as	   seen	   in	   the	   effect	   of	  NaV1.5-­‐blocking	   (Figure	   14b)	   and	   confirmed	  with	   synthetic	  
data	   (Figure	   17a).	   Second,	   CV	   evaluation	   is	   limited	   to	   isochronal	   contours,	   with	   no	   use	   of	   the	  
information	   lying	   between	   the	   linearly	   interpolated	   pixels.	   In	   retrospect,	   the	   isochronal	   contours	  
depend	   on	   the	   ability	   to	   detect	   activation	   times	   that	   are	   by	   themselves	   dependent	   on	   noise	  
(measurement	  noise,	  motion	  artifacts)	  and	  sampling	  rate.	  Third,	  the	  choice	  of	  particular	  isochronal	  
points	  depends	  on	  the	  conserved	  symmetry	  and	  the	  value	  returned	  by	  the	  cost	  function.	  A	  threshold	  
is	   therefore	   necessary	   to	   either	   include	   a	   particular	   isochrones	   or	   exclude	   it.	   In	   consequence,	  
isochrones	   showing	   asymmetry	   of	   the	   contours	   due	   to	   the	   ellipsoid	   shape	   of	   the	   heart	   or	   to	  
boundary	  conditions	  are	  excluded,	  which	   limits	   the	  ROI	   to	   fewer	   than	  5-­‐6	   isochrones	   (Figure	  11a	  
and	   b,	   left	   panels).	   Fourth,	   our	   data	   showed	   that	   deviations	   from	   anisotropy	   cause	   each	   fitted	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ellipsis	  to	  assume	  a	  separate	  center	  that	  could	  drift	  significantly	  from	  the	  pacing	  site,	  which	  is	  the	  
natural	   point	   of	   activation	   for	   all	   contours.	   This	   center	   drift	   affects	   the	   lengths	   of	   the	   axes	   and	  
causes	  scattering	  in	  isochronal	  points,	  rendering	  a	  linear	  fit	  invalid	  for	  velocity	  evaluation.	  	  
	  
Limitations.	  Our	  study	  is	  applicable	  to	  2D	  isochronal	  maps.	  The	  ellipsoid	  shape	  of	  the	  heart	  alters	  
the	  detection	  of	  activation	  times	  near	  the	  boundaries.	  Adopting	  a	  ROI	  approach,	  where	  the	  wave	  can	  
be	   safely	   assumed	   to	   travel	   parallel	   to	   the	   epicardial	   surface,	   considerably	   reduces	   this	   effect.	  
Modifications	  are	  necessary	  if	  those	  methods	  are	  to	  be	  applied	  on	  a	  3D	  model.	  Another	  limitation	  is	  
the	  inability	  to	  correlate	  the	  outcomes	  of	  each	  method	  with	  epicardial	  fibers’	  orientation.	  To	  further	  
strengthen	  the	  arguments	  presented,	  a	  direct	  correlation	  between	  fibers’	  orientation	  and	  velocities	  
should	  be	  emphasized.	  
	  
4.2. Reduced Excitability and APD Prolongation in mdx-hearts  
The	   cardiac	   tissue	   is	   inherently	   anisotropic,	   a	   property,	   which	   has	   been	   implicated	   in	  
arrhythmogenesis520,	   617.	   In	   our	   experiments,	   the	   mdx	   mouse	   provides	   a	   heart	   model	   of	   lower	  
excitability	   (due	   to	   loss	   of	   NaV1.5	   exclusively	   on	   the	   LM)	   compared	   to	   its	   WT	   counterpart.	   We	  
additionally	  chose	  to	  alter	  excitability	   in	  these	  cardiac	  substrate	  by	  using	  Flecainide,	  which	  blocks	  
NaV1.5	  in	  its	  open	  state511,	   618	  (as	  described	  in	  the	  Introduction	  section	  1.4.7,	  the	  availability	  of	  the	  
binding	  site	  of	  the	  drug	  is	  channel-­‐state	  dependent619).	  The	  slow	  binding	  and	  unbinding	  kinetics	  of	  
Flecainide	   are	   at	   the	   core	   of	   its	   use-­‐dependence	   effects;	   a	   property	   of	   incremental	   blocking	  with	  
successive	  beats454,	  619.	  We	  have	  estimated	  in	  our	  experiments	  the	  number	  of	  successive	  beats	  (20-­‐
30	  beats	  in	  a	  train	  of	  60	  pulses)	  necessary	  from	  the	  start	  of	  pacing	  until	  steady	  state	  blockade	  was	  
reached	   at	   each	   time	   point,	   during	   exposure	   to	   Flecainide	   when	   a	   measurement	   is	   recorded.	   It	  
should	   be	   noted	   here,	   that	   the	   term	   “steady	   state”	   doesn’t	   refer	   to	   a	   true	   equilibrium	   of	   drug	  
blockade,	  rather	  to	  the	  sequence	  of	  repetitive	  APs	  of	  similar	  morphology	  that	  indicates	  steady	  state	  
conditions.	  It’s	  expected	  that	  fluctuations	  of	  drug	  blockade	  take	  place	  during	  each	  cycle	  of	  pacing	  as	  
NaV1.5	   shifts	   between	   the	   different	   conformational	   states118.	   For	   open-­‐state	   blockers,	   the	  
percentage	  of	  drug-­‐bound	  sites	   increases	  very	   fast	   initially	   then	  starts	   to	  decrease,	  as	   the	  binding	  
site	   remains	  open459.	  This	  process	  occurs	  during	   the	  brief	   time	   interval	  of	  depolarization,	   (~1ms)	  
during	  which	  NaV1.5	  opens,	  followed	  almost	  instantaneously	  by	  fast	  inactivation11,	  620.	  
	  
By	   lowering	   INa,f	   using	   Flecainide	   in	   the	  WT	   and	  maybe	   furthermore	   in	   the	  mdx,	  we	   studied	   how	  
various	  factors	  might	  come	  into	  play	  in	  facilitating	  preferential	  longitudinal	  or	  transversal	  block	  in	  
anisotropic	  preparations	  where	   the	  whole	  hearts	   remain	   intact.	   Preferential	  directional	  block	  has	  
been	   investigated	   previously	   and	   the	   interventions	   that	   decrease	   NaV1.5	   availability	   in	   the	  
anisotropic	  tissue	  have	  been	  leading	  to	  conflicting	  results.	  Spach	  et	  al.	  showed	  that	  anisotropy	  could	  
lead	   to	   a	   preferential	   decrease	   in	   the	   longitudinal	   direction,	   facilitating	   conduction	   block	   and	  
reentry319.	   They	   also	   argue	   that	   despite	   larger	   discontinuities	   along	   the	   transversal	   direction,	  
propagation	   was	   more	   robust	   and	   maintained	   primarily	   by	   the	   continuously	   larger	   maximal	  
upstroke	   velocities	   measured	   in	   this	   direction319.	   In	   Spach’s	   model	   of	   directional	   differences	   in	  
open-­‐state	  blocking,	  the	  author	  argue	  that	  since	  the	  rate	  of	  rise	  of	  the	  AP	  was	  measured	  to	  be	  faster	  
along	   the	   transversal	   direction	   in	   their	   preparations,	   the	   opening	   time	  of	  NaV1.5	  must	   be	   shorter	  
during	  depolarization	  along	  this	  direction,	  than	  along	  the	  longitudinal	  one621.	  They	  also	  argue	  that	  
drug	   molecules	   are	   expected	   to	   behave	   in	   a	   non-­‐biased	   fashion,	   i.e.	   irrespective	   of	   anisotropic	  
considerations,	  whenever	  the	  channels’	  binding	  sites	  suddenly	  become	  available	  the	  drug	  molecule	  
should	  bind,	   following	   the	  principle	   of	  mass	   action	  of	   a	   random	  distribution622.	  Henceforth,	   small	  
directional	  differences	  (occurring	  on	  lower	  time	  scales	  than	  a	  ms)	  in	  the	  opening	  time	  of	  the	  channel	  
would	   result	   in	   considerable	   differences	   in	   the	   blocking	   mechanism	   of	   NaV1.5	   open-­‐state	  
antagonists621.	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Other	  investigators	  reported	  that	  transversal	  block	  was	  more	  favorable	  in	  the	  anisotropic	  tissue623-­‐
625,	  particularly	  when	  GJs	  conductance	  was	  severely	  reduced	  using	  heptanollxxvi624.	  Another	  study	  by	  
de	   Diego	   et	   al.	   showed	   that	   under	   conditions	   where	   INa,f	   was	   reduced	   in	   anisotropic	   tissues,	  
whenever	  Vmax	  and	  Vmin	  decreased	  proportionately	  keeping	  the	  AR	  unaltered,	  conduction	  block	  was	  
not	  observed626.	   Indeed	  similar	  changes	   in	  Vmax	  and	  Vmin	  were	  observed	   in	   the	  mdx	  heart,	  keeping	  
the	   AR	   unaltered	   under	   no	   treatment	   conditions	   (Figure	   27).	   As	   the	   velocity	   in	   the	   medium	  
increased	  with	   Flecainide	   at	   later	   stages	   of	   the	   protocol	   (Figure	   22),	   AR	  was	   significantly	   altered	  
(Figure	  27).	  
4.2.1. Relationship between NaV1.5 Availability, (dF/dt)max and CV 
In	   the	  mdx	  mouse,	   INa,f	   is	   decreased	   by	  ~29%	   (Patch	   clamp)237,	  which	   translates	   into	   a	   global	   CV	  
decreaselxxvii	   (along	   both	   axes	   of	   propagation)238.	   In	   light	   of	   these	   findings	   and	   the	   fact	   that	   the	  
resting	  membrane	  potential	  in	  the	  mdx	  cells	  is	  not	  more	  depolarized	  than	  the	  one	  in	  the	  WT237,	  we	  
measured	   the	   upstroke	   velocities	   of	   the	   propagating	   wave	   on	   the	   epicardial	   surface	   in	   both	  
directions	  and	  we	  found	  that	  (dF/dt)max	  correlates	  well	  with	  CV	  measurements	  on	  two	  levels:	  First,	  
(dF/dt)max	  is	  larger	  along	  the	  long	  axis	  and	  smaller	  transversally	  in	  both	  WT	  and	  mdx	  (i.e.	  directional	  
differences	  exist	  at	  the	  level	  of	  the	  upstroke	  velocities).	  Second,	  (dF/dt)max	  acquires	  lower	  values	  in	  
the	  mdx	  than	  in	  the	  WT.	  Interestingly,	  our	  calculations	  show	  that	  (dF/dt)max	  decrease	  in	  the	  mdx	  is	  
proportional	   to	   the	   decrease	   in	   INa,f	   found	   in	   patch	   clamp	   experiments,	   with	   a	   ~28%	   and	   ~30%	  
decrease	   in	   the	   mdx	   with	   respect	   to	   the	   WT	   along	   the	   longitudinal	   and	   transversal	   directions	  
respectively	   (Figure	   24a	   and	   b,	   Control	   conditions).	   The	   percentage	   decrease	   in	   the	   velocities	  
measured	  in	  the	  mdx	  was	  lower	  than	  the	  ones	  observed	  in	  (dF/dt)max	  and	  INa,f	  with	  20-­‐25%	  in	  Vmax	  
and	  17-­‐21%	  in	  Vmin	  (Figure	  22a	  and	  b,	  Control	  conditions).	  These	  findings	  suggest	  that	  propagation	  
in	   the	   murine	   epicardium	   exhibits	   both	   continuous	   and	   discontinuous	   propertieslxxviii.	   The	  
proportionality	   relationship	  between	   the	  decrease	   in	   INa,f	   and	   (dF/dt)max	   in	   either	  direction	   in	   the	  
mdx	   is	  a	  property	  of	  continuous	  propagation92,	   627.	  However,	  (dF/dt)max	  also	  shows	  dependence	  on	  
the	  direction	  of	  propagation	   relative	   to	   the	  axis	  of	   the	   cardiac	   cells,	  which	   is	   a	  property	  of	   rather	  
discontinuous	  propagation319.	  In	  a	  continuous	  medium,	  the	  effect	  of	  axial	  resistance	  (presence	  of	  GJ	  
along	  the	  longitudinal	  axis	  of	  the	  cell	  and	  its	  absence	  laterally)	  is	  to	  simply	  shrink	  the	  spatial	  scale	  
over	   which	   depolarization	   takes	   place,	   leaving	   the	   time	   course	   of	   depolarization	   practically	  
unchanged251.	  In	  other	  words	  in	  a	  continuous	  medium,	  (dF/dt)max	  is	  expected	  to	  reflect	  excitability	  
of	   the	   epicardium	   independent	   of	   the	   direction	   in	   which	   the	   wave	   propagates.	   As	   explained	   in	  
section4.1.1,	   the	   size	   of	   the	   cardiac	   cell	   plays	   a	  major	   role	   in	   propagation.	   It’s	   suggested	   that	   the	  
murine	  epicardium	  can	  be	  lumped	  into	  a	  “single	  macroscopic	  model	  cell”254,	  whenever	  the	  smaller	  
size	   murine	   cardiac	   cells	   are	   present	   in	   a	   homogeneous	   tissue551,	   with	   a	   regular	   network	   of	  
electrically	  well-­‐coupled	  cells628.	  Despite	  the	  fact	  that	  in	  the	  murine	  heart	  intracellular	  dynamics	  can	  
be	   assumed	   to	   be	   almost	   continuous590,	   the	  directional	   changes	   in	   the	  measured	   (dF/dt)max	   show	  
that	  cardiac	  propagation	  in	  the	  murine	  epicardium	  evidently	  acquires	  discontinuous	  properties.	  
	  
Although	   it	   has	   been	   shown	   that	   neither	   the	   relationship	   between	   INa,f	   and	   (dF/dt)max,	   nor	   the	  
relationship	  between	  (dF/dt)max	  and	  CV	  are	  linear	  in	  systems	  with	  discontinuous	  propagation,	  it	  has	  
been	  assumed	  that	  effects	  of	  AADs	  on	  CV	  should	  correlate	  directly	  with	  their	  effects	  on	  (dF/dt)max.	  
We	  show	  CV	  (Figure	  21a)	  and	  (dF/dt)max	  dispersion	  maps	  (Figure	  23a	  and	  b)	  within	  a	  ROI	  on	  the	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxxvi	  Heptanol	   is	   a	   chemical	   substance	  used	   to	  modulate	   the	   junctional	   current	  promoting	  uncoupling	  by	  decreasing	   the	  
opening	  probability	  of	  GJ	  channels.	  Reference:	  American	  Journal	  of	  Physiology	  (1992)	  262:C1531-­‐8.	  
lxxvii	  Refer	  to	  section	  4.1.1.	  
lxxviii	   Refer	   to	   the	   Introduction	   section	   1.3.1	   for	   a	   detailed	   description	   of	   the	   differences	   between	   continuous	   and	  
discontinuous	  conduction	  in	  the	  cardiac	  tissue.	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epicardial	   surface	   for	  WT	   and	  mdx	   under	   conditions,	  where	   no	   treatment	  was	   applied	   and	   at	   t10	  
from	  exposure	  to	  Flecainide.	  It	  became	  evident	  that	  both	  hearts	  initially	  respond	  to	  Flecainide	  with	  
a	   decrease	   in	   (dF/dt)max	   and	   CV	   in	   almost	   all	   locations,	   in	   both	   substrates.	   WT	   hearts	   however	  
showed	   a	   peculiarity	   in	   their	   conduction	   profile:	   a	   focus	   of	   increased	   velocities	  mainly	   along	   the	  
long	  axis	  of	  the	  cells	  became	  evident	  at	  t10	  (~60%	  increase	  in	  Vmax	  in	  this	  example,	  Figure	  21a,	  lower	  
row,	  left).	  In	  Figure	  22a,	  box	  plots	  started	  to	  show	  a	  collective	  increase	  in	  Vmax	  within	  the	  WT	  group	  
at	   7min	   from	   exposure	   to	   Flecainide.	   In	   the	   meantime,	   the	   mdx	   heart	   remains	   devoid	   of	   any	  
heterogeneity	   in	   conduction	   (Figure	   21a,	   lower	   row,	   right)	   and	   CV	   was	   continuously	   decreasing	  
(Figure	  22a	  and	  b).	  From	  (dF/dt)max	  maps	  (Figure	  23a	  and	  b)	  and	  bar	  graphs	  (Figure	  24a	  and	  b),	  the	  
maximum	  AP	   upstroke	   velocity	  was	   responding	   to	   Flecainide	   by	   a	   continuous	   decrease	   in	   either	  
substrate.	   The	   peculiarity	   observed	   in	   the	   CV	  profile	   of	   the	  WT	   at	   t10	  was	   not	   correlated	  with	   an	  
increase	  in	  (dF/dt)max	  at	  the	  same	  location.	  This	  indicates	  that	  (dF/dt)max	  and	  CV	  varied	  in	  the	  same	  
direction	  up	  to	  7min	  exposure	  to	  Flecainide,	  beyond	  which	  they	  changed	  in	  opposite	  directions.	  	  
	  
Examples	   of	   such	   “supernormal	   conduction”	   were	   previously	   reported	   in	   the	   canine99,	   549	   and	  
sheep97	   Purkinje	   fibers,	   where	   no	   uniform	   relationship	   between	   (dF/dt)max	   and	   CV	   was	  
demonstrated	  at	  different	  experimental	  conditions	  including	  hyperkalemia,	  hypercalcemia	  and	  with	  
the	   use	   of	   drugs	   (such	   as	   phenytoin,	   digoxin).	   Dominguez	   and	   Fozzard97	   and	   others549	   found	   no	  
alteration	   in	  cable	  properties	  sufficient	   to	  explain	  speeding	  of	  conduction	   in	  sheep	  Purkinje	   fibers	  
subjected	   to	   hyperkalemia,	   in	   the	   absence	   of	   a	  more	   depolarized	   resting	  membrane	   potential	   or	  
shift	  in	  the	  threshold	  potential.	  They	  suggested	  therefore	  that	  the	  likely	  explanation	  for	  the	  speeding	  
of	   conduction	   was	   increased	   “excitability”	   that	   developed	   as	   the	   takeoff	   potential	   was	   reaching	  
threshold.	  Excitability	  of	  the	  cardiac	  tissue	  was	  described	  as	  a	  confluence	  of	  conditions	  such	  as	  the	  
relative	   proximity	   of	   the	   membrane	   potential	   to	   threshold	   during	   terminal	   repolarization,	   slow	  
diastolic	   repolarization	   and	   alterations	   of	   the	   ionic	   environment,	   which	   could	   be	   experimentally	  
measured	  by	  the	  amount	  of	  injected	  current	  necessary	  to	  bring	  the	  tissue	  to	  threshold99.	  	  
	  
Our	  experimental	  results	  show	  that	  as	  WT	  hearts	  were	  exposed	  to	  Flecainide,	  CV	  was	  considerably	  
increased	  (the	  value	  reached	  was	  ~60%	  larger	  at	  t10	  than	  it	  was	  originally	  at	  t0)	  in	  finite	  regions	  of	  
the	  heart	  under	  steady	  pacing	  conditions	  with	  no	  evidence	  of	  a	  simultaneous	  increase	  in	  (dF/dt)max,	  
nor	  excitability.	  Instead,	  speeding	  of	  conduction	  occurred	  in	  regions	  of	  spatially	  extended	  decrease	  
in	  upstroke	  velocity.	  Kléber	  and	  Rudy	  suggested	  a	  transient	  decrease	  in	  INa,f	  threshold	  requirements	  
to	   account	   for	   supernormal	   conduction254.	   As	   the	   wave	   emanates	   from	   the	   stimulation	   site,	  
depolarizing	   charges	   bring	   the	   depressed	   (lower	   available	   NaV1.5	   for	   excitation)	   and	   quiescent	  
tissue	   to	   threshold.	   Simply	  put,	   an	  area	  of	   transient	  decrease	   in	   INa,f	   activation	  would	   require	   less	  
depolarizing	  charges	  for	  NaV1.5	  activation.	  In	  the	  presence	  of	  decreased	  upstroke	  velocity,	  the	  rate	  
of	   change	   of	  membrane	   potential	   at	   takeoff	   potential	   is	   also	   reduced	   and	   slow	   depolarization	   to	  
peak	  voltage	  will	   increase	  the	  electrochemical	  driving	   force	   for	  Na+,	  hence	  could	  cause	  a	  transient	  
increase	  in	  INa,f	  	  and	  CV	  in	  that	  finite	  region	  of	  the	  heart629.	  	  
	  
This	  mechanism,	  although	  speculative,	  may	  account	   for	  the	   local	   increase	   in	  CV	   in	  the	  presence	  of	  
depressed	  excitability,	  but	  doesn’t	  explain	  why	  the	  mdx	  heart,	  with	  lower	  amount	  of	  NaV1.5,	  failed	  to	  
develop	  the	  same	  speeding	  of	  conduction	  under	  the	  same	  experimental	  conditions.	  Nonetheless,	  we	  
have	   shown	   using	   optical	   mapping	   and	   by	   lowering	   NaV1.5	   availability	   using	   Flecainide,	   that	  
longitudinal	  velocity	  is	  enhanced	  whereas	  transversal	  velocity	  is	  reduced	  under	  steady	  state	  pacing,	  
favoring	  therefore	  the	  probability	  of	  a	  transversal	  block	  occurring	  in	  the	  setting	  of	  a	  premature	  beat.	  
A	   limitation	  of	  optical	  mapping,	  as	  explained	  in	  the	  previous	  section	  of	  this	  chapter	  (4.1.3),	   is	   that	  
the	  increase	  or	  decrease	  in	  CV	  of	  the	  electrical	  wave	  propagating	  on	  the	  epicardial	  surface	  does	  not	  
necessarily	   reflect	   the	   dynamics	   of	   the	   electrical	   activity	   in	   unmapped	   subepicardial	   layers.	   A	  
transmural	  study	  is	  consequently	  necessary	  to	  investigate	  subsurface	  events	  with	  Flecainide.	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We	   extensively	   showed	   in	   section	   3.1,	   that	   the	   non-­‐uniform	   loss	   of	   NaV1.5	   from	   the	   LM	   of	  mdx	  
cardiomyocytes	   lead	   to	   a	   global	  decrease	   in	  CV	   in	   all	   directions,	   keeping	   the	  AR	  unaltered.	   In	   the	  
presence	   of	   directional	   differences	   in	   the	   measured	   (dF/dt)max	   (Figure	   23	   and	   Figure	   24),	   we	  
recognize	   that	   the	  mouse	   epicardium	  exhibits	   a	   degree	   of	   discontinuous	  propagation,	   despite	   the	  
smaller	   size	   of	   murine	   cardiomyocytes.	   Under	   conditions	   of	   NaV1.5	   blocking,	   (dF/dt)max	   overall	  
decrease	   between	   t0	   and	   t10	   (Figure	   27c)	  was	   on	   average	   similar	   in	   both	   directions	   in	   the	  WT	   (a	  
decrease	  of	  51±17%	  along	  the	  longitudinal	  axis	  and	  52±10%	  transversally),	  whereas	  the	  mdx	  heart	  
showed	   slightly	   different	   directional	   changes	   in	   (dF/dt)max	  with	   Flecainide	   (a	   decrease	   of	   44±9%	  
longitudinally,	  39±6%	  transversally).	  Despite	  these	  similarities	  in	  the	  overall	  decrease	  of	  (dF/dt)max	  
longitudinally	  and	  transversally	  in	  the	  WT	  heart	  (Figure	  27c),	  the	  decay	  curves	  (Figure	  25)	  highlight	  
a	   directional	   discordance	   in	   the	   decay	   rates	   of	   this	   parameter	   notably	   in	   the	   early	   5	  minutes	   of	  
exposure	  to	  Flecainide.	  This	  suggests	  that	  the	  time	  course	  of	  the	  upstroke	  not	  only	  is	  dependent	  on	  
the	   spatial	   configuration	   in	   the	   normal	   heart,	   but	   its	   modulation	   by	   Flecainide	   is	   also	   subject	   to	  
anisotropic	   considerations.	   This	   indicates	   a	   potential	   stronger	   involvement	   of	   discontinuities	   in	  
propagation	  of	  the	  murine	  epicardial	  AP	  with	  NaV1.5	  blocking.	  
	  
We	   have	   argued	   in	   section	   4.1.1	   that	   in	   contrast	   to	   the	   inhomogeneous	   intracellular	   propagation	  
expected	   in	   large	  cardiac	  cells537,	  murine	  cells	  could	  behave	  as	  a	  syncytium	  due	  to	   their	  relatively	  
smaller	   size	   and	   their	   presence	   in	   a	   network	   of	   strongly	   well-­‐coupled	   units,	   that	   intracellular	  
inhomogeneity	   is	   of	  minor	   influence	   on	  macroscopic	   anisotropic	   conduction539.	   To	   further	   refine	  
this	  argument,	  the	  latter	  statement	  stands	  for	  small	  size	  cells	  particularly	  when	  CV	  in	  the	  medium	  is	  
fast	   enough	   (as	   discussed	   in	   section	   4.1.1,	  where	   these	   conditions	  were	   fulfilled).	   Cellular	   scaling	  
could	  be	  dynamically	  described	  by	  intracellular	  conduction,	  i.e.	  by	  how	  fast	  the	  depolarizing	  charges	  
that	   enter	   the	   quiescent	   cell	   from	   one	   end	   propagate	   within	   it,	   can	   progressively	   change	   the	  
membrane	  potential	  and	  trigger	  NaV1.5	  activation.	  By	  blocking	  NaV1.5	  and	  reducing	  the	  velocity	  of	  
the	  traveling	  wave	  in	  the	  medium,	  local	  depolarization	  dynamics	  also	  become	  slower.	  On	  that	  scale,	  
the	  small	  size	  cell	  becomes	  larger;	  therefore	  displays	  large	  size	  cells	  intracellular	  dynamics.	  	  
	  
While	  this	  accounts	  for	  the	  directional	  discrepancy	  observed	  in	  the	  rate	  of	  decay	  of	  (dF/dt)max	  in	  the	  
WT	  heart,	   the	   rate	  of	   change	   in	   (dF/dt)max	   in	   the	  mdx	   becomes	  more	  understandable	   (Figure	  25a	  
and	  b)	  by	  considering	  the	   following:	   the	   longitudinal	  (dF/dt)max	  decay	  curves	   for	   the	  WT	  and	  mdx	  
are	   almost	   superimposable	   (Figure	   25a,	   left),	   the	   transversal	   ones	   significantly	   diverge	   from	   one	  
another	   in	   favor	   of	   the	  WT	   curve,	  which	   decays	   at	   a	  much	   faster	   rate	   in	   the	   early	   phases	   of	   the	  
treatment	   (Figure	   25a,	   right).	   The	   decay	   curves	   along	   the	   longitudinal	   direction	   reveal	   almost	  
similar	   kinetics	   between	   the	  mdx	   and	  WT,	   suggesting	   that	   clustering	  of	  NaV1.5	   at	   the	  GJs	   and	   the	  
passive	   properties	   at	   the	   IDs	   are	   not	   altered	   between	   the	   two	   substrates	   with	   the	   addition	   of	  
Flecainide.	  With	   the	   lack	  of	  NaV1.5	  on	   the	  LM	  of	   cardiomyocytes	   in	   the	  mdx	   heart,	  modulation	  by	  
Flecainide	  along	  the	  transversal	  direction	  is	  no	  longer	  possible.	  A	  sequel	  of	  Flecainide’s	  activity	  on	  
the	  available	  channels	  at	  the	  IDs	  could	  account	  for	  the	  observed	  decay	  in	  (dF/dt)max	  in	  the	  mdx	  heart	  
along	  the	  transversal	  direction.	  
	  
It’s	  particularly	  important	  to	  mention	  that	  the	  latter	  interpretation	  is	  valid	  with	  the	  assumption	  that	  
the	  epicardial	   layer,	  where	  activation	  is	  measured,	   is	  a	  perfect	  2D	  plane	  of	  cells	  (from	  a	  geometric	  
perspective)	  and	  transmural	  effects	  on	  activation	  are	  assumed	  to	  be	  negligible.	  This	  is	  a	  limitation	  of	  
the	  experimental	  method,	  whenever	  a	  3D	  object	  is	  projected	  on	  a	  2D	  surface.	  In	  reality,	  the	  mapped	  
epicardial	  layer	  is	  not	  isolated	  (in	  the	  intact	  heart)	  and	  transmural	  components	  could	  influence	  CV	  
measurements,	   if	   the	  wave	   traveling	  across	   the	  wall	   is	   for	   some	   reason	   faster	   than	   the	  epicardial	  
propagation.	  This	  could	  account	  for	  an	  “apparent”	  increase	  in	  velocity	  or	  “supernormal	  conduction”	  
in	  the	  presence	  of	  depressed	  excitability.	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4.2.2. AP Early Phase Prolongation: A Localized Effect of NaV1.5 Loss  
The	  repercussions	  of	  the	  considerable	  reduction	  (29%)	  in	  INa,f	  in	  the	  mdx	  cells237	  are	  not	  limited	  to	  
(dF/dt)max	   (Figure	   24,	   Control),	   nor	   CV	   (Figure	   22,	   Control)	   in	   the	   dystrophic	   substrate,	   but	   they	  
were	  also	  inflicted	  in	  APD	  prolongation,	  particularly	  APD25	  (Figure	  32a,	  Control)	  with	  an	  increase	  of	  
~60%	  in	  APD25	  along	  either	  direction.	  The	  effects	  of	  NaV1.5	  loss	  in	  the	  mdx	  become	  increasingly	  less	  
significant	  beyond	  the	  early	  stages	  of	  repolarization;	  hence	  almost	  no	  difference	  in	  APD	  is	  detected	  
at	   50%	   repolarization	   (Figure	   30a	   and	   b)	   or	   beyond	   (Figure	   32b).	   This	   result	   emphasizes	   the	  
specificity	  of	   ionic	  channels’	   involvement	  with	   in	   the	  context	  of	  dystrophin	  deficiency.	  NaV1.5	   loss	  
under	   control	   conditions	   in	   the	  mdx	   heart	   orchestrates	   a	   temporally	   localized	   effect	   during	   the	  
sequential	  activation	  of	  ionic	  channels	  that	  follows	  phase	  0	  of	  the	  AP.	  This	  is	  tailed	  by	  a	  fast	  enough	  
repolarization	  that	  eventually	  compensates	  for	  the	  previous	  delay	  in	  phase	  1	  and	  early	  phase	  2	  to	  
bring	   the	   APmdx	   to	   phase	   4,	   at	   the	   same	   time	   as	   the	   APWT	   (Figure	   19).	   The	   direct	   influence	   of	  
(dF/dt)max	   on	  APD25	  was	   further	   elucidated	   in	   Figure	   35.	   Although	   an	   exact	   quantification	   of	   this	  
relationship	  cannot	  be	  computed	   from	  this	  graph,	   it	  was	  apparent	   that	   fast	  enough	  upstrokes	  (i.e.	  
WTLong)	   were	   correlated	   with	   brief	   APD25	   (Figure	   35a)	   and	   as	   the	   upstroke	   velocities	   became	  
continuously	  smaller	  (whether	  for	  WTTrans	  or	  mdx	  either	  direction),	  APD25	  became	  more	  prolonged.	  
Since	   the	   time	   scales	  of	   the	  processes	   that	   follow	   the	  upstroke	  are	  of	   finite	  value,	   an	   increasingly	  
faster	   (dF/dt)max	  will	   not	   reduce	  APD25	   beyond	   the	  minimal	   time	   required	   for	   Ito,1	   to	   activate	   and	  
inactivate.	   On	   the	   other	   hand,	   interventions	   that	   reduce	   the	   upstroke	   velocity	   could	   alter	   Ito,1	  
kinetics	  and	  amplitude	  significantly,	  due	  to	  the	  latter’s	  strong	  outward	  rectification	  properties	  with	  
a	   dependency	   on	   the	   change	   in	   Vmbr	   as	   phase	   0	   reaches	   its	   peak107,	   630.	   In	   conditions	   where	   no	  
Flecainide	   is	   added,	   ICa,L	   kinetics	   of	   activation	   are	   considered	   relatively	   slow	   to	   contribute	  
substantially	  to	  the	  upstroke	  or	  the	  early	  phases	  (25%	  repolarization)	  that	   follow	  the	  upstroke162.	  
Therefrom,	  we	  could	  attribute	   the	   less	  prominent	  notch,	  decreased	  phase	  1	  and	  higher	  plateau	   in	  
APmdx	   with	   a	   restricted	   APD	   prolongation	   to	   the	   consequential	   loss	   of	   NaV1.5	   that	   generated	   a	  
shallower	  upstroke	  and	  delays	  in	  early	  repolarization	  in	  the	  mdx	  heart.	  
	  
The	  effects	  observed	  in	  APD25	  are	  not	  limited	  to	  the	  epicardial	  locations,	  from	  which	  the	  APs	  were	  
picked,	  but	  they	  exceed	  these	  local	  values	  to	  the	  spatial	  distribution	  of	  each	  of	  the	  AP	  repolarization	  
levels.	  APD	  dispersions	  (ΔAPD)	  were	  extracted	   from	  the	  corresponding	  APD	  maps	  (Figure	  28	  and	  
Figure	   31)	   to	   quantify	   the	   extent	   of	   APD	   repolarization	   differences	   in	   the	   mapped	   epicardial	  
surfaces.	   Although	   histograms	   (Figure	   29)	   do	   not	   provide	   information	   regarding	   the	   spatial	  
distribution	   of	   the	   heterogeneities	   whenever	   found,	   we	   could	   visualize	   the	   APD	   spatial	  
configuration	  directly	  from	  the	  maps	  themselves.	  For	  the	  first	  time,	  our	  data	  show	  that	  NaV1.5	  loss	  
from	   the	   LM	   in	   the	   mdx	   not	   only	   associates	   with	   prolongation	   of	   APD25,	   but	   also	   contributes	  
significantly	   to	   the	   widening	   of	   the	   ΔAPD25	   by	   more	   than	   60%	   compared	   to	   its	  WT	   counterpart	  
(Figure	   33).	   As	   the	  AP	   approaches	   full	   repolarization,	   the	   effects	   due	   to	   lower	  NaV1.5	   availability	  
become	  weaker	  and	  consistently	  no	  significant	  change	  in	  the	  dispersion	  of	  APD	  values	  is	  observed	  
for	  either	  APD50	  or	  APD75	   (Figure	  33).	  This	   indicates	   that	  despite	  NaV1.5	   intense	   clustering	  at	   the	  
IDs242,	  244	  in	  the	  normal	  heart,	  the	  remaining	  NaV1.5	  channels	  on	  the	  LM	  obviously	  play	  a	  crucial	  role	  
in	  homogenizing	  APD	  values	  and	  their	  distribution	  at	  early	  phases	  of	  APD	  repolarization,	   for	  their	  
loss	  has	  the	  potential	  to	  significantly	  influence	  the	  extent	  of	  spatial	  heterogeneity	  up	  to	  more	  than	  
60%.	  Since	  this	  widening	  of	  dispersion	   is	  restricted	  to	  APD25,	  and	  doesn’t	   include	  APD50	  or	  APD75,	  
the	  direct	   implication	  of	   such	  a	   finding	   in	  arrhythmogenesis	   is	   yet	   to	  be	   clarified.	  This	  might	  also	  
point	   to	   the	   possibility	   that	   the	   mdx	   cell	   could	   have	   developed	   a	   compensatory	   repolarization	  
machinery	  that	  smoothes	  out	  later	  repolarization	  abnormalities	  in	  APDs	  in	  value	  and	  dispersion	  at	  
the	  level	  of	  the	  multicellular	  tissue.	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4.3. A Novel Mechanism Behind Flecainide Proarrhythmia 
The	  experimental	  findings,	  which	  appear	  closer	  to	  our	  observations	  with	  Flecainide,	  were	  published	  
by	  Krishnan	  and	  Antzelevitch	  in	  1993,	  in	  which	  high	  concentrations	  of	  Flecainide	  ([10-­‐20μM])	  were	  
capable	  of	  not	  only	  inducing	  differential	  responses	  between	  endocardium	  and	  epicardium	  in	  the	  dog	  
heart,	  but	  rather	  opposite	  effects	  in	  canine	  epicardial	  strips	  with	  either	  prolongation	  or	  abbreviation	  
of	  the	  APD	  at	  different	  exposure	  times	  to	  the	  drug411.	  Canine	  epicardial	  and	  endocardial	  preparations	  
were	   perfused	   with	   Flecainide	   and	   were	   paced	   at	   different	   cycle	   lengths	   (CL	   =	   200-­‐2000ms).	  
Transmembrane	  potentials	   recorded	   from	  one	  or	   a	   few	  more	   sites	   on	   the	   epicardium	  using	   glass	  
microelectrodes,	   measuring	   upstroke	   velocities,	   APD50	   and	   APD90.	   They	   observed	   that	   Flecainide	  
[15μM]	  produced	  prominent	  prolongation	  of	  both	  APD50	  and	  APD90	  in	  the	  epicardium	  after	  30min	  of	  
Flecainide	   exposure.	   Along	   with	   the	   increase	   in	   APD,	   was	   an	   increase	   in	   the	   delay	   between	   the	  
upstroke	  of	  phase	  0	  and	  phase	  2	  of	  the	  AP,	  and	  diminution	  of	  the	  upstroke	  velocities.	  However,	  after	  
40min	   exposure	   to	   Flecainide,	   further	   decrease	   in	   phase	   1	   resulted	   in	   an	   “all-­‐or-­‐none	  
repolarization”	  in	  the	  epicardial	  cells,	  leading	  to	  loss	  of	  the	  plateau	  and	  a	  premature	  termination	  of	  
the	  AP411.	  These	  experiments	  clearly	  show	  that	  NaV1.5	  blockade	  can	  produce	  opposite	  effects	  on	  the	  
APD	  in	  the	  epicardium.	  As	  they	  recorded	  from	  three	  sites	  on	  the	  epicardium,	   it	  was	  observed	  that	  
APD	   prolongation	   or	   abbreviation	   was	   rate	   and	   time	   dependent,	   where	   different	   sites	   displayed	  
distinctive	   rate	  dependent	  properties.	  APD	  restitution	  curves	  measured	   from	  the	   three	  sites	  were	  
almost	  congruent	  at	  shorter	  S1-­‐S2	  intervals	  (~150-­‐300ms)	  with	  a	  basic	  cycle	  length	  of	  2000ms,	  and	  
diverged	  considerably	  at	  S1-­‐S2	  intervals	  larger	  than	  350ms	  up	  to	  600ms.	  	  
	  
Despite	  some	  similarities	  between	  the	  latter	  observations	  and	  ours,	  particularly	  with	  epicardial	  APs	  
that	  initially	  showed	  a	  prolongation	  with	  Flecainide	  followed	  by	  an	  abbreviation,	  major	  and	  crucial	  
differences	   exist	  between	   their	   results	   and	  ours	  on	   several	   scales.	  The	   comparison	  between	   their	  
results	   and	   ours	   should	   be	   done	   with	   caution:	   starting	   from	   the	   different	   animal	   models	   used	  
(canine	  vs.	  murine	  hearts),	  the	  experimental	  tools	  to	  characterize	  the	  electrophysiology	  in	  the	  tissue	  
(extracellular	   electrodes	   at	   a	   few	   sites	   on	   the	   epicardium	   vs.	   optical	   mapping	   using	   10,000	  
recording	  sites	  and	  a	  spatial	  resolution	  of	  100μm),	  the	  high	  concentrations	  of	  Flecainide	  that	  are	  of	  
little	  practical	  significance	  in	  a	  clinical	  setting631,	  632	  (15μM	  vs.	  1μM;	  therapeutic	  range	  of	  Flecainide	  
[0.5-­‐2μM]lxxix)	  and	  the	  adopted	  pacing	  protocol	  to	  reveal	  the	  heterogeneity	  in	  the	  epicardium	  (S1-­‐S2	  
protocol	   vs.	   steady	   state	  pacing	   at	   a	   fixed	  BCL).	   The	   impacts	   of	   these	  differences	   are	   tackled	   in	   a	  
more	  detailed	  manner	  in	  the	  next	  subsections	  (4.3.1	  and	  4.3.2).	  	  
	  
The	  concentrations	  of	  drugs	  Krishnan	  and	  Antzelevitch	  used	  in	  their	  in-­‐vitro	  studies	  were	  very	  high	  
compared	  to	  ours411.	  The	  trend	  in	  pharmacological	  interventions	  is	  to	  use	  as	  high	  concentrations	  as	  
possible,	   until	   an	   effect	   is	   observed633,	   634.	   Although	   these	   pharmacological	   studies	   are	   of	   great	  
scientific	   importance,	   serious	   questions	   should	   be	   raised	   concerning	   the	   ones	   that	   use	   tens	   or	  
hundreds	   of	  mM	   of	   drug	   to	   study	   their	   channel	   blocking	   action,	  when	   the	   therapeutic	   range	   lies	  
more	   than	   4-­‐5	   orders	   of	   magnitude	   lower452.	   We	   therefore	   attempted	   to	   use	   clinically	   valid	  
concentrations,	   to	   obtain	   a	   more	   realistic	   correlation	   with	   what	   could	   possibly	   be	   clinically	  
observed.	  
4.3.1. APDxx Prolongation and Increased APDxx Dispersion (ΔAPDxx) with 
Flecainide in the Murine Heart 
Flecainide	  has	  been	   reported	   to	   cause	  APD90	  prolongation	   in	  mammalian	  ventricular	  myocytes479,	  
635,	  as	  well	  as	  human,	  guinea	  pig,	  and	  canine	  atria636,	  637.	  However	  it	  was	  also	  shown	  to	  cause	  APD90	  
shortening	  in	  canine	  Purkinje	  fibers635.	  In	  our	  measurements,	  APD	  prolongation	  was	  observed	  at	  all	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repolarization	   levels	   (APD25,	   APD50	   and	  APD75)	  with	   Flecainide	   (Figure	   30,	   Figure	   32,	   Figure	   42),	  
and	  most	   prominently	   in	  APD25	  measurements	   (Figure	  34,	   Figure	  43)	   in	   all	   substrates	   (WT,	  mdx,	  
and	  ΔKPQ).	  This	  suggests	  that	  with	  an	  increasingly	  shallower	  upstroke,	  the	  amplitudes	  and	  kinetics	  
of	  sequential	  ionic	  currents	  could	  be	  modified,	  causing	  shifts	  in	  the	  phases	  of	  the	  epicardial	  AP	  with	  
respect	   to	   voltage	   and	   time.	   In	   reality,	   with	   the	   strong	   use-­‐dependence	   of	   Flecainide,	   APD	  
prolongation	  was	  not	  expected.	  Since	  our	  experiments	  were	  conducted	  using	  only	  one	  frequency	  of	  
stimulation,	  carried	  at	  steady	  state,	  we	  cannot	  comment	  on	  how	  the	  rate	  of	  APD	  prolongation	  would	  
change,	  if	  different	  frequencies	  were	  involved,	  neither	  can	  we	  speculate	  on	  the	  restitution	  behavior	  
of	   the	  APD	   in	   the	   presence	   of	   Flecainide.	   Although	  we	   have	   observed	   an	  APD	  prolongation	   in	   all	  
sinus	   measurements	   (both	   WT	   and	   mdx)	   with	   Flecainide	   compared	   to	   the	   starting	   control	  
conditions,	  this	  finding	  is	  not	  reliable	  because	  the	  measured	  APDs	  are	  at	  different	  locations	  on	  the	  
restitution	   curve	   (due	   to	   the	  varying	  diastolic	   interval	  between	   initial	   control	   conditions	   (t0)	   and	  
after	  Flecainide	  was	   introduced	   into	   the	  system).	  At	  control	  conditions,	   the	  sinus	  rate	  was	  no	   less	  
than	  8-­‐8.3Hz	  (i.e.	  480-­‐500	  bpmlxxx).	  After	  ten	  minutes	  of	  Flecainide	  exposure,	  the	  sinus	  rate	  dropped	  
to	  a	  value	  between	  4.5-­‐5.8Hz	  (270-­‐350	  bpm)	  in	  almost	  all	  preparations.	  Hence,	  we	  cannot	  confirm	  
whether	  the	  observed	  APD	  prolongation	  is	  secondary	  to	  pure	  Flecainide	  effects	  or	  due	  to	  the	  final	  
lower	  heart	  rates.	  	  
	  
The	  observation	  that	  Flecainide	  causes	  an	  actual	  prolongation	  of	  the	  APD	  doesn’t	  correlate	  well	  with	  
the	   fact	   that	   this	   drug	   has	   a	   strong	   use-­‐dependence	   block479.	   Indeed,	   Flecainide	   is	   unique	   among	  
AADs,	   where	   use-­‐dependence	   block	   of	   NaV1.5	   causes	   a	   prolongation	   of	   the	   APD	   and	   not	  
retraction499,	  638.	  This	  might	  suggest	  that	  Flecainide	  blocks	  other	  channels	  than	  just	  NaV1.5.	  Follmer	  
et	   al.	   showed	   that	   Class	   Ic	   agents	   have	   a	  markedly	   different	   ionic	   profile	   among	  NaV1.5	   blockers:	  
Flecainide	   has	   the	   potential	   to	   block	   the	   rapid	   component	   of	   the	   delayed	  K-­‐rectifier	   current	   (IKr)	  
using	   concentrations	   as	   low	   as	   2.1μM	   in	   cat	   ventricular	  myocytes639.	   Although	   the	   concentration	  
used	  in	  the	  latter	  experiments	  is	  at	  least	  twice	  as	  large	  as	  the	  one	  used	  with	  our	  murine	  hearts,	  we	  
cannot	   eliminate	   the	  possibility	   that	  blocking	  K+	   channels	   could	  be	   involved	   in	   the	  observed	  APD	  
prolongation	  with	  Flecainide.	  
	  
In	  a	  previous	  study	  done	  by	  Starmer	  et	  al.,	  they	  showed	  that	  prolonging	  refractoriness	  by	  blocking	  
NaV1.5	   alone	   increases	   the	   likelihood	   of	   unidirectional	   block	   in	   the	   presence	   of	   premature	  
excitations	  in	  an	  otherwise	  normal	  tissue492.	  Follmer	  et	  al.	  showed	  that	  the	  interaction	  of	  Flecainide	  
with	   K+	   channels	   closely	   correlated	   with	   channel	   activation,	   suggesting	   an	   open-­‐state	   blocking	  
effect639.	   As	   the	   result	   of	   the	   two	   previous	   findings,	   Follmer	   et	   al.	   argue	   that	   the	   antiarrhythmic	  
efficacy	   of	   Flecainide	   resides	   in	   its	   ability	   to	   act	   on	   both	   NaV1.5	   and	   K+	   channels,	   by	   prolonging	  
refractoriness	  in	  the	  setting	  of	  decreased	  excitability,	  without	  the	  need	  to	  solely	  reduce	  INa,f	  in	  order	  
to	  achieve	  the	  same	  degree	  of	  refractoriness639.	  
	  
APD	  prolongation	  is	  of	  different	  magnitude	  for	  different	  levels	  of	  repolarization,	  with	  Flecainide.	  For	  
higher	  repolarization	  levels	  for	  which	  the	  APDs	  were	  originally	  defined	  (i.e.	  the	  closer	  temporally	  is	  
the	   repolarization	   level	   to	   the	   upstroke),	   the	   more	   prominent	   is	   the	   percentage	   increase	   in	  
prolongation	  observed	  between	  t0	  and	  t10,	   in	  either	  WT	  or	  mdx	  (Figure	  34).	  Both	  APD50	  and	  APD75	  
showed	  no	  directional	  bias,	  in	  such	  a	  way	  that	  the	  percentage	  increase	  didn’t	  vary	  whether	  the	  APs	  
were	  picked	  up	  along	   the	   longitudinal	  or	   transversal	  directions.	  To	   illustrate,	   in	   the	  WT	  APD50,Long	  
prolonged	  by	  ~65%	  and	  APD50,Trans	  by	  ~60%.	  Although	   the	  percentage	   increases	   in	   the	  mdx	  were	  
slightly	   higher	   (but	   not	   statistically	   significant)	   compared	   to	   the	  WT,	   no	   directional	   preferences	  
were	   detected;	   APD50,	   Long	   and	   APD50,Trans	   prolonged	   by	  ~70%	   and	  ~69%	   respectively.	   APD75	   and	  
APD90	  in	  both	  WT	  and	  mdx	  prolonged	  overall	  by	  ~40%	  and	  ~30%	  respectively	  in	  both	  directions.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxxx	  In	  cardiology,	  the	  heart	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  is	  measured	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  per	  minute.	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The	  dynamics	  of	  APD25	  were	  dramatically	  different	  than	  other	  APDs.	  This	  parameter	  appeared	  to	  be	  
the	  most	  susceptible	  to	  Flecainide,	  acquiring	  both	  direction-­‐	  and	  substrate-­‐dependences	  (Figure	  34)	  
as	   the	   treatment	   progressed.	   In	   the	  WT,	   the	  prolongation	   of	  APD25	   peaked	   along	   the	   longitudinal	  
direction	  with	  an	  increase	  exceeding	  ~190%,	  vs.	  ~170%	  in	  the	  transversal	  direction.	  The	  mdx	  heart,	  
with	   lower	   available	   NaV1.5	   channels,	   showed	   significantly	   lower	   percentages	   of	   APD25	   increase	  
between	   t0	   and	   t10	  upon	  exposure	   to	  Flecainide,	  with	  ~155%	  and	  ~110%	   in	   the	   longitudinal	   and	  
transversal	  directions,	  respectively.	  These	  data	  emphasize	  three	  important	  findings:	  	  
• As	  APD25	  encloses	  the	  time	  interval	  from	  AP	  takeoff	  till	  the	  end	  of	  phase	  1,	  it	  represents	  the	  
interval	  during	  which	  the	  dynamical	  processes	  the	  most	  affected	  by	  functional	  NaV1.5	  take	  
place.	   In	  other	  words,	   this	  correlates	  well	  with	  the	   fact	   that	  under	  control	  conditions,	  only	  
APD25	  showed	  a	  significant	  difference	  between	  WT	  and	  mdx,	  whereas	  other	  APDs	  were	  not	  
statistically	   different	   (Figure	   30,	   Figure	   32).	   In	   our	   simplistic	   assumptions,	   the	   major	  
difference	  in	  the	  plasma	  membrane	  ionic	  composition	  between	  WT	  and	  mdx	  is	  the	  absence	  
of	   NaV1.5	   on	   the	   LM	   in	   the	   mutated	   heart.	   Hence,	   if	   subsequent	   ionic	   currents	   were	  
perturbed	   in	   the	  mdx	   compared	   to	   the	  WT	   in	   the	   earliest	   phases	   of	   repolarization	   (in	   the	  
absence	  of	  Flecainide),	  they	  should	  stem	  from	  the	  differences	  in	  NaV1.5	  availability	  between	  
the	  two	  substrates	  (Figure	  19).	  
• Flecainide	   enhanced	   the	   appearance	   of	   directional	   bias	   only	   in	  APD25,	  whether	   in	   the	  WT	  
alone	   (by	   comparing	   longitudinal	   to	   transversal	   directions),	   in	   the	   mdx	   alone	   or	   when	  
comparing	   the	   two	   substrates.	   The	   lower	   percentage	   increases	   in	   APD25,mdx	   (compared	   to	  
APD25,WT)	   further	   underline	   that	   the	   lack	   of	   NaV1.5	   on	   the	   LM	   means	   lower	   available	  
channels	  to	  modulate.	  Henceforth,	  the	  total	  change	  induced	  by	  Flecainide	  in	  either	  direction	  
is	  expected	   to	  be	  reduced	   in	   the	  mdx	   (as	   it	  was	   indeed	  observed	   in	   the	  statistics	   in	  Figure	  
34).	  
• The	   increased	   susceptibility	   of	   APD25	   to	   Flecainide	   (compared	   to	   APD50,	   APD75	   or	   APD90)	  
highlights	   that	   in	   our	   experiments,	  whether	   [1μM]	   Flecainide	   also	   blocks	  K+	   channels,	   the	  
main	   functional	   effect	   of	   the	   drug	   is	   localized	   to	   high	   enough	   phases	   of	   the	   AP,	   where	  
repolarizing	  K+	  channels	  play	  practically	  no	  role.	  	  
	  
Because	   of	   the	   fact	   that	   APD25	   incorporates	   other	   AP	   processes	   beyond	   the	   upstroke	   phase,	   its	  
sensitivity	   to	   directional	   influences	   is	   less	   pronounced	   than	   the	   one	   observed	   for	   the	   maximum	  
upstroke	  velocity	  (dF/dt)max	  (Figure	  25),	  where	  the	  decay	  in	  (dF/dt)max	  was	  similar	  between	  WT	  and	  
mdx	   along	   the	   longitudinal	   direction,	   but	   more	   pronounced	   in	   the	   WT	   along	   the	   transversal	  
direction	   (compatible	   with	   the	   differences	   in	   NaV1.5	   cellular	   distribution	   between	   the	   two	  
substrates).	  Hypothetically	  speaking,	  if	  APD25	  were	  to	  represent	  the	  phase	  of	  the	  AP	  where	  NaV1.5	  is	  
the	  only	  functional	  channel,	   then	  the	  behavior	  of	  APD25	  and	  (dF/dt)max	  with	  Flecainide	  at	  any	  time	  
point	  of	  the	  treatment	  with	  Flecainide	  should	  exactly	  match.	  Since	  the	  latter	  statement	  is	  precisely	  
not	   true,	   as	   Flecainide	   exposure	   proceeded,	   the	   coupling	   between	   ADP25	   and	   (dF/dt)max	   became	  
increasingly	   ambiguous,	   indicating	   a	   decoupling	   between	   the	   two	   parameters	   (Figure	   35).	   This	  
could	   suggest	   that	  as	   the	  upstroke	  velocity	  becomes	  progressively	  weaker,	  under	   the	   influence	  of	  
the	  drug,	   the	  ability	   to	  NaV1.5	   to	  orchestrate	   the	  sequential	  activation	  of	   the	  consecutive	  channels	  
becomes	  increasingly	  more	  limited	  (Figure	  35b).	  At	  t10,	  further	  deterioration	  of	  the	  upstroke	  would	  
hinder	  the	  capacity	  of	  NaV1.5	  to	  even	  coordinate	  the	  earliest	  phases	  of	  the	  AP	  (particularly	  the	  ones	  
involving	  Ito,1	  and	  ICa,L)	  after	  the	  upstroke;	  a	  mechanism	  that	  could	  promote	  electrical	   instability	  in	  
the	  tissue.	  	  
	  
The	   spatial	   distribution	   of	   the	   above	  macroscopic	   processes	   couldn’t	   have	   been	   elucidated	   using	  
traditional	  microelectrodes	  positioned	  at	  few	  sites	  of	  the	  epicardium.	  The	  strength	  of	  the	  observed	  
findings	  relies	  in	  the	  methodology	  used	  to	  dissect	  both	  spatially	  and	  temporally	  the	  effects	  related	  
to	   the	   propagating	   electrical	   activity	   across	   the	   entire	   epicardium.	   Furthermore,	   without	   optical	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mapping,	   the	   increase	   in	   spatial	   dispersion	   of	   repolarization	   (SDR)	   couldn’t	   have	   been	   described	  
with	  the	  precision	  adopted	  in	  this	  work.	  Flecainide	  not	  only	   induced	  a	  differential	  prolongation	  in	  
the	  APD	  values,	  but	  also	  in	  the	  spatial	  organization	  of	  these	  APDs	  across	  the	  epicardium,	  where	  WT	  
and	  mdx	   hearts	   both	   showed	   a	   pronounced	   increase	   in	   their	   SDR	   at	   different	   AP	   repolarization	  
(Figure	  33).	  Under	  control	  conditions	  (i.e.	  when	  no	  Flecainide	  was	  introduced),	  APD25	  was	  not	  only	  
significantly	   prolonged	   in	   the	   mdx,	   but	   also	   the	   dispersion	   of	   the	   APD25	   (i.e.	   ΔAPD25)	   was	  
significantly	   widened	   in	   the	  mdx	   (ΔAPD25,WT	   =8.4±1.7ms,	   ΔAPD25,mdx	   =13.1±4.0ms,	   p-­‐value<0.01).	  
Although	  ΔAPD25,mdx	  was	  higher	  on	  average	   (29.3±7.1ms)	   than	  ΔAPD25,WT	   (25.6±6.6ms),	  bistability	  
erupted	  in	  at	  least	  70%	  of	  the	  WT	  hearts	  (n=10)	  at	  t10	  and	  in	  0%	  of	  mdx	  heart	  (n=7).	  The	  emergence	  
of	  bistability	  in	  the	  APD50	  profile	  in	  the	  WT	  heart	  at	  t10	  led	  to	  the	  significance	  increase	  in	  dispersion	  
(Figure	  33).	  Hence,	  we	  believe	  that	  the	  ΔAPD50,WT	  and	  ΔAPD75,WT	  widening	  at	  t10	  is	  a	  consequence	  of	  
bistability,	  rather	  the	  causative	  agent	  behind	  it.	  	  
	  
To	  further	  illustrate	  why	  this	  point	  could	  be	  crucial	  in	  our	  understanding	  of	  symmetry	  breaking	  in	  
APD,	   the	   same	   analysis	   of	   APD	   prolongation	   and	   dispersion	   was	   carried	   out	   in	   the	   ΔKPQ	  model	  
treated	  with	  Flecainide	  [1μM]	  and	  their	  WT	  control,	  over	  a	  protocol	  that	  lasted	  for	  5min	  (due	  to	  the	  
premature	   loss	   of	   steady	   state	   conditions	   with	   the	   ΔKPQ	   model	   beyond	   5min	   of	   treatment).	  
Although	  the	  spatial	  organization	  of	  APDs	  in	  the	  ΔKPQ	  heart	  doesn’t	  show	  the	  same	  sharp	  transition	  
observed	   previouslylxxxi,	   the	   heterogeneous	   distribution	   of	   APD25	   and	   APD50	   at	   t5	   indicates	   the	  
presence	  of	  steep	  gradients	  between	  the	  distinct	  zones	  observed	  on	  the	  epicardial	  surface	  (Figure	  
39a	  and	  b).	  Although	  ΔAPD50,WT	  was	   significantly	  higher	   in	   the	  WT	  at	   t5	   compared	   to	  ΔAPD50,ΔKPQ,	  
symmetry	   breaking	   emerged	   in	   the	   ΔKPQ	   and	   not	   the	  WT	   (the	   difference	   in	   APD50	   values	   is	   not	  
significantly	  different	  between	  the	  two	  groups,	  Figure	  42).	  We	  believe	  that	  since	  we	  are	  principally	  
targeting	  NaV1.5	  with	  Flecainide,	  the	  mechanism	  by	  which	  modulation	  of	  NaV1.5	  occurs	  is	  capable	  of	  
influencing	   the	   subsequent	   events	   leading	   to	   symmetry	   breaking.	   We	   hypothesize	   that	   in	   the	  
presence	   of	   Flecainide,	   neither	   APD25	   prolongation	   nor	   widening	   of	   ΔAPD25	   alone	   may	   evoke	  
symmetry	  breaking	  in	  a	  well-­‐coupled	  tissue.	  However,	  cumulatively,	  whenever	  the	  global	  change	  in	  
ΔAPD25	   with	   Flecainide	   exceeds	   the	   overall	   prolongation	   in	   APD25,	   the	   substrate	   becomes	   more	  
susceptible	  to	  symmetry	  breaking	  (indicated	  by	  the	  statistics	  in	  Figure	  43).	  The	  latter	  statement	  is	  
by	  far	  just	  a	  hypothesis	  based	  on	  an	  observation	  from	  our	  experiments,	  further	  investigations	  using	  
computer	  models	  of	  the	  mouse	  heart	  will	  be	  required	  to	  find	  out,	  whether	  symmetry	  breaking	  with	  
Flecainide	  could	  occur	  under	  the	  pre-­‐requisites	  set	  above.	  
	  
The	   concept	  of	  heterogeneous	   repolarization,	   as	   a	   facilitator	  of	   arrhythmogenic	   activity,	   has	  been	  
recognized	  for	  more	  than	  four	  decades407-­‐409.	  When	  transmembrane	  repolarization	  at	  some	  sites	  of	  
the	  cardiac	  tissue	  outlasts	  repolarization	  at	  an	  adjacent	  site,	  local	  current	  will	  be	  expected	  to	  flow	  in	  
proportion	  to	  the	  voltage	  gradient	  between	  the	  two	  sites411.	  If	  the	  current	  is	  of	  sufficient	  magnitude,	  
it	   can	   reexcite	   the	   earlier	   repolarizing	   site	   by	   bringing	   the	   cells’	   potential	   to	   threshold	   triggering	  
reentry264.	   The	   prominent	   increase	   in	   SDR	   observed	   in	   our	   murine	   hearts	   is	   likely	   to	   be	  
arrhythmogenic	   because	   the	   dispersion	   in	   repolarization	   occurs	   over	   very	   short	   distances264	  
(approximately,	   the	  apico-­‐basal	   length	  of	   the	  murine	  heart	   is	  ~6mm	  and	   the	  width	  of	   the	  LV	   free	  
wall	   in	  our	   field	  of	   view	  ~3mm),	   creating	  a	  very	   steep	   repolarization	  gradient	   (in	   the	  example	   in	  
Figure	   28a,	   the	   gradient	   can	   exceed	   20ms.mm-­‐1	   across	   the	   borderline	   from	   the	   zone	   with	   the	  
prolonged	  APDs	   to	   the	  zone	  of	   the	  abbreviated	  ones).	   It’s	  currently	  believed	   that	   the	  steepness	  of	  
the	   repolarization	   gradient,	   rather	   than	   the	   total	  magnitude	   of	   the	   dispersion	   in	   a	   cardiac	   tissue,	  
determines	  the	  arrhythmogenic	  susceptibility	  of	  the	  substrate	  involved263,	  264.	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4.3.2. Induction of Bistability by Flecainide in the Murine Heart 
The	  striking	  bistability	  emerged	  in	  the	  murine	  LV	  (Figure	  28a,	  second	  row,	  right)	  at	  t10	  exclusively	  
in	   the	   WT:	   The	   epicardium	   appears	   to	   accommodate	   two	   juxtaposed	   regions	   with	   a	   steep	  
repolarization	  gradient	  exceeding	  40ms,	  in	  response	  to	  the	  same	  steady-­‐state	  entraining	  frequency.	  
This	   pattern	   formation	   is	   independent	   of	   anisotropy:	   the	   activation	   pattern	   of	   the	   spreading	  
electrical	   wave	   at	   t10	   hasn’t	   deviated	   from	   anisotropy	   (Figure	   20b,	   left).	   Moreover,	   sinus	  
measurements	  showed	  the	  same	  spatial	  configuration	  of	  the	  prolonged	  and	  abbreviated	  APDs	  (as	  in	  
their	  10Hz	  paced	  counterparts)	  once	  the	  pattern	  is	  formed	  at	  t10.	  This	  indicates	  that	  in	  our	  study,	  the	  
bistability	   observed	   in	   APD	   behavior	   is	   a	   genuine	   characteristic	   of	   the	  WT	   substrate	   exposed	   to	  
Flecainide,	  which	  is	  independent	  of	  frequency	  of	  stimulation	  and	  the	  nature	  or	  pattern	  of	  activation	  
spread.	  
	  
Moe	   and	  Mendez	   argued	   that	   dramatic	   differences	   in	  APD	   could	   not	   occur	   between	  well-­‐coupled	  
cells640,	  because	  electrotonic	   influences	  and	  wave	   front	  collision	  sites	  act	   to	   level	  out	  any	   intrinsic	  
heterogeneity	  in	  AP	  morphology	  over	  a	  large	  spatial	  extent640,	  641.	  Others	  also	  suggested	  that	  abrupt	  
transitions	  in	  APD	  to	  be	  possible	  only	  in	  poorly	  coupled	  cells557	  and	  if	  electrotonic	  interactions	  were	  
too	  weak	   to	   smooth	   out	   the	  APD,	   they	   are	   also	   likely	   to	   be	   as	  weak	   not	   to	   sustain	   a	   reexcitation	  
process640.	  Sampson	  and	  Henriquez	  investigated	  the	  role	  of	  heart	  size,	  tissue	  properties	  and	  spatial	  
distribution	   of	   different	   types	   of	   cells	   on	   functional	   APD	   dispersion642.	   They	   demonstrated	   in	   a	  
simulation	  study,	  that	  electrotonic	  modulation	  of	  APD	  tends	  to	  dominate	  the	  intrinsic	  differences	  in	  
cell	   properties	   in	   the	   small	   mouse	   heart642.	   They	   also	   showed	   that	   intrinsic	   heterogeneity	   in	  
membrane	  properties	  is	  more	  prominent	  when	  the	  heart	  becomes	  significantly	  larger642.	  Using	  the	  
Luo-­‐Rudy	  mammalian	  model	  in	  a	  three	  dimensional	  model	  of	  mouse	  heart	  geometry,	  they	  showed	  
that	   an	   intrinsic	   transmural	   variation	   in	   APD	   of	   30ms	   was	   gradually	   smoothed	   out	   across	   the	  
ventricular	   wall,	   without	   giving	   rise	   to	   any	   functional	   heterogeneity	   in	   the	   medium.	   Their	  
simulations	  were	  in	  concordance	  with	  Knollmann	  et	  al.,	  who	  reported	  no	  significant	  differences	  in	  
APD90	   were	   observed	   transmurally	   in	   the	   mouse	   heart,	   despite	   prior	   findings	   that	   revealed	  
significant	   cellular	   heterogeneity	   in	   isolated	   cells521.	   They	   concluded	   that	   functional	   gradients	   of	  
APD	  in	  small	  hearts	  are	  difficult	  to	  create	  and	  that	  the	  mouse	  heart	  will	  not	  exhibit	  appreciable	  APD	  
dispersion	   unless	   in	   the	   setting	   of	   significant	   uncoupling.	   Consequently,	   they	   concluded	   that	   the	  
mouse	  heart	  could	  be	  a	  poorer	  model	  for	  reproducing	  arrhythmia	  mechanisms	  that	  rely	  on	  SDR642.	  
	  
Using	   high-­‐resolution	   optical	   mapping	   techniques,	   our	   experimental	   study	   demonstrates	   that	   a	  
network	  of	  homogeneously	  (LV	  free	  wall	  only)	  well-­‐coupled	  murine	  epicardial	  cells	  in	  intact	  heart	  
preparations	  can	  simultaneously	  accommodate	  multistable	  excitatory	  states,	  where	  adjacent	  zones	  
of	  heterogeneous	  repolarization	  properties	  with	  a	  gradient	  exceeding	  40ms	  can	  coexist.	  We	  showed	  
that	  Flecainide,	  a	  NaV1.5	  blocker	  agent	  used	  in	  clinically	  valid	  conditions,	  has	  the	  potential	  to	  induce	  
multistability	   in	   a	   normal	   cardiac	   tissue	   with	   perfectly	   homogeneous	   electrophysiological	  
properties	  at	  control	  conditions.	  By	  resolving	  electrical	  activity	  down	  to	  a	  length	  scale	  of	  100μm	  and	  
a	   frame	   rate	   of	   0.5ms,	   we	   measured	   the	   different	   electrophysiological	   components	   including	  
excitability,	   CV,	   APD	   and	   SDR,	   in	   order	   to	   characterize	   with	   significantly	   higher	   accuracy	   the	  
electrical	  instabilities	  that	  could	  arise	  in	  treating	  a	  mouse	  heart	  with	  Flecainide.	  This	  bistability	  was	  
observed	   exclusively	   in	   the	   WT	   mouse	   hearts.	   These	   results	   highlight	   the	   fact	   that	   the	  
electrophysiological	   changes	   induced	   by	   Flecainide	   occur	   in	   a	   healthy	   murine	   heart	   and	   are	  
responsible	   for	   complex	  pattern	   formation.	  On	   the	  other	  hand,	   the	  mdx	  heart	  appears	  resistant	   to	  
these	  instabilities	  at	  t10.	  We	  believe	  that	  the	  electrophysiological	  dynamics	  in	  the	  mdx	  mouse	  were	  
not	   favorable	   for	   symmetry	   breaking	   to	   occur.	   The	   role	   of	   APD25	   prolongation	   and	   ΔAPD25	   in	  
predicting	  the	  occurrence	  of	  symmetry	  breaking	  in	  a	  murine	  cardiac	  tissue	  was	  described	  in	  section	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4.3.1	   (p.	   134).	   Nevertheless,	   using	   only	   these	   functional	   data,	   we	   cannot	   delineate	   the	   exact	  
mechanism	  that	  hindered	  the	  appearance	  of	  symmetry	  breaking	  with	  Flecainide	  in	  the	  mdx	  heart.	  
	  
This	   symbiosis	   between	   slowed	   conduction	   and	   heterogeneous	   repolarization	   would	   be	   of	   a	  
particular	   importance	   in	  pathological	   diseases	  of	   the	  heart483,	  where	   structural	   heterogeneity	   can	  
amplify	   the	   predisposition	   of	   cardiac	   patients	   to	   drug-­‐induced	   arrhythmias485,	   486,	   in	   concordance	  
with	   the	   outcomes	   of	   CAST	   I474.	   In	   a	   normal	   epicardium,	   bistability	   is	   expected	   to	   give	   rise	   to	  
reentrant	  patterns	  in	  the	  presence	  of	  premature	  stimuli497.	  These	  data	  support	  the	  hypothesis	  that	  
electrophysiological	   heterogeneity	   upon	   exposure	   to	   Flecainide	   could	   play	   a	   critical	   role	   in	   the	  
proarrhythmic	   effects	   of	   the	   drug411.	   Given	   that	   arrhythmias	   are	   multicellular292,	   it	   becomes	  
legitimate	   to	  question	   the	  efficacy	  and	  applicability	  of	  antiarrhythmic	  drugs	  as	  a	  primary	  mean	  of	  
patients’	   management,	   when	   their	   outcomes	   were	   established	   based	   on	   isolated	   “single”	   cell	  
measurements643,	  644.	  
4.3.3. Hypothetical Mechanisms Behind Bistability and Arrhythmogenesis  
The	  current	  experimental	  outcomes	  with	  Flecainide	  motivated	  a	   search	   for	  a	  possible	  mechanism	  
that	   could	   potentially	   account	   for	   the	   observed	   bistability	   in	   healthy	   tissue.	   Cardiac	   excitation	  
involves	   local	  regenerative	  processes	  at	   the	   individual	  cell	   level	  and	  transmission	  of	   this	  transient	  
dynamic	   process	   from	   one	   cell	   to	   another	   via	   intercellular	   connections	   through	   the	   flow	   of	  
depolarizing	  charges.	  However,	  spread	  of	  excitation	  from	  one	  point	  to	  another	  in	  the	  cardiac	  tissue	  
occurs	   exclusively	   when	   a	   critical	   “amount”	   of	   cells	   (source)	   is	   simultaneously	   excited,	   as	   to	  
generate	  a	  depolarizing	  current	  sufficient	  to	  overcome	  the	  sink	  provided	  by	  the	  quiescent	  tissue	  in	  
order	   to	   bring	   downstream	   cells	   to	   threshold645.	   Therefore,	   several	   cells	   below	   this	   critical	  mass	  
cannot	   entrain	   its	  neighbors	   to	  acquire	   the	   same	  characteristics.	  Given	   that	  myocytes	   in	  an	   intact	  
tissue	   are	   well	   coupled	   to	   their	   neighbors,	   how	   do	   these	   cells	   synchronously	   develop	   two	   almost	  
opposing	  dynamics	  in	  such	  a	  small	  sized	  heart?	  	  
	  
We	  hypothesize	  about	  the	  generic	  mechanism	  that	  could	  have	  lead	  to	  the	  bistability	  observed	  in	  our	  
experiments.	  We	  start	  by	  considering	  two	  observed	  properties	  of	  bistability:	  	  First,	  bistability	  is	  not	  
dependent	   on	   anatomy	   or	   structure	   and	   its	   spatial	   configuration,	   whenever	   it	   appears,	   was	   not	  
conserved	   across	   preparations	   (i.e.	   among	   the	   WT	   preps).	   Second,	   WT	   hearts	   that	   eventually	  
showed	   a	   steep	   repolarization	   gradient	   with	   Flecainide	   and	   the	  mdx	   hearts	   that	   failed	   to	   do	   so,	  
shared	  similar	  APD	  distributions	  at	  initial	  conditions	  (i.e.	  in	  the	  absence	  of	  the	  drug).	  Henceforth,	  we	  
are	  reluctant	  to	  associate	  bistability	  to	  differences	  in	  the	  ionic	  machinery	  of	  individual	  cells,	  which	  
was	   shown	   by	   Szentadrassy	   et	   al.	   to	   account	   for	   apico-­‐basal	   differences	   in	   APD	   in	   the	   canine	  
ventricle646.	  We,	   therefore,	  make	   the	   assumption	   that	   all	   cells	   of	   the	   LV	   free	  wall	   epicardium	   are	  
homogeneously	  equipped	  with	  the	  same	  ionic	  channels.	  The	  first	  possibility	  assumes	  that	  each	  and	  
every	  individual	  cell	  has	  the	  capacity	  to	  either	  acquire	  a	   long	  or	  a	  short	  APD.	  The	  presence	  of	  two	  
adjacent	   zones	  with	   a	  dominating	  APD	  on	  each	   side	   suggests	   that	   cells,	  when	  present	   in	   a	   tightly	  
coupled	  mesh,	  have	  the	  potential	   to	  help	   their	  neighboring	  cells	  deciding	  on	  which	  APD	  to	  display,	  
creating	  finally	  two	  zones	  (they	  could	  be	  hypothetically	  more	  than	  just	  two)	  with	  each	  zone	  sharing	  
similar	   electrophysiological	   characteristics.	   Another	   possibility	   assumes	   the	   presence	   of	   “leader	  
cells”	  (that	  form	  a	  “critical	  mass”	  as	  explained	  earlier),	  which	  pick	  the	  initial	  conditions	  (i.e.	  a	  long	  or	  
a	  short	  APD)	  and	  force	  the	  remaining	  mass	  of	  cells	  in	  the	  mesh	  to	  follow	  their	  lead.	  The	  emphasis	  in	  
either	  hypothetical	  behavior	   is	  on	   these	   tight	  electrotonic	   interactions	   that	  overturn	   the	  cells	   in	  a	  
multistable	  system	  to	  acquire	  one	  particular	  electrophysiology	  over	  another.	  Since	  we	  are	  not	  aware	  
of	   the	   intrinsic	  dynamics	  occurring	   at	   the	   level	   of	   one	   cell,	  we	   cannot	  predict	  which	  possibility	   is	  
more	  dominant.	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From	  an	  electrophysiological	  perspective,	  we	  hypothesize	  that	  Flecainide-­‐induced	  bistability	  in	  the	  
murine	  epicardium	  could	  originate	  from	  competing	  currents	  (one	  outward	  repolarizing	  and	  another	  
inward	  depolarizing)	  acting	  between	  the	  end	  of	  phase	  0	  (i.e.	  the	  upstroke)	  and	  before	  the	  phase	  2	  of	  
the	  AP	  (i.e.	  the	  plateau)	  gains	  momentum.	  The	  reason	  for	  this	  assumption	  is	  simple:	  bistability	  was	  
prominent	  after	  25%	  AP	  repolarization,	  and	  wasn’t	  detectable	  prior	  to	  this	  level	  (Figure	  28,	  Figure	  
31).	   The	   two	   competing	   currents	   are	   Ito,1	   and	   ICa,L.	   The	   idea	   behind	   the	   “competing	   currents”	  
hypothesis	   is	   similar	   to	   the	   elegantly	   presented	  work	   by	  Weiss	   et	   al.	   in	  Heart	   Rhythm	   (2010)308,	  
which	  provided	  a	  consistent	  explanation	  for	  the	  dynamics	  of	  afterdepolarizations	  at	  the	  end	  of	  the	  
plateau	  phase,	  using	  a	  rabbit	  heart	  numerical	  model.	  
	  
The	  bidirectional	  influence	  of	  membrane	  voltage	  and	  Ca2+	  on	  each	  other	  is	  well	  documented	  in	  the	  
literature647,	   648.	   In	  a	  murine	  or	   rat	  ventricular	  myocyte,	  Ca2+	  homeostasis	   is	   strictly	  controlled	  via	  
uptake	   in	   the	   sarcoplasmic	   reticulum	  or	  SR	   (more	   than	  95%	  of	   the	   cytoplasmic	  Ca2+	   available	   for	  
mechanical	  contraction	   is	   taken	  up	  by	   the	  SR,	   the	  remaining	  5%	  through	  plasma	  channels)113.	  We	  
consider	  first	  the	  dynamics	  of	  Ca2+	  entry	  into	  the	  cell	  and	  its	  intricate	  modulation	  by	  the	  Ito,1	  current.	  
Although	  the	  INa,f	  -­‐dependent	  rapid	  depolarization	  activates	  ICa,L,	  the	  amplitude	  of	  ICa,L	  doesn’t	  reach	  
its	  maximum	  at	   the	  peak	  and	  consequently	  doesn’t	  contribute	  substantially	   to	   the	  upstroke	  of	   the	  
AP.	  Bers	  explains	  that	  this	  phenomenon	  is	  partly	  due	  to	  the	  fact	  that	  the	  activation	  of	  ICa,L	  is	  not	  just	  
voltage-­‐dependent	  but	  also	  acquires	  some	  intrinsic	  time	  scale	  of	  activation,	  leading	  to	  a	  trade-­‐off	  in	  
the	   co-­‐existence	  of	   relatively	  high	   channel	   conductance	   (gCa)	   and	   low	  driving	   force	   (Embr	   -­‐	  ECa)peak,	  
with	   ICa,L	   being	   the	   product	   of	   these	   two	   components649.	   In	   reality,	   at	   the	   AP	   overshoot,	   the	  
membrane	  voltage	   is	  ~30-­‐40mV,	  which	  is	  relatively	  close	  to	  the	  reversal	  potential	  of	  Ca2+	  (ERev,Ca),	  
which	  is	  measured	  under	  physiological	  conditions	  to	  be	  ~50-­‐60mVlxxxii,	  so	  the	  driving	  force	  of	  Ca2+	  is	  
low	  by	  the	  end	  of	  phase	  0.	  As	  the	  NaV1.5	  channels	  inactivate	  and	  the	  Ito,1	  has	  already	  activated,	  phase	  
1	  lowers	  the	  membrane	  potential,	  increasing	  the	  driving	  force	  of	  Ca2+	  into	  the	  cell.	  In	  conclusion,	  ICa,L	  
activates	  over	   two	  phases:	  A	  rapid	   increase	   in	  conductance	   followed	  by	  an	   increase	   in	   the	  driving	  
force,	   with	   Ito,1	   directly	   modulating	   Ca2+	   influx649.	   Inactivation	   of	   ICa,L	   is	   both	   voltage	   and	   Ca2+	  
dependentlxxxiii,	  with	  the	   latter	  being	  a	  far	  more	  predominant	  component	  of	   inactivationlxxxiv,	  hence	  
ICa,L	  inactivation	  is	  extremely	  slow113.	  
	  
On	   the	   other	   hand,	   Ito,1	   is	   not	   a	   voltage	   dependent	   current	   only,	   but	   also	   acquires	   outward	  
rectification	  properties107,	  which	  means	  that	  the	  amplitude	  of	  this	  current	  is	  strongly	  dependent	  on	  
the	  amplitude	  and	  velocity	  of	  the	  preceding	  upstroke,	  in	  other	  words	  on	  INa,f.	  The	  sizeable	  amplitude	  
of	  this	  current	  in	  rat	  and	  mouse	  ventricular	  cells	  abbreviates	  the	  APD	  and	  reduces	  the	  plateau	  phase	  
substantially113,	   650.	  A	  decrease	   in	   INa,f	   in	  ventricular	   cells	   is	   expected	   to	   lower	   the	   intensity	  of	   Ito,1,	  
henceforth	  decrease	  the	  early	  repolarization	  phase.	  This	  implies	  that	  the	  plateau	  will	  start	  at	  higher	  
membrane	  voltages	  than	  usual,	  an	  effect	  which	  might	  decrease	  the	  driving	  force	  of	  Ca2+	  into	  the	  cell,	  
potentially	   altering	   ICa,L	   peak	   in	   amplitude	   and	   time.	   The	   intricate	   balance	   in	   time	   (and	   within	   a	  
limited	  range	  of	  membrane	  voltages)	  between	  Ito,1	  and	  ICa,L	  peaks	  has	  the	  potential	  to	  tip	  the	  intrinsic	  
dynamics	   of	   the	   cells	   into	   one	   stable	   trajectory	   or	   another.	   In	   the	   case	   of	   the	   observed	   APD	  
bistability	  in	  our	  measurements,	  one	  stable	  state	  is	  APD	  prolongation,	  the	  other	  APD	  abbreviation.	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxxxii	   ERev,Ca,	   the	   reversal	   potential	   of	   Ca2+	   in	   physiological	   experiments	   is	  measured	   to	   be	   ~50-­‐60mV,	   in	   contrast	   to	   its	  
thermodynamical	  equilibrium	  potential	  (ECa),	  which	   is	  ~120-­‐125mV.	  Substantial	  amount	  of	  Ca2+	   flows	  across	  the	  L-­‐type	  
channels	  between	  ERev,Ca	  and	  ECa.	  But	  in	  a	  real	  cell	  at	  ERev,Ca	  the	  inward	  ICa,L	  is	  counterbalanced	  by	  the	  outward	  K-­‐current	  
(Ito,1),	  so	  the	  electrophysiologically	  important	  ICa,L	  becomes	  negligible	  at	  the	  peak,	  despite	  some	  influx	  of	  Ca2+	  (Reference:	  J	  
Physiol	  (2000)	  523:57-­‐66).	  
lxxxiii	  Refer	  to	  Introduction	  section	  1.1.4	  on	  Ca2+	  inactivation.	  	  
lxxxiv	  Since	  the	  predominant	  factor	  in	  Ca2+	  inactivation	  is	  metabolic,	  this	  process	  is	  considered	  relatively	  slow	  compared	  to	  
inactivation	  of	  other	  currents	  which	  are	  completely	  voltage	  or	  time	  dependent	  (like	  INa	  and	  Ito,1).	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Henceforth	  we	  hypothesize	  that	  by	  lowering	  INa,f	  with	  Flecainide	  and	  continuously	  reducing	  its	  rate	  
of	  increase	  as	  the	  treatment	  progresses,	  Ito,1	  activation	  and	  inactivation	  processes	  are	  also	  altered.	  A	  
plateau	   phase	   is	   sustainable	  whenever	   repolarizing	   currents	   (K+	   currents)	   are	   not	   fully	   activated	  
and	   depolarizing	   currents	   still	   didn’t	   inactivate	   (ICa,L).	   Following	   the	   upstroke	   phase,	   if	   Ito,1	   peaks	  
early	  enough,	  it	  will	  lower	  the	  membrane	  voltage	  and	  allow	  for	  the	  increase	  in	  Ca2+	  driving	  force.	  Ito,1	  
inactivates	  very	  quickly,	  allowing	  ICa,L	  to	  peak	  at	  a	  later	  stage	  as	  Ca2+	  rush	  into	  the	  cell,	  which	  would	  
ultimately	  keep	  the	  plateau	  phase	  at	  higher	  voltages.	  As	  Flecainide	  also	  affects	  IKr,	  the	  current	  would	  
be	   further	  weakened	   to	  counteract	  Ca2+	   influx	  and	   the	  plateau	   is	  substantially	   increased.	   If	  on	   the	  
other	  hand,	  Ito,1	  activation	  is	  delayed	  enough	  to	  peak	  at	  a	  later	  stage,	  phase	  1	  is	  prolonged	  and	  Ca2+	  
influx	  could	  face	  a	  fierce	  competing	  opposing	  current	  as	  it’s	  trying	  to	  reach	  its	  maximum.	  This	  would	  
obliterate	  the	  plateau	  and	  bring	  the	  cell	  into	  resting	  potential,	  abbreviating	  the	  APD.	  	  
	  
This	  hypothesis	  on	  competing	  currents	  following	  the	  upstroke	  has	  to	  await	  further	  experiments	  and	  
numerical	  simulations	  to	  be	  approved	  as	  valid	  or	  disapproved.	  One	  way	  to	  elucidate	  the	  role	  of	  Ito,1	  
would	  be	  to	  disable	  it	  by	  introducing	  4-­‐aminopyridine	  (4-­‐Ap)	  into	  the	  protocol,	  which	  could	  provide	  
important	   and	   specific	   insights	   on	   the	   role	   played	   by	   Ito,1	   in	   creating	   this	   bistability	   in	   the	  
epicardium.	   We	   expect	   that	   the	   presence	   of	   this	   antagonist	   molecule	   may	   potentially	   alter	   the	  
responsiveness	   of	   the	   epicardium	   to	   Flecainidelxxxv	   or	   even	   prevent	   bistability	   from	   occurring	  
altogether.	   Alternatively,	   hypercalcemia	  may	   favor	   one	   stable	   state	   over	   another,	   however	   it	   can	  
alter	  other	  Ca2+	  dependent	  mechanisms	   in	   the	   cell,	  which	   could	   render	   the	   final	   results	  harder	   to	  
interpret.	  Therefore,	  the	  detailed	  explanations	  given	  in	  this	  section	  should	  only	  be	  regarded	  as	  one	  
potential	  mechanism	  explaining	  the	  emergence	  of	  bistability	  in	  the	  murine	  heart.	  
	  
Although	  our	  study	  was	  limited	  to	  steady	  state	  pacing	  at	  a	  fixed	  BCL	  (100ms),	  we	  hypothesize	  that	  a	  
premature	  excitation	  occurring	  in	  the	  epicardium	  would	  give	  rise	  to	  drug-­‐induced	  arrhythmias	  that	  
are	   characterized	  by	   a	   reentrant	  mechanism.	  The	  mechanism	  by	  which	   reentry	   is	   initiated	  would	  
depend	   on	   the	   specific	   location	   of	   the	   ectopic	   beat	   with	   respect	   to	   the	   different	   zone	   of	   AP	  
morphology.	   APD	   prolongation	   goes	   hand	   in	   hand	   with	   repolarization	   abnormalities,	   hence	   is	  
capable	  of	  influencing	  conduction	  of	  the	  propagating	  impulse.	  Fibers	  with	  prolonged	  APD	  will	  elicit	  
a	  slowing	  of	  conduction	  with	  increased	  entrainment	  rate,	  so	  that	  each	  consecutive	  AP	  arises	  prior	  to	  
the	   completion	   of	   repolarization	   of	   the	   preceding	   beat.	   The	   frequency	   at	  which	   conduction	   block	  
might	  ensue	  will	  be	  relatively	  lower	  in	  the	  case	  of	  the	  prolonged	  APD,	  than	  the	  one	  associated	  with	  a	  
normal	   APD318.	   If	   the	   ectopic	   beat	   arises	   in	   the	   area	   governed	   by	   shorter	   APDs	   (APDShort),	   the	  
electrical	  wave	  would	  spread	  across	  the	  tissue,	  until	  it	  hits	  the	  borders	  separating	  the	  two	  adjacent	  
zones.	   Crossing	   to	   the	   prolonged	  APD	   zone	   (APDProlong)	  will	   depend	  on	   the	   excitatory	   state	   of	   the	  
cells	   in	   that	   region:	   if	   theses	   cells	  had	   sufficient	   time	   to	   recover	   from	   the	  previous	  excitation,	   the	  
wave	  will	   propagate.	   Otherwise,	   conduction	   block	   will	   occur.	   In	   this	   setting,	   either	   the	   electrical	  
wave	  dies	  out	  or	  persists	  somewhere	  else	  until	  the	  cells	  in	  the	  APDProlong	  zone	  regain	  excitability.	  In	  
this	   case,	   circus	  movements	   are	   highly	   probable	   and	   reentry	   occurs.	   If	   however	   the	   ectopic	   beat	  
would	  arise	  in	  APDProlong	  zone,	  the	  activation	  would	  spread	  directly	  in	  the	  APDShort	  zone,	  exciting	  the	  
cells	   in	   that	   region.	   Interestingly,	   for	   reexcitation	   to	  occur,	   sustenance	  of	  propagation	  would	   then	  
depend	  on	  the	  electrotonic	  interactions	  between	  the	  cells	  on	  either	  side	  of	  the	  borders.	  It	  has	  been	  
suggested	  that	  in	  tissues	  where	  depolarization	  is	  normally	  Na-­‐mediated,	  the	  contribution	  of	  Ca2+	  in	  
maintaining	  AP	  propagation	  increases	  significantly	  in	  the	  context	  of	  severely	  depressed	  membrane	  
excitability	   (i.e.	   <20%	   INa	   availability)585.	   In	   the	   case	   of	   Flecainide	   induced	  heterogeneity,	   it	   is	   the	  
prominent	   plateau	   at	   some	   sites	   (APDProlong)	   but	   not	   others	   (APDShort)	   that	   could	   generate	   local	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
lxxxv	  The	  effects	  due	  to	  antagonizing	  Ito,1	  using	  4-­‐AP	  were	  described	  by	  Krishnan	  and	  Antzelevitch	  in	  epicardial	  layers	  in	  the	  
presence	  of	  Flecainide.	   Ito,1	  blocking	  was	   reported	   to	  prevent	  AP	  abbreviation	   in	  epicardial	   cells	   (Reference:	  Circulation	  
(1993)	  87:562-­‐72).	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circuit	  currents411,	  by	  acting	  as	  a	  reservoir	  of	  depolarizing	  charges	  (Ca2+),	  which	  would	  increase	  the	  
electrotonic	  driving	  force	  in	  the	  abbreviated	  AP	  cells,	  consequently,	  the	  depolarizing	  current	  to	  the	  
downstream	  tissue585,	  bringing	  membrane	  voltage	  to	  threshold	  and	  initiating	  depolarization.	  Kléber	  
and	  Rudy	  described	  this	  membrane-­‐switch	  from	  Na+	  to	  Ca2+	  -­‐supported	  propagation	  as	  an	  excellent	  
example	   of	   the	   “intimate	   interaction”	   between	   passive	   network	   properties	   and	   the	   excitatory	  
membrane	   currents	  during	   conduction	   in	   the	   cardiac	   tissue254.	  Whether	   this	   switch	   in	  membrane	  
conduction	  is	  sufficiently	  strong	  to	  maintain	  a	  self-­‐perpetuating	  reentrant	  mechanism	  in	  the	  heart	  in	  
the	  context	  of	  bistability	  is	  yet	  to	  be	  investigated.	  	  
4.3.4. Inflation of Intrinsic Heterogeneity in LQTS3 with Flecainide 
As	   NaV1.5	   kinetics	   are	   altered	   in	   the	   context	   of	   the	   ΔKPQ	   mutation,	   exposing	   a	   cardiac	   tissue	  
harboring	  this	  mutation	  to	  Flecainide	  had	  two	  primordial	  aims:	  First,	  studying	  the	  effect	  of	  the	  drug	  
on	   intrinsic	   spatial	   heterogeneity	   in	   the	   context	   of	   a	   well-­‐established	   arrhythmogenic	   substrate.	  
Second,	  characterizing	  whether	  the	  symmetry	  breaking	  is	  reproducible	  in	  a	  substrate	  with	  a	  gain	  of	  
function-­‐channel.	  Our	  data	  clearly	  demonstrate	  that	  a	  typically	  anisotropic	  propagation	  in	  the	  tissue	  
(Figure	  36b)	  at	  control	  conditions	  (t0)	  deteriorated	  in	  5min	  (half	  the	  protocol	  time	  used	  for	  the	  mdx	  
and	   its	  WT	   counterpart	   in	   section	   4.3.1)	   into	   an	   atypical	   propagating	   pattern	   that	   deviates	   from	  
anisotropy,	   associated	  with	   areas	   of	   fast	   and	   slow	   conductions	   (Figure	   36c).	   Despite	   a	   severe	   CV	  
decrease	   (>50%	  along	  Vmin,	   ΔKPQ)	  on	   the	   apico-­‐basal	   axis,	   conduction	  block	  wasn’t	   observed	   in	   the	  
ΔKPQ	  hearts	  under	  steady	  state	  pacing	  entrainment	  conditions	  in	  any	  direction.	  	  
	  
From	   the	   initial	   comparison	   of	   AP	   morphologies	   (in	   the	   absence	   of	   Flecainide),	   where	   APΔKPQ	   is	  
comprehensively	  prolonged	  compared	  to	  APWT	  at	  all	  stages	  of	  repolarization	  (Figure	  36a),	  it	  became	  
evidently	  expected	   that	  all	  APDs	   (APD25,	  APD50	  and	  APD75)	   show	  a	   significant	  prolongation	   in	   the	  
ΔKPQ	  tissue	  compared	  to	  its	  WT	  counterpart	  (Figure	  42).	  Unlike	  the	  global	   increase	  in	  APD	  in	  the	  
ΔKPQ	  heart,	  dispersion	  of	   repolarization	   is	  particularly	   significant	   for	  higher	   repolarization	   levels	  
compared	   to	   the	  WT	   (i.e.	   only	   for	   ΔAPD25,	   Figure	   41).	   In	   the	   presence	   of	   Flecainide,	   APD	   values	  
increased	  in	  both	  WT	  and	  ΔKPQ	  degrading	  the	  statistical	  significance	  of	  the	  control	  findings	  (Figure	  
42).	   Furthermore,	   both	  WT	   and	   ΔKPQ	   responded	   to	   Flecainide	   by	   an	   increase	   in	   SDR	  within	   the	  
ventricular	  epicardium	  for	  both	  APD25	  and	  APD50	  (Figure	  41).	  The	  particular	  accentuation	  of	  ΔAPD25	  
with	  Flecainide	  in	  the	  ΔKPQ	  heart	  provides	  solid	  evidence	  that	  the	  abnormal	  increase	  in	  SDR,	  due	  to	  
the	  mutation,	  is	  not	  corrected	  by	  Flecainide.	  In	  reality,	  our	  data	  show	  that	  in	  addition	  to	  the	  atypical	  
complex	  spatial-­‐temporal	  patterns	  of	  activation	  in	  the	  ΔKPQ	  substrate	  (Figure	  36),	  repolarization	  is	  
exceedingly	   destabilized	   in	   the	   presence	   of	   Flecainide.	   Consistent	   with	   our	   previous	   argument	  
(section	  4.3.2),	  the	  cumulative	  effect	  of	  the	  increases	  in	  APD25	  and	  ΔAPD25	  from	  their	  initial	  control	  
values	  favored	  symmetry	  breaking	  in	  the	  ΔKPQ	  heart	  and	  not	  the	  WT,	  even	  though	  the	  increase	  in	  
ΔAPD25	  was	  significantly	  more	  considerable	  in	  the	  WT,	  compared	  to	  the	  one	  in	  ΔKPQ	  (Figure	  41).	  
	  
These	   data	   show	   that	   Flecainide	   could	   be	   dangerous	   in	   LQTS3	   patients,	   particularly	   the	   one	  
harboring	  the	  ΔKPQ	  mutation.	  The	  ever-­‐increasing	  complexity	  of	  the	  interactions	  between	  mutated	  
channels	  and	  non-­‐ideal	  antiarrhythmic	  drugs	  muddles	   the	  ability	   to	  predict	   the	  benefits,	   if	  any,	  of	  
managing	   LQTS3	   patients	   with	   Flecainide.	   Clinical	   reports	   on	   this	   level	   remain	   conflicting.	   Some	  
studies	  have	  shown	  that	  Flecainide	  has	  potentially	  therapeutic	  effects,	  since	  it	  was	  associated	  with	  
the	  normalization	  of	   the	  QTc-­‐interval	  on	  ECG567,	   569.	  Although	   the	  pathognomonic	   sign	  of	  LQTS3	   is	  
having	   a	   prolonged	   QTc	   interval,	   some	   studies	   revealed	   that	   the	   transmural	   dispersion	   of	  
repolarization	   is	   more	   indicative	   of	   the	   proarrhythmic	   propensity	   for	   developing	   of	   lethal	  
ventricular	  arrhythmias,	  which	  is	  better	  represented	  by	  Tpeak-­‐Tend	  (time	  interval	  between	  the	  peak	  of	  
the	  T	  wave	  and	  its	  end	  on	  ECG)	  than	  a	  prolonged	  QTc651.	  As	  a	  consequence,	  Tpeak-­‐Tend	  (time	  interval	  
between	   the	   peak	   of	   the	   T	   wave	   and	   its	   end	   on	   ECG)	   was	   suggested	   to	   be	   a	   more	   sensitive	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biomarker	  than	  the	  QTc-­‐interval	  in	  assessing	  arrhythmia	  risk	  in	  a	  LQTS	  patient651,	  although	  a	  direct	  
validation	   of	   Tpeak-­‐Tend	   interval	   measured	   on	   body	   surface	   ECG	   is	   still	   lacking264.	   The	   inability	   to	  
extrapolate	  experimental	  findings	  to	  clinical	  settings	  renders	  the	  interpretation	  of	  the	  experimental	  
data	  even	  more	  complicated.	  
4.3.5. Concluding Remarks 
The	  work	  presented	  in	  this	  thesis	  has	  provided	  an	  interesting	  continuum	  for	  exploring	  the	  scaling	  of	  
molecular	   perturbations	   to	  macroscopic	   behaviors,	   linking	   therefore	  molecular	   events	   that	   share	  
one	  common	  denominator	   the	  cardiac	  Na-­‐channel,	  or	  NaV1.5,	   to	  patterns	  of	   activation	  conduction	  
and	   dispersion	   of	   repolarization,	   in	   a	   mesh	   of	   well-­‐coupled	   tissues.	   By	   characterizing	   a	   set	   of	  
biophysical	   parameters	   and	   elucidating	   fundamental	   connections	   between	   them,	   we	   provided	   a	  
generic	   approach	   to	   understand	   modulations	   of	   NaV1.5	   by	   studying	   their	   macroscopic	  
consequences;	  therefore	  integrating	  our	  knowledge	  of	  the	  system	  and	  the	  data	  acquired	  at	  the	  level	  
of	   the	   whole	   organ	   in	   the	   comprehension	   of	   the	   channel’s	   behavior	   in	   both	   pathological	   and	  
pharmacological	  conditions.	  	  
	  
This	  multidisciplinary	  approach	  in	  integrative	  cardiology	  allows	  us	  to	  study	  how	  genetic	  mutations	  
and	   pharmacological	   interventions	   can	   possibly	   lead	   to	   destabilizations	   of	   the	   normal	   electrical	  
propagation	   in	   the	   cardiac	   tissue.	  For	   this	  purpose,	  we	  used	   two	  mouse	  models	  harboring	  NaV1.5	  
abnormalities	   and	   we	   further	   modulated	   the	   function	   of	   this	   channel	   by	   means	   of	   Flecainide,	   a	  
currently	  in-­‐use	  AAD.	  We	  relied	  in	  our	  methodology	  on	  a	  high	  spatial-­‐temporal	  tool	  that	  offers	  the	  
luxury	   and	   precision	   of	   studying	   complex	   extended	   spatial-­‐temporal	   dynamics	   occurring	   in	   a	  
healthy,	   as	   well	   as	   diseased,	   heart.	  We	   implemented	   and	   validated	   different	   analytical	   strategies	  
(some	  of	  them	  already	  published	  and	  used	  in	  optical	  mapping	  of	  murine	  hearts)	  to	  evaluate	  CV	  in	  
the	  excitable	  tissue	  and	  to	  further	  characterize	  instabilities	  in	  conduction	  in	  several	  models	  where	  
NaV1.5	  function	  is	  perturbed.	  
	  
We	   consistently	   observed	   bistability	   and	   symmetry	   breaking	   effects	   in	   models	   with	   normal	   and	  
increased	  channel	  availability.	  These	  manifestations	  were	  completely	  absent	  in	  the	  model	  where	  the	  
few	   NaV1.5	   channels	   were	  missing	   from	   the	   LM.	   Such	   a	   symmetry	   breaking	   effect	   is	   likely	   to	   be	  
arrhythmogenic,	   especially	   in	   the	   presence	   of	   steep	   repolarization	   gradients.	  We	   attributed	   these	  
pattern	   formations	   with	   Flecainide	   as	   proarrhythmic	   side	   effects,	   with	   potentially	   strong	   clinical	  
implications:	   clinically	   valid	   concentrations	   of	   the	   drug	   were	   sufficient	   to	   induce	   steep	  
repolarization	   gradients	   in	   the	   epicardium	   of	   small	   hearts.	   Henceforth,	   the	   same	   drug	   could	   be	  
expected	   to	   facilitate	   larger	  spatial-­‐temporal	  dispersions	   in	   larger	  hearts,	   including	  human	  hearts,	  
where	   more	   structural	   heterogeneity	   prevails	   over	   relatively	   wider	   extents.	   These	   functional	  
heterogeneities	  could	  be	  several	  orders	  of	  magnitude	  larger,	  therefore	  more	  dangerous	  and	  lethal.	  
The	  outcomes	  of	  CAST	  I	  were	  only	  the	  tip	  of	  the	  iceberg	  and	  the	  deeper	  scientists	  dive	  to	  uncover	  
the	  reasons	  why	  Flecainide	  increased	  mortality	  in	  the	  treated	  group,	  the	  more	  complex	  and	  intricate	  
the	  journey	  becomes	  to	  understand	  how	  the	  heart	  actually	  works.	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 Chapter 5 
Conclusion 
Over	   the	   last	   century,	   our	   understanding	   of	   how	   the	   heart	   functions	   has	  made	   tremendous	   leaps	  
forward,	  with	  a	  pivotal	  aim	  of	  translating	  this	  information	  into	  improved	  therapies.	  Drugs	  have	  been	  
developed	   and	   tested	   rigorously	   and	   redundantly	   in	   isolated	   cardiac	   cells	   and	   showed	   to	   exhibit	  
strong	  antiarrhythmic	  effects.	   Scientists	   thought	   they	  had	   these	  molecules	   figured	  out,	  until	  CAST	  
and	  other	  large-­‐scale	  clinical	  trials	  demonstrated	  that	  the	  knowledge	  researchers	  have	  accumulated	  
over	   the	   last	   two	   decades	   before	   CAST	   has	   simply	   failed	   to	   counteract	   death	   in	   patients	   with	  
myocardial	  infarction.	  
	  
The	   reality	   of	   how	   far	   scientists	   were	   far	   off	   at	   the	   time	   from	   preventing	   sudden	   death	   was	  
outrageous	  and	  indisputable.	  These	  promising	  molecules	  were	  not	  only	  inferior	  to	  placebo	  but	  also	  
worse;	   they	   actually	   increased	   mortality	   in	   the	   treated	   group.	   Since	   CAST,	   basic	   medical	  
investigators	   and	   clinicians	   started	   asking	   a	   new	   question:	   “Where	   did	   we	   go	   wrong?”	   It	   took	  
scientists	   a	   while	   to	   realize	   that	   studying	   the	   basic	   functional	   unit	   was	   insufficient	   to	   fully	  
characterize	  the	  effects	  observed	  in	  the	  entire	  cardiac	  tissue.	  Single	  channel	  events	  in	  a	  cell	  simply	  
provide	   an	   incomplete	  picture	  of	   the	   events	   that	   could	   take	  place	   at	   the	   level	   of	   the	  whole	  heart.	  
Scientists	   had	   had	   missed	   the	   fact	   that	   the	   relationship	   between	   cellular	   excitability	   and	  
multicellular	  conduction	  is	  inherently	  non-­‐linear,	  making	  electrophysiological	  cardiac	  events	  much	  
harder	  to	  predict.	  We	  have	  learned	  in	  the	  past	  decades	  that	  the	  heart	  is	  intrinsically	  heterogeneous	  
and	   complex	   in	   its	   design,	  mechanics	   and	   electrical	   properties	   and	  we	   have	   discovered	   that	   this	  
intriguing	   complexity	   has	   become	   by	   itself	   a	   sufficient	   drive	   for	   continuous	   research	   in	   cardiac	  
electrophysiology.	  We	  have	  gone	  a	  long	  way	  since	  CAST,	  but	  we	  are	  still	  very	  far	  from	  the	  finish	  line.	  
We	   have	   always	   known	   that	   the	   human	   life	   is	   just	   too	   precious	   to	   be	   jeopardized	   in	   one	   single	  
erratic	  beat.	  	  
	  
In	  1628,	  Sir	  William	  Harvey	  was	  tempted	  to	  think	  that	  only	  God	  knows	  how	  the	  heart	  truly	  works.	  I,	  
in	  2014,	  am	  tempted	  to	  believe	  that	  God	  never	   intended	  to	  keep	  this	  knowledge	  to	  Himself,	   that’s	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